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ABSTRACT OF THE DISSERTATION
Characterizing the Fitness Landscapes of Gut Symbionts 
in Defined Community and Diet Contexts
by 
Meng Wu
Doctor of Philosophy in Biology and Biomedical Sciences 
Human and Statistical Genetics
Washington University in St. Louis, 2014
Professor Jeffrey I. Gordon, Chair
A species’ niche is the description of all the environmental conditions required to permit a popu-
lation of that species to persist, including the effects of the population on those conditions. This 
definition includes the species’ resource requirements, as well as stress tolerances and interac-
tions with other species acting as competitors, predators, parasites, and mutualists. The human 
gut microbiota serves as a microbial ‘metabolic organ’ tasked in part with the biotransformation 
of many components of our diet. Relatively little is known about the factors that allow members 
of the human gut microbiota to persist in a habitat that experiences marked changes in its nutrient 
environment. Identification of these factors is important for understanding the mechanisms that 
determine community assembly, community responses to and recovery after various perturba-
tions, and the food webs that link microbes to one another and to their host. Therefore, in my the-
sis, I developed an experimental and computational pipeline for multi-taxon insertion sequencing 
(multi-taxon INSeq) to identify fitness determinants in multiple species and strains of human gut 
Bacteroides. Libraries of tens of thousands of transposon (Tn) mutants for each of four human gut 
Bacteroides strains, two of which represented the same species, were generated. These libraries 
were then introduced into adult germ-free mice as part of a 15-member artificial defined human 
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gut microbiota containing 11 other wild-type bacterial species. Mice were fed diets either low in 
fat and high in plant polysaccharides (LF/HPP), or high in fat and simple sugars (HF/HS). Fe-
cal samples, collected over time, were subjected to multi-taxon INSeq and my analysis pipeline, 
which was based on maximum likelihood estimation. A total of 86 core fitness determinants were 
identified across all four strains; a large fraction of these determinants were involved in various 
aspects of amino acid biosynthesis. Significant intra-species differences were detected in response 
to diet between two strains of Bacteroides thetaiotaomicron, highlighting differential strategies 
facilitating their co-existence within a complex community. By combining information gleaned 
from in vivo and in vitro INSeq experiments, as well as from in vivo and in vitro microbial RNA-
Seq, I determined that arabinoxylan, the most common hemicellulose in cereals, was able to drive 
expression of a polysaccharide utilization locus that represented a key fitness factor in Bacteroides 
cellulosilyticus WH2 when mice consumed HF/HS diet. Supplementation of the drinking water 
with this glycan in turn significantly increased the representation of B. cellulosilyticus WH2 within 
the defined community in the context of the high fat diet. Multi-taxon INSeq defined the changes in 
fitness determinants of this and the other Bacteroides in response to arabinoxylan supplementation. 
Collectively, these studies revealed multiple mechanisms by which our microbial symbionts es-
tablish themselves in the gut, including species-specific, strain-specific, as well as core responses, 
which mapped to a variety of metabolic/nutrient processing pathways. The approach described for 
mapping fitness landscapes in a community context should facilitate discovery efforts aimed at 
identifying the niches of microbiota members, as well as ways to deliberately reshape community 
structure and function through dietary interventions.
1Chapter 1
Introduction
2The human gut microbiota 
The human gut is colonized by tens of trillions of microbes, collectively known as the microbiota. 
The majority of organisms that form this community reside in the distal gut where microbial den-
sity reaches 1011-1012 cells per milliliter contents [1]. The microbiota contains members of all three 
domains of life, in addition to viruses [2-4]. The gut microbiota begins to assemble at birth and 
achieves an adult-like configuration by 24-36 months of age [5, 6]. In healthy adults, the microbiota 
is dominated by members of two bacterial phyla, the Bacteroidetes and Firmicutes [7-9]. The collec-
tive genomes and constituent genes represented in this community are called the gut microbiome. 
The microbiota plays important roles in human biology, including defense against invasion by en-
teropathogens, immune homeostasis, and a variety of metabolic activities, including those related 
to the biotransformation of components of our varied diets. 
The microbiota protects the host from enteropathogens, a process referred to as “coloniza-
tion resistance”. Studies using germ-free animals showed that they are more susceptible to infec-
tion by certain bacteria (i.e., Shigella flexneri; Salmonella spp., Streptococcus mutans) compared 
to conventionally raised animals, colonized with a microbiota from birth [10-13], or gnotobiotic 
animals colonized with specific commensal bacteria [12, 14, 15]. Observations in human patients 
and animal studies showed that disruption of the structure of the microbiota by antibiotics also 
dramatically increases the susceptibility towards enteric infections (i. e. Clostridium difficile, Sal-
monella spp.) [16-18]. 
Colonization by the microbiota begins at birth and shapes both the phenotype of the mu-
cosal and systemic immune systems. Work from germ-free animals has shown that the mucosal 
immune system is undeveloped in the absence of gut microbes [19, 20], with numerous facets 
of the immune system affected. Defects have been observed in the cellularity and organization 
of the spleen and secondary lymphoid organs such as the mesenteric lymph nodes and Peyer’s 
Patches [21], the abundance of intestinal regulatory T cells and Th17 cells [22, 23], intestinal 
IgA titers, cytotoxicity of intestinal epithelial lymphocytes, anti-microbial production etc [24]. 
3Transcriptional profiling revealed myriad differences in gene expression in intestinal epithelial 
cells between germ-free mice and mice colonized with just a single prominent member of the gut 
microbiota, Bacteroides thetaiotaomicron. Bacteroides fragilis directs maturation of the immune 
system, including the expansion and differentiation of splenic CD4+ T cells [25] and promoting the 
generation of tolerogenic peripheral Treg responses in the colon [26]. Intestinal CD4+ helper T cell 
differentiation can also be shaped by specific members of the microbiota, with segmented filamen-
tous bacteria promoting Th17 cell responses in the small intestine [22, 27, 28], and members of the 
Clostridia and Bacteroides driving Treg induction in the small intestine [23, 26, 29–32].
Accumulating evidence indicates that the gut microbiota is instrumental in the control of 
host energy metabolism. In this role, the gut microbiota could be viewed as a microbial “metabolic 
organ”. Gut microbes possess a broad array of carbohydrate active enzymes (CAZymes) that are 
not represented in our human genomes, allowing them to ferment a broad array of dietary poly-
saccharides that could otherwise not be digested. The products of microbial fermentation include 
short-chain fatty acids (e.g., acetate, propinonate and butyrate) that serve as energy sources for 
host cells (e.g., colonocytes), as well as other products, including lactate, succinate and formate.
The energy provided to the host by gut microbes is quite substantial in herbivores, ranging 
from 30-85% of metabolizable energy in rabbits [33], horses [34], and sheep [35]. In omnivores, 
such as the pig, microbe-derived nutrients are responsible for 10% of the animals’ maintenance 
energy requirement [36]. It is estimated that up to 10% of daily energy needs in humans is supplied 
from the fermentation activities carried out by the gut microbiota; the contribution is greater in 
individuals living in non-Westernized countries where there is less consumption of processed food 
and more complex dietary fibers [37, 38]. 
Studies by our lab and others have shown that the composition of gut microbiota could 
affect host energy homeostasis. Backhed et al found that the germ-free (GF) mice had about 40% 
less total body fat than age-matched conventional-raised (CONV-R) mice, even though GF mice 
consumed 29% more food. Additionally, colonization was correlated with increased hepatic lipo-
4genesis through the stimulation of ChREBP (Carbohydrate Responsive Element Binding Protein) 
and SREBP-1 (Sterol Responsive element Binding Protein) hepatic expression and enhanced glu-
cose uptake in the intestine [39, 40]. Ley et al demonstrated that obesity can be associated with an 
altered gut microbiota in a genetic model of obesity (ob/ob mice had a reduction in the abundance 
of Bacteroidetes and a proportional increase in the abundance of Firmicutes) in a rodent model 
[41], and a similar phenotype has also been observed in humans [42]. To determine if the relative 
differences of bacterial proportions leads to different body phenotypes, Turnbaugh et al transplant-
ed cecal microbiota from lean and ob/ob mice to GF wild-type recipients, and they found that mice 
harbouring the microbiota from obese mice had a fat gain, and extracted more calories from their 
food compared to the mice that received the gut microbiota from lean mouse donors [43]. More 
recent metagenome-wide association studies from different populations (Chinese, European) also 
showed changes in the composition of microbiota associated with other metabolic dysfunctions 
(e.g., type 2 diabetes) [44, 45]. 
These findings underscore the enormous utility in better understanding how the structure 
and functions of the microbiota are shaped and further, how they in turn modulate host physiology. 
Bacteroides as model human gut symbionts
Bacteroides spp. are Gram-negative, obligate anaerobic bacteria that have been used as model or-
ganisms for investigating the mechanisms governing acquisition and processing of dietary polysac-
charides. There are several reasons why members of the genus Bacteroides have become favored 
models: e.g., they are the primary fermenters in the intestine; they are prominently represented in 
the gut; they are aerotolerant and readily cultured outside their native habitat, and owing to the 
work of Abigail Salyers and her colleagues, tools have been available for their genetic manipula-
tion for quite some time facilitating molecular dissection of their impacts on host biology. 
A series of studies from members of the laboratory of Abigail Salyers, and other groups, 
demonstrated the impressive capacity of Bacteroides spp. to degrade a variety of complex polysac-
5charides. Glycan breakdown is mediated by clusters of co-regulated genes known as polysaccha-
ride utilization loci (PULs). Bacteroides thetaiotaomicon VPI-5482 was the first prominent human 
gut Bacteroides to have its genome sequenced: it contains 88 PULs comprising 866 genes that 
together comprised 18% of its genome [46, 47]. Subsequent work disclosed that a large investment 
of genome content in PULs is a common feature of gut Bacteroides. 
The first PUL described and characterized was the starch utilization system (Sus) in the 
prominent human gut symbiont, Bacteroides thetaiotaomicron [48-50]. The Sus locus contains 
eight adjacent genes (SusRABCDEFG). The signature feature of a PUL is a pair of outer mem-
brane proteins related to SusC and SusD, both of which are required for utilization of starch by 
Bacteroides thetaiotaomicron VPI-5482. SusD paralogs are predicted to be secreted lipoproteins 
peripherally associated with the outer membrane, where they play a role in polysaccharide bind-
ing. SusC paralogs are predicted to be TonB-dependent, β-barrel-type outer membrane proteins, 
and are likely needed for energy-dependent transport of glycans into the periplasmic space. Other 
features contained within PULs include ORFs encoding outer membrane and periplasmic polysac-
charide lyases (PLs), glycoside hydrolases (GHs) and carbohydrate esterases (CEs). PULs also 
contain an upstream ORF specifying a sensor/regulator, typically hybrid two component systems 
or extra-cytoplasmic function sigma (ECF-σ) and genomically linked anti- σ factors. 
Experiments testing the ability of 188 strains of 10 different human colon-derived Bac-
teroides species to ferment different plant polysaccharide and mucin sources discovered both 
species and strain-specific differences in carbohydrate utilization [51]. A recent study examined 
two closely related species, B. thetaiotaomicron and B. ovatus, represented in this original study. 
Whole genome transcriptional profiling of these isolates, in conjunction with the characterization 
of the growth phenotypes of derived mutants lacking PULs in minimal medium supplemented 
with different glycans as the sole carbon source, revealed the identify and specificity of the PULs 
that target plant polysaccharides represented in our diets, including hemicelluloses, pectins, and 
fructans [52]. Each species possesses several unique PULs: B. ovatus harbors PULs that enable it 
to use all of the common hemicelluloses, including xylan, arabinoxylan, and b-glucan, while B. 
6thetaiotaomciron does not have any. In contrast, B. thetaiotaomicron has several PULs that allow 
utilization of host glycans, while B. ovatus does not. 
Another direct demonstration of how PULs help Bacteroides to compete efficiently for the 
complex glycans in their habitat and occupy distinct niches (professions) involved an analysis of 
B. thetaiotaomicron VPI-5482 [53]. The authors found that a single extracellular b2-6 endo-fruc-
tanase that was encoded in a single PUL was required for B. thetaiotaomicron to utilize levan (a 
b2-6-linked fructan) but not inulin (a b2-1 fructan). Homology searches using the fructose-binding 
domain in the hybrid two component system associated with this B. thetaiotaomicron PUL com-
bined with a comparative genomic analysis of synteny revealed other fructan utilization PULs in 
B. caccae, B. ovatus, B. fragilis, and B. uniformis. However, only the B. thetaiotaomicron genome 
contained a b2-6 endo-fructanase, while B. caccae and B. ovatus contained genes encoding en-
zymes that target b2-1 fructans. In followup experiments involving gnotobiotic mice co-colonized 
with B. thetaiotaomicron and B. caccae and fed a diet with inulin as the sole polysaccharide, B. 
caccae displayed a competitive advantage over B. thetaiotaomicron. 
Other studies in gnotobiotic mice colonized with wild type B. thetaiotaomicron and a mu-
tant with deletion of five ECF- σ transcriptional factors that activate mucin glycan utilization genes 
have shown that loss of the latter capacity impairs persistence in the gut and imperils mother-to-
offspring transmission [47]. 
Unlike carbon acquisition, which has been intensively studied, the preferred nitrogen 
sources of Bacteroides species in the gut remain unclear. Bacteroides are capable of fixing NH3, 
primarily via glutamate dehydrogenase [54]. The inability of many Bacteroides species to sub-
stitute free amino acids, peptides, nitrate, or urea for ammonia as a nitrogen source [55] suggests 
that NH3 may be the most common source of nitrogen for Bacteroides in the intestine, though this 
remains speculative and may not apply for all species in this genus.
7Factors that contribute to selection of bacteria for colonization of a host (gut) habitat
Realized versus fundamental niches 
There have been a number of studies of both invertebrate and vertebrates that have focused on how 
microbial communities are assembled in their host habitats. For example, the light organ of the 
Hawaiian squid Euprymna scoplopes is mono-colonized with Vibrio fischeri. Work in the labora-
tory of Edward Ruby showed that a strain of V. fischeri recovered from Japanese pinecone fish (V. 
fischeri MJ11), could not colonize squid as efficiently as a squid-derived strain (V. fischeri ES114). 
Genome-wide comparisons revealed that rscS, which encoded a membrane-bound two-component 
sensor kinase that upregulates production of the Syp exopolysaccharide important for biofilm for-
mation during initial colonization, is absent from V. fischeri MJ11. Provision of this gene in trans 
allowed the fish symbiont (V. fischeri MJ11) to colonize the light organ of E. scoplopes at levels 
that were comparable to that achieved by the squid’s native strain [56]. 
Macroecologists differentiate the conditions under which an organism actually does live 
(its realized niche) from the conditions under which an organism can live (its fundamental niche) 
[57]. Earlier work from our lab described the results of reciprocal gut microbiota transplants in-
volving communities harvested from conventionally-raised zebrafish and conventionally-raised 
mouse donors and germ-free zebrafish and mouse recipients. The results of these experiments 
revealed that bacterial taxa from zebrafish that had not been described in the normal mouse gut 
microbiota could persist in the mouse gut [58]. More recent work from our lab provided evidence 
that the mouse intestinal tract, while highly selective, is within the fundamental niches of bacte-
rial phylotypes that normally reside in a wide variety of foreign (non-mouse gut) environments. In 
this study adult germ-free C57Bl/J mice, fed a standard mouse chow high in plant polysaccharides 
and low in fats, were colonized with xenomicrobiota harvested from human, zebrafish, and termite 
guts, human skin and tongue, soil, and estuarine microbial mats. Bacteria taxa from these ‘alien’ 
environments colonized and persisted in the mouse gut and their capacity to metabolize dietary 
and host carbohydrates and bile acids correlated with colonization success [59]. CAZymes shared 
8across the gut-selected xenomicrobiomes included eight glycoside hydrolase families, the most 
prominent being GH13 (includes a-amylases and pullulanases that breakdown starch), and three 
carbohydrate esterase families. The prominence of GH13 is consistent with the large amount of 
starch in the mouse chow. The relative abundances of genes encoding glycoside hydrolases (GH) 
and polysaccharide lyases (PL) were also significantly correlated with microbial biomass (families 
GH97, GH28, and GH106 being most highly correlated). Together, these results indicate that the 
mouse intestinal tract, while highly selective, is within the fundamental niches of bacterial phylo-
types derived from a wide variety of environments.
The contributions of host genetic factors
Using 16S rRNA amplicon sequencing to quantify variation in the bacterial composition of fecal 
microbiota sampled from a number of recombinant inbred (RI) mouse lines, Benson and cowork-
ers identified 13 significant quantitative trait loci (QTL) (LOD≥3.9; P<0.05)) and five suggestive 
QTL (LOD≥3.5; P<0.1) that control variability in the relative abundance of specific taxa [60]. 
Some of these loci control individual bacterial species, some control groups of related taxa, and 
some have pleiotropic effects on groups of distantly related organisms. In humans, studies of 
monozygotic and dizygotic twins have provided evidence for host genetic effects on the represen-
tation of the gut microbiota’s dominant archaeon, the methanogen Methanobrevibacter smithii, 
other bacterial taxa associated with the hydrogen economy of the gut, as well as other functionally 
distinct bacterial taxa [61, 62].
Recent work using genome-wide association studies of a number of inbred strains of mice 
has examined responses to a diet high in fats and simple sugars but devoid of complex polysaccha-
rides (HF/HS chow) versus one low in fat and high in plant polysaccharides [63]. They observed 
robust diet-induced shifts in microbiota structure: HF/HS chow fed mice had greater relative abun-
dances of several genera belonging to the Firmicutes and lower abundances of genera in the Bacte-
roidetes compared to animals fed a diet rich in plant polysaccharides and low in fat, when all other 
environmental factors were controlled. Based on an analysis of over 100 inbred strains of mice, 
9they showed these shifts were robust to genetic background. This study demonstrated how diet 
represents a foundational shaper of the configuration of gut microbiota across a range of genetic 
backgrounds.
Combining computational and experimental tools to study interactions between members 
of the gut microbiota and host
Our increasing awareness of the role played by gut symbionts in health has highlighted the im-
portance of delineating the molecular mechanisms governing how microbial communities are 
first established, how they respond to perturbations and subsequently restore themselves to their 
pre-perturbed state (resiliency), and how members of these communities influence host biology. 
Knowing the genetic determinants important for colonization and persistence in the face of spe-
cific perturbations, could lead to development of strategies for targeted manipulation of the micro-
biota that promote wellness or treat diseases where a microbiota contribution is known. This thesis 
has used human gut Bacteroides as model organisms to address this issue.
Studies of gnotobiotic mice colonized with defined consortia of sequenced members of 
the microbiota and fed defined diets with systematically manipulated variations in ingredient con-
centrations have shown how the combination of simple linear models and feature selection can be 
used to identify dietary factors that specifically alter the relative abundance of individual members 
in the community [64]. However, at the time of this study, the appropriate tools facilitating genome 
wide scans of the genes that are responsible for defining the fitness (as defined by abundance) of 
these organisms in different diets (or microbial community contexts) were not available. It was the 
absence of these tools that inspired and directed the studies that I describe in this thesis.
Identifying the conserved core- and species pan-genome, inter- and intra-species genomic 
variations by comparative genomics
High throughput sequencing is now a standard component of the microbiological toolbox, with 
thousands of publicly available bacterial genome sequences for comparison. Bacterial genome 
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sequencing and comparative genomic analysis have become standard methods for identifying or-
thologs and paralogs. Identifying genes unique to a strain/species provides the foundation for 
testable hypotheses about how the organism has evolved features that increase its fitness in certain 
environmental contexts. 
In Chapter 3, the genomes of three different human gut-derived Bacteroides spp. and two 
strains representing one of these species are compared to search for orthologs shared among all 
four isolates as well as genes that are unique to a given isolate. The similarity of related genomes 
can be determined through whole genome alignment, or alignment of their predicted proteomes. 
Strain-level variation can be generated by several mechanisms: point mutations, gene rearrange-
ments (e.g., inversions or deletions), and/or acquisition of DNA from other organisms via hori-
zontal gene transfer (HGT). HGT is a common mechanism, occurring even between distantly 
species, through exchange of plasmids, phage, transposons, and insertion elements. Horizontally 
transferred DNA sequences can be identified as discrete segments (genomic islands or GEIs) [65]. 
Comparing the genomes of the two strains from B. thetaiotaomicron in Chapter 3 led to the iden-
tification of several such GEIs, including GEIs carrying PULs, suggesting a mechanism by which 
these two strains may have adapted to different glycan niches.
One illustration of the power of using comparative genomics is provided in Chapter 2, 
where we characterize the genomes of urine and fecal E. coli isolates, obtained from time series 
studies of four women with recurrent urinary tract infections, using novel SNP (single nucleotide 
polymorphism)-based and “OGU” (Operational Gene Unit)-based analyses. We found that E. coli 
strains from women with recurrent urinary tract infection can move between the gut and urinary 
tract without a fitness trade-off. In vivo competition studies in mouse models, using isolates taken 
from one of the patients with a wholesale population shift, revealed that strain that dominated her 
last UTI episode had increased fitness in both the gut and the bladder relative to the strain that 
dominated in preceding episodes. Increased fitness correlated with genes affecting nutrient utiliza-
tion and virulence identified by comparative genomics. 
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Despite their utility, comparative genomic approaches have several limitations. While next 
generation sequencing technologies have provided large datasets of short reads, assembly of these 
short reads into long contigs that can be used to generate a finished genome sequence remains 
quite challenging, especially for de novo assemblies where there are no reference genomes. This 
challenge can be overcome by hybrid assembly methods that combine short reads with long reads 
generated using the latest in next generation sequencing platforms (PacBio, Oxford Nanopore). 
Another limitation is that current automatic annotation pipelines based on sequence homology 
with reference databases (e.g., UniProt, KEGG etc.) lead to numerous mis-annotations. Manual 
curation, coupled with experimental confirmation of function, is required for accurate annota-
tion. Finally, the most fundamental challenge is that many genes remain unannotated; even the 
intensively studied model organisms such as Escherichia coli K12 where over 50% of its ORFs 
remain uncharacterized (http://www.jcvi.org). In addition, comparative genomics only yields fea-
tures potentially important for characteristics (phenotypes) of interests. These limitations highlight 
the need for functional studies of a large number of genes across a range of species. Experimental 
techniques that harness the power of selective pressure to identify key loci are critical for answer-
ing the question of whether observed variations in gene structure/content revealed through com-
parative genomic analyses are causally related to an organisms biological properties.
Identification of genes important for fitness using expression profiling and signature-tagged 
mutagenesis (STM)
Two approaches have been used to identify factors required for growth in vivo and/or persistence 
in the intestinal tract after various perturbations (e.g., antibiotic treatment, diet change); (1) define 
gene expression (e.g., with microbial RNA-Seq) and/or (2) employ signature-tagged mutagenesis 
(STM) to identify loci genes critical for fitness.
Using model communities composed of defined collections of bacterial species/strains 
with sequenced genomes, microbial RNA-Seq can be used to quantify changes in community gene 
expression at high resolution (e.g., [66]; see Appendix B). mRNA expression data can be mapped 
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to catabolic and anabolic pathways to predict the metabolic response of the community (meta-
transcriptomics; ‘top-down’ approach) and/or the responses of individual members of the model 
community (‘bottom-up’ approach). The in vivo data can be further interpreted and expanded by 
RNA-Seq analysis of individual members grown in vitro under defined conditions (e.g., minimal 
medium supplemented with systematically varied carbon sources) to aid in the identification of 
function of genes regulated under conditions of interest (see Chapter 3 and Appendix B for an 
example of this approach) 
However, this approach has limitations. First, transcriptional induction of a given gene 
does not guarantee that it is critical to the success of its host bacterium. For example, Bacteriodes 
spp. express multiple PULs when gnotobiotic mice are fed a diet enriched in plant polysaccharides 
[52, 67] but not all of these loci may be critical for survival [68]. Secondly, genes that are not dif-
ferentially expressed under different conditions may still be critical for fitness (e.g., constitutively 
expressed genes encoding proteins with critical functions). 
A more direct/informative approach for identifying genes important for fitness under a 
given biological condition or conditions is to construct mutants, and compare their fitness against 
the parental wild-type strain. However, the process of generating targeted mutants is laborious, and 
single mutants must be tested individually. Signature-tagged mutagenesis (STM) was designed to 
enable high-throughput parallel analysis of the fitness of mutant strains. In STM, each mutant is 
tagged with a different DNA sequence in such a way that all tags can be co-amplified from the 
DNA of mixed populations [69]. This simultaneous labeling allows for identification of specific 
mutants before and after the entire mutant pool is subjected to a selection. Until recently, the de-
tection of probes has typically been performed by DNA hybridization, which requires a species-
specific microarray [70], or by sequencing of individual mutants [71]. 
Our lab recently developed a new method, named “insertion sequencing (INSeq)”, that 
combines existing STM methods with high-throughput parallel DNA sequencing [72]. The ap-
proach is based on a modified mariner transposon containing MmeI sites at each end of the trans-
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poson. MmeI is a restriction enzyme that cuts DNA at a site 20–21 bp from its recognition site in 
the inserted transposon, capturing 16-17 bp flanking genomic DNA. In this method, the genomic 
regions adjacent to the transposons can be amplified by linear extension using a biotinylated prim-
er specific for the transposon and reading outward from the insertion site. The resulting products 
are bound to magnetic streptavidin coated beads, digested with MmeI and barcoded with sample-
specific linkers appended to each restriction fragment. After limited PCR amplification, fragment 
pools are analyzed using next-generation sequencing. The sequence of each read can be used to 
map the location of a transposon in the genome, and the resulting read count measures the relative 
abundance of that mutant in the overall mutant population before and after application of a selec-
tion ([68]; see Appendix A).
This approach provides a way to define the relative abundance of tens of thousands of 
mutants in parallel, before and after exposure to a selective environment of interest. Mutants that 
decrease in relative abundance in the selective condition are likely important for fitness under that 
condition. As INSeq library preparation can be completed in a multiplex format, experiments can 
involve material obtained from high-resolution time-series studies of the effects of various in vi-
tro or in vivo selections, and from multiple biological and technical replicates. Any microbe whose 
genome has been sequenced and is amenable to mariner transposon mutagenesis can potentially 
be studied using INSeq. 
Other techniques for mapping and quantifying transposon insertions by high-throughput 
sequencing have also been developed. . They include two protocols named Tn-Seq: one version 
[73, 74] also uses an MmeI-adapted mariner transposon but does not include a transposon-specific, 
linear PCR step during library preparation. Compared with INSeq, this simpler approach to library 
preparation reduces the effort required for sequencing. The other Tn-Seq protocol [75] does not 
use an MmeI-adapted mariner transposon; instead, it uses a circularization step to capture the 
targeted DNA fragments. This could allow use of transposons that cannot be modified to include 
MmeI sites in their inverted repeats. Additional approaches, termed “high-throughput insertion 
tracking by deep sequencing (HITS)” [76] or “transposon-directed insertion-site sequencing (Tra-
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DIS)”[77] also do not require MmeI sites in the transposon. For these protocols, mutagenized 
DNA is randomly sheared, adapters are ligated to all fragments, and transposon-chromosomal 
junctions are enriched by PCR either with (HITS) or without (TraDIS) an affinity-purification step. 
In principle, these MmeI-independent methods permit capture of longer fragments of genomic 
sequence adjacent to each transposon, a feature that may be necessary for mapping insertions in 
more complex genomes or mixtures of genomes. Compared to these other methods, the INSeq 
protocol has several advantages; (i) introducing an MmeI site in the transposon allows the excised 
transposon/chromosomal junctions to be of uniform size, thus avoiding size preferences (bias) 
during PCR; (ii) the fact that INSeq is a solid-phase–based technique allows for easy separation of 
target sequences from ‘background’ chromosomal DNA; (iii) robotic automation of library genera-
tion makes the protocol amenable to monitoring changes in the representation of mutants during 
studies that require repeated, high-resolution sampling. 
As with any negative selection technique, stochastic bottlenecks in the selective process 
need to be considered when determining the optimal number of mutants to be pooled for inclu-
sion in an experiment [69, 71]. Because each insertion is mapped with nucleotide-level resolution, 
comparing the behavior of multiple mutants in the same gene highlights these selective bottle-
necks. Stochastic bottlenecks can also be identified by comparing results from multiple indepen-
dent biological replicates.
In my dissertation research, I modified the INSeq delivery vector to incorporate taxon-
specific barcodes into the mariner transposon. Differentially tagged transposons can then be used 
to generate mutant libraries from different bacterial species, allowing for multiplex STM identifi-
cation of fitness factors across many bacterial taxa in a defined model (human gut) community. The 
use of multiple taxon-specific tags allows for differentiation of mutant populations even between 
different strains of the same species, which allows for identification of fitness factor differences at 
much finer levels of taxonomy. Together, the combination of taxon-specific transposon tags, modi-
fications to the original INSeq transposon insertion site amplification and sequencing protocol, and 
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associated bioinformatics analysis suite formed a new analysis pipeline for fitness determinants 
that I dubbed “multi-taxon INSeq”. 
One major modification to the original INSeq sequencing library preparation in the multi-
taxon INSeq protocol is elimination of the linear PCR step. With the taxon-specific barcode incor-
porated into the transposon, the length available for design of the linear PCR primer was reduced, 
leading to introduction of non-specific background amplicons, especially when the desired target 
only represented a small portion of the starting material. Instead of employing linear PCR, the 
multi-taxon INSeq pipeline directly digests genomic DNA adjacent to the transposon insertion site 
with MmeI and then uses Ampure-based size selection to separate the Tn-genomic DNA junction 
digestion fragment from the genomic DNA background. 
I validated this new protocol using mock communities composed of mutant libraries with 
systematically varied abundances plus wild-type strains of other species. The results revealed that 
multi-taxon INSeq offers high specificity and precision while simultaneously amplifying multiple 
mutant libraries of different species with high reproducibility. 
The development of this new pipeline led to the challenge of how to determine the signifi-
cance of changes in the output population relative to the input population under multiple selec-
tive pressures (i.e., host immune system, diet). To address this, I applied a maximum-likelihood 
estimation on the log output to input ratio for each mutant. This analysis defined the population 
behavior that resembled wild-type as the neutral population, and calculated fitness indices for each 
mutant relative to the distribution of the reference neutral population after selection. Further de-
tails regarding the multi-taxon INSeq methodology are provided in Chapter 3. 
Using gnotobiotic mouse models to study fitness determinants 
Owing to the complexity of the microbiota, microbial-microbial and microbial-host interactions 
are difficult to study. Gnotobiotic mice representing a given inbred strain offers an opportunity to 
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do so under highly controlled environmental conditions where microbial community composition 
and diets are defined/constrained.
In this dissertation, two gnotobiotic mouse models have been used to examine fitness de-
terminants in vivo: (1) mice monoassociated with Escherichia coli strains isolated from urine 
and fecal samples collected from women with recurrent UTI and chosen based on fitness predic-
tions from comparative genomics analysis, and (2) gnotobiotic mice colonized with an artificial 
15-member microbial community consisting of 14 bacterial species, with one species represented 
by two separate strains, all isolated from the human gut. Members of this artificial community 
were selected because they were phylogenetically diverse, and their sequenced genomes encoded 
major metabolic functions identified in the human gut microbiota. In total, the community con-
tained 8 Bacteroidetes species that represent primary fermenters of dietary and host glycans, six 
Firmicutes spp., including E. rectale which is an efficient producer of butyrate and one species 
known to ferment amino acids (Clostridium symbiosum). 
In addition to the tools we mentioned above, other methods were used to profile com-
munity structure and function: they, included a new tool to quantify the competitive indexes of 
two members (FitSeq, see Chapter 2), a method to quantify relative abundance of community 
members based on short read shotgun sequencing of community DNA (COPRO-Seq, Community 
PROfiling by Sequencing, see Chapter 3), and measurement of community metabolism by gas 
chromatography-mass spectrometry (GC-MS) and ultra high-performance liquid chromatography-
mass spectrometry (UPLC-MS).
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Abstract
Urinary tract infections (UTIs) are common in women and recurrence is a major clinical problem. 
Most UTIs are caused by uropathogenic Escherichia coli (UPEC). UPEC are generally thought 
to migrate from the gut to the bladder to cause UTI. UPEC strains form specialized intracellular 
bacterial communities (IBCs) in the bladder urothelium as part of a pathogenic mechanism to 
establish a foothold during acute stages of infection. Evolutionarily, such a specific adaptation to 
the bladder environment would be predicted to result in decreased fitness in other habitats, such 
as the gut. To examine this concept, we characterized 45 E. coli strains isolated from the feces and 
urine of four otherwise healthy women with recurrent UTIs. Multi-locus sequence typing revealed 
that two of the patients maintained a clonal population in both of these body habitats throughout 
their recurrent UTIs, while the other two manifested a wholesale shift in the dominant UPEC 
strain colonizing their urinary tract and gut between UTIs. These results were confirmed when we 
subjected 26 isolates from two patients, one representing the persistent clonal pattern and the other 
representing the dynamic population shift, to whole genome sequencing. In vivo competition stud-
ies conducted in mouse models of bladder and gut colonization, using isolates taken from one of 
the patients with a wholesale population shift, and a newly developed SNP-based method for quan-
tifying strains, revealed that the strain that dominated in her last UTI episode had increased fitness 
in both body habitats relative to the one that dominated in the preceding episodes. Furthermore, 
increased fitness was correlated with differences in the strains’ gene repertoires and their in vitro 
carbohydrate and amino acid utilization profiles. Thus, UPEC appear capable of persisting in both 
the gut and urinary tract without a fitness tradeoff. Determination of all of the potential reservoirs 
for UPEC strains that cause recurrent UTI will require additional longitudinal studies of the type 
described in this report, with sampling of multiple body habitats during and between episodes.
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Introduction
More than half of all women develop at least one episode of urinary tract infection (UTI) during 
their lifetimes. Up to 25% of women have recurrent UTI, which is defined as two or more episodes 
within a 6-month period (1). The majority of community-acquired UTIs are caused by uropatho-
genic Escherichia coli (UPEC) (2). A generally accepted model for infection is that UPEC migrate 
from the gastrointestinal tract to the periurethral area, and eventually up the urethra into the blad-
der (3).
The gut and urinary tract are very distinct habitats from the perspective of their metabolic, 
immunologic, and microbial features. The gut is home to our largest population of microbes (4-6), 
while the bladder is considered a normally sterile environment, guarded by physical and biologi-
cal barriers to microbial invasion (7-9). Studies of the molecular pathogenesis of UTI in a mouse 
model (10-12) have identified numerous virulence factors, including adhesins, toxins, iron acquisi-
tion systems, capsular structures, flagellae, pathogenicity islands, and factors important for biofilm 
formation (13). Among adhesins, UPEC strains typically encode a multitude of chaperone/usher 
pathway (CUP) pilus gene clusters. CUP pili contain adhesins at their tips that play critical roles 
in host-pathogen interactions, recognizing specific receptors with stereochemical specificity (14). 
For example, FimH, the type 1 pilus tip adhesin, binds mannosylated glycoproteins, as well as N-
linked oligosaccharides of b1- and a3- integrins that are expressed on the luminal surface of the 
bladder epithelium (urothelium) in humans and mice (15, 16). Type 1 pilus-mediated binding can 
lead to invasion of UPEC into mouse and human bladder epithelial cells (17-19). Invading UPEC 
can be expelled from the host cell (20) or they can ‘escape’ into the cell’s cytoplasm where they 
replicate rapidly and form a biofilm-like structure, composed of 104-105 organisms, known as an 
intracellular bacterial community (IBC) (21, 22). Bacteria in the IBC are protected from antibi-
otics (23, 24) and from immune responses (11, 25). IBCs are transient; after maturation, UPEC 
can disperse from the IBC, exit their host cells, enter the lumen of the bladder, and subsequently 
invade other urothelial cells (21). One primary host defense that eliminates IBCs is exfoliation, 
where urothelial cells undergo an apoptotic-like cell death, detach from the underlying transitional 
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epithelium, and are eliminated in the urine (25, 26). Exfoliated bladder epithelial cells containing 
IBCs have been observed in urine collected from women with recurrent UTI but not in healthy 
controls or in cases of UTI caused by Gram-positive pathogens (26). However, exfoliation exposes 
underlying cell layers of the urothelium. Subsequent UPEC invasion of these underlying cells in 
mice results in formation of additional intracellular structures termed quiescent intracellular res-
ervoirs (QIRs) (27, 28). Bacteria in the QIR are dormant, are resistant to antibiotic treatment, and 
elude recognition by host immune defenses. Mouse models have been used to demonstrate that 
bacteria in QIRs can contribute to recurrent infection after antibiotic treatment has rendered the 
urine sterile (23, 28).
Consistent with these adaptations for colonizing the bladder habitat, UPEC have been clas-
sified as a subset of extra-intestinal pathogenic E. coli strains (ExPEC). ExPEC are distinguished 
from other gut-associated mutualistic and pathogenic E. coli strains based on the spectrum of dis-
eases they cause and their genomic features. ExPEC are typically members of the B2 and D sub-
types of E. coli and often carry pathogenicity islands (PAIs) encoding virulence-associated genes 
(29). Mutations in fimH are postulated to be an important component in the evolution of UPEC 
strains, with secondary contributions from mutations affecting other loci in gut-associated E. coli 
populations (30-32). In this conceptualization, mutations conferring a fitness advantage within the 
urinary tract are selected in this body habitat (33). The ability of multiple UPEC strains to form 
specialized intracellular structures such as the IBC (34) and QIR suggests a very specific adapta-
tion to the bladder environment. Increased fitness in the urinary tract has been hypothesized to con-
fer decreased fitness in the gut habitat of origin, so that strains successfully colonizing the urinary 
tract encounter a “dead-end” evolutionary path; this has been cited as an example of “source-sink” 
evolutionary dynamics (31, 35).
In the present study, we have used comparative genomics, in vitro assays of growth in the 
presence of a broad range of potential nutrients, and in vivo fitness tests of representative E. coli 
strains obtained from both the urine and feces of women with recurrent UTIs to address several 
questions. How dynamic are the E. coli populations in the gut and urinary tract of a given individu-
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al sampled over a period when recurrent UTIs are experienced? Can genome-wide comparisons of 
gut and urinary tract isolates provide insights into whether recurrences arise from re-inoculation of 
gut-derived bacterial strains into the urinary tract or from intracellular reservoirs within the blad-
der? Are there fitness tradeoffs due to adaptation to either the gut or urinary tract environment? We 
observed two very different patterns: recurrent UTI caused repeatedly by the same strain, or rapid 
and apparently complete replacement of one strain with another in both body habitats between UTI 
episodes (arguing against a fitness tradeoff model). We were able to correlate replacement of one 
strain by another with their genomic and metabolic features. The significance of these results is 
discussed in the context of understanding of disease pathogenesis and designing clinical transla-
tional studies focused on new approaches for pathogen surveillance and treatment.
Results
E. coli strains cluster by host instead of habitat 
One hundred fourteen women were enrolled in a now completed study of recurrent UTI (36); each 
presented with symptoms of acute cystitis. Eight of the 114 individuals had a negative enrollment 
urine culture, while two were lost to follow-up after the initial visit. Of the 104 remaining partici-
pants, nine had three episodes of recurrent UTI (i.e., the greatest number among enrollees). How-
ever, fecal and urine samples were collected at each episode in only four of these nine individuals. 
All four patients received a similar cycle of antimicrobial therapy: trimethoprim-sulfamethoxazole 
(TMP-SMZ) for their enrollment UTI, nitrofurantoin for their second UTI, and ciprofloxacin for 
their third UTI (see ref. 36 and Table S1 for further details about clinical characteristics and treat-
ment; note that patient 56 was initially treated with TMP-SMZ during episode 2 but then switched 
to nitrofurantoin when her urine isolates were found to be TMP-SMZ resistant). Sequencing near 
full-length amplicons generated from the 16S rRNA genes in the 45 strains recovered from fe-
cal and urine samples collected during the three UTI episodes experienced by each of these four 
individuals confirmed that all were E. coli. These 45 E.coli strains (Table S2), which included 
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one urine isolate and on average 3 fecal isolates from each of the four patients at the time of each 
episode of UTI, were selected for the current study to address our questions about source-sink 
dynamics (where do strains arise and how do they distribute themselves among different body 
habitats) and about the relative fitness of E. coli strains from a patient or patients that experienced 
a wholesale population shift between episodes.
To investigate the relatedness of the 45 E. coli strains and the relationships between strain 
characteristics and the body habitat from which they had been recovered, we first conducted multi-
locus sequence typing (MLST) using seven well-conserved housekeeping genes: adk (adenylate 
kinase), fumC (fumerase isozyme C), gyrB (DNA gyrase subunit B), icd (isocitrate hydrogenase), 
mdh (malate dehydrogenase), purA (adenylosuccinate synthetase), and recA (recombinase A) (see 
Table S3 for primers used for MSLT). Two patterns emerged from the MLST analysis: (i) a “stable 
clonal” pattern where isolates from the same patient were nearly indistinguishable at all time 
points surveyed (Patients 12 and 13); and (ii) a “dynamic” pattern where isolates from the same 
patient included several different MLST groups during the study (Patients 56 and 72). Even among 
the two patients with the dynamic pattern, strains isolated at a given clinic visit tended to have 
identical or very similar MLST profiles, regardless of the body site from which they had been 
recovered (Fig. 1). In the case of patient 72, sequence typing revealed two MLST groups among 
her fecal and urine isolates during episode 1. During episode 2, all her fecal and urine isolates had 
a single MLST group assignment that was the same as one of the groups in episode 1. In episode 
3, fecal and urine isolates had a single MLST group but it differed from all the MLST groups of 
strains recovered during episodes 1 and 2, leading us to conclude that she harbored nearly clonal 
E. coli populations in both body habitats, but that the population had changed between episodes 2 
and 3. In contrast, only one fecal isolate, from the second UTI episode from patient 13, differed in 
its MLST group from the group assigned to all her other fecal and urine isolates recovered at the 
time of UTI episodes 1, 2 and 3, leading us to conclude from the MLST analysis that she possessed 
a largely clonal population across episodes. 
32
Our initial assessment of clonality was based on MLST sequencing of a limited number of 
strains. While no additional strains were available to extend sampling depth to search for minor E. 
coli populations, we proceeded to collect more data on the available strains to overcome potential 
limitations of MLST in assessing strain relatedness (37). We chose to examine the three urine and 
11 fecal strains isolated from Patient 13 (stable ‘clonal pattern’) and the three urine and nine fe-
cal strains recovered from Patient 72 (‘dynamic pattern’) as two contrasting individual examples 
of colonization patterns. These isolates represent each of the three episodes of UTI experienced 
by each of these two women (Table S4). We sequenced PCR amplicons generated from the fimH 
gene. A maximum likelihood fimH gene tree is presented in Fig. S1, with the position of fimH al-
leles in the various urine and fecal isolates recovered from Patients 13 and 72 shown. All three 
of the urine isolates from Patient 13, representing each of her three UTI episodes, had fimH se-
quences that were identical to the fimH sequences in all 11 of her fecal isolates. For Patient 72, this 
sequence identity was true for the majority of isolates from the first two UTI episodes but not for 
the third UTI where the urine strain had a fimH sequence that was different from the strains repre-
senting the two previous UTIs. However, the fimH sequence of this UTI episode 3-associated urine 
isolate was identical to the fimH sequences in the contemporaneously collected four fecal isolates 
(Fig. S1). Compared to Patient 72’s first and second episode isolates, there were seven amino 
acid substitutions in the FimH allele of fecal and urine isolates from her third UTI episode: A10V, 
N70S, S78N, V119A, T234A, and A273G and N6T. The latter residue is in the signal sequence 
that is not part of the mature FimH protein assembled on the tips of pili. Positions 10, 70, 78, and 
119 are in the lectin domain of the protein, while residues occupying positions 234 and 273 are in 
the pilin domain; all are solvent exposed with the exception of position 119 in a crystal structure 
of the FimC-FimH complex (15). None are in the mannose-binding pocket. However, residue 273 
is positioned near the hydrophobic groove where donor strand complementation and donor strand 
exchange occur - processes essential for pilus biogenesis (14).
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Unsupervised hierarchical clustering of isolates based on their gene and SNP content 
To obtain more definitive data on strain relatedness and clonality, we performed whole genome 
shotgun sequencing of all six urine and all 20 fecal strains recovered from Patients 13 and 72 (60-
140X coverage; see Methods). Using the Velvet (38) and AMOScmp (39) assemblers, 25/26 of the 
isolates yielded genome assemblies that averaged 4.98 Mbp with an average N50 contig length of 
72,747 bp (Table S4). 
To identify and compare the gene content of the isolates, we first compiled a database of 
all annotated genes from the genomes of 54 E. coli strains deposited in the NCBI RefSeq database 
that were classified as ‘complete’, as well as 324 other draft E. coli genomes present in RefSeq 
and the PATRIC database (Table S5). These genes, together with the genes predicted by Glimmer3 
(41) in the assembled genomes of the newly sequenced strains from this study, were clustered 
using the program CD-HIT with default parameters (95% similarity) (42) to generate “OGUs” 
(Operational Gene Units). All raw reads for each of the 26 newly sequenced E. coli genomes were 
mapped to this E. coli pan-genome using BLAT with default parameters (43). The total number of 
raw reads mapping to a given OGU was then used as the score for that OGU. A null cutoff score 
was calculated by dividing the total number of reads by the total length of OGU representatives (as 
determined by CD-HIT); this cutoff represents the expected number of reads per OGU normalized 
by length if reads were randomly selected from all OGU representatives. OGUs with scores less 
than this cutoff were called ‘absent’; those above were called ‘present’ (44). By mapping the raw 
reads from each isolate and the in silico fragmented sequences from the finished UTI89 genome 
onto this E. coli pan-genome dataset, we identified a total of 11,151 OGUs that were present in at 
least one of the 26 clinical isolates from the two patients or in the finished genome of UTI89; 3,488 
of the 11,151 OGUs (31.3%) were conserved in all 26 strains. 
We next identified a total 295,099 SNPs among the 25 isolates at positions present in the 
finished UTI89 genome (see Methods, one fecal sample Ec72_E2F2 was excluded from this analy-
sis given the problems encountered assembling its genome; see Table S4). The SNP and OGU data 
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were then used to more rigorously examine clonality. First, based on the SNP rate (SNPs/aligned 
bp), we computed a matrix of pairwise distance measurements between isolates from our clinical 
study of recurrent UTI and the 378 strains we used in the OGU analysis. Unsupervised hierarchi-
cal clustering based on these distance measurements (Fig. S2A) showed that the clinical isolates 
that we deemed clonally related to one another by MLST also clustered together in the SNP-based 
tree of 403 strains. With the exception of one fecal strain, the SNP rate between any pair of isolates 
from Patient 13 was in the noise range (< 100 total, SNP rates <0.005/bp) regardless of their date 
of isolation or whether they were recovered from urine or feces. In the case of Patient 72, we iden-
tified distinct groups of strains among the urine and fecal isolates, representing distinct branches 
on the tree. Fecal and urine strains isolated from her first and second UTI episodes clustered sepa-
rately from those of the third UTI episode. Second, the OGU-based, unsupervised hierarchical 
clustering of the 404 strains produced the same patterns for the 26 isolates as those obtained from 
SNP rates (Fig. S2B). Thus, based on their SNP and OGU content, we considered UTI episodes 
1-3 in Patient 13 to have all been caused by the same UPEC strain (which in turn was very similar 
to the strain recovered from feces and urine during UTI episode 3 in Patient 72). 
Finally, we quantified the growth of each isolate from Patient 72 under 190 different cul-
ture conditions using Biolog phenotype microarrays (see Methods). Phenotype-based hierarchical 
clustering of her urine and fecal isolates yielded results that were virtually the same as those ob-
tained from the MLST-, OGU-, and SNP-based comparisons (see Fig. 4A and below for additional 
information about the relationship between growth properties and gene content).
Tests of relative fitness in representative urinary isolates from patient 72
Our SNP- and OGU-based hierarchical clustering segregated the 26 isolates from current study 
and other isolates, including UPEC and ExPEC strains, into two major clades at the top level of 
the tree. This first tree division is consistent with previous phylogenetic characterizations of vari-
ous other E. coli strains (e.g., groups A, B1, and D in clade 1 and B2 in clade 2) and we refer to 
this top tree division using the terms clade 1 and clade 2 for convenience (Figs. 2, 3). Comparison 
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of the content of known virulence factors in the 26 sequenced isolates from our study and the 54 
complete E. coli genomes from RefSeq revealed that strains located in clade 1 had significantly 
fewer virulence genes compared to strains in clade 2 (see Table S6 for p-values, Chi-square tests). 
We selected urine isolate Ec72_E1U1 obtained from Patient 72 during her first UTI epi-
sode and located in clade 1 as a proxy for fecal and urine samples from her first two UTI episodes, 
and urine isolate Ec72_E3U1 recovered from her last UTI episode and located in clade 2 as a proxy 
for all urine and fecal isolates from this episode and a very close strain to all urinary and fecal iso-
lates from all three UTI episodes in Patient 13. (Figs. 2 and 3). Since her urine strain from episode 
1 was replaced by the urine strain in episode 3, we asked whether the episode 3 strain had higher 
relative fitness compared to the episode 1 strain in both the bladder and gut. If this were true, it 
would provide a counter-example to the notion that there is a fitness tradeoff between the urinary 
tract and gut, and would suggest that the urinary tract is not necessarily a “sink” or evolutionary 
“dead-end” habitat for UPEC strains.
To address this question, we first turned to a well-established mouse model of UTI (45). The 
UTI episode 1 strain was marked with low copy plasmids containing genes conveying resistance 
to kanamycin (pACYC177; KanR) or chloramphenicol (pACYC184; ChlorR). The UTI episode 3 
strain was marked with pACYC184 (ChlorR). The p15A origin driving replication and segregation 
of these plasmids confers stable inheritance in E. coli and many other Enterobacteriaceae (46). In 
vitro competition experiments revealed that these plasmids were indeed stable in both strains, and 
that there was no growth (fitness) defect between the marked strains and their unmarked counter-
part, as judged by quantifying colony forming units (CFUs) over the course of 8 h of growth under 
shaking conditions or during 48 h of growth under static conditions in LB medium. Furthermore, 
there was no significant difference in growth of the episode 1 strain (Ec72_E1U1) when it con-
tained pACYC177 (KanR) versus pACYC184 (ChlorR).
We subsequently compared the fitness of Ec72_E1U1 with Ec72_E3U1 by co-inoculat-
ing a 1:1 mixture of the Ec72_E1U1/ pACYC177 (KanR) and Ec72_E3U1/pACYC184 (ChlorR) 
36
strains into the bladders of female C3H/HeN mice (1-3×107 CFU of each strain; n=5 mice). Mice 
were sacrificed 24h after inoculation, and the number of bladder CFU of each strain was defined 
by plating bladder homogenates on selective media. The marked episode 3 strain (Ec72_E3U1/
pACYC184) was the only strain detectable in bladders 24h post inoculation, with the exception 
of one mouse where the episode 1 strain was present at a low level (103 CFU; Fig. 5A). In follow-
up single strain infections using unmarked strains without any antibiotic resistance plasmids, the 
episode 1 strain was undetectable in the bladder tissue of mice 24h post-inoculation while the 
episode 3 strain achieved a median colonization density of 5.2 X104 CFU/bladder (range 4.4x102 
– 1.12x108) (Fig. 5A). Confocal microscopy of bladder whole mounts, prepared 6, 12, 16, and 24 
h after mice were mono-infected with the same strains containing pANT4 (encoding GFP; 47) 
revealed that the episode 3 but not the episode 1 strain was able to form small IBCs (Fig. S3), 
consistent with other reports that intracellular infection contributes to fitness during UTI. Ad-
ditionally, we analyzed urine samples as well as bladder and kidney homogenates prepared from 
mice 24h after transurethral inoculation of ten times more CFUs (108) of one or the other of these 
strains (or the reference control UPEC strain UTI89). The results revealed barely detectable levels 
of the episode 1 strain, Ec72_E1U1, in bladder homogenates, although it was present in kidney 
and urine. In contrast, the episode 3 strain (and the control UTI89 isolate), was present in all three 
sample types and at significantly higher levels than the episode 1 strain (p<0.05; 2-way ANOVA 
and Mann Whitney U test; Fig. S4).
To test the stability of these plasmids during a much longer period of colonization in the 
gut, we introduced a 1:1 mixture of the episode 1 strain marked with pACYC177 (KanR) or pA-
CYC184 (ChlorR) into adult germ-free male C57Bl/6J mice using a single oral gavage (n=5 mice). 
Fecal samples were collected daily during the first four days after gavage, and then every 2 days 
for 2 weeks. Samples were plated on LB agar without and with antibiotics. Total fecal levels of 
E. coli ranged from 0.9-1.3 x 107 CFU/mg (wet weight) throughout the experiment (non-selective 
medium). However, levels of the ChlorR marked strain fell throughout the experiment, while levels 
of the KanR marked strain remained constant (Fig. 5B), indicating that in contrast to short term 
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(24h) colonization of the bladder, pACYC184 (ChlorR) conferred a fitness disadvantage, or that 
this plasmid was being lost from the episode 1 strain during the 2 week period of monitoring gut 
colonization. 
To circumvent the problem of having to mark strains with plasmids, we developed a meth-
od we named FitSeq that differentiates sequenced strains based on their SNP content and pro-
vides a digital output of their abundance (see Methods). To validate FitSeq, we began with an in 
silico simulation using reads from the whole genome sequencing datasets obtained from strains 
Ec72_E1U1 and Ec72_E3U1. Mixtures of reads were created with the fractional representation 
of Ec72_E1U1 set at 0.4, 0.5 and 0.6, and the observed ratios of the two strains calculated based 
on SNP content over a 5 order of magnitude range of input reads (10-1,000,000/strain). Fig. S5A 
demonstrates that 100,000 reads are more than sufficient to determine the ratio of the two strains. 
Next, the two strains were each grown in monoculture, genomic DNA was extracted, and the two 
purified DNAs mixed in a manner such that the fractional representation of strain Ec72_E1U1 was 
systemically varied from 0 to 1 in 0.05 increments. An Illumina sequencer was used to generate 36 
nt reads from these defined mixtures. Employing 500,000 reads per sample, in silico simulations of 
the type described above and direct analysis of the defined mixtures showed excellent correlation 
between expected and detected representation (R2=0.999, Fig. S5B).
With these results in hand, we gavaged germ-free, adult male and female C57BL/6J mice 
(n=5/group) with a 1:1 mixture of the two urine strains recovered from Patient 72 during her UTI 
episodes 1 and 3. Fecal samples were collected as described above. FitSeq disclosed that the strain 
from episode 1 was rapidly outcompeted by the episode 3 strain in the guts of both male and fe-
male animals (Fig. 5C), similar to the temporal profile seen in the original human patient.
Mechanisms that could underlie the increased fitness of episode 3 strain from Patient 72 in 
both the bladder and gut environment 
Our assembly of Ec72_E1U1 and Ec72_E3U1 indicated that they share 4,714 OGUs and have 
1,432 and 1,969 unique OGUs, respectively. To better understand the differences in fitness of 
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the episode 1 and 3 strains, we undertook a more in depth genomic and phenotypic analysis. We 
generated a more complete assembly of their genomes after re-sequencing [150 nt x 2 (paired 
end) Illumina MiSeq reads; 39-42 fold coverage of each genome; N50 contig length, 108,524 bp 
(Ec72_E1U1) and 126,534 bp (Ec72_E3U1); Table S4]. There was a high correlation between 
gene coverage with the initial short read assembly and gene coverage with the longer MiSeq reads 
(r2=0.99). In addition, BLAST searches of the new genome assemblies confirmed the presence or 
absence of OGUs (as defined from the earlier analysis), at both the nucleotide and predicted pro-
tein levels.
The episode 3 strain, Ec72_E3U1, contains the complete fim operon encoding type 1 pili. 
While the episode 1 strain, Ec72_E1U1, has a full fimH gene, it is missing the other structural 
genes required for assembling a functional type 1 pilus. Indeed, under laboratory growth condi-
tions, we were unable to induce expression of functional type 1 pili in Ec72_E1U1 as measured by 
hemagglutination of guinea pig red blood cells. Consequently, this strain was unable to form type 1 
pilus-dependent biofilms after growth in LB broth in polyvinylchloride wells. The episode 1 strain 
was also deficient in forming pellicle biofilms during growth in YESCA broth (note that pellicle 
biofilm formation is not dependent on type 1 pili; 48). In contrast, the episode 3 strain was similar 
to the prototypic human cystitis isolate UTI89 in assays for type 1 pilus expression and function 
(Fig. S6A,B), but unlike UTI89, it was not capable of pellicle biofilm formation (Table S7).
The episode 1 strain (Ec72_E1U1) was significantly depleted in genes involved in flagellar 
assembly function (p<0.05, c2 test). Ten core flagellar assembly genes are present in the episode 3 
strain and absent in the episode 1 strain: they include genes essential for formation of the MS ring 
(fliF), the C ring (fliG, fliM and fliN), and the export apparatus (fliH, fliI, fliO, fliQ, fliP and fliR) 
(Fig. S7). The lack of these essential components of the basal body would severely impact the abil-
ity of the flagellum to rotate, thus affecting motility. Indeed, the episode 1 strain was non-motile, 
while the episode 3 strain and UTI89 were motile as measured in swimming and swarming as-
says (Fig. S6C, Table S7). The other four strains recovered from the urine and feces of patient 72 
that clustered together with Ec72_E1U1 in the MLST-, OGU- and SNP-based trees (Ec72_E1F1, 
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Ec72_E2U1, Ec72_E2F1, Ec72_E2F2 in Figs. 1,2,3, and S2) also lacked these ten core flagellar 
assembly genes (Table S8A). 
The episode 3 strain possessed most of the canonical UPEC virulence-associated patho-
genicity island (PAI) elements (PAI-II, PAI-III, PAI-IV), 8 chaperone-usher pilus systems, and 
several additional toxins and iron acquisition systems (a-hemolysin and four major siderophore 
systems). In contrast, the episode 1 strain was missing most of these PAIs, had only one intact 
chaperone-usher pilus system, and lacked all of the siderophore systems and toxins associated with 
UPEC (Table S6 and Fig. S8). In vitro assays confirmed the absence of a-hemolysin activity in 
this strain (see Ec72_E1U1 in Table S6 and Fig. S8). 
The episode 3 strain was also enriched in phosphotransferase systems (PTS) relative to the 
episode 1 strain (p<0.05, c2 test). The genes encoding PTS-Sor-EIIA, PTS-Sor-EIIB, PTS-Sor-
EIIC, PTS-Sor-EIID, which comprise L-sorbose-specific enzymes II in the phosphenolpyruvate 
(PEP)-dependent PTS system (Fig. S9), were absent in the less fit episode 1 strain and present 
in the episode 3 strain. Three components are required in the PTS system: the two common PTS 
proteins, enzyme I (EI) and HPr, which transfer a phosphoryl group from PEP to the substrate-
specific Enzymes II (EII) complex. Enzymes II are involved in the first step of sorbose utilization, 
transport of L-sorbose into the cell and phosphorylation to L-sorbose-1-phosphate. The absence of 
this particular sorbose PTS EII suggested that the episode 1 strain cannot use L-sorbose, a fact con-
firmed in the phenotypic microarray assay (Fig. 4B). L-Sorbose derived from dietary vegetables 
exists in both the human gut and urinary tract (49). L-Sorbose utilization is a distinctive feature of 
virulent E. coli, including ETEC, EIEC, STEC, EPEC, and other UPEC strains (50). The lack of 
the L-sorbose PTS-system was also observed in (i) the genomes of the four other strains judged 
to be clonal with Ec72_E1U1 based on MLST-, OGU-, SNP analyses (Ec72_E1F1, Ec72_E2U1, 
Ec72_E2F1, Ec72_E2F2) and (ii) the 13 reference strains in phylogenetic group A that clustered 
with this clonal population in the tree shown in Figs. 2 and 3 (Table S8B). 
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The differential representation of other genes in the genomes of these two strains suggest a 
genetic basis for the observed differences in their in vitro growth phenotypes (Fig. 4B) and fitness 
in the gut and bladder (Fig. 5A,C). For example, genes involved in galactose utilization were more 
prominent in the episode 3 strain and correlated with its higher growth rates on substrates requiring 
galactose metabolism (Fig. 4B). Defects in galactose utilization are known to affect colonization 
of the intestine. In fact, E. coli uses multiple sugars for growth in the intestine and multiple muta-
tions affecting different sugar utilization pathways have an additive effect on the colonization lev-
els of the enterohemorrhagic E. coli strain EDL933 in CD-1 mice (51). Peptides or amino acids are 
the primary carbon source for E. coli during UTI (52), and peptide transport, gluconeogenesis and 
the TCA cycle are required for UTI caused by the UPEC strain CFT073 (49,52). The phenotype 
microarray analysis disclosed that the more fit episode 3 strain had higher growth rates on all four 
dipeptides and 10 of 22 amino acids tested (Fig. 4B). Nine of these ten amino acids are glucogenic 
in the TCA cycle. Genes involved in gluconeogenesis and TCA cycle were enriched in the variable 
component of the episode 3 isolate’s genome, compared to the episode 1 isolate’s genome (Table 
S9). 
Discussion
We have conducted a study analyzing the genomic features of E. coli strains isolated from 
the feces and urine of four women during recurrent bouts of UTI and assessed the relative fitness 
of representative strains in mouse models. We found two very different colonization patterns with 
respect to the dominant E. coli population in the gut and bladder (two patients/pattern). One pat-
tern, exemplified by Patient 13, can have stable and seemingly clonal E. coli populations in the gut 
and urinary tract for several months over the course of multiple recurrent urinary tract infections. 
In contrast, other patients, illustrated by Patient 72, have a very dynamic pattern with a wholesale 
shift in the major population colonizing both the intestinal and urinary tract occurring over the 1 
month period between her second and third episodes of UTI. Unsupervised hierarchical clustering 
of both genetic and phenotypic data (MLST, whole genome gene and SNP content, and in vitro 
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growth on 190 substrates) supported the clonal relationship of strains representing these dominant 
E. coli populations. 
We tested the in vivo fitness of two isolates: (1) Ec72_E1U1, a representative of the strains 
present in Patient 72’s gut and bladder during her first two episodes, and (2) Ec72_E3U1, a repre-
sentative of the gut and urine isolates from the last UTI episode of Patient 72. The results revealed 
that the latter strain had higher fitness in both the mouse bladder and gut, consistent with the 
population shift documented in both the gut and bladder of patient 72. These fitness differences 
correlate with a number of genomic and metabolic features that provide insights about the require-
ments for survival in these body habitats. Nonpathogenic E. coli strains generally contain fewer 
chaperone-usher pilus systems than pathogenic strains (53). We found that the less competitive 
episode 1 strain carries fewer pilus systems (only one of the 13 known CUP systems in E. coli) 
than the episode 3 strain. Moreover, there were seven predicted amino acid differences between 
the FimH proteins encoded by the two isolates. FimH residues 70 and 78 define two major groups 
of FimH sequences (54, 55); the first UTI episode isolate (Ec72_E1U1) has 70N and 78S, which 
are associated with fecal and non-UPEC strains, while the third UTI isolate (Ec72_E3U1) has 70S 
and 78N, which are associated with UPEC strains.
Flagella are thought to be important for UTI pathogenesis. The flagellum consists of a basal 
body, hook and filament. Flagellar synthesis is a highly ordered and regulated process involving 
three classes of genes. Class I genes include flhDC, which encode the FlhD/FlhC complex that 
functions as a transcriptional activator of flagellar class II operons. Class II genes encode the basal 
body and hook, as well as FliA and FlgM, which are the sigma factor and anti-sigma factor that 
regulate transcription of class III genes. Class III genes encode the hook-associated proteins and 
the filament of the flagellum (FliC), as well as proteins necessary for motility (e.g., MotA, MotB) 
(56). Studies of isogenic wild-type and DfliC strains have shown that loss of the flagellar protein 
FliC results in reduced persistence in the urinary tract of mice, while IBC formation and dispersal 
are not affected (57). E. coli strains are classically grouped by serotyping based on their LPS O-
antigens and flagellar H-antigens. Nearly all E. coli have an H-typeable flagellar antigen, includ-
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ing nonmotile strains. H-typeable but nonmotile strains include sorbitol-fermenting O157 strains 
isolated from hemolytic uremic syndrome in which there is a 12bp deletion in flhC (58). The urine 
isolate and one fecal isolate from the first two UTI episodes in patient 72, which would be typed 
as an H30 strain based on sequence identity to fliC from strain HW32 (59), have deletions that 
eliminate a subset of flagellar class II genes. All these strains, which include the episode 1 strain, 
Ec72_E1U1, have an intact flhDC operon. Thus, deletion of genes encoding flagellar structural 
protein represents another (alternative) route to disruption of E. coli motility.
No common set of virulence determinants has been identified that is specific to UPEC 
strains and absent from E. coli strains that have a mutualistic relationship with their host (60, 
61). The general lack of known virulence determinants in the episode 1 strain from Patient 72 
raises the question of how this strain was able to cause a symptomatic UTI. The episode 1 strain, 
Ec72_E1U1, and the closely related episode 2 strain, Ec72_E2U1, were isolated from the urine of 
patient 72. They were cultured from midstream urine samples using previously well-defined and 
validated protocols (36) that make fecal contamination highly unlikely. In a recent study, 80% and 
40% of urine isolates collected from women with symptomatic UTI were capable of expressing 
functional type 1 and P pili, respectively, after in vitro growth (60). In addition, studies of isolates 
from women with asymptomatic bacteriuria have found that they are enriched for UPEC strains 
that have lost the ability to make functional pili (62). Thus, alternate mechanisms for E. coli colo-
nization of the urinary tract exist. The association of UTI symptoms with the episode 1 strain is 
even more puzzling given its limited number of chaperone-usher pili, its fimH sequence, its lack of 
PAIs, and its clustering with other non-pathogenic strains based on comparison of their sequenced 
genomes. Sexual intercourse has been shown to introduce bacteria into the female bladder (3). Pa-
tient 72 engaged in sexual intercourse just prior to bacteriuria and the development of symptoms 
(36). Therefore, it seems reasonable to propose that Ec72_E1U1, despite lacking functional P and 
type 1 pili, was inoculated into her bladder in sufficient quantities to maintain itself for a period of 
time to cause symptoms. Indeed, we found that an inoculation of 108 CFU of Ec72_E1UI into the 
bladders of mice was sufficient to maintain bacteriuria and kidney colonization even in the absence 
43
of significant invasion of the bladder urothelium (Fig. S4). Furthermore, studies in mouse models 
have shown that certain UPEC strains that are defective in IBC formation can be complemented to 
form IBCs when there is co-infection with other UPEC (34); thus, in the context of a mixed infec-
tion, this strain may be able to persist within the bladder. In contrast, Ec72_E3U1 colonized and 
invaded the bladder. Our finding that the episode 3 strain Ec72_E3U1 has intact coding sequences 
for functional type 1 pili and flagella and a greater flexibility in utilizing carbon sources available 
in the gut and urinary tract emphasizes the multigenic underpinnings of virulence, provides mech-
anistic understanding for its observed displacement of the less fit Ec72_E1U1 between Patient 72’s 
UTI episodes 1 and 3, and underscores the need to examine the role of metabolic capabilities in 
determining the fitness of UPEC in two body habitats involved in disease pathogenesis. For ex-
ample, we have shown that mutants with deletions in sdhB (required for conversion of succinate to 
fumarate in the TCA cycle) or mdh (catalyzes metabolism of malate to oxaloacetate; loss of mdh 
blocks the TCA cycle and glyoxylate shunt) are both attenuated in a mouse model of UTI, correlat-
ing with a decreased ability to form IBCs (63). 
The observation of the same strain of E. coli in both urine and fecal isolates during a given 
UTI episode and across successive UTI episodes is somewhat surprising given the hypothesis that 
the urinary tract is an evolutionary dead end from which E. coli do not emerge to seed other habi-
tats (31). Two possibilities that are not mutually exclusive could explain our results: (i) UPEC are 
very fit in both the gut and urinary tract, and UTI results from gut to bladder inoculation but the 
reverse never happens; (ii) UPEC transiently occupy, and in fact dominate, the gut E. coli popula-
tion en route to the urinary tract, and because we have sampled strains only during UTI episodes, 
we observe the same strain in both the feces and urine. These two possibilities differ in that (i) 
assumes high UPEC fitness in the gut, while (ii) does not. Given our gut colonization data in gno-
tobiotic mice, it seems that (i) is the more likely of these two possibilities.If the urinary tract is not 
an evolutionary dead end, then a third possibility needs to be considered: the urinary tract may be 
a source for gut colonization with UPEC. The third possibility is consistent with a scenario where 
there is dynamic fluxing between both body habitats so that a strain originating from the gut causes 
44
a UTI episode and UPEC from the bladder/urine subsequently re-seed the gut; this ‘cycle’ could 
lead to the ‘homogeneity’ that we see in our study where the one strain dominates in both habitats 
during a given UTI.
Overall, this is a complex issue, as gut colonization by UPEC can be consistent with the 
urinary tract as a dead-end; i.e., if UTI always arises from infection with gut bacteria, then human-
human transmission and epidemics of UTI could be caused merely by fecal-oral transmission of 
bacteria from gut to gut without requiring intervening occupancy of the urinary tract. Two obser-
vations argue against this notion. First, in the case of Patient 72, we find that the relative fitness 
of gut and urinary isolates in mice follows their dynamics in humans, and that isolates with higher 
relative fitness co-exist simultaneously in both host habitats. Second, in an analysis of heterosexual 
couples, colonization of the gut of both partners by the same strain of E. coli was associated with 
cunnilingus (64). One explanation for this latter result involves transmission from the urinary tract 
of the female to the gut of the male. Foodborne transmission of extra-intestinal E. coli may also 
represent a possible route of dissemination (65, 66).
The concept in evolutionary theory that specialization to one environment is generally 
detrimental to fitness in another has been extensively explored in the context of microbial survival 
in the presence and absence of antibiotics. Fitness costs due to adaptation to antibiotic pressure 
are seen. However, compensatory mutations that restore fitness and no-cost adaptive mutations 
have been identified in numerous systems (67). Interestingly, in C. jejuni, fitness tradeoffs are 
very clear in the development of resistance to macrolide antibiotics, yet evolution of resistance 
to fluoroquinolones confers equal or higher overall fitness in the absence of antibiotic pressure in 
animal models of infection, demonstrating that fitness landscapes can be dynamic and complex 
(68, 69). Therefore, while some UPEC strains may suffer in their gut fitness, our data from Patient 
72 indicate that a pathway to high fitness in both urinary tract and gut exists. This is interesting in 
light of the highly specialized intracellular infection pathway used by many UPEC in the bladder, 
the efficiency of which varies from strain to strain (21, 22, 34). IBC formation is multifactorial, 
and there is evidence that this is a selected process among UPEC strains (33). Type 1 pili mediate 
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binding to uroplakins (16, 25) but play an additional intracellular role in IBC formation (33, 70) 
and thus are key features of both UTI and IBC formation. Selection for this specialization towards 
uroepithelial cells is expected to decrease fitness in other habitats such as the gut, especially in a 
source-sink model where the urinary tract is an evolutionary dead end. We have now demonstrated 
that fitness in the urinary tract and gut are not necessarily inversely related (e.g., the episode 3 but 
not the episode 1 strain from patient 72 forms IBCs). It may be useful to consider how selection 
for the biofilm-like IBC in uroepithelial cells could enhance survival in the gastrointestinal tract, 
which is lined with a mucus layer containing polysaccharides that can serve as a nutrient repository 
as well as a place for attachment and establishment of syntrophic relationships with other members 
of the microbiota. In other words, the IBC may be a focal point for patho-adaptive changes that 
also increase fitness of strains in the gut. 
Our findings provide a rationale for additional studies of populations of women represent-
ing different ages, genotypes, and lifestyles (including different diets and nutritional status) in or-
der to address the question of the origins of recurrent UTI and the relative importance of dynamic 
and stable patterns of colonization. If UPEC are able to move freely between the gut and urinary 
tract, this complicates our inference of the ultimate reservoir for recurrent UTI. Therefore, further 
studies of the type described in this report are needed to determine the migration directions of these 
bacteria between different sites within an individual and between individuals. We envision these 
studies as a part of a translational medicine pipeline directed at developing more informed con-
cepts about the pathogenesis of recurrent UTI, as well as more effective therapies. For example, 
whole genome sequencing of isolates obtained from time series studies of patients with recurrent 
UTI should help determine whether the majority of E. coli isolates obtained from the gut and uri-
nary tract of an individual at a given time point are clonally related, and whether or not there are 
barriers to homogenization across different body habitats (oral, fecal/perianal, vaginal, periurethral 
and bladder). FitSeq and the type of animal models employed here can then be used to compare 
the fitness of UPEC strains that sweep to dominance in the gut and urinary tract of a human host 
in the setting of UTI. The results may influence standard of care: e.g., whether long-term surveil-
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lance of the fecal microbiota coupled with sampling microbial communities from other body habi-
tats can identify population shifts in patients with histories of UTI prior to the onset of UTI. This 
surveillance may also help define new approaches to chemoprophylaxis, either involving existing 
antibiotics or next generation compounds that target UPEC through novel mechanisms, such as 
mannosides that impede or block FimH-mediated binding of UPEC strains to mannosylated epi-
thelial surface receptors (71)
Materials and Methods
Strains. The TOP trial was conducted using protocols approved by the Human Studies Committee 
of the University of Washington. Exclusion criteria included known anatomic or functional abnor-
malities of the urinary tract, symptoms or signs of acute pyelonephritis, chronic illness requiring 
medical supervision, pregnancy or planned pregnancy in the three month period following enroll-
ment. Clinical information and strains were collected during the trial as described in Czaja et al 
(36). 
Amplicon sequencing. Genomic DNA was prepared from each E. coli isolate using the 
Promega Wizard Genomic DNA kit (Promega, Madison, WI) according to the manufacturer’s 
instructions. Near full length ampilcons from the 16S rRNA gene were generated by PCR and 
sequenced using the dideoxy chain termination method as described (72). Gene targets for MLST, 
including the fimH allele, were amplified with the primers listed in Table S3 in the following reac-
tion mixture: 1x PCR buffer (Invitrogen, Grand Island, NY) supplemented with 2.5mM MgCl2, 
1.4M betaine, 1.3% DMSO, and 200mM dNTPs, 5ng of template, 12.5pmol of each primer, and 
1 unit of Taq polymerase (Invitrogen, Grand Island, NY) in 50 mL total volume. Reactions were 
heated to 95°C in a thermocycler for 5 min, then cycled 35 times using the following conditions: 
95°C for 1 min, 55°C for 1 min, and 72°C for 1-3 min (depending on the expected product size). 
Reactions were finished with a 10 min incubation at 72°C, cooled to room temperature, and sub-
sequently purified using the Qiagen QiaQuick PCR purification kit according to manufacturer’s 
instructions. Amplicons were sequenced using standard dye-terminator capillary sequencing. Base 
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calling and assembly of multiple reads were performed using the programs Phred, Phrap, and 
Consed with default parameters.
Biolog phenotype microarrays. Phenotype microarrays were run according to the manu-
facturer’s standard protocols. Briefly, a strain was grown on solid LB agar with no antibiotic selec-
tion at 37°C overnight. Cells were scraped from this plate, resuspended in 10 mL of buffer IF 0a 
GN/GP Base IF (Biolog), normalized to a transmittance of 85% using the Biolog Turbidimeter, 
diluted 100-fold in buffer IF 0a GN/GP Base IF with Biolog Dye mix, and then pipetted into Bio-
log PM1 or PM2 plates. Plates were subsequently incubated at 37°C in the Biolog machine for 48 h 
with colorimetric measurements made every 30 min. Data were exported from the Biolog software 
as total AUC (area under the curve) for the 48 h assay, giving 96 AUC values for each PM plate. 
These values were subjected to unsupervised hierarchical clustering to determine the relatedness 
of the phenotype microarray profiles for each strain.
Whole genome sequencing and assembly. Genomic DNA libraries for the Illumina GA-II 
sequencer were prepared according to the manufacturer’s protocol. Each strain was sequenced (36 
nt reads) using 2 lanes of the 8-lane flow cell. The output files were converted to FASTA format, 
ignoring quality scores, and assembled with the Velvet short read assembler (version 0.7) using 
custom Perl scripts to optimize k-mer length and minimum coverage parameters for both N50 
length and total assembly length. AMOScmp (version 2.0.5) was used to further improve the as-
sembly with default parameters. 
Paired-end libraries with 500 bp inserts were prepared for strain Ec72_E1U1 and Ec72_
E3U1 as described by the manufacturer of the Illumina MiSeq instrument. Sample-specific, 8 nt 
Hamming barcodes 73) were incorporated into the sequencing adapter for multiplex sequencing [8 
barcodes per strain; two strains sequenced in a single MiSeq flowcell; 16 barcodes per MiSeq flow 
cell to get a balanced base composition during the first four cycles of the sequencing run (critical 
for accurate cluster calling as well as good phase and pre-phasing values)]. The output FASTQ 
files were assigned to each strain using the barcodes (0.68 million reads for Ec72_E1U1 and 0.78 
48
million reads for Ec72_E3U1), and then assembled with MIRA (version 3.4.0) using default pa-
rameters (74).
SNP analysis. Analysis of assembled genomes for SNPs was done as described (44). UTI89 
was used as the reference finished UPEC genome. All genomes were aligned against UTI89 using 
BLASTN with default parameters. Only the alignment with highest p-value reported by BLASTN 
was used for each assembled contig. The position of each SNP, based on UTI89 genome sequence, 
was recorded. SNP rates were calculated for each pair of assembled genomes by counting the num-
ber of sequence differences only at positions in the UTI89 reference genome where both genomes 
had contigs that aligned. The total number of sequence differences in overlapping regions of the 
genomes was divided by the total length of overlapping regions, yielding SNP rate per aligned 
base pair.
Competitive tests of fitness. All experiments involving mice were performed using proto-
cols approved by the Washington University Animal Studies Committee. In vivo fitness tests in the 
urinary tract were performed as previously described (45). Briefly, bacteria were grown under type 
1 pili-inducing conditions (two passages at 37°C in LB broth without shaking for 16-20 h, with a 
1:1000 dilution between passages). These static cultures were briefly agitated to resuspend settled 
bacteria. Cells were collected by centrifugation (~3,000 x g for 10 min at 4°C) and resuspended 
in PBS to an OD600 of 1.0. An equal mixture of two strains was inoculated transurethrally into the 
bladders of 7-8 week old female C3H/HeN mice. Twenty four hours later, mice were sacrificed 
and their bladders were removed aseptically, placed in 1 mL of PBS, mechanically homogenized 
with a stainless steel electric tissue homogenizer (PRO Scientific, Oxford, CT) for 15-20 sec, and 
plated on LB/agar plates with and without antibiotics [kanamycin (50 mg/mL), chloramphenicol 
(100 mg/mL), or kanamycin plus chloramphenicol]. CFU counts were defined after a 12-18 h in-
cubation at 37°C under aerobic conditions. Single infections were performed similarly, except that 
bacterial suspensions were mixed 1:1 with PBS, to achieve a final OD600 of 0.5 before inoculation. 
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FitSeq. To assess their relative fitness in the gut, E. coli strains Ec72_E1U1 and Ec72_
E3U1 were grown under type 1 pili-inducing conditions. The two strains were mixed in equal pro-
portions (2-3×108 CFU/200μL/strain) and inoculated by oral gavage into germ-free 8–10-week-
old C57BL/6J mice. Mice were maintained in plastic flexible film gnotobiotic isolators and fed a 
standard autoclaved chow diet (B&K Universal, East Yorkshire, U.K; diet 7378000) ad libitum. 
Fecal samples were collected from each mouse 1, 2, 3, 4, 6, 8, 10, 12, and 14 days after gavage. 
Each fecal pellet was placed in 1 mL of PBS and homogenized by vortexing. A 10 mL aliquot of the 
homogenate was plated directly on LB agar (n=4 plates/sample). Twenty four hours later, colonies 
were collected by scraping (1 mL PBS). Genomic DNA was isolated using the phenol:chloroform 
method (72), and then fragmented by sonication to 300~500 bp (BioruptorÒ sonicator for ultra-
sonic liquid processing; 20 cycles of 30 sec ON at high power/30 sec OFF).
Illumina sequencing libraries were prepared as described by the manufacturer. Sample-
specific, 8 nt Hamming barcodes 73) were incorporated into the sequencing adapter for multiplex 
sequencing (n=96 samples/lane of an Illumina HiSeq 2000 flowcell; 80-100 million reads/lane; 
>500,000 42 nt reads/sample).
Raw-reads were assigned to each sample using the barcodes, and then mapped to the data-
base containing the genomes of both strains using Eland (75). Only reads that could be uniquely 
assigned to one of the two genomes were used to score the relative representation of that strain in a 
given fecal sample. Counts for each strain were normalized by the informative genome size (IGS). 
The IGS of each strain was calculated by generating, in silico, a mock sample containing a 1:1 ratio 
of both strains, and then mapping the sample reads back to each genome: the IGS for each strain 
was calculated from the number of reads that mapped uniquely to that strain’s genome. The ratio 
of the two strains was calculated as r(FitSeq) after normalization by IGS.
Since bacterial cells had been harvested from LB agar plates after a 24 h incubation, to 
calculate the ratio (r) of strains in fecal samples, we needed to transform r(FitSeq) using the 
relative growth rate. To measure the relative growth rate, a 1:1 mixture of strain Ec72_E1U1 and 
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Ec72_E3U1 were grown on LB agar for 24 h at room temperature as above. Bacterial cells were 
collected and the detected ratio (r(1:1)) calculated by FitSeq. Knowing that the original ratio of 
the two strains was 1, the relative growth rate ratio (u1/u2) of the two strains could be calculated 
as . Five independent mixtures were prepared and measured, and the average results used as the 
ratio for growth rate of the two strains on LB agar. Thus, we were able to calculate the ratios of 
two strains in fecal samples as .
Characterization of virulence related phenotypes in vitro. Hemagglutination assays were 
performed on cells normalized to an OD600 of 1.0 as described previously (n=3 biological rep-
licates performed on different days; 2 technical replicates/biological replicate) (76). For biofilm 
assays, shaken cultures were grown overnight at 37°C in LB were subcultured at a 1:1000 dilution 
into LB and grown statically in untreated polyvinylchloride 96 well plates at room temperature 
for 48 h. Adherent biomass was stained with 0.05% crystal violet, rinsed, solubilized with 35% 
acetic acid and quantified by measuring absorbance at 595 nm of the solubilized crystal violet 
(assays performed in duplicate; 5 technical replicates/biological replicate). Pellicle biofilms were 
performed by subculturing a 1:1000 dilution of an overnight LB shaken culture into Yeast Extract/
Casamino Acid (YESCA) medium and incubating statically at 30°C for 72 h (pellicle assays per-
formed twice). For motility assays, cultures were incubated statically at 37°C for 24 h in 10 mL 
of LB, subcultured at a 1:1000 dilution into 10 mL of fresh LB, and incubated again statically at 
37°C for 24 h. Swimming motility was measured in 0.25% LB agar and swarming motility was 
measured in 0.6% LB agar supplemented with 0.5% glucose (swimming and swarming data shown 
are representative of results obtained from two separate experiments) (76). Hemolysin production 
was examined by plating on blood agar (assays performed in duplicate).
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Figure Legends
Fig. 1. MLST analysis of patient isolates. An eBURST diagram constructed based on publicly 
available E. coli MLST sequence types. MLST types from patient isolates from the present study 
are represented by colored circles; the color denotes the patient while the size (diameter) of the 
circle indicates the proportion of strains that share that same MLST type or an MLST type that 
differs by only one allele.
Fig. 2. Heatmap of SNP differences between E. coli strains. SNP rates (SNPs/aligned bp) be-
tween different sequenced strains were interpreted as a distance matrix. Hierarchical clustering 
was done on this symmetric matrix of SNP rates. Color in the central heatmap represents SNP rate 
as shown in the legend at the top left. A tree based on Euclidean distance is shown to left of the cen-
tral heatmap. The colors of the strains indicate their patient of origin. UTI89_finished refers to the 
finished UTI89 genome (40), while UTI89_illumina is the re-sequenced and re-assembled genome 
from a 36 nt read dataset generated for this study. The comparison between the UTI89_finished 
and UTI89_illumina identified the noise range of the sequencing and assembly pipeline we used.
Fig. 3. OGU-based clustering of sequenced E. coli genomes. The presence or absence of OGUs 
in the newly sequenced UPEC genomes characterized in the present study and 54 other publicly 
available E. coli strains were used to construct an OGU matrix. Hierarchical clustering was per-
formed on the matrix based on Euclidean distance. There are two clades suggested by the cluster-
ing analysis. Phylogenetic group membership of the strains is indicated with bars at the right of the 
figure. All isolates from Patient 13 are colored red while all isolates from Patient 72 are colored 
green. The two strains used for in vivo competition experiments and phenotype microarray analy-
ses are highlighted.
Fig. 4. Growth phenotypes of isolates from Patient 72. (A) Unsupervised hierarchical cluster-
ing of growth phenotypes as defined by Biolog phenotype microarrays. Squares represent fecal 
samples, circles denote urine samples, and the numbers inside squares and circles indicate the 
episode number from which the strain was derived. (B) Comparison of the growth phenotypes 
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of strains Ec72_E1U1 and Ec72_E3U1 from UTI episodes 1 and 3, on carbohydrate, nucleoside 
and amino acid substrates. Carbohydrate substrates that result in greater than 10-fold growth of 
the episode 3 strain are shown. See Fig. S10 for other carbohydrates examined. Utilization of the 
bracketed carbohydrates requires genes involved in galactose metabolism. The color key denotes 
growth relative to the reference UPEC strain, UTI89.
Fig. 5. In vivo fitness of urine isolates from Patient 72’s UTI episodes 1 and 3. (A) Urine iso-
lates obtained from UTI episodes 1 (isolate Ec72_E1U1) and 3 (Ec72_E3U1) were introduced 
separately or together into the bladders of female C3H/HeN mice. Data points represent CFUs/
bladder in individual mice, and horizontal bars represent the median of CFUs/bladder of that strain 
in the experiments. Data on the y-axis are presented in log scale: therefore all 0s were plotted as 1 
for visualization. (B) The plasmid pACYC184 (ChlorR) was lost during a two-week colonization 
of the intestines of gnotobiotic mice or conferred a fitness disadvantage. CFU on LB agar plates 
without antibiotics represent all Ec72_E1U1 in the fecal samples. CFU on LB agar plates with 
kanamycin or chloramphenicol represent the Ec72_E1U1 carrying the corresponding antibiotic-
resistance plasmid from the same fecal sample (data shown as mean +/- SEM). (C) FitSeq de-
termination of the relative fitness of strains from Patient 72’s UTI episodes 1 and 3 in the gut of 
gnotobiotic mice (data shown as mean +/- SEM).
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Supplemental Materials
Supplemental Figure Legends
Fig. S1. Maximum likelihood fimH gene tree incorporating the UPEC strains characterized 
in the present study. fimH sequences analyzed in (33) are included to provide background fimH 
variability within E. coli. Squares indicate fecal isolates while circles are urine isolates. The num-
ber inside each symbol indicates the UTI episode from which the strain was isolated.
Fig. S2. Hierarchical clustering of 404 E. coli strains including the 26 characterized in the 
present study. (A) SNP-based unsupervised hierarchical clustering of the clinical isolates from 
the present study with 378 strains with ‘finished’, ‘complete’, or draft genomes available in the 
NCBI RefSeq and PATRIC databases. (B) OGU-based unsupervised clustering of 26 clinical iso-
lates with 378 strains with finished or draft genomes available in public database. All isolates from 
Patient 13 are colored red while all isolates from Patient 72 are colored green.
Fig. S3. The episode 3 UTI strain Ec72_E3U1 forms IBCs. Confocal images of IBCs found in 
infections of the mouse bladder using the reference UPEC strain, UTI89 (A,B) and the episode 3 
isolate from patient 72, Ec72_E3U1 (C,D). Bacterial strains express GFP and appear green. Epi-
thelial cells are stained with wheat germ agglutinin (red) to show uroplakin expression. Images 
are taken 6 h post-infection (A,C) or 12 h post-infection (B,D). Scale bar in (A), 10mm (same in 
all panels).
Fig. S4. Assays of urinary tract colonization with episode 1 and 3 strains from patient 72. 
C3H/HeN mice were inoculated transurethrally with 1-5x108 CFUs of (A) UTI89, (B) Ec72_E1U1, 
or (C) Ec72_E3U1. 24 h after infection, urine samples were collected and mice were sacrificed. 
Bladders and kidney pairs were homogenized in PBS to a final volume of 1 ml and bacterial titers 
defined in urine and tissue homogenates (n=10 mice for each strain from patient 72, n=5 animals 
for the reference UTI89 strain; lines connect data points generated from a given animal).
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Fig. S5. Parameter testing and validation of FitSeq. (A) In silico simulation of the accuracy of 
FitSeq at different levels of sequencing coverage. Three different defined fractional representa-
tions of Ec72_E1U1 in a mixture of Ec72_E1U1 and Ec72_E3U1 were used to test the coverage 
requirement. The x-axis is the total number of reads while the y-axis plots the detected representa-
tion as calculated by FitSeq. (B) Validation of FitSeq by in silico simulation sequencing of defined 
mixtures. The expected representation and the detected representation are highly correlated in both 
the in silico simulation and the defined mixtures at a coverage of 500,000 reads/sample (R2=0.999).
Fig. S6. In vitro characterization of Ec72_U1E1 and Ec72_U3E1. (A) Biofilm formation as-
sayed after a 48 h static incubation, at room temperature in LB media, in 96-well polyvinyl chlo-
ride assay plates. Adherent biomass was defined by staining the material in each well with crystal 
violet, solubilizing the crystal violet with acetic acid, and recording A595 values for each well 
(data normalized to UTI89). (B) Guinea pig red blood cell hemagglutination titers, with and with-
out mannose (determined with cells normalized to OD600
 = 1.0, as described previously (76); (C) 
Swimming motility. Cultures of each strain were incubated statically at 37oC for 24 h, subcultured 
and incubated again under the same conditions and inoculated into 0.25% LB agar. Swim diameter 
was assessed 6.5 h after inoculation. Mean values ± SD are plotted
Fig. S7. Genes encoding flagellar proteins that are present/absent in the genomes of UTI 
episode 1 (Ec72_E1U1) and episode 3 (Ec72_E3U1) strains. Figure adapted from the KEGG 
database (version 58). A red ‘X’ indicates genes that are absent in the Ec72_E1U1 but present in 
Ec72_E3U1.
Fig. S8. UPEC virulence-associated elements present/absent in the genomes of UTI episode 
1 (Ec72_E1U1) and episode 3 (Ec72_E3U1) strains recovered from patient 72 compared to 
UPEC strain UTI89. Each gene is represented by a square and is colored red if present, and black 
if absent, as determined by the OGU-based pan-genome analysis.
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Fig. S9. PTS pathway components involved in L-sorbose utilization. The components of L-
sorbose-specific enzymes II (EII-A, EII-B, EII-C and EII-D) are absent in the Ec72_E1U1 strain 
but present in the Ec72_E3U1 strain.
Fig. S10. Comparison of growth phenotypes of Ec72_E1U1 and Ec72_E3U1 strains from 
UTI episodes 1 and 3. The color key indicates the level of growth during a 48 h inc
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Supplemental Table Legends
Table S1. Clinical characteristics and treatment of the four patients with three episodes of 
recurrent UTI.
Table S2. Summary of 45 isolates analyzed for this study, including those subjected to whole 
genome sequencing.
Table S3. Genes targeted for MLST and primers employed for generating PCR amplicons 
for DNA sequencing.
Table S4. Genome sequencing and assembly metrics for urine and fecal isolates obtained 
from Patients 13 and 73 during their three episodes of UTI.
Table S5. Reference genomes used for OGU- and SNP-based analyses.
Table S6. Representation of known virulence factors in the genomes of the 26 isolates from 
the present study and in 54 other E. coli genomes classified as ‘complete’ in the NCBI RefSeq 
database. (A) Distribution of virulence factors in each strain. “Reference genome” refers to the se-
quenced genome whose annotation was used to assign “Gene name”. (B) The number of virulence 
factors per virulence system (e.g., adherence, iron update) represented in each of the 80 genomes. 
Table S7. Comparison of YESCA pellicle, Congo Red staining, and swarming phenotypes of 
strains EC72_E1U1, EC72_E3U1 and UTI89.
Table S8. Representation of genes involved in flagellar assembly and PTS-sorbose systems 
in the 26 clinical isolates from the present study and in the 54 reference complete E. coli ge-
nomes. (A) Flagellar assembly system. (B) Phosphotransferase system (PTS) for L-sorbose.
Table S9. Representation genes (OGUs) assigned to KEGG pathways in the shared and vari-
able components of the EC72_E1U1 and EC72_E3U1 genomes.
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multiple Bacteroides strains in vivo
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Center for Genome Sciences and Systems Biology, Washington University School of Medicine, 
St. Louis, MO 63108
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Abstract
Defining the mechanisms critical for maintaining the highly adaptive and durable relationship 
between the human gut microbiota and its hosts is necessary if we are to understand how this com-
munity contributes to our health status, and how it can be manipulated to promote wellness. To 
help address this challenge, we generated libraries of tens of thousands of transposon (Tn) mutants 
for each of four human gut Bacteroides strains, two of which represented the same species. These 
libraries were introduced into singly-caged adult germ-free mice as part of a 15-member artificial 
human gut microbiota containing 11 other wild-type bacterial species. Mice received one of two 
distinct diets, or an ordered sequence of both. Multi-taxon INsertion Sequencing (INSeq) provided 
a digital readout of the remarkably consistent pattern of community assembly, identified shared as 
well as species-, strain-, and diet-specific fitness determinants associated with a variety of meta-
bolic/nutrient processing pathways, enabled quantitative gene-level measurement of the resiliency 
of the responses to diet perturbations, revealed that arabinoxylan, the most common hemicellulose 
in cereals, could be used to deliberately manipulate the representation of a prominent commu-
nity member, Bacteroides cellulosilyticus WH2, and defined the niche adjustments of this and the 
other Bacteroides to arabinoxylan supplementation of a high fat diet. The approach described for 
mapping fitness landscapes in a community context should facilitate discovery efforts aimed at 
identifying the niches of microbiota members, as well as ways to deliberately reshape community 
structure and function through dietary interventions.
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Introduction
A species’ niche is the description of all of the environmental conditions required to permit a 
population of that species to persist, including the effects of the population on those conditions (1). 
This definition includes the species’ resource requirements, stress tolerances, and interactions with 
other species that act as competitors, predators, parasites, and mutualists. Relatively little is known 
about the genetic factors that allow members of the human gut microbiota to occupy their niches. 
Identification of these factors is important for understanding the mechanisms that determine com-
munity assembly, community responses to and recovery after various perturbations, and the food 
webs that link microbes to one another and to their host. Discovery of these factors should spawn 
new approaches for intentional manipulation of the functional properties of the microbiota.
The human gut microbiota is notable for its high level of strain diversity (2-4). A current 
view is that strains acquired by an individual early in life persist for decades and that strains are 
shared among family members (4). Gut bacterial species in an individual are typically represented 
by multiple strains, each with somewhat divergent gene content; this feature likely contributes to 
the ability of the microbiota to adapt to changing conditions, but prompts the question of the de-
gree to which given sets of strains share or compete for niche space in the gut ecosystem. Given 
the large effort being mobilized to identify naturally occurring human gut bacteria that can be used 
as next generation probiotics, answers to this question have therapeutic implications. 
Deleterious mutations in genes that affect or effect interactions between an organism and 
its environment provide insights into the key factors that define that organism’s niches. In this 
report we describe an approach for simultaneously identifying genetic determinants of fitness for 
multiple members of a defined artificial human gut microbiota installed in gnotobiotic mice fed 
distinct diets monotonously or in an ordered sequence. We focus on four sequenced human gut 
Bacteroides strains: B. cellulosilyticus WH2, B. ovatus ATCC 8483, B. thetaiotaomicron VPI-5482 
and B. thetaiotaomicron 7330. Culture-independent surveys of a number of human populations in-
dicate that all three of these Bacteroides species are prominently represented in the guts of healthy 
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individuals (3, 5). All four strains contain numerous genes involved in the recognition and pro-
cessing of otherwise indigestible dietary polysaccharides (6-9; Table S1). We apply genome-wide 
transposon mutagenesis to these three prominent human gut-derived Bacteroides species, and the 
two strain representatives of one of them, and colonize singly-housed, germ-free mice with all 
four mutant libraries together with a defined consortium of 11 other wild-type human gut bacterial 
species representing major phylogenetic lineages present in the microbiota. This approach allowed 
us to examine assembly of the 15-member artificial community, and to characterize responses to 
dietary perturbation, and recovery after these perturbations (resilience) at the community level, the 
individual species/strain level, as well as the gene level. We identify shared as well as species- and 
strain-specific genetic and metabolic features that impact fitness of Bacteroides in the gut environ-
ment.
Results
Characterizing multiple transposon mutant libraries simultaneously in vivo (multi-taxon 
INSeq)
Each library we generated from the four bacterial strains was composed of 87,000-170,000 iso-
genic transposon (Tn) mutants. Each mutant contained a single site of insertion of the Tn element. 
75.5-91.4% of the open reading frames (ORFs) in these four Bacteroides contained a Tn insertion, 
allowing us to conclude that disruption of these genes did not preclude growth in the rich medium 
used to construct the libraries. Each ORF was covered by an average of 20 to 39 Tn insertions 
(Table S2; Figure S1A-D). These Tn mutant libraries were introduced into germ-free mice to-
gether with 11 wild-type species that are common constituents of the adult gut microbiota (Figure 
1A). To permit simultaneous analysis of multiple mutant libraries in the same recipient gnotobiotic 
mouse, a mariner transposon delivery vector with MmeI sites positioned at each end of the Tn (10, 
11) was modified so that it contained two taxon-specific barcodes (Figure 1B). MmeI digestion 
of microbial DNA prepared from the gut contents or feces of recipient gnotobiotic mice cleaves 
genomic DNA at a site 20-21 bp distal to the restriction enzyme’s recognition site. The site of Tn 
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insertion and the relative abundance of each Tn mutant in the input libraries introduced into mice 
and in the ‘output’ communities recovered from these animals were defined using a multi-taxon 
insertion sequencing (INSeq) protocol. This protocol enables sequencing of the 16-17 bp of flank-
ing genomic sequence in addition to the taxon-specific barcode positioned within the transposon 
(Figure 1B). A software package (SI Methods) was used to assign sequencing reads based on the 
sample-specific barcode, and the taxon-specific barcode. Control experiments, using ‘mock com-
munities’ composed of the 15-member collection of cultured human gut bacteria with different 
proportions of the mutant libraries (ranging from 0.5-40% of the community) revealed that this 
protocol had high specificity (91.6±0.84% of reads mapped to sites of Tn insertion), high sensitiv-
ity (a mutant library representing as little as 0.5% of the entire community could be characterized), 
and good reproducibility (R2>0.9; n=5 technical replicates/mock community) (Table S2, see SI 
Methods and SI Results for details). 
To identify mutations that were deleterious in the gut, we calculated a “fitness index” for 
each gene based on the relative abundance of its INSeq reads in the output community (e.g., fecal 
microbiota) compared to input library. Using an approach based on the Expectation Maximization 
(EM) algorithm, we observed that the output to input log-ratios for the entire mutant population 
were bimodally distributed, with the vast majority of mutants (genes) falling in a normal distribu-
tion to the right of a much smaller distribution with much lower fitness. To identify deleterious mu-
tations, we calculated a z-score (fitness index) for the difference between each gene’s log-ratio and 
the mean of the upper normal distribution (Figure 1C-E). A p-value was determined based on a 
normal distribution using a Z-test, and a q-value assigned after applying a multiple hypothesis test-
ing correction (FDR). To avoid misidentifying genes as significant fitness determinants, we only 
considered those that were significantly depleted across biological repeats (significant q-values in 
4 out of 5 samples). In silico simulations revealed that this EM algorithm-based procedure yielded 
a false positive rate of less than 5% for mutants in genes whose relative abundance was >0.002% 
(Figure S2). These simulations were verified by applying the analysis pipeline to our mock com-
munities (Table S2). ORFs satisfying the criteria of having a significant q-value in one diet condi-
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tion, and no fitness defects in any biological replicates under another diet condition, were defined 
as ‘diet-specific fitness factors’. 
Community assembly, response to diet, and resilience 
Adult (10-12-week-old) male germ-free C57BL/6J mice were placed on either a low-fat/high-
plant polysaccharide (LF/HPP) chow or a diet where calories were largely derived from hydroge-
nated vegetable shortening and beef tallow, and where carbohydrates were limited to sucrose, corn 
starch, and maltodextrin (plus an indigestible cellulose binder) [‘high saturated fat’/’high simple 
sugar’ (HF/HS) diet]. Diets were started 7 d before a single oral gavage of the artificial community 
containing the four mutagenized strain libraries and 11 wild-type strains (Figure 2A). Control 
experiments used a 15-member community composed of all wild-type strains, or 15-member com-
munities that only contained a single mutant library (Figure S3A). Groups of singly-caged mice 
were maintained on either the LF/HPP or HF/HS diet for the duration of the experiment, while 
other groups were subjected to a reciprocal set of diet oscillations (LF/HPPèHF/HSèLF/HPP 
or HF/HSèLF/HPPèHF/HS) (n=5 mice/diet treatment/community type; Figure 2A). Short-read 
shotgun sequencing (COmmunity PROfiling by Sequencing; COPRO-Seq) of DNA prepared from 
fecal samples collected over the course of each experiment was used to define the relative abun-
dance of each community member. 
When considered as a whole, each mutant library acted similarly to the parental wild-type 
strain in terms of its proportional abundance in the community (Figure S3B, Table S3). In both 
monotonously fed treatment groups, the relative abundance of B. cellulosilyticus WH2 was high, 
although significantly greater in animals fed LF/HPP chow (36±1.6% versus 16±3.1% after 16 
days on the diets; p<0.01, Mann-Whitney test). B. ovatus had a striking preference for condi-
tions associated with LF/HPP chow feeding (11±0.7% versus 0.8±0.3%; p<0.01, Mann-Whitney 
test) (Figure S4A-B). Strain-specific differences were also evident; B. thetaiotaomicron VPI-5482 
was more successful in the LF/HPP diet context than B. thetaiotaomicron 7330 (9±0.5% versus 
0.02±0.04 %; p<0.05, Mann-Whitney test) while the 7330 strain had significantly higher abun-
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dance than the VPI-5482 strain when animals were consuming the HF/HS diet (6±1.4% versus 
3±0.5%; p<0.05, Mann-Whitney test) (Figure S4C-D). 
Multi-taxon INSeq allowed us to obtain a genome-wide, gene-level view of the effects of 
dietary selection pressures on fitness. Analysis of the relative abundances of all B. cellulosilyticus 
mutants in fecal samples collected at 4, 10, and 16 days post-gavage in the two monotonous diet 
treatment groups disclosed that by day 4 the mutant population had already manifested diet-spe-
cific configurations (PERMANOVA, p=0.001). The relative abundances of B. cellulosilyticus mu-
tants were remarkably consistent between individually-caged mice monotonously fed a given diet, 
including groups of mice housed in different gnotobiotic isolators (Student’s unpaired t-test; Fig-
ure S5A) This within treatment group consistency (defined by Hellinger distances) was sustained 
as the configuration of the mutant population evolved during the ensuing 11 days of monotonous 
diet consumption (Figure 2D, Figure S5B-C).
Multi-taxon INSeq of fecal samples collected at the end of 16 days of monotonous diet 
consumption yielded 517 HF/HS diet-specific B. cellulosilyticus fitness determinants and 33 LF/
HPP diet-specific determinants: 270 of the 517 HF/HS diet-specific genes had KEGG Orthology 
(KO) assignments; among this group, there was a significant enrichment of genes belonging to 
the KEGG categories ‘Membrane Transport’ [e.g., an operon involved in iron transport, another 
involved in zinc transport, plus several Major Facilitator Superfamily transporters (glucose, man-
nose, xylose and phosphate)], ‘Metabolism of Cofactors and Vitamins’ (e.g., five genes in the co-
balamin biosynthesis pathway, consistent with the view that the capacity to synthesize and utilize 
cobalamin and other substituted corrins is an important determinant of survival in the gut (10, 12), 
and ‘Protein Folding and Associated Processing’ (see Table S4A for the functional annotations and 
fitness indices of these genes). 
The two groups of mice subjected to a reciprocal set of diet oscillations [LF/HPP (4d)
èHF/HS (6d)èLF/HPP(6d) or HF/HS(4d)èLF/HPP(6d)èHF/HS(6d)] exhibited consistent 
and marked diet-specific changes in overall community structure as defined by COPRO-Seq (Fig-
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ure 2B,C; also see the patterns of change in relative abundances of B. cellulosilyticus and B. ova-
tus in Figure S4A,B). Followup INSeq analysis of the same fecal DNA samples used for COPRO-
Seq measurements afforded an opportunity to simultaneously characterize the degree to which the 
aggregate collections of B. cellulosilyticus and B. ovatus mutants were able recover from a diet 
disturbance (an INSeq-based definition of resiliency) and the variation in such recovery between 
animals (an INSeq-based measure of stochasticity). The configuration of the B. cellulosilyticus 
mutant population exhibited diet-specific changes. However, during the ‘recovery phase’, when 
these two groups of mice were returned to the starting diet of the sequence, the B. cellulosilyticus 
mutant library shifted towards a state similar but not identical to that observed in monotonously fed 
hosts (Figure 2D). Of the 517 genes identified as HF/HS specific fitness determinants in monoto-
nously fed animals, 146 had significantly higher fitness scores in animals that had been switched 
temporarily to LF/HPP chow and then returned to the HF/HS diet compared to mice that had only 
consumed the HF/HS diet [includes the 6 genes comprising the only one of its 113 PULs identified 
as a HF/HS diet-specific fitness determinant (see Table S4A and below)]. Similarly, 21 of the 33 
genes designated as LF/HPP-specific fitness in monotonously fed mice had significantly higher 
z-scores in mice that had been temporarily switched to the HF/HS diet and then returned to LF/
HPP chow (Table S4A). As with B. cellulosilyticus WH2, diet oscillations of the type A to B to A 
(or B to A to B) led to increased similarity in the overall patterns of fitness in the B. ovatus mutant 
library compared to those that were monotonously fed (Figure S6; Table S4B). This response to 
perturbation may represent an important mechanism behind the maintenance of diet-specific traits 
in a member or members of a microbiota harbored by hosts experiencing more varied diets (here 
we are using mutants as proxies for functional ‘traits’). 
Identifying core in vivo fitness determinants in four Bacteroides strains 
Genes that are conserved among the four Bacteroides strains and that show a significant effect on 
fitness in all strains in both diets contexts can be defined as a core set of in vivo fitness determi-
nants for these members of this genus; as such they inform us about the resource requirements and 
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selective pressures these taxa experience in the gut in this community context and under these two 
dietary conditions.
In total, 2,204 genes are conserved among all four Bacteroides strains. Multi-taxon INSeq 
of fecal samples, collected from mice colonized for 16d and monotonously fed one or the other diet 
revealed 86 conserved genes with significant diet-independent effects on fitness in all four strains 
(Table S5). The fitness indices (z-scores) for these genes varied as a function of strain but less so 
across the different diets (p<0.001; two-way ANOVA). Twenty of the 86 core fitness determinants 
were components of KEGG pathways involved in various aspects of amino acid biosynthesis and 
metabolism (Figure S7). In follow-up studies, the B. cellulosilyticus mutant library was grown 
to stationary phase in minimal medium lacking amino acids and containing one of several car-
bon sources [glucose, xylose, arabinose, or wheat arabinoxylan (the most common hemicellulose 
in cereals)], or in control rich medium [tryptone-yeast extract-glucose (TYG) (n=6 replicates/
growth condition)]. INSeq analysis of the input library and stationary phase cultures (Table S6) 
confirmed that Tn mutagenesis of the 20 core fitness determinants annotated as being involved in 
the biosynthesis of 11 amino acids precluded growth in any of four types of amino acid-depleted 
minimal media but did not affect growth in the rich medium. Together, these results emphasize the 
important contribution of amino acid biosynthesis to the survival of these Bacteroides strains in 
the niches they occupy in the 15-member community, at least in the two diet contexts considered 
in this study. 
Regulators of carbohydrate utilization were also represented among the 86 shared in vivo 
fitness factors. They include homologs of BT4338, a Crp-like transcription factor that controls a 
proposed global sugar catabolic regulon (13) encompassing up to 30 genes/genome that participate 
in utilization of arabinose, xylose, fucose, galacturonate, pectin and b-hexosamines. [Three core 
fitness genes are required for growth in arabinose: araA (L-arabinose isomerase), araP (arabinose 
transporter) and araR (NrtR family transcriptional regulator of arabinose utilization genes)]. Ho-
mologs of BT3992, an anti-sigma factor that in B. thetaiotaomicron functions as part of a trans-
envelope signaling system that coordinately regulates expression of three polysaccharide utiliza-
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tion loci (PULs) and a capsular polysaccharide synthesis (CPS) locus (14) were also represented 
among the group of shared diet-independent Bacteroides fitness factors.
We tested the hypothesis that genes that played a key role in determining fitness of the four 
Bacteroides strains in the gut ecosystem would be expressed at higher levels in the gut than in rich 
medium or in minimal medium containing single carbon sources including arabinose, arabinox-
ylan, xylose, or glucose. To do so, we performed microbial RNA-Seq on fecal samples collected 
at the same time as samples for INSeq. The results revealed that only 14 of the 86 core fitness 
determinants had significantly higher levels of expression in vivo under both diet conditions than 
under any of the in vitro conditions examined (n=4 mice/diet treatment; n=3 biological replicates/
in vitro growth condition) (Figure S8A). The fact that expression of the remaining 72 core fitness 
determinants, including the regulator of the proposed sugar catabolic regulon (Figure S8B), was 
not higher in vivo than in in vitro emphasizes the limitations of using mRNA levels as an exclusive 
parameter for nominating genes as critical for survival in a given (gut) environmental context. 
Differences in fitness determinants in the two B. thetaiotaomicron strains
B. thetaiotaomicron VPI-5482 is one of the most-studied human gut Bacteroides (6, 7, 13, 15-17). 
B. thetaiotaomicron 7330 is a strain recovered from a healthy adult [see Figure 3A for alignments 
of the two genomes, Table S7A for the representation of genes in KEGG categories, KEGG path-
ways for the two strains, and Table S7B for a list of the 94 PULs encompassing 777 predicted 
ORFs in the 7330 strain, 18 of which (130 ORFs) are unique (their protein products had <90% 
similarity to any protein in the predicted VPI-5482 proteome)].The 7330 strain is much more suc-
cessful in the 15-member community context when mice are consuming the HF/HS diet. While 
the relative representation of each B. thetaiotaomicron strain in the 15-member community varied 
by 340-fold depending upon the diet, their total relative abundance in the community was the 
same across the two diets (Figure 3B), raising the possibility that the strains might compete for 
a niche in this community and that occupancy of this niche by one or the other strains is highly 
sensitive to diet. Therefore, we used INSeq to identify factors that define their distinct dietary 
94
niches (Table S8; includes the 236 HF/HS-diet specific fitness determinants in B. thetaiotaomi-
cron 7330, listed in decreasing rank order of their FDR q-values. No KEGG category or pathway 
was significantly enriched among these 236 ORFs (Table S8B). In the absence of dietary polysac-
charides, B. thetaiotaomicron VPI-5482 adaptively forages on host mucosal glycans suggesting 
that the capacity to consume both dietary and host-derived glycans is one of the mechanisms by 
which it is able to survive in the gut (7, 18, 19). The HF/HS diet-specific and 7330 strain-specific 
fitness factors include genes in two operons specifying components of cation efflux systems plus 
a number of glycoside hydrolases predicted to be involved in the catabolism of mucosal glycans 
(Figure 3C,D; Table S8B). The latter include genes (Btheta7330_1384, Btheta7330_3308 and 
Btheta7330_3311) that encode three hexosaminidases (EC 3.2.1.52 cleaves GalNAc residues) that 
are also represented in the VPI-5482 genome but where they do not convey a significant fitness 
effect. Thus, one functional distinction between the two strains revealed by multi-taxon INSeq is 
that they likely use different strategies for adaptive foraging of mucosal glycans in the absence of 
dietary polysaccharides.
Individual Bacteroides species contain multiple capsular polysaccharide biosynthesis 
(CPS) loci, allowing for a large number of combinations of locus expression in different envi-
ronmental contexts. We used multi-taxon INSeq to identify CPS loci and their component genes 
that were critical for fitness in vivo within and across species and strains as a function of diet. 
The two B. thetaiotaoimicron strains vividly illustrate the unique contributions of individual loci 
to survival. CPS4 was the only one of the VPI 5482 strain’s eight CPS loci that functioned as a 
significant fitness determinant in the context of the 15-member community and either of the two 
diets (as shown in Figure S9B, 20 of its 21 genes, covered by >1200 Tn mutants were defined as 
essential). In contrast, CPS6, a structurally distinct locus in the 7330 strain composed of 18 genes, 
was the only one among its six CPS loci critical for its fitness in either diet context (all 18 genes, 
covered by >750 mutants, had significant fitness indices; Figure S9C). INSeq established that this 
strain-specificity for CPS fitness effects was evident along the length of the gut (data not shown). 
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Identifying a diet supplement that can specifically manipulate B. cellulosilyticus abundance
B. cellulosilyticus WH2 is equipped with the largest number of carbohydrate active enzymes (CA-
ZYmes, comprising glycoside hydrolases, polysaccharide lyases, carbohydrate esterases, glycos-
yltransferases, carbohydrate binding modules) in any sequenced Bacteroidetes genome reported 
to date (9). Its 503 CAZYmes are distributed among 113 PULs. Remarkably, only one of the 113 
PULs in B. cellulosilyticus WH2 (BACWH2_4070-76) functioned as a significant fitness determi-
nant in the HF/HS diet context (Figure 4A). With the exception of this PUL’s hybrid two-compo-
nent system transcriptional regulator, all of its other six genes, which include a predicted xylanase 
(BACWH2_4072), a predicted b-galactosidase (BACWH2-4071), and a sialate O-acetylesterase 
(EC3.1.1.53; BACWH2-4070), satisfied our criteria for designation as HF/HS diet-specific fitness 
determinants. Foraging on mucus glycans that contain N-acetyl-O-acetylneuraminate residues 
would represent an adaptive response of this organism to a high fat diet that does not contain com-
plex polysaccharides (including xylans). The fitness indices of the 117 Tn mutants that mapped 
to the six genes in this PUL were remarkably consistent between individually-caged animals as 
a function of their diet. Moreover, as noted above, the relative abundances of these mutants was 
higher in mice that had undergone a HF/HS-LF/HPP-HF/HS diet oscillation than in mice monoto-
nously fed the HF/HS diet (Figure 4A). 
Our previous in vitro studies of B. cellulosilyticus WH2 cultured in minimal medium sup-
plemented with one of 31 distinct carbohydrate substrates, plus RNA-Seq analysis of the bacte-
rium recovered at mid-log phase from culture in those minimal media that supported its growth, 
revealed that this PUL was induced by xylan and arabinoxylan (9; Figure S10A). B. ovatus, the 
only other Bacteroides strain in the artificial community that could grow in minimal medium 
containing purified arabinoxylan as the sole carbon source (Figure S10B) contains a PUL (BACO-
VA_4389-94) that is induced when this medium was supplemented with arabinoxylan (or xylan). 
Multi-taxon INSeq of fecal samples collected from mice harboring the 15-member community 
showed that unlike the xylan and arabinoxylan-inducible B. cellulosilyticus PUL, this PUL is not 
required for survival of B. ovatus in the HF/HS diet context (Figure S10C).
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Given these results, we examined the effects of consumption of arabinoxylan purified from 
wheat on the relative abundances of B. cellulosyliticus WH2 and B. ovatus and their fitness de-
terminants. Our rationale was that we could use arbinoxylan to induce expression of the one B. 
cellulosilyticus WH2 PUL that was a key fitness factor in the HF/HS diet context (this diet does 
not contain xylans), and that PUL induction would be accompanied by improved fitness. Prior to 
colonization with the 15-member community containing the INSeq libraries, one group of germ-
free mice received the HF/HS diet plus drinking water supplemented with wheat-derived arabinox-
ylan (7.5% w/v) for seven days. Another group received the same diet but without arabinoxylan 
in their drinking water. All groups were then gavaged with the artificial community: the group 
pre-treated with arabinoxylan continued to receive the HF/HS diet and supplemented water ad li-
bitum for the next 14 days and then was switched to unsupplemented water. A reciprocal treatment 
group received unsupplemented water plus the HF/HS diet for 14 days followed by a switch to 
arabinoxylan-supplemented water. A third group received unsupplemented water plus the low fat, 
high plant polysaccharide (LF/HPP) diet for 14 days followed by a switch to supplemented water 
(while being maintained on the LF/HPP chow); these animals served as a control since the targeted 
PUL only manifests itself as a fitness determinant in the context of the high fat, polysaccharide-
deficient diet (n=5 individually caged mice per treatment group) (Figure 4B). 
COPRO-Seq analysis of fecal samples collected at the end of each 14 d treatment period 
demonstrated that arabinoxylan produced a significant increase in B. cellulosilyticus WH2 abun-
dance in mice fed the HF/HS diet (adjusted p-value <0.01; Student’s t-test) but no effect on the 
LF/HPP diet context (Figure 4C; n=5 singly housed mice/treatment arm). Consistent with the 
INSeq results showing that the arabinoxylan utilization PUL in B. ovatus is not a fitness determi-
nant in the HF/HS diet context, we observed no significant effects of arabinoxylan treatment on 
the relative abundance of this community member (Figure 4C). We confirmed these findings in a 
separate experiment where two groups of gnotobiotic mice harboring the 15-member community 
were treated for 56 days with a HF/HS diet with or without supplementation of their drinking 
water with 15% arabinoxylan. In this higher dose, longer duration, monotonous diet experiment, 
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the abundance of B. cellulosilyticus WH2 increased significantly (as did levels of cecal short chain 
fatty acids and deconjugated bile acids), while B. ovatus showed no response (Figure S11A,B). 
Arabinoxylan treatment did not produce a statistically significant difference in total body weight 
(Student’s t-test).
We identified 294 B. cellulosilyticus WH2 genes that functioned as fitness factors when 
mice consumed the HF/HS diet without arabinoxylan supplementation that were no longer signifi-
cant fitness determinants when water was supplemented with arabinoxylan (listed in Table S9A by 
KEGG category and ranked according to their fitness index in the unsupplemented HF/HS diet). 
These genes included the arabinoxylan- and xylan-inducible PUL, BACWH2_4070-4075 (Figure 
S12A). (Note B. cellulosyliticus WH2 contains another PUL encoding a predicted xylanase; this 
PUL (BACWH2_4044-4055) is induced by xylan and arabinoxylan in vitro but is not a fitness de-
terminant when mice are consuming the HF/HS diet ± arabinoxylan, suggesting that together these 
two PULs provide redundant yet distinguishable functions expressed by B. cellulosilyticus WH2 
in the 15-member community context). 
The only KEGG category significantly enriched for genes that no longer function as fitness 
determinants when HF/HS treated mice receive arabinoxylan is ‘Membrane transport’ (see Figure 
S12B for a ranking based on their q-scores). They encode one nucleoside H+ symporter, one ABC-
type sugar transporter, two MFS-type fucose transporters, proteins involved in metal ion transport 
(iron, zinc), a MFS- and an ABC-type drug resistant transporter, and three ABC-type antimicrobial 
peptide transporters (Figure S12B). The only B. ovatus genes in the Membrane transport’ cat-
egory that lose their significant fitness index scores with arabinoxylan treatment are two MFS-type 
multidrug transporters and one ABC-type antimicrobial peptide transporter (these transporters are 
not homologous to those identified in B. cellulosilyticus). Mucosa-associated fucosylated glycans 
are adaptively foraged by human gut Bacteroides spp. (7, 19, 20); these Bacteroides also regulate 
production of antimicrobial peptides by the epithelium (21, 22). Recent studies have shown that 
fucose derived from gut mucosal glycans can be used as a signal by pathogens to change their 
virulence gene expression in ways that aid invasion/colonization of the gut (23, 24). Integrating 
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these findings suggests that arabinoxylan supplementation reduces the need of B. cellulosilyticus 
(but not B. ovatus) to adaptively forage on host-derived mucosal (e.g., fucosylated) glycans, and 
that the diminished requirements for anti-microbial peptide transporters reflec alterations in the 
organisms’ interactions with the gut mucus barrier.
A total of 24 genes were identified in the B. cellulosilyticus WH2 genome that were sig-
nificant fitness determinants when mice received the HF/HS diet plus arabinoxylan but not when 
animals received the HF/HS diet alone (Table S9A): they included (i) all genes in an operon 
(BACWH2_0804-0806) that includes a sulfotransferase and sulfate transferase (EC 3.7.74), con-
sistent with the observed increase in deconjugated bile acids documented by UPLC-MS of cecal 
contents (Figure S11B), and (ii) several genes that highlight how increases in arabinoxylan avail-
ability enhance the importance of ammonium utilization for synthesis of amino acids and proteins 
in this community and diet context [an ammonium transporter (BACWH2_4959), plus glutamine, 
glutamate, and asparagine synthetases (BACWH2_0058, BACWH2_4974, and BACWH2_4972, 
respectively)]. 
Even though B. ovatus did not manifest a significant change in its relative abundance when 
mice received arabinoxylan supplemented water, multi-taxon INSeq revealed 31 genes that were 
not fitness determinants when mice consumed HF/HS chow alone but ‘acquired’ significant z-
scores when arabinoxylan was introduced (for a list, see Table S10B). They include seven closely 
linked glycosyltransferase genes, including two raffinose-raffinose alpha-galactotransferase ho-
mologs (EC2.4.1.166) and a galactoside 2-L-fucosyltransferase (EC2.4.1.69)], suggesting that this 
organism changes its glycan utilization strategies when it encounters arabinoxylan in the gut en-
vironment. 
Prospectus 
There are several important definitions of the niche in the field of macroecology and evolution-
ary biology. Elton defined the niche as an animal’s “place in the biotic environment, its relations 
to food and enemies”(25); i.e., as the role an organism was playing in the food web. Hutchinson 
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(1957) described the niche as an n-dimensional hypervolume, where the dimensions are values 
of the environmental conditions and resources that contain the requirements of an individual or 
species to persist (as a population) (26); these requirements become axes in the coordinate system 
that describes the niche. One of the dangers of focusing on resources alone as the description of 
a microbe’s niche is that it places an immediate precedence on resource competition as a major 
mechanism for community structure, and less (or zero) focus on other interactions. For instance, 
the presence of predators (phage) or mutualists (co-feeding) can mediate coexistence between 
competing species in some situations. In our study, multi-taxon INSeq is used to provide an ‘op-
erational’ description of an organism’s niche by determining which sets of genes allow a bacterial 
strain to co-exist with other strains/species under a defined set of habitat conditions (gnotobiotic 
mice representing a given genetic background, colonized with a given set of sequenced organisms 
and fed a given set of diets). In principle, this approach can be applied to gut and non-gut habitats 
in gnotobiotic mice representing different genetic backgrounds, harboring different microbial con-
sortia and manipulated in various ways (diet, immune system, etc) to obtain a more comprehensive 
picture of how host genotype impacts niches. It also offers a way to address fundamental as well 
as applied questions: e.g., functionally discriminating strains when exploring issues related to the 
genetic foundations of opportunism, defining stochasticity during community assembly, resiliency 
after a perturbation, selecting lead probiotic candidates for bioremediation of perturbed/dysbiotic 
microbial communitiesm identifying compounds that affect the functional configurations of a tar-
geted microbiota, and for characterizing the nutritional effects/value of diets and their ingredients. 
100
Acknowledgements
We thank David O’Donnell and Maria Karlsson for their assistance with gnotobiotic mouse hus-
bandry, plus Alejandro Reyes for many helpful suggestions. This work was supported in part by 
grants from the NIH (DK70977 and DK30292) and the Crohn’s and Colitis Foundation of America.
Data deposition
INSeq, COPROSeq, and microbial RNASeq datasets have been deposited in the European Nucle-
otide Archive (ENA). 
101
References 
1. J. M. Chase, M. A. Leibold, Ecological niches : linking classical and contemporary 
approaches. Interspecific interactions (University of Chicago Press, Chicago, 2003).
2. C. Human Microbiome Jumpstart Reference Strains et al., A catalog of reference genomes 
from the human microbiome. Science 328, 994-999 (2010).
3. J. Qin et al., A human gut microbial gene catalogue established by metagenomic sequencing. 
Nature 464, 59-65 (2010).
4. J. J. Faith et al., The long-term stability of the human gut microbiota. Science 341, 1237439 
(2013).
5. C. Human Microbiome Project, Structure, function and diversity of the healthy human 
microbiome. Nature 486, 207-214 (2012).
6. J. Xu et al., A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 
299, 2074-2076 (2003).
7. J. L. Sonnenburg et al., Glycan foraging in vivo by an intestine-adapted bacterial symbiont. 
Science 307, 1955-1959 (2005).
8. E. C. Martens et al., Recognition and degradation of plant cell wall polysaccharides by two 
human gut symbionts. PLoS Biology 9, e1001221 (2011).
9. N. P. McNulty et al., Effects of diet on resource utilization by a model human gut microbiota 
containing Bacteroides cellulosilyticus WH2, a symbiont with an extensive glycobiome. 
PLoS Biology 11, e1001637 (2013).
10. A. L. Goodman et al., Identifying genetic determinants needed to establish a human gut 
symbiont in its habitat. Cell host & microbe 6, 279-289 (2009).
11. A. L. Goodman, M. Wu, J. I. Gordon, Identifying microbial fitness determinants by 
insertion sequencing using genome-wide transposon mutant libraries. Nature Protocols 6, 
1969-1980 (2011).
102
12. P. H. Degnan, N. A. Barry, K. C. Mok, M. E. Taga, A. L. Goodman, Human gut microbes 
use multiple transporters to distinguish vitamin B(1)(2) analogs and compete in the gut. 
Cell Host & Microbe 15, 47-57 (2014).
13. D. A. Ravcheev, A. Godzik, A. L. Osterman, D. A. Rodionov, Polysaccharides utilization in 
human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction 
of metabolic and regulatory networks. BMC Genomics 14, 873 (2013).
14. E. C. Martens, R. Roth, J. E. Heuser, J. I. Gordon, Coordinate regulation of glycan 
degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. 
J Biol Chem 284, 18445-18457 (2009).
15. A. R. Reeves, J. N. D’Elia, J. Frias, A. A. Salyers, A Bacteroides thetaiotaomicron outer 
membrane protein that is essential for utilization of maltooligosaccharides and starch. J 
Bacteriol 178, 823-830 (1996).
16. A. R. Reeves, G. R. Wang, A. A. Salyers, Characterization of four outer membrane proteins 
that play a role in utilization of starch by Bacteroides thetaiotaomicron. J Bacteriol 179, 
643-649 (1997).
17. J. A. Shipman, J. E. Berleman, A. A. Salyers, Characterization of four outer membrane 
proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron. J 
Bacteriol 182, 5365-5372 (2000).
18. E. C. Martens, H. C. Chiang, J. I. Gordon, Mucosal glycan foraging enhances fitness and 
transmission of a saccharolytic human gut bacterial symbiont. Cell Host & Microbe 4, 447-
457 (2008).
19. P. C. Kashyap et al., Genetically dictated change in host mucus carbohydrate landscape 
exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci USA 110, 17059-
17064 (2013).
103
20. L. V. Hooper, J. Xu, P. G. Falk, T. Midtvedt, J. I. Gordon, A molecular sensor that allows 
a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl 
Acad Sci USA 96, 9833-9838 (1999).
21. L. V. Hooper, T. S. Stappenbeck, C. V. Hong, J. I. Gordon, Angiogenins: a new class of 
microbicidal proteins involved in innate immunity. Nature Immunology 4, 269-273 (2003).
22. H. L. Cash, C. V. Whitham, C. L. Behrendt, L. V. Hooper, Symbiotic bacteria direct 
expression of an intestinal bactericidal lectin. Science 313, 1126-1130 (2006).
23. A. R. Pacheco et al., Fucose sensing regulates bacterial intestinal colonization. Nature 492, 
113-117 (2012).
24. K. M. Ng et al., Microbiota-liberated host sugars facilitate post-antibiotic expansion of 
enteric pathogens. Nature 502, 96-99 (2013).
25. C. S. Elton, Animal ecology. (University of Chicago Press, Chicago, 2001).
26. G. E. Hutchinson, Concluding Remarks Cold Spring Harbor Symposia on Quantitative 
Biology 22, 13 (1957).
27. M. Krzywinski et al., Circos: an information aesthetic for comparative genomics. Genome 
Research 19, 1639-1645 (2009).
28. F. E. Rey et al., Dissecting the in vivo metabolic potential of two human gut acetogens. J 
Biol Chem 285, 22082-22090 (2010).
29. J. J. Faith, N. P. McNulty, F. E. Rey, J. I. Gordon, Predicting a human gut microbiota’s 
response to diet in gnotobiotic mice. Science 333, 101-104 (2011).
30. Z. Ning, A. J. Cox, J. C. Mullikin, SSAHA: a fast search method for large DNA databases. 
Genome Research 11, 1725-1729 (2001).
31. S. Anders, W. Huber, Differential expression analysis for sequence count data. Genome 
Biology 11, R106 (2010).
104
32. F. E. Rey et al., Metabolic niche of a prominent sulfate-reducing human gut bacterium. 
Proc Natl Acad Sci USA 110, 13582-13587 (2013).
105
Figure Legends
Figure 1. Experimental and computational pipeline for multi-taxon INSeq. (A) Mutant librar-
ies (input populations) are pooled together with other wild-type strains to form an artificial com-
munity of sequenced members of the microbiota; this consortium is then introduced into germ-free 
mice. Community assembly, the effects of diet perturbation, and recovery from diet oscillations 
are characterized at a community-, strain- and gene- level. (B) Preparation of a sequencing library 
for multi-taxon INSeq. Genomic DNA from a sample is digested with MmeI and transposon-sized 
fragments (~1.5 kb) are isolated, ligated to adapters with a sample-specific barcode and ampli-
fied by PCR to create the final sequencing library. The sample barcode and chromosomal DNA 
flanking the site of transposon insertion are sequenced using read 1 sequencing primer (SP). The 
strain-specific barcodes are sequenced with an INSeq index SP. Note that each Tn carries two 
sequences, colored green and aqua that together comprise its taxon-specific barcode. (C-E) Data 
analysis pipeline. Sequencing reads are binned first by their sample-specific barcodes, and then 
by their strain-specific barcodes. Each read is then mapped to the strain’s genome to identify the 
insertion site from which it originated. The read count for each insertion site is tallied, normalized 
by sequencing depth, and the normalized sums for all insertion sites within a gene are combined. 
For each strain, the read count for a given gene represented in the output community is compared 
to the read count in the input population (panel C). The log ratio of output to input counts for each 
mutagenized gene in the strain is calculated and the expectation-maximization (EM) method used 
to define the bimodal distribution (panel D): the population on the right, delineated by the green 
line, is composed of mutants with normally-distributed log-ratios; the population delineated by the 
red line described mutants with lower log ratios that fall into a distinctly different distribution. A 
z-score is calculated for each gene by comparing the differences between its log-ratio and the mean 
of the upper normal population (panel E).
Figure 2. The effect of diet and diet oscillations on the structure of the 15 member artificial 
community containing 11 wild-type strains and the four mutant libraries, and the structure 
of the mutant population. (A) Experimental design. 10-12-week-old germ-free male C57BL/6J 
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mice were gavaged with the indicated consortium of 15 strains. Animals were given the LF/HPP 
and/or the HF/HS diet in the order shown. Fecal samples were collected at the indicated time 
points for INSeq and microbial RNA-Seq analyses. (B,C) Principal coordinates analysis (PCoA) 
of Hellinger distance measurements based on COPRO-Seq data. Each colored circle represents a 
fecal community sampled from an individually-caged mouse belonging to the indicated diet treat-
ment group. (D) PCoA of Hellinger distance measurements based on the relative abundance of B. 
cellulosilyticus WH2 Tn mutants in fecal samples, as defined by multi-taxon INSeq analysis. Each 
colored circle represents the population of all mutants in B. cellulosilyticus WH2 sampled from 
an individual mouse in the indicated diet treatment group at a given time point. Each empty circle 
represents the average location of the mutant population for a given group at a given time point. 
The lines connect time points in a given group. The color of the lines indicates the diet. Dashed 
lines indicate the diet oscillation groups. 
Figure 3. HF/HS diet-specific fitness determinants in B. thetaiotaomicron 7330. (A) Circos 
(27)-generated alignment of the B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron 7330 ge-
nomes. Grey lines connect genes encoding homologous proteins present in the two genomes. The 
color-coded outer circle denotes the similarity between these proteins: green, >90% identity (based 
on Blastp alignment); blue, 70%-90% identity; red, <70% identity; black, intergenic regions. (B) 
COPRO-Seq analysis of the relative abundance of the two B. thetaiotaomicron strains in the fecal 
microbiota of mice sampled two weeks after gavage while consuming the HF/HS or LF/HPP diets. 
Mean values ± SEM are shown (n=5 individually caged mice harboring a community consisting 
of 11 wild-type and the four mutant libraries/treatment group). Note that the summed relative 
abundance of the two strains remains the same even though the relative representation of the in-
dividual strains is significantly different in the two diet contexts (p<0.001, 2-way ANOVA). (C) 
HF/HS diet-specific fitness determinants in B. thetaiotaomicron 7330 involved in degradation of 
glycosaminoglycans associated with the intestinal mucosa (genes highlighted in red with their EC 
annotations). (D) HF/HS diet-associated changes in the z-scores of 7330-strain-specific fitness de-
terminants that are involved in transcription regulation (Btheta7330_2549) or are components of 
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operons encoding transport systems (vertical lines denote individual operons).
Figure 4. Arabinoxylan increases the relative abundance of B. cellulosilyticus WH2 in vivo. 
(A) INSeq analysis reveals that all genes in PUL BACWH2_4070-6 have significant fitness indices 
(z-values) in the HF/HS diet. BACWH2_4076, encoding a hybrid two-component system regula-
tor (HTCS), is the only gene in this PUL that has a significant fitness effect on the LF/HPP diet. 
Functional annotations for genes in the PUL are shown together with direction of their transcrip-
tion. Fitness indices for each gene in the different diet contexts (orange, HF/HS, green LF/HPP) 
are plotted as mean values ± SEM. The horizontal dashed line indicates the cutoff for significance 
(p<0.05; z-test with FDR correction). (B) Experimental design. Adult C57BL/6J germ-free mice 
were gavaged with a consortium containing 11 wild type strains plus the four Bacteroides INSeq 
libraries. Animals were fed the HF/HS or LF/HPP diets with or without supplementation of their 
drinking water with 7.5% arabinoxylan (n=5 individually-caged mice/group). (C) The relative 
abundance of B. cellulosilyticus WH2 and B. ovatus was defined by COPRO-Seq analysis of fe-
cal samples collected at the indicated time points. Mean values ± SEM are plotted. *** , p <0.001 
compared to the reference group A at 14 days post-gavage (dpg); +++, p <0.001 for within group 
comparisons of the 30 dpg versus 14 dpg fecal sample (Student’s t-test after FDR correction). B. 
ovatus, the only other Bacteroides strain in the community that exhibited significantly increased 
growth in minimal medium supplemented with arabinoxylan (Figure S10B) did not manifest a 
significant change in relative abundance in vivo when arabinoxylan was added to the drinking 
water (ns, not significant).
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Supplemental Materials
Supplemental Methods
Whole genome transposon mutagenesis of Bacteroides spp. 
We introduced taxon-specific barcodes into the mutagenesis vector (pSAM_Bt or pSAM_Bcell-
WH2) (Figure 1B) by PCR amplification using vector DNA as template and the various primer 
pairs described in Table S10A. Amplification conditions were as follows: initial denaturation at 
94 °C for 2 min, followed by 25 cycles of denaturation (94 °C for 15 sec), annealing (58 °C for 30 
sec), and amplification (58 °C for 90 sec). The vector was then digested with KpnI and BamHI, and 
the linear product ligated to the amplicon, yielding the barcoded Tn mutagenesis vector. 
Whole genome transposon mutagenesis of B. ovatus (ATCC 8483T), B. thetaiotaomicron 
7330 and B. cellulosilyticus WH2 was performed using the respective vectors and a modified ver-
sion of a previously published protocol (10). To improve conjugation efficiency, we combined 
100 mL of a mid-log phase culture of one of the Bacteroides strains that had been grown in TYG 
medium under anaerobic conditions (75% N2, 20%CO2, 5% H2), with 25 mL of a mid-log phase 
culture of E. coli l17, harboring the respective Tn mutagenesis vector, grown under aerobic condi-
tions in LB medium supplemented with 100 mg/mL of ampicillin. Immediately after the cultures 
were combined, they were passed through a 0.2mm diameter cellulose nitrate filter membrane 
(Thermo Scientific). The membrane, containing retained bacteria, was then placed on top of brain-
heart infusion (BHI) agar supplemented with 10% horse serum (Colorado Serum Co.) and the cells 
allowed to mate for 6 h at 37oC under aerobic conditions. The conjugates were harvested from the 
filter by scraping, resuspended in TYG medium and plated on BHI agar supplemented with eryth-
romycin (50 mg/mL) and gentamicin (200 mg/mL), after which the plates were incubated for 2 d at 
37 °C under anaerobic conditions. 87,000-170,000 isogenic transposon mutants/strain were pooled 
in TYG medium containing 30% glycerol and aliquots were stored at -80 °C.
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Gnotobiotic mice
All experiments involving mice were performed using protocols approved by the Animal Stud-
ies Committee of Washington University School of Medicine. Germ-free 10-12-week-old male 
C57BL/6J mice were individually caged in flexible plastic gnotobiotic isolators. Animals were 
given autoclaved LF/HPP diet (B&K chow #73780000, Zeigler Bros, Inc.) or HF/HS diet (Harlan 
Teklad TD96132) sterilized by gamma irradiation (20-50 kGy). Mice were fed ad libitum and 
maintained under a strict 12 h light cycle (lights on at 0600h, off at 1800h).
Mice were placed on the LF/HPP or HF/HS diet for one week and then received a single 
gavage of 300 mL of MegaMedium 1.0 (Table S11) containing an equivalent mixture of B. cellu-
losilyticus WH2::INSeq, B. ovatus::INSeq, B. thetaiotaomicron VPI-5482::INSeq and B. thetaio-
taomicron 7330::INSeq transposon libraries, plus 11 other wild-type species (Bacteroides caccae 
ATCC43185T,  Bacteroides uniformis ATCC 8492,  Bacteroides vulgatus ATCC 8482, Parabac-
teroides distasonis ATCC 8503, Eubacterium rectale ATCC 33656,  Ruminococcus obeum ATCC 
29174,  Clostridium scindens ATCC 35704,  Clostridium symbiosum ATCC 14940,  Clostridi-
um spiroforme DSM 1552,  Dorea longicatena DSM 13814, and Collinsella aerofaciens ATCC 
25986). [The 11 wild-type strains had been grown separately in MegaMedium under anaerobic 
conditions to an OD600 of 1.0 prior to pooling of 4 mL aliquots of each monoculture. Two mL of 
each INSeq library (OD600 = 10) was then combined with the 44 mL pool of the 11 wild-type strains. 
The 300 mL aliquot of this mixture used for the gavage contained ~108 colony forming units. In 
separate control experiments, mice received a gavage containing 14 wild-type strains and only one 
INSeq mutant library. The design of single diet and two diet oscillation experiments, including the 
time points when fecal samples were collected, are described in Figures 2, 4, S3 and S11. 
COmmunity PROfiling by Sequencing (COPRO-Seq) 
Total DNA was isolated from mouse fecal samples, or samples obtained from the cecum and mid-
colon at the time of sacrifice, using phenol:chloroform:isoamyl alcohol and then purified further 
with the QIAquick PCR Purification kit (Qiagen). The concentration of DNA was measured (Qubit 
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Quant-IT dsDNA BR protocol;Life Technologies) and adjusted to 5 ng/mL in 100 mL EB buffer. 
DNA was subsequently fragmented by sonication to 150-350 bp (median size ~250 bp) and the 
products were purified using the MinElute PCR purification kit (Qiagen). DNA libraries for se-
quencing on Illumina HiSeq 2000 or MiSeq instruments were prepared using a multistep protocol 
that involved end-repair, A-tailing, and ligation to customized sample-specific barcoded Illumina 
adapters. The resulting adapter-ligated DNA was size-selected (250-350 bp) using agarose gel 
electrophoresis and then used as a template for enrichment PCR (cycling conditions: 98 °C for 
30 sec, followed by 18 cycles of 98 °C for 10 sec, 65 °C for 30 sec, 72 °C for 45 sec, and then 72 
°C for 5 min). The resulting amplicons were pooled and subjected to multiplex sequencing (50 nt 
unidirectional reads; 96 samples/pool; 150-200 million reads/pool). Datasets were analyzed using 
custom Perl scripts (9).
Multi-taxon insertion sequencing
DNA purified from a sample containing the transposon mutant library or libraries (either the in-
put library, or feces collected from gnotobiotic mice at various times after their colonization with 
the artificial community containing one or four of the libraries, or cecal or mid-colonic contents 
obtained at the time of sacrifice) was digested with MmeI. The resulting digestion products were 
purified using a ratio of AMPure beads designed to recover ~1.5 kb fragments (the size fraction 
that would include transposons and chromosomal DNA sequences flanking their sites of insertion 
in the genomes of host strains). The purified fragments were ligated to double-stranded adapters 
containing a sample-specific barcode, and the ligation products were amplified by limited cycles 
of PCR using the primers shown in Table S10 and the following conditions: 94 °C for 2 min, fol-
lowed by 22 cycles of 94 °C for 15 sec, 65 °C for 1 min, 68 °C for 30 sec, and then 68 °C for 5 min. 
PCR products containing sample-specific and taxon (strain)-specific barcodes were purified from 
each reaction, quantified (Qubit), combined in equimolar amounts into a pool (n=24-48 samples; 
final concentration, 10 nM DNA in 50 mL of EB buffer), and subjected to multiplex sequencing 
with an Illumina HiSeq 2000 instrument (150-200 million unidirectional 50 nt reads/pool; note 
that the sample-specific barcodes and chromosomal DNA adjacent to the site of transposon in-
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sertion were sequenced using the Illumina read 1 primer while the strain-specific barcodes were 
sequenced using a customized INSeq index primer shown in Table S10). For further details of the 
library preparation and sequencing protocol, see https://gordonlab.wustl.edu/SuppData/Multi_tax-
on_libraryprepprotocol.
A software package previously used for single taxon INSeq was modified to process and 
analyze data generated from multi-taxon INSeq (available at https://gordonlab.wustl.edu/Supp-
Data/Multi-taxon_analysis_pipeline). Briefly, Illumina 50 nt reads and the 7 nt INSeq index reads 
(see Figure 1B) in FASTQ format were first split by sample using the 4- or 7-nt sample-specific 
barcodes (Figure 1B), and then further binned by strain using the 4-nt strain-specific barcodes. 
The remaining portion of the read contains 43-46 nt from the Tn and 16-17 nt from chromosomal 
DNA adjacent to the site of Tn insertion. After trimming the Tn sequences, reads were mapped to 
the genome of its assigned strain to identify the insertion site from which it originated (no mis-
matches were allowed). Read counts from each insertion site (i.e., reads that mapped to the 5’ or 3’ 
termini of the Tn) were tallied, normalized by sequencing depth, and the normalized sums for all 
insertion sites within a gene were combined. Methods used for calculating a fitness index for genes 
targeted by a Tn are described in the main text.
To validate that the number of sequencing reads reflect the relative abundances of the mu-
tants when its library represented a small portion of the artificial community, or when the commu-
nity contained multiple mutant libraries whose abundances varied over a wide range, we created 
a series of “spike-in” communities consisting of a fixed and consistent amount of DNA isolated 
from a pool of fecal samples collected from mice colonized for 16 d with the 15 wild-type strains 
and fed the HF/HS or LF/HPP diet plus varying concentrations of one or more of the INSeq librar-
ies. In total, we created four one species spike-in communities (one each where the abundance of 
B. thetaiotaomicron VPI-5482::INSeq, B. thetaiotaomicron 7330::INSeq, and B. ovatus::INSeq 
was 1%, and one community where the abundance of B. cellulosilyticus::INSeq was 10%), plus 
three multi-taxon INSeq communities (Mock_Even, where each of the four INSeq libraries each 
represented 10% of the total DNA, and Mock_LF/HPP and Mock_HF/HS where each of the four 
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mutant libraries represented the observed abundance of the respective wild-type strain on these di-
ets) (Table S2). Once the mock community DNA was prepared, it was subjected to the multi-taxon 
INSeq library preparation, sequencing, and analysis procedures described above.
In vitro analysis of the B. cellulosilyticus WH2 INSeq library
Four milliliters of the B. cellulosilyticus::INSeq library were mixed with 4 mL of 2X minimal 
medium (Table S11). Aliquots (0.5 mL) of this mixture (OD600~5) were immediately introduced 
into 250 mL of minimal medium supplemented with a single carbon source [5 mg/mL of glucose, 
xylose, arabinose, or wheat arabinoxylan (Megazyme, P-WAXYL, Low Viscosity; ~8cSt)], or into 
TYG medium. The resulting cultures (n=2 for each type of media) were incubated at 37 °C in an 
anaerobic Coy chamber until they reached stationary phase. Three aliquots (technical replicates) 
were withdrawn from each culture, bacterial cells were pelleted by centrifugation at 3,100 x g 
for 10 min at 4 °C, and the cell pellets were stored at -80 °C until they were subjected to INSeq 
analysis. 
Microbial RNA-Seq
Fecal samples collected and immediately frozen at -80 °C. Total fecal RNA was extracted from 
each sample using phenol-chloroform-isoamyl alcohol (25:24:1, pH 4.5; Ambion). Protocols for 
(i) removing residual DNA, (ii) depleting small RNAs (e.g., tRNA) plus ribosomal RNA (5S, 16S, 
and 23S rRNA) from the sample, (iii) synthesizing double-strand cDNA, and (iv) multiplex se-
quencing with an Illumina HiSeq 2000 instrument (8-10 samples pooled; 200 million unidirection-
al 50 nt reads/pool) have been described previously (28, 29). Reads were mapped to the genomes 
of community members using the SSAHA2 aligner with default parameters (30). The number of 
mapped raw read counts was normalized across samples using the DESeq package in R (31). 
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Gas chromatography-mass spectrometry (GC-MS) and ultra high performance liquid 
chromatography-mass spectrometry (UPLC-MS) of cecal metabolites.
Details of the methods used for targeted GC-MS of short chain fatty acids have been described 
elsewhere (32). Briefly, 10 mL of a mixture of internal standards (20 mM acetic acid-13C2,D4, pro-
pionic acid-D6, butyric acid-
13C4, lactic acid-3,3,3-D3 and succinic acid-
13C4), 20 mL of 33% HCl 
(v/v) and 1 mL of diethyl ether was added to the cecal contents of a given animal. The mixture was 
homogenized, centrifuged and the organic fraction was removed. The diethyl ether extraction was 
repeated. After combining the two ether extracts, 60 mL of the extract was derivatized with 20 mL 
N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) for 2 h at room temperature. 
Derivatized samples (1 mL) were injected with 15:1 split into an Agilent 7890A gas chromatogra-
phy system, coupled with a 5975C mass spectrometer detector (Agilent, CA). The quantity of each 
metabolite was determined from the spike-in internal standards and a calibration curve. Quantities 
were normalized to the initial weight of the sample.
To perform targeted UPLC-MS of bile acids, frozen cecal samples were spiked with 1 vol/
wt of internal standard (200 mg/ml  cholic acid 
13C1 in water) and then homogenized with 20 vol/
wt of cold methanol. Samples were subsequently placed at -20 °C for 1 h and then centrifuged 
(20,800 x g for 10 min at room temperature). The resulting supernatant (200 mL) was collected 
and dried in a SpeedVac at room temperature. Dried samples were ressuspended in 100 mL of 95:5 
water:ethanol, allowed to clarify (5 min at room temperature), and were then subjected by cen-
trifugation (20,800 x g for 10 min at 4 °C). The resulting supernatant was subjected to UPLC-MS 
using a Waters Acquity I Class UPLC system (Waters Corp., Milford, MA) coupled to an LTQ-
Orbitrap Discovery (Thermo Fisher Corporation). Mobile phases used for negative ionization were 
(A) consisted of 5 mM ammonium bicarbonate in water and (B) 5 mM ammonium bicarbonate in 
95/5 acetonitrile/water. Bile acids standards were subjected to the same protocol and used to build 
standard calibration curves for sample measurements.
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Supplemental Results
Reproducibility, sensitivity and precision of multi-taxon INSeq 
For each of the four mutant libraries, technical replicates of the input mutant population were 
prepared, sequenced using multi-taxon INSeq, and the resulting datasets analyzed with the multi-
taxon INSeq pipeline. The coefficient of determination (R2) of the replicates was 0.995, 0.996, 
0.972 and 0.997 for B.thetaiotaomicron VPI-5482::INSeq, B. thetaiotaomicron 7330::INSeq, B. 
ovatus::INSeq and B. cellulosilyticus WH2::INSeq, respectively (Figure S13), thereby establish-
ing the highly reproducible nature of the multi-taxon INSeq protocol and mapping strategies.
As noted in Supplemental Methods, we created a series of mock communities where the 
representation of each INSeq mutant library was varied from 1-10%. Figure S14 plots read counts 
obtained from each library and from the corresponding mock communities. The Spearman correla-
tion coefficent between the abundances of mutants in the ‘starting’ input library and when it was 
portrayed as a community member at a level of 1% was 0.996 (B. thetaiotaomicron VPI-5482), 
0.990 (B. thetaiotaomicron 7330 strain), 0.992 (B. cellulosyliticus WH2), and 0.976 (B. ovatus). 
For mock communities containing all four mutant libraries at equivalent levels of 10% 
(Mock_Even), or at the abundances documented for the corresponding wild-type strains in mice 
containing a 15 member all wild-type community characterized 16 d after colonization and con-
sumption of the LF/HPP or HF/HS diets (Mock_LF/HPP, and Mock_HF/HS), the correlation coef-
ficients were all >0.95 (Table S2). 
We also performed simulations where the read depth of each input library was systemati-
cally varied from 10,000 -1,000,000, and the false positive rate for a gene having a significant 
fitness index (z-score) was calculated. The results revealed a false positive rate of <5% for genes 
whose relative abundance in a library is >0.002% (20 reads/million) at a read depth of ≥30,000 for 
the library (Figure S2). The results of these simulations were validated using experimental data 
generated from the mock communities (Table S2).
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Evidence that the behavior of each mutant library in the artificial community was equivalent 
to that of the corresponding wild-type strain
COPRO-Seq analysis was used to compare the relative abundances of the four Bacteroides strains 
at the end of each diet phase in five different community contexts: one containing 15 wild-type 
strains; three containing 14 wild-type strains plus one of the mutant INSeq libraries (B. thetaio-
taomicron VPI-5482, B. thetaiotaomicron 7330, and B. ovatus), plus a community containing 11 
wild-type strains and the four mutant libraries.
The results revealed that in each diet context, there were no statistically significant dif-
ferences in the abundances of a given Bacteroides strain in any of the five community contexts 
(ANOVA; Figure S3B, Table S3A,B).
Microbial RNASeq was performed on fecal samples collected at the time of sacrifice from 
mice harboring artificial communities composed of 15 wild-type strains or 14 wild-type strains 
plus the B. ovatus::INSeq library (see Figure S3A; average 20 million reads/sample). The pres-
ence or absence of the B. ovatus mutant library had no significant effect on the community meta-
transcriptome as judged by principal coordinates analysis based on pairwise comparisons of tran-
script abundances using the Hellinger distance metric (Figure S3C). In addition, the Spearman 
correlation coefficient between the level of expression of each B. ovatus gene in the all wild-type 
community and in the community with the mutant library was 0.939 (Figure S3D).
Fecal samples collected from mice containing each of the three types of communities with 
14 wild-type strains and one mutant library at the end of the first diet phase of the experiment 
shown in Figure S3A were subjected to INSeq analysis and the results compared to mice consum-
ing the same diet but colonized with the community containing 11 wild-type strains plus the four 
mutant libraries. The correlation coefficient of the relative abundances of mutants was 0.977, 0.973 
and 0.913 for B.ovatus::INSeq, B.thetaiotaomicron VPI-5482::INSeq, and B.thetaiotaomicron 
7330::INSeq, respectively, indicating the individual mutants behave similarly when the commu-
nity harbors one or four mutant libraries. 
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Supplemental Figure Legends
Figure S1. Distribution of Tn mutants in the genomes of each of the four Bacteroides strains 
included in the artificial human gut community. Key; Track 1 (innermost circle), GC skew with 
yellow denoting values greater than 0 and purple values less than 0; Track 2, histogram of the 
number of Tn insertions at each site in the targeted genome (normalized to one million INSeq reads 
from the library); Track 3, another depiction of the distribution of Tn insertions, showing genes 
with relative abundances >0.002% in the entire community; Track 4, all genes in the genome are 
plotted with those represented in polysaccharide utilization locus (PULs) colored green and those 
in capsular polysaccharide synthesis (CPS) loci colored red. 
Figure S2. Estimating the precision of multi-taxon INSeq in identifying significant fitness de-
terminants in the four Bacteroides strains. See Supplemental Methods and Supplemental Results 
for details of the in silico simulations. 
Figure S3. Comparison of data obtained from gnotobiotic mice harboring different artificial 
communities and subjected to diet oscillations. (A) Experimental design showing community 
types in each treatment group and diet oscillation protocols. (B) PCoA analysis of Hellinger dis-
tances based on COPRO-Seq datasets generated from fecal samples collected from mice in this 
series of experiments and in the experiments described in Figure 2. Mean values ± SEM of the 
positions of all communities from all mice sampled at the end of the indicated diet period, on 
PC1 of the ordination plot are shown. PC1 explains 44% of the variance in the entire dataset. n,s., 
not significant based on 2-way ANOVA. (C) Mean values ± SEM for the positions of communi-
ties on PC1 based on Hellinger distance measurements of fecal meta-transcriptomes, defined by 
RNA-Seq assays of biospecimens collected at end of each diet treatment period. n.s., no signifi-
cant difference (2-way ANOVA) in the meta-transcriptomes of fecal communities composed of 
all wild-type strains compared to sampled communities containing 14 wild-type strains and the B. 
ovatus INSeq library (n=5 mice harboring each community type; all mice in both groups fed the 
following sequence of diets; LF/HPPèHF/HSèLF/HPP; fecal samples were collected at the end 
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of the last diet period). (D) Correlation of gene expression levels for B. ovatus as a member of the 
15 wild-type strain community or as a member of the 14-wild-type strain community containing 
the B. ovatus INSeq library. The same fecal samples used for the PCoA analysis shown in panel 
C were used for the Spearman correlation analysis plotted in this panel. Each circle represents a 
transcript from a gene. The x- and y-axes plot the number of reads (expressed as reads per kb per 
million reads, RPKM) for each gene. (E-G) Spearman correlation values of the abundances of Tn 
mutants for each targeted gene in the indicated strains in mutant libraries represented in the differ-
ent community contexts indicated. Data are based on multi-taxon INSeq of fecal samples collected 
from animals at the end of the first diet phase shown in panel A of this figure and in Figure 2 (n=5 
mice/treatment group). Each dot represents a targeted gene. The number of INSeq reads assigned 
to each gene with Tn insertions has been normalized per million reads/INSeq library.
Figure S4. Changes in the relative abundances of Bacteroides strains in the artificial human 
gut community as a function of diet. Fecal samples were collected from groups of mice harbor-
ing the 11 wild type strains and four Bacteroides INSeq libraries (n=5 individually housed mice/
treatment group; mean values ± SEM, based on COPRO-Seq analysis, are plotted) 
Figure S5. Hellinger distances of the relative abundance of B. cellulosilyticus WH2 Tn mu-
tants in fecal samples within and across the treatment groups. Sampling occurred at 4, 10 and 
16 days post gavage (dpg). For each panel, the first four columns represent the Hellinger distance 
(variation in the configuration of mutant population as judged from the relative abundances of its 
members) present in fecal samples collected from members of the indicated treatment group at the 
indicated time point. The next two columns represent the Hellinger distance between fecal samples 
in mice belonging to one of the monotonous diet treatment groups compared to respective diet 
oscillation group. The last column represents the Hellinger distance between fecal samples in mice 
belonging to the two monotonous diet treatment arms of the experiment. Mean values ± SEM are 
plotted. *** p<0.001, Student’s t-test with FDR correction; ns, not significant.
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Figure S6. Consistent diet-specific configurations observed in the population of B. ovatus mu-
tants. PCoA of Hellinger distance measurements based on the relative abundances of B. ovatus Tn 
mutants in fecal samples. Each colored circle represents the population of all mutants in B. ovatus 
sampled from an individual mouse in the indicated diet treatment group at a given time point. Each 
empty circle represents the average location of the mutant population along PC1/PC2 in a given 
treatment group at a given time point. Lines connect time points within a given group. The color of 
the lines indicates the diet. Dashed lines are used to delineate the diet oscillation groups. 
Figure S7. Mapping core Bacteroides fitness determinants to amino acid biosynthetic path-
ways. Red arrows define steps in the indicated KEGG amino acid biosynthetic pathways. Enzymes 
catalyzing these steps are identified by their enzyme commission (EC) numbers. Genes encoding 
ECs identified as diet-independent in vivo fitness factors shared among the four Bacteroides strains 
are highlighted by grey boxes. Black arrows outline steps in the KEGG ‘Central Carbohydrate 
Metabolism Pathways’ that are linked to the indicated amino acid biosynthetic pathways.
Figure S8. Comparison between INSeq measurements of fitness indices and microbial RNA-
Seq measurements of gene expression levels for the 86 identified core fitness determinants. 
Data are from B. cellulosilyticus WH2. Fecal samples were collected from mice that harbored the 
11 wild-type strains and the four mutant libraries and were members of two monotonous diet treat-
ment groups shown in Figure 2. INSeq or microbial RNA-Seq data from all mice in both groups 
(n=8 animals) were used for the analysis. In addition, microbial RNA-Seq data were generated 
from monocultures of B. cellulosilyticus WH2 at mid-log phase of growth in minimal medium 
containing either glucose, xylose, arabinose, or wheat arabinoxylan as the sole carbon source, or 
in TYG medium (n=3 biological replicates/growth condition). (A) Plot showing fold-difference 
in expression of the 86 core fitness determinants in vivo versus in vitro and their fitness indices in 
vivo. The locus designation for the B. cellulosilyticus homolog of the each of identified 86 core 
fitness determinants is shown. *, Expression of the gene is significantly greater in vivo versus in 
vitro (p<0.05; Student’s t-test with FDR correction). (B) Microbial RNA-Seq showing expression 
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of three core fitness determinants encoding three transcription factors in vivo versus in vitro. n.s., 
not significant; ****, p<0.0001 (Student’s t-test, FDR correction).
Figure S9. Strain-specific fitness determinants in B. thetaiotaomicron. (A) Annotation of genes 
in CPS4 and CPS6 in the two B. thetaiotaomicron strains. Homologs represented in the two CPS 
loci are connected using grey bars. (B) All but one of the 21 genes that comprise the CPS4 locus 
in B. thetaiotaomicron VPI-5482 are significant fitness determinants in both diet contexts. (C) All 
18 genes in CPS6 of B. thetaiotaomicron 7330 are significant fitness factors in both diet contexts. 
Genes highlighted in red are unique to the respective strain. Mean values ± SEM for fitness indices 
are shown (n=5 individually caged mice/monotonous diet treatment group; fecal samples obtained 
at the end of the experiment outlined in Figure 2. 
Figure S10. Effects of arabinoxylan on the Bacteroidetes strains present in the 15-member 
artificial community. (A) Microbial RNA-Seq documenting that expression of all genes in PUL 
BACWH2_4070-6 (except its linked HTCS regulator) is significantly greater when B. cellulosilyti-
cus is cultured in a minimum medium containing xylan or arabinoxylan as the sole carbon source 
compared to minimal medium containing glucose, arabinose, or xylose. Read counts (expressed 
on log scale) were normalized using DESeq. ***, p<0.001 [ANOVA with multiple test correction 
(Tukey-Kramer)]. (B) Comparison of growth characteristics of the indicated community members 
cultured under anaerobic conditions in minimal medium supplemented with 0.5% (wt/vol) of wheat 
arabinoxylan. Mean values ± SEM are shown for triplicate monocultures of each strain. Only B. 
cellulosyliticus and B. ovatus show significant growth under these conditions. (C) Fitness indices 
of genes in the B. ovatus arabinoxylan-induced PUL BACOVA_4389-94 as defined by multi-taxon 
INSeq analysis of fecal samples obtained from mice harboring the artificial community containing 
11 wild-type strains and the four mutant libraries and monotonously fed either the LF/HPP or HF/
HS diet (n=5 mice/treatment group; all animals sampled on the last day of the experiment shown 
in Figure 2). Mean values ± SEM are shown. Dashed line indicates the threshold cutoff level used 
to define a significant z-score.
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Figure S11. The effects of arabinoxylan supplementation of the drinking water for 2 months 
in mice colonized with a consortium of 15 wild-type strains and fed the HF/HS diet. (A) 
Experimental design. (B) The relative abundances of B. cellulosilyticus WH2 and B. ovatus in 
fecal samples collected at 14 dpg were defined by COPRO-Seq. Mean values ± SEM are plot-
ted. ***, p<0.001; n.s., not significant (Student’s t-test). (C) GC-MS analysis of short chain fatty 
acids (SCFA) and UPLC-MS analysis of bile acids in cecal contents harvested at the end of the 
experiment from mice in both treatment arms (n=5/group). *, p<0.05; **, p<0.01; ***, p<0.001 
(Student’s t-test). Arabinoxylan supplementation produces an increase in the abundance of B. cel-
lulosyliticus but not B. ovatus in the fecal microbiota, significant increases in cecal levels of all 
three SCFA assayed, significant decreases in conjugated bile acids (tauro-b-muricholic acid and 
taurocholic acid), plus significant increases in the deconjugated bile acids (b-muricholic acid, a-
mucricholic acid and cholic acid). 
Figure S12. Arabinoxylan supplementation greatly impacts the fitness indices of genes in 
one but not both arabinoxylan-inducible B. cellulosilyticus PULs, BACWH2_4070-4076 and 
BACWH2_4044-4055. Multi-taxon INSeq was performed on fecal samples obtained 14 dpg from 
mice belonging to groups A and B in Figure 4B (n=5/treatment arm). Mean values ± SEM are 
plotted. (A) For most genes in the BACWH2_4070-4076 PUL, z-scores are significant on the HF/
HS diet in the absence of arabinoxylan supplementation but not when mice receive drinking water 
supplemented with arabinoxylan. The exceptions are BACWH2_4076 encoding the linked HTCS, 
and BACWH2_4073 which specifies a hypothetical protein; these two genes retain their fitness 
effects under both diet conditions. In contrast, none of genes in the other arabinoxylan-inducible 
PUL, BACWH2_4044-4055, have a fitness effect whether or not mice receive arabinoxylan. (B) 
The effect of arabinoxylan on the fitness indices of genes that encode various membrane transport-
ers. 
Figure S13. Reproducibility of multi-taxon INSeq Illumina library preparation and sequenc-
ing protocols. Technical replicates were prepared and sequenced from each mutant library. Each 
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point represents the abundance of Tn insertions in a single gene. Values for R2, the coefficient of 
determination on log-transformed abundance values, are shown for each comparison of replicates. 
Figure S14. Sensitivity and reliability of INSeq library preparation and sequencing proto-
cols . Technical replicates were prepared from each mutant library and subjected to the multi-taxon 
INSeq sequencing and analysis pipeline. Each point represents the abundance of insertions in a 
single gene. The coefficient of determination (R2) on log-transformed abundance values is indi-
cated.
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Supplemental Figures
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Figure S2.
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Figure S3.
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Figure S4.
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Figure S5.
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Figure S6.
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Figure S7.
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Figure S8.
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Supplemental Tables
Table S1. CAZymes encoded in the genomes of the four Bacteroides strains subjected to 
whole genome transposon mutagenesis.
Table S2. INSeq library characteristics and validation of the multi-taxon INSeq pipeline. (A) 
Characteristics of the four Bacteroides INSeq libraries. (B) Application of multi-taxon INSeq to 
mock communities.
Table S3. COPRO-Seq analysis of fecal microbiota sampled over time from mice belonging 
each treatment group. (A) Mice described in Figure 2 harboring the artificial community con-
taining 11 wild-type strains plus four mutant libraries. (B) Mice described in Figure S3 harboring 
either a 15-member community composed of all wild-type strains or one of three mutant libraries 
containing 14 wild-type strains and one mutant library. 
Table S4. Diet-independent and diet-specific fitness determinants identified in B. cellulosilyti-
cus and B. ovatus. (A) B. cellulosilyticus WH2. (B) B. ovatus.
Table S5. A core group of fitness determinants identified by multi-taxon INSeq as being 
shared among the four Bacteroides strains. 
Table S6. Fitness determinants identified in B. cellulosilyticus WH2 at stationary phase after 
growth in TYG medium or in minimal medium containing single carbon sources.
Table S7. Comparison of B. thetaiotaomicron VPI-5482 and 7330 genomes. (A) Summary of 
the total number of genes assigned to KEGG categories, KEGG pathways. (B) PULs identified in 
the 7330 strain. 
Table S8. Diet-independent and diet-specific fitness determinants identified in the two Bac-
teroides thetaiotaomicron strains. (A) B. thetaiotaomicron VPI-5482. (B) B. thetaiotaomicron 
7330. 
141
Table S9. Fitness determinants in B. cellulosilyticus WH2 and B. ovatus when mice are con-
suming a HF/HS diet with or without arabinoxylan supplementation. (A) B. cellulosilyticus 
WH2. (B) B. ovatus
Table S10. Primers and adapters used for the indicated steps of the multi-taxon INSeq proce-
dure. (A) Vector construction. (B) Preparation of Illumina sequencing library. (C) Illumina index 
sequencing.
Table S11. Media used for bacterial culture in this study. (A) MEGAMedium 1.0. (B) Minimal 
Medium.
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Chapter 4
Future directions
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Creation of clonally arrayed multi-taxon INSeq transposon mutant libraries
After identifying “core” fitness genes, species/strain-specific and diet-specific fitness determinants 
from the studies described in Chapter 3, a natural move forward is to further study specific mutant 
strains of interest in isolation, after their recovery from the mixed population of mutants used for 
multi-taxon INSeq. However, the creation of individually targeted mutants by molecular cloning 
would be laborious and time-consuming. INSeq allows the array of the transposon mutant library 
into a collection of isolated individual mutants in multi-well plates, then simultaneously map thou-
sands of individually archived transposon mutant strains in parallel to define their genetic back-
ground [1, 2]. Applying this method to create clonally arrayed transposon mutant libraries for the 
multi-taxon INSeq libraries generated in the study described in Chapter 3 would dramatically ex-
pand our ability to perform mechanistic follow-up studies, as well as confirm the effects of specific 
mutations on the host; for example, we could perform direct competition of a collection of mutants 
against the wild-type parental strain in gnotobiotic mice under defined diet conditions to validate 
our INSeq results. Moreover, the study of mutants in isolation would facilitate further dissection 
of the precise mechanisms by which a particular gene mediated the fitness of a strain of interest.
There are several fitness determinants identified from the multi-taxon INSeq that are of 
particular interest. One group includes two transcriptional regulators identified as core fitness 
determinants in Bacteroides. One of these factors is a homolog of BT4338, a putative Crp-like 
transcription factor that controls a proposed global sugar catabolic regulon [3]. By retrieving the 
individual mutant(s) from an arrayed INSeq library, we can compare their growth phenotypes 
to wild-type in vitro under different nutrient conditions: e.g., minimal medium with arabinose, 
xylose, fucose and other carbon sources selected based on metabolic predictions made from the 
in vivo INSeq data. This, combined with transcriptional analysis to define the regulon affected 
by this transcription factor, could provide a better map of the metabolic pathways affected by the 
regulator, and offer insights into their importance for fitness in the gut environment. Homologs of 
BT4720, an extracytoplasmic function (ECF)-type sigma factor is another core Bacteroides fit-
ness determinant of interest since expression of this factor is dramatically upregulated (~55 fold 
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increase) in vivo compared to in vitro growth. ECF-type sigma factors regulate PULs involved in 
glycan degradation and capsular polysaccharides biosynthetic loci [4]. By retrieving strains con-
taining mutations in this gene, we could identify the genes/pathways regulated by this core fitness 
determinant in order to gain new insights about critical genes/pathways that allow Bacteroides spp 
to survive in the gut.
Another set of genes that would be interesting to further characterize are represented in two 
related CPS loci identified as strain-specific fitness determinants in Bacteroides thetaiotaomicron. 
The ability to synthesize multiple capsular polysaccharides is likely an important biological prop-
erty for long-term survival of Bacteroides in a complex competitive intestinal ecosystem that is 
under selective pressure from the immune system [5-7]. We have shown that for the two strains of 
Bacteroides thetaiotaomicron examined using multi-taxon INSeq, only one CPS locus per strain 
was important for fitness regardless of which of the two diets were administered. Comparative ge-
nomic analysis revealed these two loci are in synteny in terms of their genomic locations in the two 
Bacteroides thetaiotaomicron strains, and that they share homologous transcriptional regulators. 
However, the genes involved in the assembly of monosaccharides into polymers are different be-
tween the two loci, suggesting that the capsules they synthesize have different structures. To study 
this, capsular polysaccharides could be extracted from the wild-types and their CPS mutants and 
the monosacchride composition of their extracellular polysaccharides analyzed by high pH anion 
exchange chromatography with pulsed amperometric detection (HPAEC-PAD) after acid hydroly-
sis [8]. Retrieving and characterizing Tn mutants in the transcriptional regulators contained within 
these loci could identify how they (and perhaps other loci) are regulated by these factors, whether 
these patterns of regulation are shared between the two B. thetaiotaomicron strains, and shed light 
on why these genes are such important fitness determinants in the gut environment.
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The effects of the arabinoxylan on interactions between the artificial community and host 
in the context of the HF/HS diet
The ‘spread’ of diets high in fat and protein but low in fruits and vegetables, may be associated 
with the increase in the incidence of diseases such as metabolic syndrome, inflammatory bowel 
disease (IBD), and cancer in countries undergoing ‘Westernization’. Epidemiologic studies of IBD 
in China, Korea and Puerto Rico have documented that the incidence of IBD is rising in these areas 
[9-11]: a systematic review of nineteen studies, encompassing 2,609 IBD patients and over 4,000 
controls revealed a positive association between high intake of total fat, mono- and disaccharides, 
and meat and increased risk of IBD, while high fiber and fruit/vegetable intake were associated 
with decreased IBD risk [12]. However, much more work is needed to define the mechanisms that 
underlie the deleterious effects of Western diets.
In the studies described in Chapter 3, when arabinoxylan was added to the drinking water 
of mice consuming a HF/HS diet, we observed a diminished requirement for fucose transporters 
in B. cellulosilyticus WH2, which remained at a relatively high relative abundance, but not in B. 
ovatus, which became almost undetectable in the community on HF/HS diet. Fucose cleavage 
from mucosal fucosylated glycans is an import nutrient source for Bacteroides spp. when dietary 
fibers are deficient, such as in the case of the HF/HS diet [13-16]. The differential requirement for 
fucose transporter genes between these two species may be related to the capacities of these Bac-
teroides species to adaptively forage host glycans, and their fitness on the HF/HS diet. There was 
also a diminished requirement for anti-microbial peptide and other multidrug transporters in both 
B. cellulosilyticus WH2 and B. ovatus. The shared requirement for multidrug and anti-microbial 
peptide transporters raises the question of whether consumption of HF/HS diet changes interac-
tions between the host (notably components of its gut mucosal barrier) and these members of the 
microbiota. These interactions include the physical juxtaposition of the organisms with the mucus 
that overlies the gut epithelium.
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Although we identified arabinoxylan-associated changes in the overall abundance of B. 
cellulosilyticus WH2, we did so using fecal samples; we did not interrogate abundance along the 
length of the gut nor did we examine the physical location of the organism across the width of 
the intestine. Techniques providing information regarding the spatial organization of microbial 
cells in the gut thus need to be applied to decipher whether arabinoxylan shapes localization as 
well as abundance of members of the gut microbiota. Fluorescence in situ hybridization (FISH), a 
commonly used technique to address such issues, is limited in its ability to characterize the loca-
tions of members of complex microbial communities by the number of fluorophores that can be 
differentiated simultaneously. As a result, these studies typically employ “universal” probes that 
target most or all bacteria, or probes designed to label taxonomically-related species;. In a col-
laboration between the Gordon lab and Gary Borisy lab, a new high resolution imaging technique, 
‘combinational labeling and spectral imaging fluorescence in situ hybridization’ (CLASI-FISH; 
[17, 18]), was applied to define the spatial structure of defined model human gut communities in 
gnotobiotic mice. This method allows us to visualize at least 15 different species simultaneously, 
with the potential to possibly visualize as many as hundreds of species. By applying CLASI-FISH 
to gut tissue sections prepared from mice colonized with the 15-member community and fed the 
HF/HS diet with/without arabinoxylan supplementation, we expect to be able to observe how ara-
binoxylan changes the biogeographical features of community members. A testable hypothesis is 
B. cellulosilyticus WH2 is more dominant in the mucus layer when mice are consuming HF/HS 
diet without arabinoxylan due to their ability and need to consume host glycans.
If we observe greater representation of B. cellulosilyticus in the inner mucus layer when 
arabinoxylan is not included in the drinking water (or diminution in the thickness of the mucus lay-
er as a result of adaptive foraging of mucus glycans), we could further characterize barrier function 
by using FACS to define the microbes that are targeted by the IgA response, and as well as expres-
sion of epithelial cell-derived antibacterial markers (i.e., a-defensins, Reg3g (RegIIIg), Pla2g2a 
(phospholipase A2) using laser capture microdissection of epithelial cells and host RNA-Seq.
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Application of multi-taxon INSeq into other model human gut symbionts
The results we obtained from studies with gnotobiotic mice show how multi-taxon INSeq 
provides a simultaneous readout of the genetic underpinnings of the niches of multiple members 
represented in a microbial community inhabiting the gut ecosystem as a function of dietary pertur-
bations. This approach could be applied into other models where we are interested in identifying 
potential mechanisms to allow for targeted changes in the structure and function of the microbiota.
A series of studies in the Gordon lab has been focused on examining interrelationships 
between obesity and gut microbiota. The microbiota of obese humans have reduced bacterial di-
versity compared to lean individuals [19] as well as reduced gene diversity [20, 21]. Transplanting 
the intact uncultured or the culturable component of the fecal microbiota obtained from twin pairs 
stably discordant for obesity into groups of germ-free mice can recapitulate the composition of the 
donor’s communities and differences in body composition [22]. Co-housing of mice harboring the 
transplanted “lean” microbiota prevented development of an increased adiposity and body mass 
phenotype in the mice transplanted with the microbiota of an obese donor, and transformed the 
metabolic profile of the resulting microbiota into a lean-like state. This process was associated with 
invasion of members of Bacteroidales (including B. cellulosilyticus) from the lean community into 
the guts of cagemates harboring the obese donor microbiota. Invasion and phenotypic rescue were 
diet-dependent, occurring with the diet representing low in fat and high in fruits and vegetables, 
but not with the diet high in fat and low in fruits and vegetables. By applying multi-taxon INSeq 
to the invading “lean” Bacteroidales spp. and identifying the key fitness determinants that allows 
them to establish within “obese” communities, we could identify key nutrients that support this 
process. This application of multi-taxon INSeq follows the paradigm established in Chapter 3, in 
which we identified one PUL important for B. cellulosilyticus WH2 on the HF/HS diet, and then 
used the predicted carbohydrate preference of this PUL in order to design a dietary supplement that 
specifically boosted the levels of B. cellulosilyticus WH2 on HF/HS by 3-fold. Multi-taxon INSeq 
is a particularly attractive technique for studying the rescue of the obesity phenotype by Bacte-
roides observed by Ridaura, et al, since the majority of the invasion species are Bacteroides and 
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B. cellulosilyticus is one of the leading invasive taxa. By assessing the genes which are essential 
to allow members of the Bacteroides to invade ‘obese’ communities, several strategies could be 
designed to promote growth of bacteria that help to confer a lean state.
Finally, many additional taxa within the gut microbiota have been implicated as effectors 
of host phenotypes. For example, Faecalibacterium prausnitzii and other Clostridia strains have 
anti-inflammatory effects [23, 24]; Ruminococus obeum restricts the virulence of the diarrhea-
inducing pathogen Vibrio cholerae [25]; Bifidobacterium longum, an efficient utilizer of milk oli-
gosaccharides commonly incorporated into probiotic formulations, improves lactose tolerance and 
prevents food allergies [26, 27]. The ability of INSeq to be adapted to any bacterium where we are 
able to express a functional mariner transposase and a selectable marker means that our multi-tax-
on INSeq pipeline have broad utility in identifying bacterial genes that mediate many processes, 
opening up new avenues for the exploration of the role of the microbiota in host health and disease.
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IntroDuctIon
Development of the protocol
By exposing populations of transposon mutants to selective con-
ditions in vitro or in vivo, it is possible to identify changes in the 
representation of mutants, thereby allowing identification of genes 
and pathways that are key to fitness under the conditions being 
examined. In principle, this approach could be applied to any 
microbe whose genome has been sequenced and that is amenable 
to basic genetic manipulation (insertion of foreign DNA, antibiotic 
selection). INSeq combines existing methods for signature-tagged 
mutagenesis1 with new techniques for high-throughput DNA 
sequencing such that the precise location and relative abundance 
of tens of thousands of mutants can be determined in parallel. 
This approach is based on the modification of mariner, the broad 
host-range, randomly integrating, transposable element, to allow 
short fragments of genomic DNA adjacent to the site of transposon 
insertion to be captured, sequenced and quantified2. Mutants that 
decrease in relative abundance in a selective condition are likely 
to be in genes that are important for fitness under that condition; 
mutants that increase in abundance under the selection high-
light genes that could be deleterious. The protocol described here 
includes substantial improvements from our earlier publication2; 
because library preparation can now be performed in 96-well, 
bead-based format, reagent costs and sample losses are minimized, 
and large numbers of samples can be barcoded and sequenced in 
a single sequencing run.
Applications of the method
As INSeq library preparation can be completed in multiplex format, 
experiments can involve material obtained from high-resolution 
time-series studies of the effect of in vitro or in vivo selections, 
and from multiple biological and technical replicates. Any microbe 
whose genome has been sequenced and that is amenable to mariner 
transposon mutagenesis could potentially be investigated with 
INSeq. This method can also be used to efficiently determine the 
insertion site of transposon mutant strains that have been clonally 
arrayed in a multiwell format (Box 1). This latter technique relies 
on a combinatorial pooling approach: a small number of pools are 
defined, and a liquid-handling robot is used to place each mutant 
strain into a subset of these pools in a unique pattern. The pools 
are then characterized by INSeq, and the presence/absence pat-
tern of a given insertion site across the pools reflects the unique 
pattern associated with the corresponding bacterial strain in the 
multiwell collection. Alternative pooling patterns that use larger 
numbers of pools to further reduce the likelihood of mistaking 
one strain for another can also be considered3–5. These alternatives 
would be appropriate if many mutants in the population were likely 
to carry insertions at the same location in the genome, but they 
require greater effort in preparing libraries because of the increased 
number of pools. Furthermore, these alternate techniques were not 
developed specifically for mapping transposon insertions and may 
require modification in order to accomplish this goal.
Limitations and alternative techniques
In bacterial genomes, a high percentage (>90%) of insertions can 
be precisely localized using INSeq. With more complex organisms, 
the short (16–17 bp) fragments of adjacent chromosomal sequence 
captured and quantified by MmeI digestion may be insufficient 
to uniquely identify transposon locations. As with any negative 
selection technique, stochastic bottlenecks in the selective process 
need to be considered when determining the optimal number of 
mutants to be included in an experiment. Because each inser-
tion is mapped with nucleotide-level resolution, comparing the 
behavior of multiple mutants in the same gene highlights these 
selective bottlenecks.
Other techniques for mapping and quantifying transposon inser-
tions by high-throughput sequencing are also available6–10. They 
include two protocols named Tn-Seq: one version8,10 also uses an 
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Insertion sequencing (Inseq) is a method for determining the insertion site and relative abundance of large numbers of transposon 
mutants in a mixed population of isogenic mutants of a sequenced microbial species. Inseq is based on a modified mariner 
transposon containing MmeI sites at its ends, allowing cleavage at chromosomal sites 16–17 bp from the inserted transposon. 
Genomic regions adjacent to the transposons are amplified by linear pcr with a biotinylated primer. products are bound to 
magnetic beads, digested with MmeI and barcoded with sample-specific linkers appended to each restriction fragment. after 
limited pcr amplification, fragments are sequenced using a high-throughput instrument. the sequence of each read can be used 
to map the location of a transposon in the genome. read count measures the relative abundance of that mutant in the population. 
solid-phase library preparation makes this protocol rapid (18 h), easy to scale up, amenable to automation and useful for a variety 
of samples. a protocol for characterizing libraries of transposon mutant strains clonally arrayed in a multiwell format is provided.
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MmeI-adapted mariner transposon but does not include a transpo-
son-specific, linear PCR step during library preparation. Compared 
with INSeq, this simpler approach to library preparation could 
reduce the effort required for sequencing. The other Tn-Seq proto-
col9 does not use an MmeI-adapted mariner transposon; instead, it 
uses a circularization step to capture the targeted DNA fragments. 
This could allow the use of transposons that cannot be modified to 
include MmeI sites in their inverted repeats. Additional approaches, 
termed ‘high-throughput insertion tracking by deep sequenc-
ing (HITS)’6 or ‘transposon-directed insertion-site sequencing 
(TraDIS)’7 also do not require MmeI sites in the transposon. For 
these protocols, mutagenized DNA is randomly sheared, adapters 
are ligated to all fragments, and transposon-chromosomal junc-
tions are enriched by PCR either with (HITS) or without (TraDIS) 
 Box 1 | Combinatorial pooling and mapping of clonally arrayed transposon 
mutant libraries by INSeq ● tIMInG ~1.6 h per 96-well tray 
Timing estimate assumes the use of an EpMotion liquid-handling robot. Additional time is required for preparing the arrayed mutant 
collection by manually or robotically picking transposon-mutagenized colonies into 96-well trays and conducting INSeq library prepara-
tion on the pooled strains.
 1. Prepare EpMotion programs. Two sets of pooling patterns are provided in the analysis package INSeq_analysis/Arrayed_library 
directory (supplementary Data 1): ‘16384_strings.txt’ is the list of 24-bit strings with a minimum Hamming distance of 6; and 
‘13000_strings.txt’ is the subset of these that are less likely to be mistaken for each other if multiple archived strains happen to carry 
transposons at the identical genome coordinate. The larger set can be used to map up to 170 96-well trays, whereas the smaller set is 
preferable for arrayed libraries of under 135 trays. A script called write_dws.pl translates these pooling patterns into programs for 
the EpMotion robot. Each program will pool 5 trays (20 programs are needed for a 100-tray mutant library, for example).
To create EpMotion .dws files, go to the data analysis package INSeq_analysis/Arrayed_library directory (supplementary Data 1)  
and type:
perl write_dws.pl  < pooling pattern >  < number of programs > 
This will create an output directory called ‘Write_dws_output_X_programs’. Create a new application on the EpMotion, and then import 
the .dws files in this directory into the new application and confirm that they are functioning properly. (Note that the provided script 
is designed for Midwest Scientific 96-well culture trays (cat. no. TP92696) and the EpMotion Thermorack for 24 cryotubes (cat. no. 
960002491). Alternatives may require changes to the program). The write_dws.pl script will also create a map file that will be 
used in the data analysis step. Although the software provided is designed for the EpMotion instrument, analogous programs could be 
written for other liquid-handling robots if they can be run from a text-format file.
 2. Prepare the mutant collection by manually or robotically picking transposon-mutagenized colonies into 96-well trays containing 
250 µl of culture medium and appropriate antibiotics. Incubate under standard conditions to allow cultures to grow to turbidity, and 
note any wells with poor or no growth.
 3. For each 96-well culture tray, prepare two 96-well archive trays by adding 30 µl of sterile culture medium plus 40% (vol/vol) 
glycerol to each well. Transfer 30 µl of the turbid culture to the corresponding well in each of these archive trays, mix well and seal  
with foil lid before storing archive trays at  − 80 °C. Turbid cultures may need to be mixed before dispensing into archive trays.  
To recover strains from the archive trays, wipe down the foil lid with 70% (vol/vol) ethanol and puncture the well of interest with 
a sterile pipette tip. Draw a small amount of frozen material onto the tip of the pipette without allowing the entire plate to thaw. 
Restreak this material onto agar plates, and place a small foil patch over the targeted well in the archive tray before returning it to 
the  − 80 °C freezer.
 4. Seal culture trays in groups of five with Parafilm and store at 4 °C.
 5. On the EpMotion, initiate the Pool_group_1.dws program. Set up the robot deck as shown in the graphical interface with tips, 
input culture trays nos. 1–5 and a cryovial rack containing 24 2-ml screw-cap cryovials (lids removed and vials labeled with program 
and pool number). In the cryovial rack, tubes in the top row should be labeled 1–6, the tubes in the second row 7–12, etc. While the 
program is running, monitor the waste tip bucket to ensure that it does not overflow. When the program is complete, cap the 2-ml 
output cryovials and store them at  − 20 °C.
 crItIcal step Each program takes ~8 h to complete. Consider adding a growth inhibitor if your mutants are likely to grow during  
this process. If the robot is performing without interventions required, programs can be run overnight. Also, if input trays have been 
stored at 4 °C, cultures may need to be resuspended manually before being placed in the robot. See supplementary Movie 2 for a  
demonstration of the pooling procedure.
 6. Run pooling programs on each subsequent set of five culture trays as described in Step 5.
 7. When pooling is complete, thaw all cryovials, vortex well and combine half of the volume of each cryovial with same number from 
each pooling program to create 24 final pools. Regardless of the number of programs run, there should be 24 pools at this point. Save 
the remainder of each cryovial at  − 20 °C.
 crItIcal step Be sure to combine like pools and not to combine different pools from a single program.
8. Prepare INSeq libraries from each of the 24 pools (Steps 1–78), associating a different barcode with each pool.
9. Run the data analysis pipeline as described in the arrayed library section of the README.txt included in the analysis package.
 crItIcal step The cutoffs for presence or absence of a strain in a pool may need to be determined empirically by examining the 
distribution of reads across pools for a given data set. As a starting point, normalize counts per pool for each strain by the overall 
number of reads in the pool; for each strain, set the presence or absence of a pool to 0 if there are less than three reads associated 
with that pool and to 1 if there are three or more reads associated with the pool.
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an affinity-purification step. In principle, these MmeI-independent 
methods could allow the capture of longer fragments of genomic 
sequence adjacent to each transposon, a feature which may be nec-
essary for mapping insertions in more complex genomes.
The INSeq protocol we describe below has several advantages 
compared with these other methods: (i) introducing an MmeI site 
in the transposon allows the excised transposon/chromosomal 
junctions to be of uniform size, thus avoiding size preferences 
during PCR; (ii) the linear PCR step at the beginning of the pro-
tocol enriches the target and increases the efficiency of library 
preparation; (iii) the solid-phase–based technique separates target 
sequences from chromosomal DNA background, making it easy to 
scale up to a 96-well plate format; (iv) robotic automation makes 
the protocol amenable to monitoring changes in the representation 
of mutants during studies that require repeated, high-resolution 
sampling; and (v) descriptions for modifying the INSeq protocol to 
map arrayed mutant libraries are provided in Box 1. If other trans-
posons that cannot be modified with MmeI sites are used, alterna-
tive protocols such as the Tn-seq method described by Gallagher 
et al.9, HITS6 or TraDIS7 are preferable.
Experimental design
Overview.  An overview of the INSeq protocol is provided in 
Figure 1. Steps 1–16 describe the procedure used for extraction 
of DNA. In Steps 17–20, DNA is further purified using columns. 
Steps 21–23 describe a linear PCR procedure that is designed to 
enrich the transposon/chromosomal junction regions by using 
a primer complementary to the transposon-specific sequence. 
Steps 21–23 are necessary for two reasons. First, they add a biotin 
tag to each target molecule, which facilitates high-throughput, low-
volume solid-phase library preparation. Second, the linear PCR 
enriches for the desired target molecules early in the procedure, 
minimizing the amount and cost of enzymes needed for subsequent 
reaction steps. In Steps 24–36, the linear PCR product is bound to 
magnetic beads, allowing the PCR product to be separated from 
‘background’ chromosomal DNA by affinity capture. Second strand 
synthesis (and creation of the double-stranded MmeI site) takes 
place in Steps 37–43; because MmeI requires two sites for efficient 
DNA cleavage11, a second MmeI recognition site is provided in trans 
via the double-stranded DNA (dsDNA) fragment M12. Steps 
44–52 use MmeI to cut the dsDNA fragment to a uniform length 
(64–65 bp). The product of this reaction consists of the ampli-
fied transposon region generated by the linear PCR, plus 16–17 bp 
of chromosomal DNA. In Steps 53–63, sequencing adapters are 
ligated to the transposon/chromosomal junction to introduce the 
complementary sequence for the sequencing primer used by the 
Illumina Genome Analyzer/HiSeq instrument. By varying the four-
nucleotide barcode sequences in the adapter, multiple samples can 
be sequenced in a single lane of an Illumina flow cell. With limited 
cycles of PCR (Steps 64–78), targets are enriched in the linear range. 
PCR products are then purified by gel extraction to remove extra 
primers and adapters, and they are then sequenced. Data analysis is 
described in Steps 79–86; detailed documentation of data analysis 
tools is available in the README.txt in the INSeq_analysis package 
(Supplementary Data 1). Box 1 describes an additional protocol 
for combinatorial pooling and mapping of clonally arrayed trans-
poson mutant libraries by INSeq.
Starting material. Steps 1–16 describe the procedure used for 
extraction of DNA from the transposon library (the ‘input mutant 
population’) and from biological specimens containing mutants 
that survive a given selection (the ‘output mutant population’). 
These steps for DNA isolation were originally developed for mouse 
feces and for samples obtained from the more-proximal regions of 
the mouse gastrointestinal tract such as the cecum, and can also be 
used for in vitro mutant populations. Transposon mutant libraries 
can be introduced into a wide variety of biological systems (e.g., 
various animal or environmental habitats) or characterized in many 
different in vitro formats (e.g., chemostats, tissue culture). In these 
cases, users should isolate crude DNA using protocols designed for 
the specific system chosen for study. Whatever the system, experi-
ments need to be designed so that the amount of input and output 
material is sufficient for library preparation. For example, if the 
mutagenized species constitutes 100% of a microbial community, 
then the initial purification steps as described in the PROCEDURE 
ideally should yield  >500 ng of DNA. If the mutagenized species 
represents only 50% of the population, then the amount of starting 
material should be doubled.
Oligonucleotide sequence design. The linear PCR primer BioSamA 
is 5′-biotinylated and encodes a TEG spacer to reduce steric hin-
drance during the solid-phase enzymatic steps. The primer also 
encodes a transposon-specific region with a 26-bp sequence com-
plementary to sequences found on both sides of the transposon 
(underlined in Supplementary Table 1). Adapters encode 4-bp 
barcodes (marked in bold in Supplementary Table 1) that allow 
(a) Extract DNA from samples (Steps 1–20) (b) Linear PCR with biotinylated primer (Steps 21–23)
(c) Bind to beads, fill in (Steps 24–43) (d) Digestion, ligation
      (Steps 44–63)
(e) Amplification, sequencing
     (Steps 64–78)
(B = biotinylated primer)
B B
Mmel
NN
B
16 bp
NN
Sample-specific barcode (SP = IIIumina sequencing primer)
SP
NN
Streptavidin beads
B
B
B
B
(e.g., fecal sample)
Figure 1 | Overview of insertion  
sequencing protocol. (a) Genomic  
DNA is extracted and purified from a  
sample containing the transposon mutant 
library (e.g., input transposon mutant  
libraries or output samples, such as fecal 
samples obtained from gnotobiotic mice  
after colonization). (b) Linear PCR is 
performed to amplify the transposon with 
adjacent chromosomal DNA. (c) The PCR 
product is purified by binding to solid-phase 
beads; second strand DNA is synthesized.  
(d) DNA fragments are digested by MmeI  
and then ligated to sequencing adapters with 
a sample-specific barcode. (e) Products from 
stage d are amplified in a limited PCR step 
and sequenced. The inverted repeat region is shown as a black triangle. For convenience, stages c–e illustrate only one side of the transposon; in 
reality both sides are amplified and sequenced.
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sample multiplexing and produce a 2-bp NN overhang (comple-
mentary to the overhang produced by MmeI digestion) for ligation. 
For each adapter, two complementary oligonucleotide sequences 
are provided in Supplementary Table 1: LIB_AdaptT_x and LIB_
AdaptB_x, where x is the unique barcode specified by the adapter). 
These pairs of oligonucleotide sequences are annealed to each other 
during the PROCEDURE. The LIB-PCR primers encode the neces-
sary sequences for Illumina library preparation and sequencing.
Replicates and controls. Biological and technical replicates 
should be performed. The number of biological replicates 
required depends on the experimental system under study 
and should be determined empirically. Technical replicates 
can include identical samples associated with different sam-
ple-specific barcodes. The number of technical replicates 
should be determined by the user; two per biological sample 
is likely to be sufficient. No-DNA negative controls will help 
identify cross-contamination between samples; these con-
trols should be run in parallel with DNA-containing samples. 
Cross-contamination can occur if beads transfer from tube lids 
to the users’ gloves to other samples: this can be avoided with 
careful technique.
MaterIals
REAGENTS
Phenol:chloroform:isoamyl alcohol (25:24:1), pH 7.9 (Applied Biosystems, 
cat. no. AM9712) ! cautIon This mixture is hazardous; handle properly 
during experiments.
Sodium acetate (3 M), pH 5.5 (Applied Biosystems, cat. no. AM9740)
Isopropanol (100%, Fisher Scientific, cat. no. A416-4) ! cautIon Isopropanol 
is flammable; handle properly during experiments.
Ethanol (100%, Pharmco-AAPER, cat. no. 111ACS200) ! cautIon Ethanol 
is flammable; handle properly during experiments.
TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7; Ambion, cat. no. AM9861)
NaCl (NaCl powder, Fisher Scientific, cat. no. S271-10)
Tris base (Trizma base, Sigma-Aldrich, cat. no. T1503-1KG)
EDTA (EDTA powder, Sigma-Aldrich, cat. no. s657-500)
RNase A (Qiagen, cat. no. 19101)
QIAquick PCR purification kit (Qiagen, cat. no. 28106)
Platinum Pfx DNA polymerase (Invitrogen, cat. no. 11708-021)
Deoxyribonucleotide triphosphates (dNTPs; 10 mM, Invitrogen,  
cat. no. 18427-013)
Dynabeads M-280 streptavidin (Invitrogen, cat. no. 112-05D)
Hexanucleotide mix (Roche, cat. no. 11277081001)
Klenow fragment (3′–5′ exo-; 5 U µl − 1; New England Biolabs,  
cat. no. M0212S)
MmeI (New England Biolabs, cat. no. R0637S)
T4 DNA ligase (2,000,000 U ml − 1; New England Biolabs, cat. no. M0202T)
Agarose (Roche, cat. no. 11388991-001)
Electrophoresis buffers (TBE, borate buffer12 or equivalent)
NaOH (250 mM, Fisher Scientific, cat. no. S318 3)
Boric acid (Sigma-Aldrich, cat. no. B7901-500)
DNA ladder (10 bp, Invitrogen, cat. no. 10821-015)
GelGreen nucleic acid stain (10,000× stock prepared in water; Biotium,  
cat. no. 41005)
Ficoll 400 (20% (wt/vol), Sigma-Aldrich, cat. no. F4375)
Disodium EDTA (0.1 M, Sigma-Aldrich, cat. no. BP120-500)
Xylene cyanol (0.25% (wt/vol), Sigma-Aldrich, cat. no. X4126-10G)
Bromophenol blue; (0.25% (wt/vol), Sigma-Aldrich, cat. no. 114391-5G)
QIAquick gel extraction kit (Qiagen, cat. no. 28706)
Primer sequences are provided in Supplementary Table 1 (Integrated DNA 
Technologies)
Magnesium chloride (MgCl
2
)
For the arrayed library mapping protocol given in Box 1 only
 Glycerol (J.T. Baker, cat. no. 2136-01)
EQUIPMENT
Zirconium beads (0.1 mm diameter, BioSpec Products, cat. no. 11079101z)
Screw-top cryovials (2 ml, Axygen Products, cat. no. SCT-200-SS-C-S)
Phase Lock gel, light, 2 ml (5 Prime, cat. no. 2302820)
BeadBeater homogenizer (BioSpec)
Refrigerated microcentrifuge
Magnetic particle concentrator (MPC) for 1.5-ml tubes (Invitrogen,  
cat. no. 123-21D)
MPC for PCR tubes
Electronic 200-µl eight-channel pipettor with variable speed control
Heated oven or water bath set to 50 °C
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Vacuum evaporator
Thermocycler capable of a ramp rate of 0.1 °C s − 1
Electrophoresis equipment for agarose gels
Non-UV gel illuminator
Invitrogen QuBit DNA spectrophotometer (or similar, for DNA  
concentrations ≤ 1 ng µl − 1)
DNA sequencing facility with Illumina Genome Analyzer/HiSeq instrument
For the arrayed library mapping protocol given in Box 1 only
EpMotion 5075PC liquid-handling robot with TS50 single-channel 
dispensing tool and rack for 24 cryotubes  crItIcal Eppendorf, cat. no. 
960002491 was used, but temperature control is not necessary. Note that 
with the EpMotion, each set of five plates in the arrayed library takes ~8 h 
to pool. Higher-throughput liquid-handling robots are likely to be faster.
EpMotion tips (50-µl tips, nonfiltered, 1 × 96 tips per culture tray  
(Eppendorf, cat. no. 960050200)
Culture trays, 96 well (Midwest Scientific, cat. no. TP92696)
Parafilm (Pechiney)
Data analysis resources
fasta format sequence file and .ptt format annotation file(s) for the genome 
of interest
Bowtie short read aligner (Release 0.12.7 (ref. 13))
INSeq data analysis package (INSeq_analysis; Supplementary Data 1)
INSeq sample data package (INSeq_demo, downloadable from  
http://gordonlab.wustl.edu/SuppData.html)  crItIcal This package  
can be run on a computational cluster or a desktop/laptop computer under 
a UNIX system with 4 GB memory, perl and Bowtie (http://bowtie-bio.
sourceforge.net/index.shtml) installed. Basic understanding of Unix and 
perl are required for data analysis.
Tab-delimited operon file in the following format (optional; where P
A,B
 is a 
value between 0 and 1 (inclusive) reflecting the probability that gene A and 
gene B belong to the same operon14)
Gene A PA,B
Gene B PB,C
Gene C PC,D
REAGENT SETUP
Buffer A (2×) Buffer A is prepared using 200 mM NaCl, 200 mM Tris, and 
20 mM EDTA; pH is adjusted to 8 with concentrated HCl.  crItIcal This and 
all other buffers can be stored for months at room temperature (20–25 °C).
Bind and wash (B&W) buffer (2×) B&W buffer is prepared using 2 M NaCl, 
10 mM Tris, and 1 mM EDTA; pH is adjusted to 7.5 with concentrated HCl.
B&W buffer (1×) Dilute 2× B&W buffer to 1:1 with dH
2
O.
LoTE buffer Combine 3 mM Tris and 0.2 mM EDTA; adjust pH to 7.5 with 
concentrated HCl.
Borate buffer Borate buffer is prepared using 250 mM NaOH in dH
2
O; pH 
is adjusted to 8–8.5 with boric acid.
Xylene cyanol DNA dye (10×) Dye is prepared using 20% (wt/vol) Ficoll 
400, 0.1 M disodium EDTA and 0.25% (wt/vol) xylene cyanol.
Bromophenol blue DNA dye (10×) Dye is prepared using 20% (wt/vol) 
Ficoll 400, 0.1 M disodium EDTA and 0.25% (wt/vol) bromophenol blue.
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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proceDure
Isolation of crude Dna ● tIMInG 4 h
1| Add 250 µl of zirconium beads to the sample (e.g., ~109 colony-forming units of an in vitro mutant population or  <600 mg 
of cecal/fecal contents from mice colonized with a mutant population) in a 2-ml screw-top vial (cryovial). These beads help 
with cell disruption. Note that this procedure describes the processing of a single sample, but multiple samples can readily 
be processed in parallel.
2| Add 500 µl of 2× buffer A, 210 µl of 20% (wt/vol) SDS and 500 µl of phenol:chloroform:isoamyl alcohol (25:24:1).  
Chill the sample on ice.
3| Use the BeadBeater on the ‘homogenize’ setting for 2 min. Rest the sample on ice for 2 min and repeat bead-beating for 
2 min.
4| Centrifuge the tubes in a refrigerated microcentrifuge (4 °C, 6,800g, 3 min).
5| Transfer the aqueous phase (~600 µl) to a Phase Lock gel tube (prespun as described in the manufacturer’s instructions).
6| Add an equal amount (600 µl) of phenol:chloroform:isoamyl alcohol to the Phase Lock gel tube and mix by inversion.
7| Centrifuge the tube in a microcentrifuge (room temperature, 18,000g, 5 min).
8| Transfer the aqueous phase to a microcentifuge tube and discard the organic phase.
9| Add 600 µl of cold ( − 20 °C) 100% isopropanol to the microcentrifuge tube.
10| Add 60 µl (one-tenth volume) of 3 M sodium acetate (pH 5.5), and mix thoroughly by vortexing.
11| Incubate at  − 20 °C for at least 1 h.
 pause poInt The sample can be stored overnight or longer at  − 20 °C at this point.
12| Centrifuge the tube in a refrigerated microcentrifuge (4 °C, 18,000g, 20 min). Carefully decant and discard the supernatant.
13| Wash the pellet with 500 µl of 100% ethanol and centrifuge it in a refrigerated microcentrifuge (4 °C, 18,000g, 3 min). 
Carefully decant and discard the supernatant.
14| Remove any excess ethanol by gently tapping the tube upside-down on a laboratory tissue.
15| Evaporate any remaining supernatant in a vacuum evaporator (no heat, check at 5-min intervals until dry).
16| Resuspend the pellet in 200 µl of TE buffer (pH 7). Incubate in an oven or water bath at 50 °C for 30 min, vortexing 
every ~10 min. The pellet will dissolve much faster once it has been dislodged from the wall of the microcentrifuge tube.
rnase treatment and cleanup of crude Dna using QIaquick columns ● tIMInG 1 h
17| Transfer 100 µl of the crude DNA sample to a new tube. The remainder should be stored at  − 20 °C or  − 80 °C.
18| Add 0.5 µl of RNase A and incubate the tube at room temperature for 2 min. RNase treatment ensures accurate DNA 
quantitation in subsequent steps.
19| Clean up the sample using QIAquick PCR purification columns according to the manufacturer’s instructions. Make sure 
that all the ethanol-containing wash buffer is removed from each column before elution by pipetting around the inner rim 
with a 10-µl tip, if necessary. Elute each sample in 52 µl of buffer EB (part of QIAquick kit).
20| Measure the DNA concentration of each sample using a spectrophotometer (either a UV-based or dye-based system  
is acceptable).
 pause poInt The sample can be stored for months at  − 20 °C or  − 80 °C at this point.
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linear pcr ● tIMInG 2 h
21| Assemble the linear PCR reactions on ice.
component Volume per sample
dH2O to 100 µl
Pfx buffer 10 µl
10 mM dNTPs 2 µl
50 mM MgCl2 2 µl
BioSamA (1 pmol µl − 1) 5 µl
Clean DNA (from Step 20) 0.5–2 µg
Pfx polymerase 1 µl
22| Split the reaction into 2 × 50 µl in PCR tubes and run them on a thermocycler as follows: 94 °C for 2 min, followed by 
50 cycles of 94 °C for 15 s and 68 °C for 1 min.
23| Pool the tubes containing the same DNA sample, run them over a QIAquick PCR cleanup column according to the  
manufacturer’s instructions, and elute them in 50 µl of buffer EB.
Bind linear pcr products to beads ● tIMInG 1 h
24| Resuspend streptavidin-coated beads by shaking.
25| Add beads (32 µl per sample) to a new microcentrifuge tube (1 ml maximum; use multiple tubes if a larger volume  
is required).
26| Place the tube on the MPC for 1–2 min.
27| Carefully remove the supernatant with a pipette.
28| Remove the tube from MPC and add 1,000 µl of 1× B&W buffer; gently resuspend by pipetting.
29| Repeat Steps 26–28 twice for a total of three washes.
30| Remove the final wash and add 2× B&W buffer (52 µl per sample). Aliquot into PCR strip tubes (one tube per sample,  
50 µl per tube).
31| Add the entire volume of one sample from Step 23 to the tube.
32| Incubate at room temperature with gentle mixing for 30 min.
33| Place the tube on the MPC for 2 min.
34| Carefully remove the supernatant with a pipette. 
 crItIcal step To avoid disturbing the beads, set the electronic multichannel pipettor to its slowest setting, place the 
end of the tip against the opposite side of the tube from the beads, and slowly move the tip downward as the supernatant is 
removed. See supplementary Movie 1 for a demonstration.
? trouBlesHootInG
35| Remove the tube from the MPC and add 100 µl of 1× B&W buffer; gently resuspend by pipetting.
36| Repeat Steps 33–35 twice, but resuspend beads in 100 µl of LoTE buffer each time.
 pause poInt The sample can be stored at 4 °C overnight at this point.
second strand synthesis ● tIMInG 1 h
37| Denature the sample by heating in a thermocycler: 95 °C for 2 min, then chill quickly to 4 °C.
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38| Prepare second strand mix on ice.
component Volume per sample (ml)
dH2O 16
10× hexanucleotide mix 2
10 mM dNTPs 1
Klenow (exo-) 1
39| Collect the beads with the MPC, carefully discard the supernatant, remove the tube from the MPC, and then gently  
resuspend the sample in 20 µl of second strand mix.
40| Incubate the samples in a thermocycler at 37 °C for 30 min. Mix by gently tapping the tube every 10–15 min.
41| Add 100 µl of LoTE buffer to the sample, collect the beads in the MPC, and then carefully discard the supernatant.
42| Repeat Step 41.
43| Resuspend the beads in 100 µl of LoTE buffer.
 pause poInt The sample can be stored at 4 °C overnight at this point.
MmeI digestion ● tIMInG 2.5 h
44| Prepare 50 µM double-stranded M12 oligonucleotide11 by combining the following in a new PCR tube.
M12_top (100 µM in EB) 15 µl
M12_bot (100 µM in EB) 15 µl
1 M NaCl 1.5 µl
45| Anneal oligonucleotides in a thermocycler: 95 °C for 5 min; cool to 4 °C at a rate of 0.1 °C s − 1; store in 5-µl aliquots 
at  − 20 °C for future use.
46| Prepare MmeI buffer mix on ice.
component Volume per sample (ml)
dH2O 16.8
10× NEBuffer 4a 2
32 mM SAMa 0.08
M12 dsDNA 0.2
aPart of the MmeI restriction enzyme package from NEB.
47| Collect the beads from Step 43 with the MPC, carefully discard the supernatant, remove the tube from the MPC, and then 
gently resuspend each sample in 19 µl of MmeI buffer mix.
48| Add 1 µl of MmeI to the sample.
49| Incubate in the thermocycler at 37 °C for 1 h. Gently mix the sample every 10–15 min.
50| Add 100 µl of LoTE buffer to the sample, collect the beads in the MPC, and then carefully discard the supernatant.
51| Repeat Step 50.
52| Resuspend the beads in 100 µl of LoTE buffer.
 pause poInt The sample can be stored at 4 °C overnight at this point.
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linker ligation ● tIMInG 2.5 h
53| Prepare a 50 µM stock of barcoded, double-stranded sequencing adapters (one barcode sequence per sample) by  
combining the following in a new PCR tube.
LIB_AdaptT_(barcode) (100 µM in EB) 15 µl
LIB_AdaptB_(barcode) (100 µM in EB) 15 µl
1 M NaCl 1.5 µl
54| Anneal oligonucleotides in a thermocycler: 95 °C for 5 min; cool to 4 °C at a rate of 0.1 °C s − 1.
 pause poInt Adapters can be stored for months in 5-µl single-use aliquots at –20 °C for future use.
55| If they are frozen, thaw dsDNA sequencing adapters on ice (one barcode per sample). Dilute each 50 µM stock of dsDNA 
sequencing adapter to 5 µM in ice-cold 1× T4 DNA ligase buffer. 
 crItIcal step If the adapters are not thawed on ice, they can dissociate into single-stranded DNAs.
56| Prepare ligation mix on ice.
component Volume per sample (ml)
dH2O 16.4
10× T4 DNA ligase buffer 2
57| Collect the beads from Step 52 with the MPC, carefully discard the supernatant, remove the tube from the MPC and  
gently resuspend the sample in 18.4 µl of ligation mix.
58| Add 0.6 µl of 5 µM dsDNA sequencing adapter (from Step 55) containing a unique barcode to the sample. Record which 
barcode is associated with the sample.
59| Add 1 µl of T4 DNA ligase to the sample.
60| Incubate in a thermocycler at 16 °C for 1 h. Gently mix every 10–15 min.
61| Add 100 µl of LoTE buffer to the sample, collect the beads in the MPC and carefully discard the supernatant.
62| Repeat Step 61.
63| Resuspend the beads in 100 µl of LoTE buffer.
 pause poInt The sample can be stored at 4 °C overnight at this point.
pcr and final purification ● tIMInG 4 h
64| Assemble the PCR mix on ice.
component Volume per sample (ml)
dH2O 31.5
10× Pfx buffer 10 (used at 2× standard concentration)
10 mM dNTPs 2
50 mM MgCl2 2
5 µM LIB-PCR5 2
5 µM LIB-PCR3 2
Pfx polymerase 0.5
65| Collect the beads from Step 63 with the MPC, carefully discard the supernatant, remove the tube from the MPC and  
gently resuspend the sample in 50 µl of PCR mix on ice.
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66| Run on a thermocycler, as follows, and prepare a 2% (wt/vol) agarose gel (1–2 lanes per sample plus 2 ladder lanes per 
gel; GelGreen dye at 1:10,000 dilution; wide-tooth comb) while PCR is running. Run at 94 °C for 2 min followed by 18 cycles 
of: 94 °C for 15 s, 60 °C for 1 min, 68 °C for 2 min and then 68 °C for 4 min.
 pause poInt The sample can be stored at 4 °C overnight at this point.
67| Collect the beads on the MPC and transfer the supernatant to a new PCR tube.
68| Prepare the DNA ladder.
10-bp DNA ladder 4 µl
Bromophenol blue loading dye 1× final concentration
dH2O 20 µl final volume
69| Add xylene cyanol loading dye to the sample (supernatant from Step 67) to 1× final concentration. 
 crItIcal step Xylene cyanol is used because bromophenol blue can migrate near the same position as the desired 125-bp 
PCR product, thereby obscuring the band in the gel. The use of bromophenol blue in the ladder lanes will provide an  
approximate position of the samples in the gel during electrophoresis.
70| Load the DNA ladder onto the first and last lanes of the gel.
71| Load the sample into its own lane of the gel. If the wells are too small for the full volume, split the sample over  
two lanes.
72| Run the gel for 30 min at 200 V. 
 crItIcal step Time and voltage may need to be adjusted on the basis of gel size and buffer composition; these param-
eters work well for 7-cm gels run in borate buffer.
73| Use a non-UV gel illuminator to excise the band at ~125 bp, minimizing surplus agarose in the gel fragment. Place the 
gel fragment in a microcentrifuge tube (if two lanes were used per sample, the similar fragments can be placed in the same 
tube as long as the total weight remains under 300 mg).
? trouBlesHootInG
74| Clean up the sample using QIAquick gel purification columns according to the manufacturer’s instructions (including the 
isopropanol step for small fragments). Be certain that all of the ethanol-containing wash buffer is removed from the column 
before elution by pipetting around the inner rim with a 10-µl tip, if necessary. Elute in 32 µl of buffer EB. Gel purification 
ensures that primer-dimers or other erroneous products do not contribute to the DNA quantification or sequencing in  
subsequent steps.
75| Quantify the sample on a QuBit or similar spectrophotometer. 
 crItIcal step DNA concentration is typically 0.1–5 ng µl − 1, which is below the reliable detection limit of many UV  
absorbance–based spectrophotometers.
76| All samples should subsequently be normalized to the same concentration. If all samples are ≥0.83 ng µl − 1, adjust an  
aliquot of each sample to 10 nM in EB buffer. On the basis of an expected fragment length of 125 bp, the formula for a 
10 nM normalization is volume of DNA (µl)  =  10 × final volume (µl) / (DNA concentration (ng µl − 1) × (106) × (1/649) × 
(1/125)). If sample concentrations are  <0.83 ng µl − 1, adjust an aliquot of each sample to 1 nM in EB buffer. Tip: the for-
mula for a 1 nM normalization is the volume of DNA (µl)  =  1 × final volume (µl) / (DNA concentration (ng µl − 1) × (106) × 
(1/649) × (1/125)).
77| Combine an equal volume of each sample into a single tube. 
 crItIcal step Required volumes may vary by sequencing facility. Be sure to inform the sequencing facility of whether the 
sample is at 10 or 1 nM.
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78| Submit for Illumina sequencing. The optimum loading concentration may vary by sequencing center or by Genome  
Analyzer model; we currently use 6 pM for GA-IIx and HiSeq machines.
? trouBlesHootInG
Data analysis ● tIMInG ~3 min per million raw reads
79| Download the data analysis package (INSeq_analysis.zip; supplementary Data 1) and sample data package (INSeq_demo. 
zip; downloadable from http://gordonlab.wustl.edu/SuppData.html) and save each to your own directory.
80| Bowtie is used to map sequences to the reference genome. Download this mapping software from http://bowtie-bio.
sourceforge.net/index.shtml and install in your system. Edit the ‘config.txt’ file in the data analysis package (INSeq_analysis)  
by changing the bowtie_dir variable to the path where bowtie was installed. Detailed instructions are provided in the  
README file in the INSeq_analysis folder (see supplementary Data 1).
81| Go to the uncompressed data analysis package (INSeq_analysis; see supplementary Data 1) and then to the ‘indexes’ 
directory. From this location, create a new directory with the organism’s name (e.g., BthetaVPI_5482). Put the genome file 
in .fasta format and the annotation files (in .ptt format) in the new directory. Go into the new directory and construct a 
bowtie index by typing the command:
“path to bowtie directory”/bowtie-build  < fasta file >  < name of index, same as the new 
directory > 
? trouBlesHootInG
82| Create an experiment directory where you would like to store your analysis results. For example:
mkdir /Users/mwu/Documents/Experiment_1
83| Create a mapping file that contains the barcode for each sample in tab-delimited format in the experiment directory:
 < barcode > < Sample Name > 
84| From the experiment directory, run the analysis pipeline by running the wrapper script INSeq_pipeline.pl with the usage:
perl “path for analysis package”/INSeq_pipeline.pl -i  < the raw reads file > -m  
 < Barcodes mapping file > -s  < indexed genome name > -d  < length_disrupt_percent (max = 1) > 
Required arguments: -i gives the input raw reads file, -m gives the mapping file and -s gives the name of the indexed genome 
to which the reads should be mapped.
Optional arguments: -d gives the region of the gene in which insertions are expected to disrupt gene function. The default is 1, 
which means that when the insertion falls anywhere within the gene (100%), the gene’s function will be considered to be 
disrupted. Setting the -d argument to 0.9, for example, would exclude insertions in the distal 10% of the gene when  
calculating the total number of reads/insertions for that gene.
? trouBlesHootInG
85| The INSeq_pipeline.pl will generate several mappingjobsXXX.job under the experiment directory. On a desktop/laptop, run them in 
series by typing sh mappingjobsXXX.job for each job, or (on a cluster) run in parallel. Several output files will be generated:
INSEQ_experiment.scarf_assigned.txt: reads are assigned to different samples on the basis of the sample-specific barcode.
INSEQ_experiment.scarf.log: contains some statistics for the analysis process, including the total number of reads, the per-
centage of reads being mapped and trimmed (that have the transposon), how many insertions in the sample (coverage) with 
the number of raw reads (reads after filtering in the normalization step) and the scale factor being used for normalization.
Several output files will be placed in the ‘results’ folder:
INSEQ_experiment.scarf_Samplename.bowtiemap: a raw mapping output file from bowtie.
INSEQ_experiment.scarf_Samplename.bowtiemap_processed.txt_chromosomename: a text file containing the processed 
 mapping output, with the format:
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 < chromosome name >  < insertion position >  < reads mapped to the left side of the  
insertion >  < reads mapped to the right side of the insertion >  < the total number of 
reads mapped to that position > 
INSEQ_experiment.scarf_Samplename.bowtiemap_processed.txt_chromosomename_filter_cpm.txt: a text file with positions 
having more than three total reads, and normalized to counts per million reads.
INSEQ_experiment.scarf_Samplename.bowtiemap_processed.txt_chromosomename_filter_cpm.txt_mapped: a text file that lists 
genes mapped by insertions, only when the insertions located at the proximate XX percentage (specify by the -d option) are 
considered to interrupt the function of genes. The format is:
 < gene name >  < the total number of unique insertions in the gene >  < the sum of  
normalized read counts in that gene >  < gene annotation from the ptt file > 
? trouBlesHootInG
86| Cleanup: as there are many intermediate files generated along the pipeline, if storage space is a big concern, deleting 
them is optional. You can run ‘clean_up.sh’ from the experiment folder by using command sh clean_up.sh, which will 
remove the sorted barcode assigned reads file, the folder ‘bcsortedseqs’ and the mappingjob files.
? trouBlesHootInG
Troubleshooting advice can be found in table 1.
taBle 1 | Troubleshooting table.
step problem possible reason solution
34 Beads are lost during wash 
steps
Electronic multichannel pipettor is too 
fast
If alternate pipettors are not available, perform this 
step manually
73 Bands are faint or inconsist-
ent between samples
Ligation adapters not properly 
annealed, or have barcodes that pre-
vent proper annealing
Use technical replicates (same input DNA with different 
sample-specific barcodes) to determine whether the bar-
code or the input DNA is the problem
78 Illumina sequencing pro-
duces fewer reads than 
expected
Sequence characteristics prevent proper 
function of Illumina base-calling soft-
ware
Provide the sequencing facility with information about 
common and variable bases in your expected sequences 
on the basis of the barcodes used
81 Error message ‘bowtie-build: 
No such file or directory’
Command did not specify the location 
of bowtie
Make sure to include the entire path for bowtie, e.g., 
‘/Users/XXX/bowtie-0.12.7/bowtie-build Bt.fna BtVPI 
5482’
84 Analysis pipeline cannot 
recognize the raw reads file
The raw reads file is not in the scarf 
format
Convert your raw reads file to scarf format
85 Error message ‘bowtie: No 
such file or directory’
The analysis package could not locate 
bowtie
Check the ‘config.txt’ in Step 80; make sure the bowtie_
dir variable is the path where your bowtie installation is 
located. For example, bowtie_dir=‘/Users/XXX/bowtie-
0.12.7’
Error message ‘Could not 
locate a bowtie index corre-
sponding to base name ‘XXX’’
The analysis package could not find 
the bowtie index. The analysis package 
is looking for the index file located in 
‘INSEQ_analysis/indexes/XXX/XXX’ (XXX 
is the ‘indexed genome name’ specified 
in Step 84 by argument -s)
Check the location and the name of your index file. Make 
sure it is UNDER the ‘INSeq_analysis/indexes’ direc-
tory (it should be in the position exactly inside of the 
‘indexes’ folder), and check that the name of the index, 
which is the prefix of the .X.ebwt file, is consistent with 
the name of the directory. If not, remake the ebwt file 
using bowtie-build and repeat Step 81
(continued)
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● tIMInG
Steps 1–16, Isolation of crude DNA: 4 h
Steps 17–20, Cleanup of crude DNA using QIAquick columns: 1 h
Steps 21–23, Linear PCR: 2 h
Steps 24–36, Bind linear PCR product to beads: 1 h
Steps 37–43, Second strand synthesis: 1 h
Steps 44–52, MmeI digestion: 2.5 h
Steps 53–63, Linker ligation: 2.5 h
Steps 64–78, PCR and final purification: 4 h
Steps 79–86, Data analysis: initial analysis requires ~3 min per million raw reads on a 3.06 GHz Intel Core 2 Duo processor 
with 4 GB memory
Box 1, arrayed library preparation: ~1.6 h per 96-well tray, plus time for picking colonies into trays and INSeq  
library preparation
antIcIpateD results
The INSeq analysis pipeline produces several output files with data at the level of individual insertion locations, genes and 
(optionally) operons. Good libraries should have  >95% of reads that contain the transposon sequence, consistent read 
counts generated from both sides of each insertion and consistent data from biological and technical replicates. A real data 
set from a successful library preparation is provided in the INSeq_demo files.
Note: Supplementary information is available via the HTML version of this article.
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Abstract
The human gut microbiota is an important metabolic organ, yet little is known about how its individual species interact,
establish dominant positions, and respond to changes in environmental factors such as diet. In this study, gnotobiotic mice
were colonized with an artificial microbiota comprising 12 sequenced human gut bacterial species and fed oscillating diets
of disparate composition. Rapid, reproducible, and reversible changes in the structure of this assemblage were observed.
Time-series microbial RNA-Seq analyses revealed staggered functional responses to diet shifts throughout the assemblage
that were heavily focused on carbohydrate and amino acid metabolism. High-resolution shotgun metaproteomics
confirmed many of these responses at a protein level. One member, Bacteroides cellulosilyticus WH2, proved exceptionally fit
regardless of diet. Its genome encoded more carbohydrate active enzymes than any previously sequenced member of the
Bacteroidetes. Transcriptional profiling indicated that B. cellulosilyticus WH2 is an adaptive forager that tailors its versatile
carbohydrate utilization strategy to available dietary polysaccharides, with a strong emphasis on plant-derived xylans
abundant in dietary staples like cereal grains. Two highly expressed, diet-specific polysaccharide utilization loci (PULs) in B.
cellulosilyticus WH2 were identified, one with characteristics of xylan utilization systems. Introduction of a B. cellulosilyticus
WH2 library comprising .90,000 isogenic transposon mutants into gnotobiotic mice, along with the other artificial
community members, confirmed that these loci represent critical diet-specific fitness determinants. Carbohydrates that
trigger dramatic increases in expression of these two loci and many of the organism’s 111 other predicted PULs were
identified by RNA-Seq during in vitro growth on 31 distinct carbohydrate substrates, allowing us to better interpret in vivo
RNA-Seq and proteomics data. These results offer insight into how gut microbes adapt to dietary perturbations at both a
community level and from the perspective of a well-adapted symbiont with exceptional saccharolytic capabilities, and
illustrate the value of artificial communities.
Citation: McNulty NP, Wu M, Erickson AR, Pan C, Erickson BK, et al. (2013) Effects of Diet on Resource Utilization by a Model Human Gut Microbiota Containing
Bacteroides cellulosilyticus WH2, a Symbiont with an Extensive Glycobiome. PLoS Biol 11(8): e1001637. doi:10.1371/journal.pbio.1001637
Academic Editor: Jonathan A. Eisen, University of California Davis, United States of America
Received March 26, 2013; Accepted July 12, 2013; Published August 20, 2013
Copyright:  2013 McNulty et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The majority of this work was supported by grants from the NIH (DK30292, DK70977). Other sources of support included the Crohn’s and Colitis
Foundation of America, the European Research Council under the European Union’s Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement
no. 322820, and an ORNL Laboratory Director’s Exploratory Seed Money grant (for metaproteomics). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: CE, carbohydrate esterase; COPRO-Seq, community profiling by sequencing; EC, enzyme commission; ECF, extracytoplasmic function; GH,
glycoside hydrolase; GT, glycosyltransferase; HF/HS, high-fat/high-sugar; HTCS, hybrid two-component system; INSeq, insertion sequencing; LF/HPP, low-fat/high-
plant polysaccharide; MM, minimal medium; MPC, magnetic particle collector; NBC, normalization by community; NBS, normalization by species; PCoA, principal
coordinates analysis; PL, polysaccharide lyase; PoMA, percentage of maximum achieved; PSMs, peptide-spectrum matches; PTS, phosphotransferase system; PUL,
polysaccharide utilization locus; RFO, raffinose family oligosaccharide.
* E-mail: jgordon@wustl.edu
Introduction
A growing body of evidence indicates that the tens of trillions of
microbial cells that inhabit our gastrointestinal tracts extend our
biological capabilities in important ways. Microbial enzymes
process many compounds that would otherwise pass through our
intestines unaltered [1], and cases of particular nutrient substrates
favoring the growth of particular taxa are being reported [2–5].
Changes in diet are therefore expected to lead to changes in the
composition and function of the microbiota [6–10]. However, our
understanding of diet–microbiota interactions at a mechanistic
level is still in its infancy.
The absence of a complete catalog of the microbial strains and
associated genome sequences that comprise a given microbiota
complicates efforts to describe how particular dietary substrates
influence individual taxa, how taxa cooperate/compete to utilize
nutrients, and how these many interactions in aggregate lead to
emergent host phenotypes. Gnotobiotic mice colonized with
defined consortia of sequenced human gut microbes, on the other
hand, provide an in vivo model of the microbiota in which the
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identity of all taxa and genes comprising the system are known.
Within these assemblages, expressed mRNAs and proteins can be
attributed to their genome, gene, and species of origin, and
findings of interest can be pursued in follow-up in vitro or in vivo
experiments. These systems also afford an opportunity to tightly
control experimental variables to a degree not possible in human
studies and have proven useful in studying microbial invasion,
microbe–microbe interactions, and the metabolic roles of key
ecological guilds [11–15]. Studies aiming to better understand
community-level assembly, resilience, and adaptation are therefore
likely to benefit from a focus on such defined systems. However,
the limited taxonomic and functional representation within
artificial communities of modest complexity requires that caution
be exercised when extrapolating results to more complex, naturally
occurring gut communities (see Prospectus).
Culture-independent surveys of the healthy adult gut microbiota
consistently conclude that it is composed primarily of members of
two bacterial phyla, the Bacteroidetes and Firmicutes [16–21].
The dominance of these two bacterial phyla suggests that their
representatives in the human gut are exquisitely adapted to its
dynamic conditions, which include a constantly evolving nutrient
environment. Members of the genus Bacteroides are known to be
adept at utilizing both plant- and host-derived polysaccharides
[22]. Comparisons of available Bacteroides genomes with those from
other gut species indicate that the former are enriched in genes
involved in the acquisition and metabolism of various glycans,
including glycoside hydrolases (GHs) and polysaccharide lyases
(PLs), as well as linked environmental sensors that control their
expression (e.g., hybrid two-component systems, extracytoplasmic
function (ECF) sigma factors and anti-sigma factors). Many of
these genes are organized into polysaccharide utilization loci
(PULs) that are distributed throughout the genome [23,24].
Recent studies have focused on better understanding the
evolution, specificity, and regulation of PULs in the genomes of
species like Bacteroides thetaiotaomicron and Bacteroides ovatus [25,26].
Little is known, however, about the metabolic strategies adopted
by multiple competing species in more complex communities, how
dietary changes lead to reconfigurations in community structure
through changes in individual species, or whether dietary context
influences which genes dominant species rely on to remain
competitive with other microbes, including those genes that are
components of PULs.
Here, we adopt a multifaceted approach to study an artificial
community in gnotobiotic mice fed changing diets in order to
better understand (i) the process by which such a community
reconfigures itself structurally in response to changes in host diet;
(ii) how aggregate community function, as judged by the
metatranscriptome and metaproteome, is impacted when host
diet is altered; (iii) how the metabolic strategies of its individual
component microbes change, if at all, when the nutrient milieu is
dramatically altered, with an emphasis on one prominent but
understudied member of the human gut Bacteroides; and (iv)
whether a microbe’s metabolic versatility/flexibility correlates with
competitive advantage in an assemblage containing related and
unrelated species.
Results and Discussion
Sequencing the Bacteroides cellulosilyticus WH2 Genome
Though at least eight complete and 68 draft genomes of
Bacteroides spp. are currently available [27], there are numerous
examples of distinct clades within this genus where little genomic
information exists. To further explore the genome space of one
such clade, we obtained a human fecal isolate whose four 16S
rRNA gene sequences indicate a close relationship to Bacteroides
cellulosilyticus (Figure S1A,B). The genome of this isolate, which we
have designated B. cellulosilyticus WH2, was sequenced deeply,
yielding a high-quality draft assembly (23 contigs with an N50
value of 798,728 bp; total length of all contigs in the assembly,
7.1 Mb; Table S1). Annotation of its 5,244 predicted protein-
coding genes using the carbohydrate active enzyme (CAZy)
database [28] revealed an extraordinary complement of 503
CAZymes comprising 373 GHs, 23 PLs, 28 carbohydrate esterases
(CEs), and 84 glycosyltransferases (GTs) (see Table S2 for all
annotated genes in the B. cellulosilyticus WH2 genome predicted to
have relevance to carbohydrate metabolism). One distinguishing
feature of gut Bacteroides genomes is the substantial number of
CAZymes they encode relative to those of other intestinal bacteria
[29]. The B. cellulosilyticus WH2 CAZome is enriched in a number
of GH families even when compared with prominent representa-
tives of the gut Bacteroidetes (Figure S2A). When we expanded
this comparison to include all 86 Bacteroidetes in the CAZy
database, we found that the B. cellulosilyticus WH2 genome had the
greatest number of genes for 19 different GH families, as well as
genes from two GH families that had not previously been observed
within a Bacteroidetes genome (Figure S2B). Altogether, B.
cellulosilyticus WH2 has more GH genes at its disposal than any
other Bacteroidetes species analyzed to date.
In Bacteroides spp., CAZymes are often located within PULs [30].
At a minimum, a typical PUL harbors a pair of genes with
significant homology to the susC and susD genes of the starch
utilization system (Sus) in B. thetaiotaomicron [30–32]. Other genes
encoding enzymes capable of liberating oligo- and monosaccha-
rides from a larger polysaccharide are also frequently present. The
susC- and susD-like genes of these loci encode the proteins that
comprise the main outer membrane binding and transport
apparatus and thus represent key elements of these systems. A
search of the B. cellulosilyticus WH2 genome for genes with strong
Author Summary
Our intestines are populated by an almost unimaginably
large number of microbial cells, most of which are bacteria.
This species assemblage operates as a microbial metabolic
organ, performing myriad tasks that contribute to our well-
being, including processing components of our diet. The
way this incredible machine assembles itself and operates
remains mysterious. One approach to understanding its
properties is to create artificial communities composed of
a limited number of sequenced human gut bacterial
species and to install them in the guts of germ-free mice
that are then fed different diets. In this report, we adopt
this approach. We describe the genome sequence of a
new gut bacterial isolate, Bacteroides cellulosilyticus WH2,
which is equipped with an unprecedented number of
carbohydrate active enzymes. Deploying four different
‘‘omics’’ technologies, we characterize the response to
diet, the relative stability, and the temporal dynamics of a
12-species artificial bacterial assemblage (including B.
cellulosilyticus WH2) implanted in germ-free mouse guts.
We also combine high-throughput substrate utilization
screens and RNA-Seq to generate reference data analo-
gous to a ‘‘Rosetta stone’’ in order to decipher what types
of carbohydrates B. cellulosilyticus encounters and uses
within the gut, and how it interacts with other organisms
that have similar and/or distinct ‘‘professions.’’ This work
sets the stage for future ecological and metabolic studies
of more complex assemblages that more fully emulate the
properties of our native gut communities.
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homology to the susC- and susD-like genes in B. thetaiotaomicron VPI-
5482 revealed an unprecedented number of susC/D pairs (a total
of 118). Studies of other prominent Bacteroides spp. have found that
the evolutionary expansion of these genes has played an important
role in endowing the Bacteroides with the ability to degrade a wide
range of host- and plant-derived polysaccharides [25,33]. Analysis
of deeply sampled adult human gut microbiota datasets indicates
that B. cellulosilyticus strains are common, colonizing approximately
77% of 124 adult Europeans characterized in one study [18] and
62% of 139 individuals living in the United States examined in
another survey [20]. We hypothesized that the apparent success of
B. cellulosilyticus in the gut is derived in part from its substantial
arsenal of genes involved in carbohydrate utilization.
Measuring Changes in the Structural Configuration of a
12-Member Model Microbiota in Response to a Dietary
Perturbation
To test the fitness of B. cellulosilyticus WH2 in relation to other
prominent gut symbionts, and the importance of diet on its fitness,
we carried out an experiment in gnotobiotic mice (experiment 1,
‘‘E1,’’ Figure S3). Two groups of 10–12-wk-old male germ-free
C57BL/6J animals were moved to individual cages within
gnotobiotic isolators (n=7 animals/group). At day zero, each
animal was colonized by oral gavage with an artificial community
comprising 12 human gut bacterial species (Figure 1A, Table S3).
Each species chosen for inclusion in this microbial assemblage met
four criteria: (i) it was a member of one of three bacterial phyla
routinely found in the human gut (i.e., Bacteroidetes, Firmicutes,
or Actinobacteria), (ii) it was identified as a prominent member of
the human gut microbiota in previous culture-independent
surveys, (iii) it could be grown in the laboratory, and (iv) its
genome had been sequenced to at least a high-quality draft level.
Species were also selected for their functional attributes (as judged
by their annotated gene content) in an effort to create an artificial
community that was somewhat representative of a more complex
human microbiota. For example, although more than half of the
species in the assemblage were Bacteroidetes predicted to excel at
the breakdown of polysaccharides, several were also prominent
inhabitants of the human gut that are thought to have limited
carbohydrate utilization capabilities (e.g., Firmicutes from Clos-
tridium cluster XIVa). Some attributes for the 12 strains included
in the artificial community are provided in Table S4.
For 2 wk, each treatment group was fed a standard low-fat/
high-plant polysaccharide (LF/HPP) mouse chow, or a ‘‘West-
ern’’-like diet where calories are largely derived from fat, starch,
and simple sugars (high-fat/high-sugar (HF/HS)) [12]. Over the
course of 6 wk, diets were changed twice at 2-wk intervals, such
that each group began and ended on the same diet, with an
intervening 2-wk period during which the other diet was
administered (Figure S3).
Using fecal DNA as a proxy for microbial biomass, the plant
polysaccharide-rich LF/HPP diet supported 2- to 3-fold more total
bacterial growth (primary productivity) despite its lower caloric
density (3.7 kcal/g versus 4.5 kcal/g for the HF/HS diet; Figure
S4A). The HF/HS diet contains carbohydrates that are easily
metabolized and absorbed in the proximal intestine (sucrose, corn
starch, and maltodextrin), with cellulose being the one exception
(4% of the diet by weight versus 46.3% for the other carbohydrate
sources). Thus, in mice fed the HF/HS diet, diet-derived simple
sugars are likely to be rare in the distal gut where the vast majority
of gut microbes reside; this may provide an advantage to those
bacteria capable of utilizing other carbon sources (e.g., proteins/
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Figure 1. COPRO-Seq analysis of the structure of a 12-member artificial human gut microbial community as a function of diet and
time. (A) The 12 bacterial species comprising the artificial community. (B) Principal coordinates analysis (PCoA) was applied to relative abundance
data generated by COPRO-Seq from two experiments (E1, E2), each spanning 6 wk. Following colonization (day 0), mice were switched between two
different diets at 2-wk intervals as described in Figure S3. COPRO-Seq data from E1 and E2 were ordinated in the same multidimensional space. For
clarity, only data from E2 are shown here (for the E1 PCoA plot, see Figure S5A). Red/blue, feces; pink/cyan, cecal contents. (C) Proportional abundance
data from E1 illustrating the impact of diet on fecal levels of a diet-sensitive strain with higher representation on HF/HS chow (B. caccae), a diet-
sensitive strain with higher representation on LF/HPP chow (B. ovatus), a diet-insensitive strain with no obvious diet preference (B. thetaiotaomicron),
and a diet-sensitive strain with a preference for the LF/HPP diet that also achieves a high level of representation on the HF/HS diet (B. cellulosilyticus
WH2). Mean values 6 SEM are shown. Plots illustrating changes in abundance over time for all species in both experiments are provided in Figure
S4C.
doi:10.1371/journal.pbio.1001637.g001
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oligopeptides, host glycans). In mice fed the LF/HPP diet, on the
other hand, plant polysaccharides that are indigestible by the host
should provide a plentiful source of energy for saccharolytic
members of the artificial community.
To evaluate the impact of each initial diet and subsequent diet
switch on the structural configuration of the artificial community,
we performed shotgun sequencing (community profiling by
sequencing; COPRO-Seq) [11] of DNA isolated from fecal
samples collected throughout the course of the experiment, as
well as cecal contents collected at sacrifice. The relative
abundances of the species in each sample (defined by the number
of sequencing reads that could be unambiguously assigned to each
microbial genome after adjusting for genome uniqueness) were
subjected to ordination by principal coordinates analysis (PCoA)
(Figure S5A). As expected, diet was found to be the predominant
explanatory variable for observed variance (see separation along
principal coordinate 1, ‘‘PC1,’’ which accounts for 52% of
variance). The overall structure of the artificial community
achieved quasi-equilibrium before the midpoint of the first diet
phase, as evidenced by the lack of any significant movement along
PC1 after day five. A structural reconfiguration also took place
over the course of ,5 d following transition to the second diet
phase. Notably, the two treatment groups underwent a near-
perfect inversion in their positions along PC1 after the first diet
switch; the artificial community in animals switched from a LF/
HPP to HF/HS diet took on a structure like that which arose by
the end of the first diet phase in animals consuming the HF/HS
diet, and vice versa. The second diet switch from phase 2 to 3
resulted in a similar movement along PC1 in the opposite
direction, indicating a reversion of the artificial community’s
configuration to its originally assembled structure in each
treatment group. These results, in addition to demonstrating the
significant impact of these two diets on the structure of this 12-
member artificial human gut community, also suggest that an
assemblage of this size is capable of demonstrating resilience in the
face of substantial diet perturbations.
The assembly process and observed diet-induced reconfigura-
tions also proved to be highly reproducible as evidenced by
COPRO-Seq results from a replication of E1 (experiment 2, ‘‘E2’’).
In this follow-up experiment, fecal samples were collected more
frequently than in E1, providing a dataset with improved temporal
resolution. Ordination of E2 COPRO-Seq data by PCoA showed
that (i) for each treatment group in E2, the artificial community
assembles in a manner similar to its counterpart in E1; (ii)
structural reconfigurations in response to diet occur with the same
timing as in E1; and (iii) the quasi-equilibria achieved during each
diet phase are highly similar between experiments for each
treatment group (compare Figures 1B and S5A). As in E1, cecal
data for each E2 treatment group overlap with their corresponding
fecal samples, and DNA yields from E2 fecal samples vary
substantially as a function of host diet (Figure S4B).
COPRO-Seq provides precise measurements of the propor-
tional abundance of each member species present in the artificial
community. Data collected in both E1 and E2 (Table S5) revealed
significant differences between members in terms of the maximum
abundance levels they achieved, the rates at which their
abundance levels were impacted by diet shifts, and the degree to
which each species demonstrated a preference for one diet over
another (Figure S4C). Changes in each species’ abundance over
time replicated well across animals in each treatment group,
suggesting the assembly process and diet-induced reconfigurations
occur in an orderly, rules-based fashion and with minimal
stochasticity in this artificial community. A species’ relative
abundance immediately after colonization (i.e., 24 h after
gavage/day 1) was, in general, a poor predictor of its abundance
at the end of the first diet phase (i.e., day 13) (E1 R
2 = 0.23; E2
R2 = 0.27), suggesting that early dominance of the founder
population was not strongly tied to relative success in the assembly
process.
In mice initially fed a HF/HS diet, four Bacteroides spp.
(Bacteroides caccae, B. cellulosilyticus WH2, B. thetaiotaomicron, and
Bacteroides vulgatus) each achieved a relative abundance of$10% by
the end of the first diet phase (day 13 postgavage), with B. caccae
attaining the highest levels (37.164.9% and 34.265.5%; group
mean 6 SD in E1 and E2, respectively). In animals fed the plant
polysaccharide-rich LF/HPP chow during the first diet phase, B.
cellulosilyticus WH2 was dominant, achieving levels of 37.162.0%
(E1) and 41.663.9% (E2) by day 13. B. thetaiotaomicron and B.
vulgatus also attained relative abundances of .10%.
Changes in diet often resulted in rapid, dramatic changes in a
species’ proportional representation. Because the dynamic range
of abundance values observed when comparing multiple species
was substantial (lowest, Dorea longicatena (,0.003%); highest, B.
caccae (55.0%)), comparing diet responses on a common scale using
raw abundance values was challenging. To represent these
changes in a way that scaled absolute increases/decreases in
relative abundance to the range observed for each strain, we also
normalized each species’ representation within the artificial
community at each time-point to the maximum proportional
abundance each microbe achieved across all time-points within
each mouse. Plotting the resulting measure of abundance
(percentage of maximum achieved; PoMA) over time demon-
strates which microbes are strongly responsive to diet (experience
significant swings in PoMA value following a diet switch) and
which are relatively diet-insensitive (experience only modest or no
significant change in PoMA value following a diet switch).
Heatmap visualization of E1 PoMA values (Figure S5B) indicated
that those microbes with a preference for a particular diet in one
animal treatment group also tended to demonstrate the same diet
preference in the other. Likewise, diet insensitivity was also
consistent across treatment groups; diet-insensitive microbes were
insensitive regardless of the order in which diets were introduced.
Of the diet-sensitive taxa, those showing the most striking
responses were B. caccae and B. ovatus, which strongly preferred the
‘‘Western’’-like HF/HS diet and the polysaccharide-rich LF/HPP
diet, respectively (Figures 1C and S4C). Among the diet-insensitive
taxa, B. thetaiotaomicron showed the most stability in its represen-
tation (Figures 1C and S4C), consistent with its reputation as a
versatile forager. Paradoxically, B. cellulosilyticus WH2 was both
diet-sensitive and highly fit on its less-preferred diet; although this
strain clearly achieved higher levels of representation in animals
fed the LF/HPP diet, it also maintained strong levels of
representation in animals fed the HF/HS diet (Figures 1C and
S4C).
When taking into account the abundance data for all 12
artificial community members, proportional representation at the
end of the first diet phase (i.e., day 13) was a good predictor of
representation at the end of the third diet phase (i.e., day 42) (E1
R2 = 0.77; E2 R
2 = 0.84), suggesting that the intervening dietary
perturbation had little effect on the ultimate outcomes for most
species within this assemblage. However, one very low-abundance
strain (D. longicatena) achieved significantly different maximum
percentage abundances across the two treatment groups in each
experiment, suggesting that steady-state levels of this strain may
have been impacted by diet history. In mice initially fed the LF/
HPP diet, D. longicatena was found to persist throughout the
experiment at low levels on both diet regimens. In mice initially
fed the HF/HS diet, D. longicatena dropped below the limit of
Modeling Diet–Human Gut Microbiota Interactions
PLOS Biology | www.plosbiology.org 4 August 2013 | Volume 11 | Issue 8 | e1001637
detection before the end of the first diet phase, was undetectable
by the end of the second diet phase, and remained undetectable
throughout the rest of the time course. This interesting example
raises the possibility that for some species, irreversible hysteresis
effects may play a significant role in determining the likelihood
that they will persist within a gut over long periods of time.
The Cecal Metatranscriptome Sampled at the Time of
Sacrifice
These diet-induced reconfigurations in the structure of the
artificial community led us to examine the degree to which its
members were modifying their metabolic strategies. To establish
an initial baseline static view of expression data for each microbe
on each diet, we developed a custom GeneChip whose probe sets
were designed to target 46,851 of the 48,023 known or predicted
protein-coding genes within our artificial human gut microbiome
(see Materials and Methods). Total RNA was collected from the cecal
contents of each animal in E1 at the time of sacrifice and
hybridized to this GeneChip. The total number of genes whose
expression was detectable on each diet was remarkably similar
(14,929 and 14,594 detected in the LF/HPPRHF/HSRLF/HPP
and HF/HSRLF/HPPRHF/HS treatment groups, respectively).
A total of 11,373 genes (24.3%) were expressed on both diets
(Figure S6A), while 2,003 (4.3%) were differentially expressed to a
statistically significant degree, including 161 (6.1%) of the 2,640
genes in the microbiome encoding proteins with CAZy-recognized
domains. Figure S6B illustrates the fraction of the community-level
CAZome and several species-level CAZomes expressed on each
diet (see Table S6 for a comprehensive list of all genes, organized
by species and fold-change in expression, whose cecal expression
was detectable on each diet and all genes whose expression was
significantly different when comparing data from each treatment
group).
Among taxa demonstrating obvious diet preferences (as judged
by relative abundance data), B. caccae and B. cellulosilyticus WH2
provided examples of CAZy-level responses to diet change that
were different in several respects. Our observations regarding the
carbohydrate utilization capabilities and preferences of B. caccae
are summarized in Text S1. However, our ability to evaluate shifts
in B. caccae’s metabolic strategy in the gut was limited by its very
low abundance in animals fed LF/HPP chow (i.e., our mRNA and
subsequent protein assays were often not sensitive enough to
exhaustively sample B. caccae’s metatranscriptome and metapro-
teome). In contrast, the abundance of B. cellulosilyticus WH2, which
favored the LF/HPP diet, remained high enough on both diets to
allow for a comprehensive analysis of its expressed genes and
proteins. This advantage, along with the exceptional carbohydrate
utilization machinery encoded within the genome of this organism,
encouraged us to focus on further dissecting the responses of B.
cellulosilyticus WH2 to diet changes.
Detailed inspection of the expressed B. cellulosilyticus WH2
CAZome (503 CAZymes in total) provided an initial view of this
microbe’s sophisticated carbohydrate utilization strategy. A
comparison of the top decile of expressed CAZymes on each diet
disclosed many shared elements between the two lists, spanning
many different CAZy families, with just over half of the 50 most
expressed enzymes on the plant polysaccharide-rich LF/HPP
chow also occurring in the list of most highly expressed enzymes
on the sucrose-, corn starch-, and maltodextrin-rich HF/HS diet
(Figure 2A). Twenty-five of the 50 most expressed CAZymes on
the LF/HPP diet were significantly up-regulated compared to the
HF/HS diet; of these, seven were members of the GH43 family
(Figure 2B). The GH43 family consists of enzymes with activities
required for the breakdown of plant-derived polysaccharides such
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Figure 2. B. cellulosilyticus WH2 CAZyme expression in mice fed
different diets. (A) Overview of the 50 most highly expressed B.
cellulosilyticus WH2 CAZymes (GHs, GTs, PLs, and CEs) for samples from
each diet treatment group. List position denotes the rank order of gene
expression for each treatment group, with higher expression levels
situated at the top of each list. Genes common to both lists are
identified by a connecting line, with the slope of the line indicating the
degree to which a CAZyme’s prioritized expression is increased/
decreased from one diet to the other. CAZy families in bold, colored
letters highlight those list entries found to be significantly up-regulated
relative to the alternative diet (i.e., a CAZyme with a bold green family
designation was up-regulated on the LF/HPP diet; a bold orange family
name implies a gene was up-regulated significantly on the HF/HS diet).
Statistically significant fold-changes between diets are denoted in the
‘‘F.C.’’ column (nonsignificant fold-changes are omitted for clarity). (B)
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as hemicellulose and pectin. Inspection of the enzyme commission
(EC) annotations for the most up-regulated GH43 genes shows
that they encode xylan 1,4-b-xylosidases (EC 3.2.1.37), arabinan
endo-1,5-a-L-arabinosidases (EC 3.2.1.99), and a-L-arabinofur-
anosidases (EC 3.2.1.55). The GH10 family, which is currently
comprised exclusively of endo-xylanases (EC 3.2.1.8, EC 3.2.1.32),
was also well represented among this set of 25 genes, with four of
the seven putative GH10 genes in the B. cellulosilyticus WH2
genome making the list. Strikingly, of the 45 predicted genes with
putative GH43 domains in the B. cellulosilyticus WH2 genome,
none were up-regulated on the ‘‘Western’’-style HF/HS diet.
The most highly expressed B. cellulosilyticus WH2 CAZyme on
the plant polysaccharide-rich chow (which was also highly-
expressed on the HF/HS chow) was BWH2_1228, a putative a-
galactosidase from the GH36 family. These enzymes, which are
not expressed by humans in the stomach or intestine, cleave
terminal galactose residues from the nonreducing ends of raffinose
family oligosaccharides (RFOs, including raffinose, stachyose, and
verbascose), galacto(gluco)mannans, galactolipids, and glycopro-
teins. RFOs, which are well represented in cereal grains consumed
by humans, are expected to be abundant in the LF/HPP diet
given its ingredients (e.g., soybean meal), but potential substrates in
the HF/HS diet are less obvious, possibly implicating a host
glycolipid or glycoprotein target.
Surface glycans in the intestinal epithelium of rodents are
decorated with terminal fucose residues [34] as well as terminal
sialic acid and sulfate [35]. Hydrolysis of the a-2 linkage
connecting terminal fucose residues to the galactose-rich extended
core is thought to be catalyzed in large part by GH95 and GH29
enzymes [36]. The B. cellulosilyticus WH2 genome is replete with
putative GH95 and GH29 genes (total of 12 and 9, respectively),
but only a few (BWH2_1350/2142/3154/3818) were expressed in
vivo on at least one diet, and their expression was low relative to
many other CAZymes (see Table S6). Cleavage of terminal sialic
acids present in host mucins by bacteria is usually carried out by
GH33 family enzymes. B. cellulosilyticus WH2 has two GH33 genes
that are expressed on either one diet (BWH2_3822, HF/HS) or
both diets (BWH2_4650), but neither is highly expressed relative to
other B. cellulosilyticus WH2 CAZymes. Therefore, utilization of
host glycans by B. cellulosilyticus WH2, if it occurs, likely requires
partnerships with other members of the artificial community that
express GH29/95/33 enzymes (see Table S6 for a list of members
that express these enzymes in a diet-independent and/or diet-
specific fashion).
Among the 50 most highly expressed B. cellulosilyticus WH2
CAZymes, 12 were significantly up-regulated on the HF/HS diet
compared to the LF/HPP diet, with members of family GH13
being most prevalent. While the enzymatic activities and substrate
specificities of GH13 family members are varied, most relate to the
hydrolysis of substrates comprising chains of glucose subunits,
including amylose (one of the two components of starch) and
maltodextrin, both prominent ingredients in the HF/HS diet.
GeneChip-based profiling of the E1 cecal communities provided
a snapshot of the metatranscriptome on the final day of the final
diet phase in each treatment group. The analysis of B. cellulosilyticus
WH2 CAZyme expression suggested that this strain achieves a
‘‘generalist’’ lifestyle not by relying on substrates that are present at
all times (e.g., host mucins), but rather by modifying its resource
utilization strategy to effectively compete with other microbes for
diet-derived polysaccharides that are not metabolized by the host.
Community-Level Analysis of Diet-Induced Changes in
Microbial Gene Expression
To develop a more complete understanding of the dynamic
changes that occur in gene expression over time and throughout
the artificial community following diet perturbations, we per-
formed microbial RNA-Seq analyses using feces obtained at select
time-points from mice in the LF/HPPRHF/HSRLF/HPP
treatment group of E2 (Figure S3).
We began with a ‘‘top-down’’ analysis in which every RNA-Seq
read count from every gene in the artificial microbiome was
binned based on the functional annotation of the gene from which
it was derived, regardless of its species of origin. In this case, the
functional annotation used as the binning variable was the
predicted EC number for a gene’s encoded protein product.
Expecting that some changes might occur rapidly, while others
might require days or weeks, we searched for significant
differences between the terminal time-points of the first two diet
phases (i.e., points at which the model human gut microbiota had
been allowed 13 d to acclimate to each diet). The 157 significant
changes we identified were subjected to hierarchical clustering by
EC number to determine which functional responses occurred
with similar kinetics. The results revealed that in contrast to the
rapid, diet-induced structural reconfigurations observed in this
artificial community, community-level changes in microbial gene
expression occurred with highly variable timing that differed from
function to function. These changes were dominated by EC
numbers associated with enzymatic reactions relevant to carbo-
hydrate and amino acid metabolism (see Table S7 for a summary
of all significant changes observed, including aggregate expression
values for each functional bin (EC number) at each time-point).
Significant responses could be divided into one of three groups:
‘‘rapid’’ responses were those where the representation of EC
numbers in the transcriptome increased/decreased dramatically
within 1–2 d of a diet switch; ‘‘gradual’’ responses were those
where the representation of EC numbers changed notably, but
slowly, between the two diet transition points; and ‘‘delayed’’
responses were those where significant change did not occur until
the end of a diet phase (Figure 3, Table S7). EC numbers
associated with reactions important in carbohydrate metabolism
and transport were distributed across all three of these response
types for each of the two diets. Nearly all genes encoding proteins
with EC numbers related to amino acid metabolism that were
significantly up-regulated on HF/HS chow binned into the
‘‘rapid’’ or ‘‘gradual’’ groups, suggesting this diet put immediate
pressure on the artificial microbial community to increase its
repertoire of expressed amino acid biosynthesis and degradation
genes. Genes with assigned EC numbers involved in amino acid
metabolism that were significantly up-regulated on the other,
polysaccharide-rich, LF/HPP diet were spread more evenly across
these three response types (Figure 3).
Careful inspection of our top-down analysis results and a
complementary ‘‘bottom-up’’ analysis in which normalization was
performed at the level of individual species, rather than at the
community level, allowed us to identify other important responses
that would have gone undetected were it not for the fact that we
were dealing with a defined assemblage of microbes where all of
the genes in component members’ genomes were known. For
example, an assessment of the representation of EC 3.2.1.8 (endo-
1,4-b-xylanase) within the metatranscriptome before and after the
Breakdown by CAZy family of the top 10% most expressed CAZymes on
each diet whose expression was also found to be significantly higher on
one diet than the other. Note that for each diet, the family with the
greatest number of up-regulated genes was also exclusively up-
regulated on that diet (LF/HPP, GH43; HF/HS, GH13). In total, 25 genes
representative of 27 families and 12 genes representative of 13 families
are shown for the LF/HPP and HF/HS diets, respectively.
doi:10.1371/journal.pbio.1001637.g002
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first diet switch (LF/HPPRHF/HS) initially suggested that this
activity was reduced to a statistically significant degree as a result
of the first diet perturbation (day 13 versus day 27; Mann–
Whitney U test, p=0.03; Figure S7A). Aggregation by species of
all sequencing read counts assignable to mRNAs encoding
proteins with this EC number revealed that over 99% of the
contributions to this functional bin originated from B. cellulosilyticus
WH2 (note the similarity in a comparison of Figure S7A and
Figure S7B), implying that the community-level response and the
response of this Bacteroides species were virtually one and the same.
A tally of all sequencing reads assignable to B. cellulosilyticus WH2
at each time-point disclosed that although this strain maintains
high proportional representation in the artificial community
throughout each diet oscillation period (range, 10.3–42.5% and
11.6–43.3% for E1 and E2, respectively), its contribution to the
metatranscriptome is substantially decreased during the HF/HS
diet phase (Figure S7C). This dramatic reduction in the extent to
which B. cellulosilyticus WH2 contributes to the metatranscriptome
in HF/HS-fed mice ‘‘masks’’ the significant up-regulation of EC
3.2.1.8 that occurs within the B. cellulosilyticus WH2 transcriptome
following the first diet shift (day 13 versus day 27; Mann–Whitney
U test, p=0.03; Figure S7D). A further breakdown of endo-1,4-b-
xylanase up-regulation in B. cellulosilyticus WH2 when mice are
switched to the HF/HS diet reveals that most of this response is
driven by two genes, BWH2_4068 and BWH2_4072 (Figure S7E).
Our realization that we were unable to correctly infer the direction
of one of the most significant diet-induced gene expression changes
in the second most abundant strain in the artificial community
when inspecting functional responses at the community level
provides a strong argument for expanding the use of microbial
assemblages comprised exclusively of sequenced species in studies
of the gut microbiota. This should allow the contributions of
individual species to community activity to be evaluated in a
rigorous way that is not possible with microbial communities of
unknown or poorly defined gene composition.
High-Resolution Profiling of the Cecal Metaproteome
Sampled at the Time of Sacrifice
In principle, protein measurements can provide a more direct
readout of expressed community functions than an RNA-level
analysis, and thus a deeper understanding of community members’
interactions with one another and with their habitat [37,38]. For
these reasons and others, much work has been dedicated to
applying shotgun proteomics techniques to microbial ecosystems
in various environments [39,40]. Though these efforts have
provided illustrations of significant methodological advances, they
have been limited by the complexity of the metaproteomes studied
and by the difficulties this complexity creates when attempting to
assign peptide identities uniquely to proteins of specific taxa.
Recognizing that a metaproteomics analysis of our artificial
community would not be subject to such uncertainty given its fully
defined microbiome and thus fully defined theoretical proteome,
we subjected cecal samples from two mice from each diet
treatment group in E1 (n=4 total) to high-performance liquid
chromatography-tandem mass spectrometry (LC-MS/MS; see
Materials and Methods). We had three goals: (i) to evaluate how our
ability to assign peptide-spectrum matches (PSMs) to particular
proteins within a theoretical metaproteome is affected by the
presence of close homologs within the same species and within
other, closely related species; (ii) to test the limits of our ability to
characterize protein expression across different species given the
substantial dynamic range we documented in microbial species
abundance; and (iii) to collect semiquantitative peptide/protein
data that might validate and enrich our understanding of
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Figure 3. Top-down analysis of fecal microbiome RNA expres-
sion in mice receiving oscillating diets. The fecal metatranscrip-
tomes of four animals in the LF/HPPRHF/HSRLF/HPP treatment group
of E2 were analyzed using microbial RNA-Seq at seven time-points to
evaluate the temporal progression of changes in expressed microbial
community functions triggered by a change in diet. After aligning reads
to genes in the defined artificial human gut microbiome, raw counts
were collapsed by the functional annotation (EC number) of the gene
from which the corresponding reads originated. Total counts for each
EC number in each sample were normalized, and any EC numbers
demonstrating a statistically significant difference in their representa-
tion in the metatranscriptome between the final days of the first two
diet phases were identified using a model based on the negative
binomial distribution [57]. Normalized expression values for 157
significant EC numbers (out of 1,021 total tested) were log-transformed,
mean-centered, and subjected to hierarchical clustering, followed by
heatmap visualization. ‘‘Rapid’’ responses are those where expression
increased/decreased dramatically within 1–2 d of a diet switch.
‘‘Gradual’’ responses are those where expression changed notably,
but slowly, between the two diet transition points. ‘‘Delayed’’ responses
are those where significant expression changes did not occur until the
end of a diet phase. EC numbers specifying enzymatic reactions
relevant to carbohydrate metabolism and/or transport are denoted by
purple markers, while those with relevance to amino acid metabolism
are indicated using orange markers. A full breakdown of all significant
responses over time and the outputs of the statistical tests performed
are provided in Table S7.
doi:10.1371/journal.pbio.1001637.g003
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functional responses identified at the mRNA level, particularly
with respect to the niche (profession) of CAZyme-rich B.
cellulosilyticus WH2.
Given the evolutionary relatedness of the strains involved, we
expected that some fraction of observed PSMs from each sample
would be of ambiguous origin due to nonunique peptides shared
between species’ proteomes. To assess which species might be
most affected by this phenomenon when characterizing the
metaproteome on different diets, we catalogued each strain’s
theoretical peptidome using an in silico tryptic digest. This
simulated digest took into account both the potential for missed
trypic cleavages and the peptide mass range that could be detected
using our methods. The results (Figure S8A, Table S8) demon-
strated that for an artificial community of modest complexity, the
proportion of peptides within each strain’s theoretical peptidome
that are ‘‘unique’’ (i.e., assignable to a single protein within the
theoretical metaproteome) varies substantially from species to
species, even among those that are closely related. We found the
lone representative of the Actinobacteria in the artificial community,
Collinsella aerofaciens, to have the highest proportion of unique
peptides (94.2%), while B. caccae had the lowest (63.0%).
Interestingly, there was not a strong correlation between the
fraction of a species’ peptides that were unique and the total
number of unique peptides that species contributed to the
theoretical peptidome. For example, C. aerofaciens (2,367 predicted
protein-coding genes) contributed only 81,894 (1.5%) unique
peptides, the lowest of any artificial community member
evaluated, despite having a proteome composed of mostly unique
peptides. On the other hand, B. cellulosilyticus WH2 (5,244
predicted protein-coding genes) contributed 241,473 (4.5%)
unique peptides, the highest of any member despite a high
fraction of nonunique peptides (18.4%) within its theoretical
peptidome. The evolutionary relatedness of the Bacteroides compo-
nents of the artificial community appeared to negatively affect our
ability to assign their peptides to specific proteins; their six
theoretical peptidomes had the six lowest uniqueness levels.
However, their greater number of proteins and peptides relative
to the Firmicutes and Actinobacteria more than compensated for this
deficiency; over 60% of unique peptides within the unique
theoretical metaproteome were contributed by the Bacteroides.
We also found that the proportion of PSMs uniquely assignable
to a single protein within the metaproteome varied significantly by
function, suggesting that some classes of proteins can be traced
back to specific microbes more readily than others. For example,
when considering all theoretical peptides that could be derived
from the proteome of a particular bacterial species, those from
proteins with roles in categories with high expected levels of
functional conservation (e.g., translation and nucleotide metabo-
lism) were on average deemed unique more often than those from
proteins with roles in functions we might expect to be less
conserved (e.g., glycan biosynthesis and metabolism) (see Table S8
for a summary of how peptide uniqueness varied across different
KEGG categories and pathways, and across different species in the
experiment). However, even in KEGG categories and pathways
with high expected levels of functional conservation, the vast
majority of peptides were found to be unique when a particular
species was not closely related to other members of the artificial
community.
Next, we determined the average number of proteins that could
be experimentally identified in our samples for each microbial
species within each treatment group in E1. The results (Figure
S8B, Table S9) illustrate two important conclusions. First,
although equal concentrations of total protein were evaluated for
each sample, slightly less than twice as many total microbial
proteins were identified in samples from the LF/HPP-fed mice as
those from mice fed the HF/HS diet (4,659 versus 2,777,
respectively). While there are a number of possible explanations,
both this finding and the higher number of mouse proteins
detected in samples from HF/HS-fed animals are consistent with
the results of our fecal DNA analysis, which indicated that the
HF/HS diet supports lower levels of gut microbial biomass than
the LF/HPP diet (Figure S4A,B). Second, a breakdown of all
detected microbial proteins by species of origin (Figure S8B)
revealed that the degree to which we could inspect protein
expression for a given species was dictated largely by its relative
abundance and the diet to which it was exposed.
Our ability to detect many of B. cellulosilyticus WH2’s expressed
transcripts and proteins in samples from both diet treatment
groups allowed us to determine how well RNA and protein data
for an abundant, active member of the artificial community might
correlate. These data also allowed us to evaluate whether or not
the types of genes considered might influence the degree of
correlation between these two datasets. We first performed a
spectral count-based correlation analysis on the diet-induced, log-
transformed, average fold-differences in expression for all B.
cellulosilyticus WH2 genes that were detectable at both the RNA
and protein level for both diets. The results revealed a moderate
degree of linear correlation between RNA and protein observa-
tions (Figure S8C, black plot; r=0.53). However, subsequent
division of these genes into functionally related subsets, which were
each subjected to their own correlation analysis, revealed striking
differences in the degree to which RNA-level and protein-level
expression changes agreed with one another. For example, diet-
induced changes in mRNA expression for genes involved in
translation showed virtually no correlation with changes measured
at the protein level (Figure S8C, red plot; r=0.03). Correlations
for other categories of B. cellulosilyticus WH2 genes, such as those
involved in energy metabolism (Figure S8C, green plot; r=0.36)
and amino acid metabolism (Figure S8C, orange plot; r=0.48),
were also poorer than the correlation for the complete set of
detectable genes. In contrast, the correlation for the 110 genes
with predicted involvement in carbohydrate metabolism was quite
strong (Figure S8C, blue plot; r=0.69), and was in fact the best
correlation identified for any functional category of genes
considered. The significant range of correlations observed in
different categories of genes suggests that the degree to which
RNA-based analyses provide an accurate picture of microbial
adaptation to environmental perturbation may be strongly
impacted by the functional classification of the genes involved.
Additionally, these data further emphasize the need for enhanced
dynamic range metaproteome measurements and better bioinfor-
matic methods to assign/bin unique and nonunique peptides so
that deeper and more thorough surveys of the microbial protein
landscape can be performed and evaluated alongside more robust
transcriptional datasets.
Identifying Two Diet-Inducible, Xylanase-Containing
PULs Whose Genetic Disruption Results in Diet-Specific
Loss of Fitness
Several of the most highly expressed and diet-sensitive B.
cellulosilyticus WH2 genes in this study fell within two putative
PULs. One PUL (BWH2_4044–55) contains 12 ORFs that include
a dual susC/D cassette, three putative xylanases assigned to CAZy
families GH8 and GH10, a putative multifunctional acetyl xylan
esterase/a-L-fucosidase, and a putative hybrid two-component
system regulator (Figure 4A). Gene expression within this PUL was
markedly higher in mice consuming the plant polysaccharide-rich
LF/HPP diet at both the mRNA and protein level. Our mRNA-
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Figure 4. Two xylanase-containing B. cellulosilyticusWH2 PULs demonstrating strong diet-specific expression patterns in vivo. (A) The
PUL spanning BWH2_4044–55 includes a four-gene cassette comprising two consecutive susC/D pairs, multiple genes encoding GHs and CEs, and a
gene encoding a putative hybrid two-component system (HTCS) presumed to play a role in the regulation of this locus. GH10 enzymes are endo-
xylanases (most often endo-b-1,4-xylanases), while some GH5 and GH8 enzymes are also known to have endo- or exo-xylanase activity. CE6 enzymes
are acetyl xylan esterases, as are some members of the CE1 family. A second PUL spanning BWH2_4072–6 contains a susC/D cassette, an endo-
xylanase with dual GH10 modules as well as dual carbohydrate (xylan) binding modules (CBM22), a hypothetical protein of unknown function, and a
putative HTCS. (B) Heatmap visualization of GeneChip expression data for BWH2_4044–55 and BWH2_4072–6 showing marked up-regulation of these
putative PULs when mice are fed either a plant polysaccharide-rich LF/HPP diet or a diet high in fat and simple sugar (HF/HS), respectively. Data are
from cecal contents harvested from mice at the endpoint of experiment E1. (C) Mass spectrometry-based quantitation of the abundance of all cecal
proteins from the BWH2_4044–55 and BWH2_4072–6 PULs that were detectable in the same material used for GeneChip quantitation in panel (B). Bars
represent results (mean 6 SEM) from two technical runs per sample. For each MS run, the spectral counts for each protein were normalized against
the total number of B. cellulosilyticus WH2 spectra acquired. (D) Comparison of in vivo PUL gene expression as measured by RNA-Seq (top) and the
degree to which disruption of each gene within each PUL by a transposon impacts the fitness of B. cellulosilyticus WH2 on each diet, as measured by
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level analysis disclosed that BWH2_4047 was the most highly
expressed B. cellulosilyticus WH2 susD homolog on this diet.
Likewise, BWH2_4046/4, the two susC-like genes within this
PUL, were the 2nd and 4th most highly expressed B.
cellulosilyticus WH2 susC-like genes in LF/HPP-fed animals,
and exhibited expression level reductions of 99.5% and 93% in
animals consuming the HF/HS diet. The same LF/HPP diet
bias was observed for other genes within this PUL (Figures 2A
and 4B) but not for neighboring genes. The same trends were
obvious and amplified when we quantified protein expression
(Figure 4C). In mice fed LF/HPP chow, only three B.
cellulosilyticus WH2 SusC-like proteins had higher protein levels
than BWH2_4044/6, and only two SusD-like proteins had
higher levels than BWH2_4045/7. Strikingly, we were unable to
detect a single peptide from 9 of the 12 proteins in this PUL in
samples obtained from mice fed the HF/HS diet, emphasizing
the strong diet specificity of this locus.
A second PUL in the B. cellulosilyticusWH2 genome composed of
a susC/D-like pair (BWH2_4074/5), a putative hybrid two-
component system regulator (BWH2_4076), and a xylanase
(GH10) with dual carbohydrate binding module domains
(CBM22) (BWH2_4072) (Figure 4A) demonstrated a strong but
opposite diet bias, in this case exhibiting significantly higher
expression in animals consuming the HF/HS ‘‘Western’’-like diet.
Our mRNA-level analysis showed that this xylanase was the
second most highly expressed B. cellulosilyticus WH2 CAZyme in
animals consuming this diet (Figure 2A). As with the previously
described PUL, shotgun metaproteomics validated the transcrip-
tional analysis (Figure 4B,C); with the exception of the gene
encoding the PUL’s presumed transcriptional regulator
(BWH2_4076), diet specificity was substantial, with protein-level
fold changes ranging from 10–33 across the locus (Table S10).
Recent work by Cann and co-workers has done much to
advance our understanding of the regulation and metabolic role of
xylan utilization system gene clusters in xylanolytic members of the
Bacteroidetes, particularly within the genus Prevotella [41]. The
‘‘core’’ gene cluster of the prototypical xylan utilization system
they described consists of two tandem repeats of susC/susD
homologs (xusA/B/C/D), a downstream hypothetical gene (xusE)
and a GH10 endoxylanase (xyn10C). The 12-gene PUL identified
in our study (BWH2_4044–55) appears to contain the only
instance of this core gene cluster within the B. cellulosilyticus WH2
genome, suggesting that this PUL, induced during consumption of
a plant polysaccharide-rich diet, is likely to be the primary xylan
utilization system within this organism. A recent study character-
izing the carbohydrate utilization capabilities of B. ovatus ATCC
8483 also identified two PULs involved in xylan utilization
(BACOVA_04385–94, BACOVA_03417–50) whose gene configura-
tions differ from those described in Prevotella spp. [25]. Interest-
ingly, the five proteins encoded by the smaller xylanase-containing
PUL described above (BWH2_4072–6) are homologous to the
products of the last five genes in BACOVA_4385–94 (i.e.,
BACOVA_4390–4). The order of these five genes in these two loci
is also identical. The similarities and differences observed when
comparing the putative xylan utilization systems encoded within
the genomes of different Bacteroidetes illustrate how its members
may have evolved differentiated strategies for utilizing hemicellu-
loses like xylan.
Having established that expression of BWH2_4044–55 and
BWH2_4072–6 is strongly dictated by diet, we next sought to
determine if these PULs are required by B. cellulosilyticus WH2 for
fitness in vivo. A follow-up study was performed in which mice were
fed either a LF/HPP or HF/HS diet after being colonized with an
artificial community similar to the one used in E1 and E2 (see
Materials and Methods). The wild-type B. cellulosilyticus WH2 strain
used in our previous experiments was replaced with a transposon
mutant library consisting of over 90,000 distinct transposon
insertion mutants in 91.5% of all predicted ORFs (average of 13.9
distinct insertion mutants per ORF). The library was constructed
using methods similar to those reported by Goodman et al. ([42];
see Materials and Methods) so that the relative proportion of each
insertion mutant in both the input (orally gavaged) and output
(fecal) populations could be determined using insertion sequencing
(INSeq). The INSeq results revealed clear, diet-specific losses of
fitness when components of these loci were disrupted (Figure 4D).
Additionally, as observed in E1 and E2, expression of each PUL
was strongly biased by diet, with genes BWH2_4072–5 demon-
strating up-regulation on the HF/HS diet and BWH2_4044–55 on
the LF/HPP diet. The extent to which a gene’s disruption
impacted the fitness of B. cellulosilyticus WH2 on one diet or the
other correlated well with whether or not that gene was highly
expressed on a given diet. For example, four of the five most highly
expressed genes in the BWH2_4044–55 locus were the four genes
shown to be most crucial for fitness on the LF/HPP diet. Of these
four genes, three were susC or susD homologs (the fourth was the
putative endo-1,4-b-xylanase thought to constitute the last element
of the xylan utilization system core). Though the fitness cost of
disrupting genes within BWH2_4044–55 varied from gene to gene,
disruption of any one component of the BWH2_4072–6 PUL had
serious consequences for B. cellulosilyticus WH2 in animals fed the
HF/HS diet. This could suggest that while disruption of some
components of the BWH2_4044–55 locus can be rescued by
similar or redundant functions elsewhere in the genome, the same
is not true for BWH2_4072–5. Notably, disruption of
BWH2_4076, which is predicted to encode a hybrid two-
component regulatory system, had negative consequences on
either diet tested, indicating that regulation of this locus is crucial
even when the PUL is not actively expressed. While many genes
outside of these two PULs were also found to be important for the
in vivo fitness of B. cellulosilyticus WH2, those within these PULs
were among the most essential to diet-specific fitness, suggesting
that these loci are central to the metabolic lifestyle of B.
cellulosilyticus WH2 in the gut.
Characterizing the Carbohydrate Utilization Capabilities
of B. cellulosilyticus WH2 and B. caccae
The results described in the preceding section indicate that B.
cellulosilyticus WH2 prioritizes xylan as a nutrient source in the gut
and that it tightly regulates the expression of its xylan utilization
machinery. Moreover, the extraordinary number of putative
CAZymes and PULs within the B. cellulosilyticus WH2 genome
suggests that it is capable of growing on carbohydrates with diverse
structures and varying degrees of polymerization. To characterize
its carbohydrate utilization capabilities, we defined its growth in
minimal medium (MM) supplemented with one of 46 different
carbohydrates [25]. Three independent growths, each consisting
insertion sequencing (INSeq, bottom). For the lower plots, fitness measurements were calculated by dividing a mutant’s representation (normalized
sequencing counts) within the fecal output population by its representation within an input population that was introduced into germ-free animals
via a single oral gavage along with other members of the artificial community. For cases in which no instances of a particular mutant could be
measured in the fecal output (resulting in a fitness calculation denominator of zero), data are plotted as ‘‘,0.01’’ and are drawn without error bars.
doi:10.1371/journal.pbio.1001637.g004
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of two technical replications, yielded a total of six growth curves
for each substrate. Of the 46 substrates tested, B. cellulosilyticus
WH2 grew on 39 (Table S11); they encompassed numerous
pectins (6 of 6), hemicelluloses/b-glucans (8 of 8), starches/
fructans/a-glucans (6 of 6), and simple sugars (14 of 15), as well as
host-derived glycans (4 of 7) and one cellooligosaccharide
(cellobiose). The seven substrates that did not support growth
included three esoteric carbohydrates (carrageenan, porphyran,
and alginic acid), the simple sugar N-acetylneuraminic acid, two
host glyans (keratan sulfate and mucin O-glycans), and fungal cell
wall-derived a-mannan. B. cellulosilyticus WH2 clearly grew more
robustly on some carbohydrates than others. Excluding simple
sugars, fastest growth was achieved on dextran (0.09960.048
OD600 units/h), laminarin (0.09560.014), pectic galactan
(0.08860.018), pullulan (0.08860.026), and amylopectin
(0.08560.003). Although one study has reported that the type
strain of B. cellulosilyticus degrades cellulose [43], the WH2 strain
failed to demonstrate any growth on MM plus cellulose
(specifically, Solka-Floc 200 FCC from International Fiber Corp.)
after 5 d. Maximum cell density was achieved with amylopectin
(1.1760.02 OD600 units), dextran (1.1260.20), cellobiose
(1.0960.08), laminarin (1.0860.08), and xyloglucan (0.9960.04).
Total B. cellulosilyticus WH2 growth (i.e., maximum cell density
achieved) on host-derived glycans was typically very poor, with
only two substrates achieving total growth above 0.2 OD600 units
(chondroitin sulfate, 0.5060.04; glycogen, 0.9960.02). The
disparity between total growth on plant polysaccharides versus
host-derived glycans, including O-glycans that are prevalent in
host mucin, indicates a preference for diet-derived saccharides,
consistent with our in vivo mRNA and protein expression data.
We also determined how the growth rate of B. cellulosilyticusWH2
on these substrates compared to the growth rates for other
prominent gut Bacteroides spp. After subjecting B. caccae to the same
phenotypic characterization as B. cellulosilyticus WH2, we combined
our measurements for these two strains with previously published
measurements for B. thetaiotaomicron and B. ovatus [25]. The results
underscored the competitive growth advantage B. cellulosilyticusWH2
likely enjoys when foraging for polysaccharides in the intestinal
lumen. For example, of the eight hemicelluloses and b-glucans tested
in our carbohydrate panel, B. cellulosilyticus WH2 grew fastest on six
while B. ovatus grew fastest on two (Table S11). B. caccae and B.
thetaiotaomicron, on the other hand, failed to grow on any of these
substrates. Across all the carbohydrates for which data are available
for all four species, B. cellulosilyticusWH2 grew fastest on the greatest
number of polysaccharides (11 of 26) and tied with B. caccae for the
greatest number of monosaccharides (6 of 15). B. thetaiotaomicron and
B. caccae did, however, outperform the other two Bacteroides tested
with respect to utilization of host glycans in vitro, demonstrating
superior growth rates on four of five substrates tested (Table S11).
B. cellulosilyticus WH2’s rapid growth to high densities on xylan,
arabinoxylan, and xyloglucan, as well as xylose, arabinose, and
galactose, is noteworthy given our prediction that two of its most
tightly regulated, highly expressed PULs appear to be involved in
the utilization of xylan, arabinoxylan, or some closely related
polysaccharide. To identify specific mono- and/or polysaccharides
capable of triggering the activation of these two PULs, as well as
the 111 other putative PULs within the B. cellulosilyticus WH2
genome, we used RNA-Seq to characterize its transcriptional
profile at mid-log phase in MM (Table S12) plus one of 16 simple
sugars or one of 15 complex sugars (Table S13) (see Materials and
Methods; n=2–3 cultures/substrate; 5.2–14.0 million raw Illumina
HiSeq reads generated for each of the 90 transcriptomes). After
mapping each read to the B. cellulosilyticus WH2 reference gene set,
counts were normalized using DESeq to allow for direct
comparisons across samples and conditions. Hierarchical cluster-
ing of the normalized dataset resulted in a well-ordered
dendrogram in which samples clustered almost perfectly by the
carbohydrate on which B. cellulosilyticus WH2 was grown
(Figure 5A). The consistency of this clustering illustrates that (i)
technical replicates within each condition exhibit strong correla-
tions with one another, suggesting any differences between
cultures in a treatment group (e.g., small differences in density
or growth phase) had at best minor effects on aggregate gene
expression, and (ii) growth on different carbohydrates results in
distinct, substrate-specific gene expression signals capable of
driving highly discriminatory differences between treatment
groups. The application of rigorous bootstrapping to our
hierarchical clustering results also revealed several cases of higher
level clusters in which strong confidence was achieved. These
dendrogram nodes (illustrated as white circles) indicate sets of
growth conditions that yield gene expression patterns more like
each other than like the patterns observed for other substrates.
Two notable examples were xylan/arabinoxylan (which are
structurally related and share the same xylan backbone) and L-
fucose/L-rhamnose (which are known to be metabolized via
parallel pathways in E. coli [44]).
Importantly, these findings suggested that by considering in vitro
profiling data alongside in vivo expression data from the artificial
community, it might be possible to identify the particular
carbohydrates to which B. cellulosilyticus WH2 is exposed and
responding within its gut environment. To explore this concept
further, we compared expression of each gene in each condition to
its expression on our control treatment, MM plus glucose (MM-
Glc). The results revealed a dynamic PUL activation network in
which some PULs were activated by a single substrate, some were
activated by multiple substrates, and some were transcriptionally
silent across all conditions tested. Of the 118 putative susC/D pairs
in B. cellulosilyticus WH2 that we have used as markers of PULs, 30
were dramatically activated on one or more of the substrates
tested; in these cases, both the susC- and susD-like genes in the
cassette were up-regulated an average of .100-fold relative to
MM-Glc across all technical replicates (Figure 5B). At least one
susC/D activation signature was identified for every one of the 17
oligosaccharides and polysaccharides and for six of the 13
monosaccharides tested (Table S14). The lack of carbohydrate-
specific PUL activation events for some monosaccharides (fructose,
galactose, glucuronic acid, sucrose, and xylose) was expected,
given that these loci are primarily dedicated to polysaccharide
acquisition. Further inspection of gene expression outside of PULs
disclosed that B. cellulosilyticus WH2 prioritizes use of its non-PUL-
associated carbohydrate machinery, such as putative phospho-
transferase system (PTS) components and monosaccharide
permeases, when grown on these monosaccharides (Table S14).
Several carbohydrates activated the expression of multiple
PULs. Growth on water-soluble xylan and wheat arabinoxylan
produced significant up-regulation of five susC/D-like pairs
(BWH2_0865/6, 0867/8, 4044/5, 4046/7, and 4074/5). No
other substrate tested activated as many loci within the genome,
again hinting at the importance of xylan and arabinoxylan to this
strain’s metabolic strategy in vivo. Cecal expression data from E1
showed that 15 of these activated PULs were expressed in vivo on
one or both of the diets tested (see circles to the right of the
heatmap in Figure 5B). In mice fed the polysaccharide-rich LF/
HPP chow, B. cellulosilyticus WH2 up-regulates three susC/D pairs
(BWH2_2717/8, 4044/5, 4046/7) whose expression is activated in
vitro by arabinan and xylan/arabinoxylan. The three most
significantly up-regulated susC/D pairs (BWH2_1736/7, 2514/5,
4074/5) in mice fed the HF/HS diet rich in sugar, corn starch,
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Figure 5. In vitro microbial RNA-Seq profiling of B. cellulosilyticus WH2 during growth on different carbohydrates. (A) Hierarchical
clustering of the gene expression profiles of 90 cultures grown in minimal medium supplemented with one of 31 simple or complex sugars (n= 2–3
replicates per condition). Circles at dendrogram branch points identify clusters with strong bootstrapping support (.95%; 10,000 repetitions). Solid
circles denote clusters comprising only replicates from a single treatment group/carbohydrate, while open circles denote higher level clusters
comprising samples from multiple treatment groups. Colored rectangles indicate the type of carbohydrate on which the samples within each cluster
were grown. (B) Unclustered heatmap representation of fold-changes in gene expression relative to growth on minimal medium plus glucose (MM-
Glc) for 60 of the 236 paired susC- and susD-like genes identified within the B. cellulosilyticus WH2 genome (for a full list of all paired and unpaired
susC and susD homologs, see Table S2). Data shown are limited to those genes whose expression on at least one of the 31 carbohydrates tested
demonstrated a .100-fold increase relative to growth on MM-Glc for at least one of the replicates within the treatment group. Yellow boxes denote
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and maltodextrin are activated in vitro by amylopectin, ribose, and
xylan/arabinoxylan, respectively. All three PULs identified as
being up-regulated at the RNA level in LF/HPP-fed mice were
also found to be up-regulated at the protein level (Figure 5B). Two
of the three PULs up-regulated at the mRNA level in HF/HS-fed
mice were up-regulated at the protein level as well. The presence
of an amylopectin-activated PUL among these two loci is
noteworthy, given the significant amount of starch present in the
HF/HS diet. The up-regulation of four other PULs in HF/HS-fed
animals was only evident in our LC-MS/MS data, reinforcing the
notion that protein data both complement and supplement mRNA
data when profiling microbes of interest.
Two of the five susC/D pairs activated by xylan/arabinoxylan
form the four-gene cassette in the previously discussed PUL
comprising BWH2_4044–55 that is activated in mice fed the plant
polysaccharide-rich chow (see Figure 4A). Another one of the five
is the susC/D pair found in the PUL comprising BWH2_4072–6
that is activated in mice fed the HF/HS ‘‘Western’’-like chow (see
Figure 4A). Thus, we have identified a pair of putative PULs in
close proximity to one another on the B. cellulosilyticus WH2
genome that encode CAZymes with similar predicted functions,
are subject to near-identical levels of specific activation by the
same two polysaccharides (i.e., xylan, arabinoxylan) in vitro, but are
discordantly regulated in vivo in a diet-specific manner. The highly
expressed nature of these PULs in the diet environment where
they are active, their shared emphasis on xylan/arabinoxylan
utilization, and their tight regulation indicate that they are likely to
be important for the in vivo success of this organism in the two
nutrient environments tested. However, the reasons for their
discordant regulation are unclear. One possibility is that in
addition to being activated by xylan/arabinoxylan and related
polysaccharides, these loci are also subject to repression by other
substrates present in the lumen of the gut, and this repression is
sufficient to block activation. Alternatively, the specific activators
of each PUL may be molecular moieties shared by both xylan and
arabinoxylan that do not co-occur in the lumenal environment
when mice are fed the diets tested in this study.
Prospectus
Elucidating generalizable ‘‘rules’’ for how microbiota operate
under different environmental conditions is a substantial chal-
lenge. As our appreciation for the importance of the gut
microbiota in human health and well-being grows, so too does
our need to develop such rules using tractable experimental
models of the gut ecosystem that allow us to move back and forth
between in vivo and ex vivo analyses, using one to inform the other.
Here, we have demonstrated the extent to which high-resolution
DNA-, mRNA-, and protein-level analyses can be applied (and
integrated) to study an artificial community of sequenced human
gut microbes colonizing gnotobiotic mice. Our efforts have
focused on characterizing community-level and species-level
adaptation to dietary change over time and ‘‘leveraging’’ results
obtained from in vitro assessments of individual species’ responses
to a panel of purified carbohydrates to deduce glycan exposures
and consumption strategies in vivo. This experimental paradigm
could be applied to any number of questions related to microbe–
microbe, environment–microbe, and host–microbe interactions,
including, for example, the metabolic fate of particular nutrients of
interest (metabolic flux experiments), microbial succession, and
biotransformations of xenobiotics.
Studying artificial human gut microbial communities in
gnotobiotic mice also allows us to evaluate the technical limitations
of current molecular approaches for characterizing native
communities. For example, the structure of an artificial commu-
nity can be evaluated over time at low cost using short read
shotgun DNA sequencing data mapped to all microbial genomes
within the community (COPRO-Seq). This allows for a much
greater depth of sequencing coverage (i.e., more sensitivity) and
much less ambiguity in the assignment of reads to particular taxa
than traditional 16S rRNA gene-based sequencing. Short read
cDNA sequences transcribed from total microbial community
RNA can also often be assigned to the exact species and gene from
which they were derived, and the same is also often true for
peptides derived from particular bacterial proteins. However,
substantial dynamic range in species/transcript/protein abun-
dance within any microbiota, defined or otherwise, imposes limits
on our ability to characterize the least abundant elements of these
systems.
The effort to obtain a more complete understanding of the
operations and behaviors of minor components of the microbiota
is an area deserving of significant attention, given known examples
of low-abundance taxa that play key roles within their larger
communities and in host physiology [2,45]. Developing such an
understanding requires methods and assays that are collectively
capable of assessing the structure and function of a microbiota at
multiple levels of resolution. The need for high sensitivity and
specificity in these approaches will become increasingly relevant as
we transition towards experiments involving defined communities
of even greater complexity, including bacterial culture collections
prepared from the fecal microbiota of humans [46]. We anticipate
that the study of sequenced culture collections transplanted to
gnotobiotic mice will be instrumental in determining the degree to
which physiologic or pathologic host phenotypes can be ascribed
to the microbiota as well as specific constituent taxa.
The recent development of a low-error 16S ribosomal RNA
amplicon sequencing method (LEA-Seq) and the application of
this method to the fecal microbiota of 37 healthy adults followed
for up to 5 years indicated that individuals in this cohort contained
195648 bacterial strains representing 101627 species [47].
Furthermore, stability follows a power-law function, suggesting
that once acquired, most gut strains in a person are present for
decades. New advances in the culturing of fastidious gut microbes
may one day allow us to capture most (or all) of the taxonomic and
functional diversity present within an individual’s fecal microbiota
as a clonally arrayed, sequenced culture collection, providing a
perfectly representative and defined experimental model of their
gut community. In the meantime, first-generation artificial
communities of modest complexity such as the one described
here offer a way of studying many questions related to the
microbiota. However, the limited complexity and composition of
our 12-species artificial community, and the way in which it was
assembled in germ-free mice, make it an imperfect model of more
areas of the map where both genes in a susC/D pair were up-regulated .100-fold for at least two of the replicates in a treatment group and where
the average up-regulation for each gene in the pair was .100-fold across all replicates of the treatment group. Two sets of columns to the right of
the heatmap indicate PULs that were detectably expressed at the mRNA level (left set of columns) and/or protein level (right set of columns) in
experiment 1 (E1). Red and black circles indicate that both genes in a susC/D pair were consistently expressed on a particular diet, as determined by
GeneChip analysis of cecal RNA ($5 of 7 animals assayed) or LC-MS/MS analysis of cecal protein (2 of 2 animals assayed). In both cases, a red circle
denotes significantly higher expression on one diet compared to the other.
doi:10.1371/journal.pbio.1001637.g005
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complex human microbiota. Native microbial communities, for
example, are subject to the influence of variables that are
notably absent from this system, such as intraspecies genetic
variability and exogenous microbial inputs. There are also taxa
(e.g., Proteobacteria, Bifidobacteria) and microbial guilds (e.g.,
butyrate producers) typical of human gut communities that are
absent from our defined assemblage that could be used to
augment this system in order to improve our understanding of
how their presence/absence influences a microbiota’s response
to diet and a spectrum of other variables of interest. These
future attempts to systematically increase complexity should
reveal what trends, patterns, and trajectories observed in
artificial assemblages such as the one reported here map or do
not map onto natural communities.
Finally, one of the greatest advantages of studying defined
assemblages in mice is that they afford us the ability to interrogate
the biology of key bacterial species in a focused manner. The
artificial community we used in our experiments included B.
cellulosilyticusWH2, a species that warrants further study as a model
gut symbiont given its exceptional carbohydrate utilization
capabilities, its apparent fitness advantage over many other
previously characterized gut symbionts, and its genetic tractability.
This genetic tractability should facilitate future experiments in
which transposon mutant libraries are screened in vivo as one
component of a larger artificial community in order to identify this
strain’s most important fitness determinants under a wide variety
of dietary conditions. Identifying the genetic elements that allow B.
cellulosilyticus to persist at the relatively high levels observed,
regardless of diet, should provide microbiologists and synthetic
biologists with new ‘‘standard biological parts’’ that will aid them
in developing the next generation of prebiotics, probiotics, and
synbiotics.
Materials and Methods
Ethics Statement
All experiments involving mice used protocols approved by the
Washington University Animal Studies Committee in accordance
with guidelines set forth by the American Veterinary Medical
Association. Trained veterinarians from the Washington Univer-
sity Division of Comparative Medicine supervised all experiments.
The laboratory animal program at Washington University is
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC).
B. cellulosilyticus WH2 Genome Sequencing
A strain of B. cellulosilyticus designated ‘‘WH2’’ (see Figure
S1A,B) was isolated from a human fecal sample during an iteration
of the Microbial Diversity Summer Course overseen by A. Salyers
(University of Illinois, Urbana-Champaign) at the Marine
Biological Laboratory (Woods Hole, MA). The genome of this
isolate was sequenced using a combination of long-read and short-
read technologies, yielding 51,819 plasmid and fosmid end reads
(library insert sizes: 3.9, 4.9, 6.0, 8.0, and 40 kb; ABI 3730
platform), 333,883 unpaired 454 reads (FLX+ and XL+ chemis-
try), and 10 million unpaired Illumina reads (HiSeq; 42 nt read
length). A hybrid assembly was constructed using MIRA v3.4.0
(method, de novo; type, genome; quality grade, accurate) with
default settings [48,49]. Gene calling was performed using the
YACOP metatool [50]. Additionally, the four ribosomal RNA
(rRNA) operons within the B. cellulosilyticus WH2 genome were
sequenced individually to ensure high sequence accuracy in these
difficult-to-assemble regions. Further details for the B. cellulosilyticus
WH2 assembly are provided in Table S1.
Bacterial Strains
Details regarding the 12 bacterial strains used in this study are
provided in Table S4. Cells were grown in supplemented TYG
(TYGS; [42]) at 37uC under anaerobic conditions in a Coy
anaerobic chamber (atmosphere: 75% N2, 20% H2, 5% CO2).
After reaching stationary phase, cells were pelleted by centrifuga-
tion and resuspended in TYGS medium supplemented with 20%
glycerol. Individual aliquots containing 400–800 mL of each cell
suspension were stored at 280uC in 1.8 mL borosilicate glass vials
with aluminum crimp tops. The identity of each species was
verified prior to its use in experiments by extracting DNA from a
frozen aliquot of cells, amplifying the 16S rRNA gene by PCR
using primers 8F/27F (AGAGTTTGATCCTGGCTCAG; [51])
and 1391R (GACGGGCGGTGWGTRCA; [52]), sequencing the
entire amplicon with an ABI 3730 capillary sequencer (Retrogen,
Inc.), and comparing the assembled 16S rRNA gene sequence to
the known reference sequence.
Preparation of Strains for Oral Gavage
Details regarding the construction of each inoculum are
provided in Table S3. The inocula used to gavage germ-free
mice in each experiment were prepared either directly from frozen
stocks (experiment 1, E1) or from a combination of frozen stocks
and overnight cultures (experiment 2, E2). The recoverable cell
density for each batch of frozen stocks used in inoculum
preparation was determined prior to pooling, while the same
values for overnight cultures were calculated after pooling. To do
so, an aliquot of cells from each overnight culture or set of frozen
stocks was used to prepare a 10-fold dilution series in phosphate-
buffered saline (PBS), and each dilution series was plated on brain-
heart-infusion (BHI; BD Difco) agar supplemented with 10% (v/v)
defibrinated horse blood (Colorado Serum Co.). Plates were grown
for up to 3 d at 37uC under anaerobic conditions in a Coy
chamber, colonies were counted, and the number of colony-
forming units per milliliter (CFUs/mL) was calculated. The
volume of each cell suspension included in the final inoculum was
normalized by its known or estimated viable cell concentration in
an effort to ensure that no species received an early advantage
during establishment of the artificial community in the germ-free
animals. Total CFUs per gavage were estimated at 8.06107 and
4.26108 for experiments E1 and E2, respectively.
Mice
Experiments were performed using protocols approved by the
animal studies committee of the Washington University School of
Medicine. For each experiment, two groups of 10–12-wk-old male
germ-free C57BL/6J mice were maintained in flexible film
gnotobiotic isolators under a strict 12 h light cycle, during which
time they received sterilized food and water ad libitum. Animals
were fasted for 4 h prior to gavage with 500 mL of a cell
suspension inoculum containing the 12 sequenced, human gut-
derived bacterial symbionts. After gavage, animals were main-
tained in separate cages throughout the course of the experiment.
Fresh fecal pellets were periodically collected directly into screw-
cap sample tubes that were immediately frozen in liquid nitrogen.
At the time of sacrifice, the contents of each animal’s cecum were
divided into thirds and snap-frozen in liquid nitrogen for later use
in DNA, RNA, and total protein isolations.
Diets
Animals were subjected to dietary oscillations comprising three
consecutive phases of 2 wk each (see Figure S3). Prior to
inoculation, germ-free mice were maintained on a standard
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autoclaved chow diet low in fat and rich in plant polysaccharides
(LF/HPP, B&K rat and mouse autoclavable chow #73780000,
Zeigler Bros, Inc). Three days prior to inoculation, one group of
germ-free animals was switched to a sterile ‘‘Western’’-like chow
high in fat and simple sugars (HF/HS, Harlan Teklad TD96132),
while the other continued to receive LF/HPP chow. After gavage,
each group of animals was maintained on its respective diet for
2 wk, after which each treatment group was switched to the
alternative diet. Two weeks later, the mice were switched back to
their original starting diet and were retained on this diet until the
time of sacrifice.
DNA and RNA Extraction
DNA and RNA were extracted from fecal pellets and cecal
contents as previously described [11].
Community Profiling by Sequencing (COPRO-Seq)
COPRO-Seq measurements of the proportional representation
of all species present in each fecal/cecal sample analyzed were
performed as previously described [11] using short-read (36 nt)
data collected from an Illumina sequencer (data were generated
using a combination of the Genome Analyzer I, Genome Analyzer
II, and Genome Analyzer IIx platforms). After demultiplexing
each barcoded pool, reads were trimmed to 25 bp and aligned to
the reference genomes. An abundance threshold cutoff of 0.003%
was set for determining an artificial community members’
presence/absence, based on the proportion of reads from each
experiment that were found to spuriously align to distractor
reference genomes of bacterial species not included in this study.
Normalized counts for each bacterial species in each sample were
used to calculate a simple intrasample percentage. In order to
make changes in abundance over time more easily comparable
between species with significantly different relative abundances,
these percentages were also in some cases normalized by the
maximum abundance (%) observed for a given species across all
time-points from a given animal. This transformation resulted in a
value referred to as the percentage of maximum achieved
(‘‘PoMA’’) that was used to evaluate which species were most/
least responsive to dietary interventions.
Ordination of COPRO-Seq Data Using QIIME
COPRO-Seq proportional abundance data were subjected to
ordination using scripts found in QIIME v1.5.0-dev [53]. Data
from both E1 and E2 were combined to generate a single tab-
delimited table conforming to QIIME’s early (pre-v1.4.0-dev)
OTU table format. This pseudo-OTU table was subsequently
converted into a BIOM-formatted table object that was used as the
input for beta_diversity.py to calculate the pairwise distances
between all samples using a Hellinger metric. PCoA calculations
were performed using principal_coordinates.py. These coordinates
and sample metadata were passed to make_3d_plots.py to
generate PCoA plots. Plots shown are visualized using v2.21 of
the KiNG software package [54].
Metatranscriptomics
GeneChip. A custom Affymetrix GeneChip (‘‘SynComm1’’)
with perfect match/mismatch (PM/MM) probe sets targeting
97.6% of the predicted protein-coding genes within the genomes
of the 12 bacterial species in this study (plus three additional
species not included in the model human gut microbiota) was
designed and manufactured in collaboration with the Affymetrix
chip design team. Control probes targeting intergenic regions from
each genome were also tiled onto the array to allow detection of
any contaminating gDNA. Hybridizations were carried out with
0.9–5.1 mg cDNA using the manufacturer’s recommended proto-
cols. Details regarding the design of this GeneChip are deposited
under Gene Expression Omnibus (GEO) accession GPL9803.
Custom mask files were generated for each species on the
GeneChip for the purpose of performing data normalization one
species at a time. Normalization of raw intensity values was carried
out in Affymetrix Microarray Suite (MAS) v5.0. MAS output was
exported to Excel where advanced filtering was used to identify
those probe sets called present in at least five of seven cecal RNA
samples in at least one diet tested. Data from probe sets that did
not meet these criteria (i.e., genes that were not expressed on either
condition) were not included in subsequent analyses. Normalized,
filtered data were evaluated using the Cyber-T web server [55] to
identify differentially expressed genes. Genes were generally
considered significantly differentially expressed in cases meeting
the following three criteria: p , 0.01, PPDE(,p) $ 0.99, and
|fold-change|$ 2.
Microbial RNA-Seq. Methods for extracting total microbial
RNA from mouse feces and cecal contents, depleting small RNAs
(e.g., tRNA) and ribosomal RNA (5S, 16S, and 23S rRNA), and
for converting depleted RNA to double-stranded cDNA were
described previously [14]. Illumina libraries were prepared [11]
from 26 fecal samples obtained from the second diet oscillation
experiment (four animals, 6–7 time-points surveyed per animal),
using 500 ng of input double-stranded cDNA/sample/library.
RNA-Seq reads were aligned to the reference genomes using the
SSAHA2 aligner [56]. Normalization of the resulting raw counts
was performed using the DESeq package in R [57]. Raw counts
derived from the metatranscriptome were normalized either at the
community level (i.e., counts from all genes were included in the
same table during normalization) for purposes of looking at
community-level representation of functions (ECs) of interest, or at
the species level (i.e., counts from each species were independently
normalized) for purposes of looking at gene expression changes
within individual species. Data adjustment (logarithmic transfor-
mation) and hierarchical clustering were performed using Cluster
3.0 [58] and GENE-E. Heatmap visualizations of expression data
were prepared using JavaTreeview [59] and Microsoft Excel. The
B. cellulosilyticus WH2 in vitro gene expression dendrogram
presented was prepared using GENE-E. Bootstrap probabilities
at each edge of the dendrogram were calculated using the
‘‘pvclust’’ package in R (10,000 replications). Clusters with
bootstrap p values .0.95 were considered strongly supported
and statistically significant.
Metaproteomics
Sample Preparation. Cecal contents were collected from
four mice and solubilized in 1 mL SDS lysis buffer (4% w/v SDS,
100 mM Tris?HCl (pH 8.0), 10 mM dithiothreitol (DTT)), lysed
mechanically by sonication, incubated at 95uC for 5 min, and
centrifuged at 21,0006g. Crude protein extracts were precipitated
using 100% trichloroacetic acid (TCA), pelleted by centrifugation,
and washed with ice-cold acetone to remove lipids and excess
SDS. Protein precipitates were resolubilized in 500 mL of 8 M urea
and 100 mM Tris?HCl (pH 8.0), reduced by incubation in DTT
(final concentration of 10 mM) for 1 h at room temperature, and
sonicated in an ice water bath (Branson (model SSE-1) sonicator;
20% amp; 2 min total (cycles of 5 s on, 10 s off)). An aliquot of
each protein extract was quantified using a bicinchoninic acid
(BCA)-based protein assay kit (Pierce). Protein samples (1 mg)
were subsequently diluted with 100 mM Tris?HCl and 10 mM
CaCl2 (pH 8.0) to a final urea concentration below 4 M.
Proteolytic digestions were initiated with sequencing grade trypsin
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(1/100, w/w; Promega) and incubated overnight at room
temperature. A second aliquot of trypsin was added (1/100) after
the reactions were diluted with 100 mM Tris?HCl (pH 8.0) to a
final urea concentration below 2 M. After incubation for 4 h at
room temperature, samples were reduced by incubation in 10 mM
DTT for 1 h at room temperature. Finally, the peptides were
acidified (protonated) in 200 mM NaCl and 0.1% formic acid,
filtered, and concentrated with a 10 kDa molecular weight cutoff
spin column (Sartorius).
LC-MS/MS Data Collection. The peptide mixture from
each mouse was analyzed in technical duplicate via two-
dimensional liquid chromatography (LC)-MS/MS on a hybrid
LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scien-
tific). Peptides (,100 mL per sample) were separated using a split
phase 2D (strong-cation exchange (SCX) and C18 reverse phase
(RP))-LC column over a 12-step gradient for each run. All MS
analyses were performed in positive ion mode. Mass spectral data
were acquired using Xcalibur (v2.0.7) in data-dependent acquisi-
tion mode for each chromatographic separation (22 h run). One
precursor MS scan was acquired in the Orbitrap at 30K resolution
followed by 10 data-dependent MS/MS scans (m/z 400–1,700) at
35% normalized collision energy with dynamic exclusion enabled
at a repeat count of 1. MS/MS spectra were searched with
SEQUEST (v.27; [60]) using the following settings: enzyme
type = trypsin; precursor ion mass tolerance = 3.0 Da; fragment
mass tolerance = 0.5 Da; fully tryptic peptides and those resulting
from up to four missed cleavages only. All datasets were filtered
with DTASelect (v1.9; [61]) using the following parameters:
Xcorrs of 1.8, 2.5, and 3.5 for singly, doubly, and triply charged
precursor ions; DeltCN $ 0.08; $2 fully tryptic peptides per
protein.
A custom-built FASTA target-decoy database [62,63] was
generated and searched with SEQUEST at a peptide-level false
positive rate (FPR) estimated at #0.5%. The database contained
theoretical proteomes predicted from the genomes of the 12
bacterial species characterized in this study (see Tables S4 and S8),
some diet components (e.g., rice and yeast), and common
contaminants (e.g., keratins). Three additional theoretical bacterial
proteomes predicted from the genomes of Eubacterium rectale,
Faecalibacterium prausnitzii, and Ruminococcus torques were included as
distractors (negative controls) that were not expected to be present
in any of the samples analyzed. An in silico tryptically digested
protein sequence database was also used to generate a theoretical
peptidome of unique peptides within a mass range of 600–
4,890 Da and #1 miscleavages.
Analysis of Proteomic Datasets. Spectral counts for each
protein were normalized by either the total number of spectra
collected for all species in a sample (normalization by community,
‘‘NBC’’), or by the total number of spectra collected for all proteins
from a given species (normalization by species, ‘‘NBS’’). p values
for each protein were calculated using the Mann–Whitney U test.
To correct for multiple comparisons, q values were calculated
using an optimized false discovery rate (FDR) approach with the
‘‘qvalue’’ package in BioConductor. Regardless of the normaliza-
tion strategy employed, p and q values were only calculated for
proteins with at least three valid runs, where a valid run was one
with more than five spectral counts. In NBC data, p and q values
were calculated for all proteins within the model metaproteome. In
NBS data, p and q values were calculated for each species-specific
set of proteins. Differences in spectral counts between treatment
groups (diets) were calculated using group medians. A protein was
designated as ‘‘UP’’-regulated if both its p and q values were less
than 0.05 and the spectral count difference between treatment
groups was greater than 5. The same criteria were applied in the
opposite direction for proteins labeled as ‘‘DOWN.’’ For proteins
labeled ‘‘NULL,’’ there was insufficient evidence to report any
significant difference between the two treatment groups. Finally, a
protein was considered detected or ‘‘present’’ in a sample if at least
four (raw) spectral counts were assigned to that protein when
aggregating the results from the two runs (technical replications)
performed on the sample.
Phenotypic Screen for the Growth of Bacteroides spp. on
Various Carbohydrates
The ability of B. cellulosilyticus WH2 and B. caccae ATCC 43185
to grow on a panel of 47 simple and complex carbohydrates was
evaluated using a phenotypic array whose composition has been
previously described [25]. Growth measurements were collected
in duplicate (two wells per substrate) over the course of 3 d at
37uC under anaerobic conditions. A total of three independent
experiments were performed for each species tested (n= 6
growth profiles/substrate/species). Total growth (Atot) was
calculated from each growth curve as the difference between
the maximum and minimum optical densities (OD600) observed
(i.e., Amax2Amin). Growth rates were calculated as total growth
divided by time (Atot/(tmax2tmin)), where tmax and tmin
correspond to the time-points at which Amax and Amin,
respectively, were collected. Consolidated statistics from all six
replicates for each of the 47 conditions tested for each species
are provided in Table S11.
Profiling B. cellulosilyticus WH2 Gene Expression During
Growth in Defined MM Containing Various
Carbohydrates
RNA-Seq. To characterize the impact of select mono- and
polysaccharides on the in vitro gene expression of B. cellulosilyticus
WH2, cells were cultured in MM supplemented with one of 31
distinct carbohydrates (for the formulation of MM and a list of the
carbohydrates used as growth substrates, see Tables S12 and S13).
After recovery from a frozen stock on BHI blood agar, a single
colony was picked and inoculated into 5 mL of MM containing
5 mg/mL glucose (MM-Glc). Anaerobic conditions were gener-
ated within each individual culture tube using a previously
described method [64] with the following modifications: (i) the
cotton plug was lit and extinguished before being pushed below
the lip of the culture tube, and (ii) 200 mL of saturated sodium
bicarbonate was combined with 200 mL 35% (w/v) pyrogallate
solution on top of the cotton plug before a bare rubber stopper was
used to seal the tube. Cultures were grown overnight at 37uC.
Twenty microliters of this ‘‘starter’’ culture were subsequently
inoculated into a series of ‘‘acclimatization’’ cultures, each
containing 5 mL of MM plus one of the 31 carbohydrates to be
tested (5 mg/mL final concentration), and anaerobic culturing was
carried out as above. This second round of culturing served two
purposes: (i) it ensured cells were acclimated to growth on their
new carbohydrate substrate prior to the inoculation of the final
cultures that were harvested for RNA, and (ii) it provided an
opportunity to obtain OD600 measurements indicating, for each
carbohydrate, the range of optical densities corresponding to B.
cellulosilyticus WH2’s logarithmic phase of growth. Finally, 50 mL of
each ‘‘acclimatization’’ culture were inoculated into triplicate
10 mL volumes of medium of the same composition, and the 90
‘‘harvest’’ cultures were grown anaerobically at 37uC. At mid-log
phase, 5 mL of cells were immediately preserved in Qiagen
RNAprotect Bacteria Reagent according to the manufacturer’s
instructions. Cells were then pelleted, RNAprotect reagent was
poured off, and the bacteria were stored at 280uC.
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After thawing, while still cold, each bacterial cell pellet was
combined with 500 mL Buffer B (200 mM NaCl, 20 mM EDTA),
210 mL of 20% SDS, and 500 mL of acid phenol:chloroform:i-
soamyl alcohol (125:24:1, pH 4.5). The pellet was resuspended by
manual manipulation with a pipette tip and transferred to a 2 mL
screwcap tube containing acid-washed glass beads (Sigma, 212–
300 mm diameter). Tubes were placed on ice, bead-beaten for
2 min at room temperature (BioSpec Mini-Beadbeater-8; set to
‘‘homogenize’’), placed on ice, and bead-beaten for an additional
2 min, after which time RNA was extracted as described above for
fecal and cecal samples.
Identification of Diet-Specific Fitness Determinants
within the B. cellulosilyticus WH2 Genome Using Insertion
Sequencing (INSeq)
Whole genome transposon mutagenesis of B. cellulosilyticus WH2
was performed using protocols originally developed for B.
thetaiotaomicron [42,46], with some modifications. Initial attempts
to transform B. cellulosilyticus WH2 with the pSAM_Bt construct
reported by Goodman et al. yielded very low numbers of
antibiotic-resistant clones, which we attributed to poor recognition
of one or more promoters in the mutagenesis plasmid. Replace-
ment of the promoter driving expression of the transposon’s
erythromycin resistance gene (ermG) with the promoter for the
gene encoding EF-Tu in B. cellulosilyticus WH2 (BWH2_3183)
dramatically improved the number of resistant clones recovered
after transformation. The resulting library consisted of 93,458
distinct isogenic mutants, with each mutant strain containing a
single randomly inserted modified mariner transposon. Of all
predicted ORFs, 91.5% had insertions covering the first 80% of
each gene (mean, 13.9 distinct insertion mutants per ORF).
At 11 wk of age, male germ-free C57BL/6J mice (individually
caged) were fed either a diet low in fat and rich in plant
polysaccharides (LF/HPP) or high in fat and simple sugars (HF/
HS). After a week on their experimental diet, animals received a
single gavage containing the B. cellulosilyticus WH2 transposon
library and 14 other species of bacteria (i.e., this artificial
community consisted of the 12 species listed in Figure 1A, plus
B. thetaiotaomicron 7330, E. rectale ATCC 33656, and Clostridium
symbiosum ATCC 14940). After 16 d, fecal pellets were collected,
and total fecal DNA was extracted.
500 ng of each fecal DNA extraction was diluted in 15 mL of
TE buffer and digested with MmeI (4 U, New England Biolabs) in
a 20 mL reaction supplemented with 10 pmoles of 12 bp DNA
containing an MmeI restriction site (to improve the efficiency of
restriction enzyme digestion) [42]. The reaction was incubated for
1 h at 37uC and then terminated (80uC for 20 min). MmeI-
digested DNA was subsequently purified using 125 mL of AMPure
beads (after washing the beads once with 100 mL of sizing solution
(1.2 M NaCl and 8.4% PEG 8000)). The digested DNA was added
to the beads and the solution incubated at room temperature for
5 min. Beads were pelleted with a magnetic particle collector
(MPC), washed twice (each time using a mixture composed of
20 mL TE buffer (pH 7.0) and 100 mL sizing solution, with bead
recovery via MPC after each wash), followed by two ethanol
washes (180 mL 70% ethanol/wash) and air-drying for 10 min.
Samples were resuspended in 18 mL TE buffer (pH 7.0), and DNA
was removed after pelleting beads with the MPC. Ligation of
adapters was performed in a 20 mL reaction that contained 16 mL
of purified DNA, 1 mL of T4 Ligase (2000 U/mL; NEB), 2 mL 106
ligase buffer, and 10 pmol of barcoded adapter (incubation for 1 h
at 16uC). Ligations were subsequently diluted with TE buffer
(pH 7.0) to a final volume of 50 mL, mixed with 60 mL of AMPure
beads, and incubated at room temperature for 5 min. Beads with
bound DNA were pelleted using the MPC and washed twice with
70% ethanol as above. After allowing the ethanol to evaporate for
10 min, 35 mL of nuclease-free water was added, and the mixture
was incubated at room temperature for 2 min before collecting the
beads with the MPC. Enrichment PCR was performed in a final
volume of 50 mL using 32 mL of the cleaned up sample DNA,
10 mL 106 Pfx amplification buffer (Invitrogen), 2 mL 10 mM
dNTPs, 0.5 mL 50 mM MgSO4, 2 mL of 5 mM amplification
primers (forward primer: 59CAAGCAGAAGACGGCATACG39,
reverse primer: 59AATGATACGGCGACCACCGAACACTC-
TTTCCCTACACGA39), and 1.5 mL Pfx polymerase (2.5 U/mL;
Invitrogen) (cycling conditions: denaturation at 94uC for 15 s;
annealing at 65uC for 1 min; extension at 68uC for 30 s; total of 22
cycles). The 134 bp PCR product from each reaction was purified
(4% MetaPhor gel; MinElute Gel Extraction Kit (Qiagen)) in a
final volume of 20 mL and was quantified (Qubit, dsDNA HS
Assay Kit; Invitrogen). Reaction products were then combined in
equimolar amounts into a pool that was subsequently adjusted to
10 nM and sequenced (Illumina HiSeq 2000 instrument).
Data Deposition
All short read Illumina data used for COPRO-Seq and RNA-
Seq analyses, GeneChip data, and genome sequencing/assembly
data are available through GEO SuperSeries GSE48537 and
NCBI BioProject ID PRJNA183545. The draft genome assembly
for B. cellulosilyticus WH2 has been deposited at DDBJ/EMBL/
GenBank under accession number ATFI00000000. Raw MS data
are available from the Dryad Digital Repository: http://dx.doi.
org/10.5061/dryad.7fj1k.
Supporting Information
Figure S1 Phylogenetic relatedness of B. cellulosilyticus
WH2 to other Bacteroides species. (A) Near full-length 16S
rRNA gene sequences from the B. cellulosilyticus WH2 isolate, its
closest relatives (two strains of Bacteroides xylanisolvens, three strains
of Bacteroides intestinalis, and the type strain of B. cellulosilyticus), and
Parabacteroides distasonis (the latter was included as an outgroup)
were aligned against the SILVA SEED using the SINA aligner
[65]. The 59 and 39 ends of the resulting multiple sequence
alignment were trimmed to remove ragged edges, and the final
alignment was used to construct an approximately maximum-
likelihood phylogenetic tree using FastTree v2.1.4 [66]. Sequences
in the trimmed alignment used to generate the tree shown
correspond to bases 22–1498 of the Escherichia coli 16S rRNA gene
[67]. Parenthetical identifiers indicate the locus tag (for B.
cellulosilyticus WH2, whose genome contains four copies of the
16S rRNA gene) or GenBank accession number (for all other
strains) of each sequence included in the phylogenetic analysis. (B)
Identity matrix summarizing the pairwise similarities (as %
nucleotide sequence identity) for all 16S rRNA gene sequences
used to construct the tree shown in panel (A).
(EPS)
Figure S2 Representation of all putative GH families
identified in the B. cellulosilyticus WH2 genome com-
pared to their representation in other sequenced
Bacteroidetes species. Enumeration of the GH repertoire of
B. cellulosilyticus WH2 relative to (A) the six other Bacteroidetes
species included in the artificial microbial community described in
Figure 1A, and (B) the 86 Bacteroidetes currently annotated in the
CAZy database. GH numbers in red signify CAZy families whose
representation is greater in B. cellulosilyticusWH2 than in any of the
other Bacteroidetes to which it is being compared. An asterisk
following a GH family number indicates that genes encoding
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proteins from that family were found exclusively in the B.
cellulosilyticus WH2 genome. In (B), GH family numbers are
ordered from left to right and from top to bottom by their average
representation within the 87 Bacteroidetes genomes included in
the analysis.
(TIF)
Figure S3 Design and sampling schedule for experi-
ments E1 and E2. In each experiment, two groups of C57BL/6J
germ-free mice were gavaged at 10–12 wk of age with a 12-
member artificial human gut microbial community (the day of
gavage, referred to as day 0, is denoted by a large black arrow).
Over time, animals were fed diets low in fat and high in plant
polysaccharides (LF/HPP, bold green) or high in fat and simple
sugar (HF/HS, bold orange) in alternating fashion. Fecal pellets
and cecal contents were collected as indicated for profiling
community membership and gene expression (sample types are
denoted by a circle’s color and the methods applied to each sample
are indicated in parentheses within the sample key). Values shown
along the time course indicate the number of days since gavage of
the artificial community into germ-free animals.
(EPS)
Figure S4 COPRO-Seq analysis of the proportional
representation of component taxa in the 12-member
artificial community as a function of time after coloni-
zation of gnotobiotic mice and the diet they were
consuming. (A) Average DNA yields from fecal and cecal
samples collected from each treatment group in experiment E1. (B)
DNA yields from samples collected in experiment E2. (C)
COPRO-Seq quantitation of the 12 bacterial species comprising
the assemblage used to colonize germ-free mice in experiments E1
and E2. Vertical dashed lines at days 14 and 28 denote time-points
at which diets were switched. Panels (A–C) share a common key,
provided in the upper right. Circles and triangles denote samples
from experiments E1 and E2, respectively. Cecal sample data
points (obtained at sacrifice on day 42 of the experiment) are
plotted as for fecal sample data, but with inverted colors (i.e.,
colored outline, solid black fill). For all panels (A–C), data shown
are mean 6 SEM.
(EPS)
Figure S5 Further COPRO-Seq analysis of the relative
abundance of components of the 12-member bacterial
community as a function of diet and time. (A) Plot of the
ordination results for experiment 1 (E1) from the PCoA
described in Figure 1B. COPRO-Seq data from E1 and E2
were ordinated in the same multidimensional space. For clarity,
only data from E1 are shown (for the E2 PCoA plot, see
Figure 1B). Color code: red/blue, feces; pink/cyan, cecal
contents. (B) Heatmap representation of the relative abundance
data from E1 normalized to each species’ maximum across all
time-points within a given animal (‘‘Percentage of maximum
achieved (PoMA)’’). Each heatmap cell denotes the mean for
one treatment group (n= 7 animals), and each treatment group
is shown as its own heatmap.
(EPS)
Figure S6 GeneChip profiling of the cecal metatran-
scriptome in mice fed different diets. (A) Venn diagram
illustrating the number of bacterial genes whose expression was
scored as ‘‘present’’ (i.e., detectable in $5 of 7 animals), only in
mice that were consuming the plant polysaccharide-rich LF/HPP
diet, only in mice that were consuming a ‘‘Western’’-like HF/HS
diet, or in both groups. (B) Overview of the diet-specificity of
CAZyme gene expression in the 12-member model microbiota
and in four prominent taxa that maintained a proportional
representation in the cecal microbiota that was .5% on each diet.
(EPS)
Figure S7 Dissecting the in vivo expression of EC
3.2.1.8 (endo-1,4-b-xylanase). (A) Gene expression in E2 fecal
samples was evaluated by microbial RNA-Seq. After data from all
12 species in the model human gut microbiome were binned by
EC number annotation and normalized (i.e., data were ‘‘commu-
nity-normalized’’ at the level of ECs), a significant decrease in the
representation of EC 3.2.1.8 in the metatranscriptome was
observed when comparing the final time-point of the first diet
phase (day 13, LF/HPP diet) and the final time-point of the second
diet phase (day 27, HF/HS diet) (Mann–Whitney U test, p=0.03).
(B) Transcribed B. cellulosilyticus WH2 genes account for .99% of
community-normalized RNA-Seq counts assignable to EC 3.2.1.8
(note how counts at the community level in panel (A) compare to
those attributable to B. cellulosilyticus WH2 in panel (B)). Thus, B.
cellulosilyticus WH2 essentially dictates the degree to which
expressed endo-1,4-b-xylanase genes are represented within the
metatranscriptome. (C) B. cellulosilyticus WH2 contributes a greater
number of community-normalized RNA-Seq counts to the
metatranscriptome in LF/HPP-fed mice than in HF/HS-fed
animals. (D) When B. cellulosilyticus WH2 gene expression data are
normalized independently of data from other taxa (i.e., when data
are ‘‘species-normalized’’), statistically significant increases in the
representation of EC 3.2.1.8 within the B. cellulosilyticus WH2
transcriptome become apparent in HF/HS-fed mice. (E) Break-
down of the total species-normalized counts in panel (D) by the B.
cellulosilyticus WH2 gene from which they were derived. For all
panels (A–E), mean values6 SEM are shown. Means for all panels
were calculated from data from four animals at each time-point,
except day 26 (n=2). In each of the first four panels (A–D), the
differences between day 13 and day 27 were deemed statistically
significant by Mann–Whitney U test (p=0.03 for each of the four
tests performed).
(EPS)
Figure S8 Shotgun metaproteomic analysis of cecal
samples from gnotobiotic mice colonized with the 12-
member artificial community. (A) Each species’ theoretical
proteome was subjected to in silico trypsinization (see Materials and
Methods). Of the resulting peptides, those specific to a single protein
within our database of all predicted proteins encoded by the
genomes of the 12 assemblage members, the mouse, and three
bacterial ‘‘distractors’’ (E. rectale, F. prausnitzii, and R. torques) were
classified as ‘‘unique,’’ while all others were considered ‘‘non-
unique.’’ The ‘‘unique’’ fraction of a species’ predicted peptides
indicates how many can be unambiguously traced back to a single
protein of origin if detected by LC-MS/MS. (B) Comparison of
the average relative cecal abundance of each assemblage member
(dark gray bars) with the percentage of proteins within its
theoretical proteome that were detected by LC-MS/MS (red
bars), and the percentage of all genes within its genome whose
expression was detected using our custom GeneChip (light gray
bars). Data shown are mean values 6 SEM. (C) Scatter plots
illustrating the Pearson correlation coefficient (r) between log-
transformed averages of diet-specific fold-differences in expression
as determined by GeneChip assay (RNA, x-axis) and LC-MS/MS
(protein, y-axis) in E1. Data points within the black scatter plot
represent the 448 B. cellulosilyticus WH2 genes for which reliable
quantitative data could be obtained for animals in both diet
treatment groups for both the GeneChip and LC-MS/MS assays
(i.e., any gene for which a signal could not be detected on at least
one diet treatment in at least one assay was excluded). Scatter plots
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in color represent the results of correlation analyses performed on
subsets of genes within the black plot whose KEGG annotations
fall within particular functional categories, including ‘‘Transla-
tion’’ (r=0.03, 59 genes), ‘‘Energy metabolism’’ (r=0.36, 58
genes), ‘‘Amino acid metabolism’’ (r=0.48, 67 genes), and
‘‘Carbohydrate metabolism’’ (r=0.69, 110 genes). For both (B)
and (C), n=2 mice per treatment group (4 mice total).
(EPS)
Table S1 Sequencing statistics for B. cellulosilyticus
WH2.
(XLSB)
Table S2 B. cellulosilyticus WH2 genome features with
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Table S5 COPRO-Seq quantitation of the relative
abundances of artificial community members over time.
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Table S6 GeneChip measurements of cecal gene ex-
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Table S8 Summary of theoretical peptidome statistics.
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sample for each species in our custom SEQUEST
database.
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Table S10 Raw and normalized MS/MS spectral counts
for detectable proteins in E1 cecal samples.
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Table S11 Growth of B. cellulosilyticus WH2 and B.
caccae on a panel of structurally diverse carbohydrates.
(XLSB)
Table S12 Preparation of minimal medium for in vitro
gene expression profiling of B. cellulosilyticus WH2.
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Table S13 Carbohydrate substrates tested during in
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Bacterial viruses (phages) are the most abundant biological group
on Earth and are more genetically diverse than their bacterial prey/
hosts. To characterize their role as agents shaping gut microbial
community structure, adult germ-free mice were colonized with
a consortium of 15 sequenced human bacterial symbionts, 13 of
which harbored one or more predicted prophages. One member,
Bacteroides cellulosilyticus WH2, was represented by a library of
isogenic transposon mutants that covered 90% of its genes. Once
assembled, the community was subjected to a staged phage attack
with a pool of live or heat-killed virus-like particles (VLPs) purified
from the fecal microbiota of five healthy humans. Shotgun sequenc-
ing of DNA from the input pooled VLP preparation plus shotgun
sequencing of gut microbiota samples and purified fecal VLPs from
the gnotobiotic mice revealed a reproducible nonsimultaneous pat-
tern of attack extending over a 25-d period that involved five
phages, none described previously. This system allowed us to (i)
correlate increases in specific phages present in the pooled VLPs
with reductions in the representation of particular bacterial taxa,
(ii) provide evidence that phage resistance occurred because of eco-
logical or epigenetic factors, (iii) track the origin of each of the five
phages among the five human donors plus the extent of their ge-
nome variation between and within recipient mice, and (iv) estab-
lish the dramatic in vivo fitness advantage that a locus within a
B. cellulosilyticus prophage confers upon its host. Together, these
results provide a defined community-wide view of phage–bacterial
host dynamics in the gut.
microbiome | artificial gut communities | viral diversity |
viral metagenomics | prophage function
The human gut is home to tens of trillions of microbial cellsrepresenting all three domains of life, although most are
bacteria. These organisms collaborate and compete for func-
tional niches and physical locations (habitats). Together, they
form a continuously functioning microbial metabolic “organ.” The
microbial diversity, interpersonal variation, and dynamism of the
human gut microbiota make the task of identifying the factors that
define community configurations extremely challenging.
In some ecosystems, phages maintain high bacterial strain
level diversity through lysis of their host strains (constant di-
versity dynamics model; refs 1, 2). The resulting emptied niche is
filled with either an evolved resistant bacterial strain or a taxo-
nomically closely related bacterial species. These dynamics have
been observed in open marine environments (1). In contrast,
a recent study of 37 healthy adults indicated that a person’s fecal
microbiota was remarkably stable, with 60% of bacterial strains
retained over the course of 5 y (3). Stability followed a power law
dynamic that when extrapolated suggests that most strains in an
individual’s gut community are retained for decades (3). In
a metagenomic analysis of virus-like particles (VLPs) purified
from the fecal microbiota of healthy adult monozygotic twins and
their mothers, sampled over the course of a year, viral commu-
nity structure exhibited high interpersonal variation. In contrast,
the viral (phage) population within an individual was very stable
over time, both at the level of sequence conservation and relative
abundance (4). These observations, as well as other reports (5–
7), suggest that temperate lifestyles, rather than a predator–prey
relationship, dominate the phage–host bacterial cell dynamic in
the distal guts of healthy humans.
To improve our understanding of viral–bacterial host dynam-
ics, we constructed a gnotobiotic mouse model containing a
simplified defined artificial community composed of 15 prom-
inent human gut-derived bacterial taxa whose genomes had been
sequenced (Dataset S1). This 15-member artificial community
was used as bait for a staged attack that involved oral gavage of
VLPs purified from human fecal samples. This system allowed us
to (i) test whether phage populations would mount a simulta-
neous attack on susceptible members of the microbial commu-
nity or whether such an attack would be nonsimultaneous (i.e.,
have an identifiable sequence), (ii) document the capture of
previously unknown viruses present in the VLP preparations by
members of the artificial community, and (iii) track induction of
native prophages.
Results and Discussion
Attacking a 15-Member Artificial Human Gut Microbiota with VLPs
Isolated from the Fecal Microbiota of Healthy Adult Humans. Our
experimental design consisted of three groups of germ-free
C57BL/6J mice (n = 5 per group). Each group was kept in a
separate gnotobiotic isolator, where each mouse was individually
caged. The first group was gavaged with the 15-member artificial
community at 8 wk of age. Three weeks later, they were each
gavaged with a pool of VLPs (p-VLP) isolated from fecal sam-
ples obtained from five healthy humans (“live p-VLP group”).
A “heat-killed p-VLP group” was also colonized with the artificial
Significance
A consortium of sequenced human gut bacteria was introduced
into germ-free mice followed by a “staged” phage attack with
virus-like particles purified from the fecal microbiota of five
healthy adult humans. Unique phages were identified attack-
ing microbiota members in nonsimultaneous fashion. Some
host bacterial species acquired resistance to phage attack
through ecological or epigenetic mechanisms. Changes in com-
munity structure observed after attack were transient. Sponta-
neous induction of prophages present in seven bacterial taxa
was modest, occurring independently of the phage attack.
Together, these results reveal a largely temperate phage–
bacterial host dynamic and illustrate how gnotobiotic mouse
models can help characterize ecological relationships in the
gut by taking into account its most abundant but least un-
derstood component, viruses.
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community but 3 wk later received a heat-killed version of the
VLPs used for the first group. The third group did not receive
a gavage of bacteria (“germ-free group”) but was gavaged with
the same live p-VLP pool given to the first group. Fecal samples
were collected from members of each treatment group at fre-
quent intervals (Fig. S1).
Neither the bacterial gavage nor the p-VLP inoculum con-
tained components that appeared to compromise gut barrier/
immune function or perturb overall health status. At the time of
sacrifice, none of the treatment groups exhibited any significant
differences in total body weight or adiposity (epididymal fat pad
weight as a percentage of total body weight; P = 0.3957 and P =
0.4794, respectively; Kruskal–Wallis test; Dataset S1). FACS
analysis did not reveal any differences between the groups in the
CD4+ and CD8+ T-cell compartments of their spleens or mes-
enteric lymph nodes (MLNs), as judged by CD44 and CD62L
T-cell activation markers, Ki-67+ (proliferation marker), and
FoxP3+ (Treg cells marker). For the germ-free group, Illumina
shotgun sequencing of ileal and colonic contents obtained at the
time of sacrifice disclosed that the p-VLP inoculum did not con-
tain bacterial taxa (or bacterial spores) that could establish them-
selves in the guts of recipient animals (Dataset S1).
Microbial biomass, defined as nanograms DNA/milligram wet
weight of feces, increased linearly and abruptly in the 4 d fol-
lowing introduction of the artificial community in both the live and
heat-killed p-VLP groups (Fig. S2A). Fecal DNA concentrations
correlated significantly with fecal bacterial cell counts (determined
by flow cytometry; Spearman correlation, 0.843; Fig. S2B).
Because the genome sequences of the 15 bacterial taxa were
known, we used community profiling by sequencing (COPRO-Seq;
ref. 8), a method based on short read (50 nt) shotgun sequencing
of total fecal community DNA, to quantify the relative abundance
of each taxon as a function of time after initial colonization and
after the staged VLP attack [2,544,433 ± 96,255 (mean ± SEM)
reads per sample; Dataset S1]. Principal coordinates analysis of
a Hellinger distance matrix constructed from the COPRO-Seq
datasets showed that most of the variation in composition over
time occurred during the period of initial community assembly
(Fig. S3A). Changes in the relative abundance of community
members also occurred following gavage of the live but not the
heat-killed p-VLP preparation (Fig. 1 A–C and Fig. S3 B–N).
A Nonsimultaneous Pattern of Change in the Abundances of Five
Phages. To identify which exogenously administered VLP-associ-
ated viruses might be causing the observed structural rearrange-
ments in community configuration, we modified our previously
reported method for purifying VLPs (4) so that it could be applied
to mouse fecal samples. We then sequenced DNA isolated from
the purified VLP preparations [n = 27; two fecal pellets/VLP pre-
paration, each amplified by multiple displacement amplification
(MDA); 49,819 ± 6,983 (mean ± SEM) pyrosequencer reads per
sample; Fig. S1 and Dataset S1]. To discriminate between activa-
tion of endogenous prophage in members of the artificial commu-
nity versus exogenous viruses derived from the p-VLP preparation,
reads generated from either the input VLPs or total mouse fecal
DNA were mapped to the sequenced genomes of bacterial com-
munity members and to the mouse genome. We used reads without
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Fig. 1. Sequential changes in the relative abun-
dance of two members of the 15-member artificial
human gut microbiota and correlation with the
appearance of two previously undescribed phages.
(A) Relative abundance plot for each bacterial
species as a function of time for either the live p-
VLP or the heat-killed p-VLP treatment groups.
Mean values ± SEM are shown (n = 5 mice). The
color key next to the plot indicates the identity of
each bacterial species. (B and C) Plots of the relative
abundance (fraction of the total community;
mean ± SEM; n = 5 animals per treatment group) of
B. caccae and B. ovatus in the fecal microbiota of
gnotobiotic mice as a function of time before and
after gavage with live purified VLPs pooled from
the fecal microbiota of five human donors or a
control heat-killed version of the same p-VLP
preparation (time of gavage indicated by the up-
ward pointing arrow; t = 0 on the x axis refers to the
time of introduction of the 15-member artificial
community into germ-free animals). The change in
abundance of these Bacteroides spp. occurs in a re-
producible sequence among individually caged mice
that received live but not heat-killed p-VLPs. (D and
E) Changes in the abundance of two phages, derived
from the p-VLP sample, in the fecal microbiota of
recipient gnotobiotic mice. Differences in the time
course of change in bacterial and viral abundances
are highlighted by the gray shading (lighter for B.
caccae and ϕHSC01). Insets in D and E are assembled
genome sequences for ϕHSC01 and ϕHSC02. The lo-
cation of genes on the positive strand (green) and
negative strand (red) are shown; those that have
significant sequence similarity to known viral genes
are colored blue (blastp E-value <10−5; Dataset S1).
The inner plot represents GC skew based on 200-bp
windows (yellow, G/C ratio is greater than the
average for the genome; purple, ratio is lower than
the average).
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significant matches to either dataset to characterize viral genomes
not represented in the starting 15-member artificial community.
In total, five viral genomes, none of which have been described
previously, were assembled and annotated from these analyses.
These viruses were detected in the gut communities of mice that
had received the live p-VLP preparation but not in the heat-
killed p-VLP group (Fig. 1 D and E, Fig. S4 A–H, and Dataset
S1). Rather than finding a concurrent attack on all susceptible
members of the model human gut microbiota, we observed
a nonsimultaneous pattern of change in the abundances of these
viruses with corresponding changes in the representation of
community members.
A DNA virus with a circular 37-kb genome, human synthetic
community phage 01 (ϕHSC01), was the first to significantly
increase in abundance. It not only encodes typical phage proteins
(e.g., terminase, tail protein, DNA polymerase; Dataset S1), but
also a protein containing a Bacteroidetes-associated carbohy-
drate-binding often N-terminal (BACON) domain (Profam ID:
PF13004) postulated to target glycoproteins and possibly host
mucin (9). From the time of its first detection in feces 24 h after
animals were gavaged with the live p-VLP preparation, the
marked increase in abundance of ϕHSC01 over the course of
the next 2 d correlated with a decrease in the abundance of
Bacteroides caccae (R2 = −0.446; P = 3.2 × 10−8 after Bonfer-
roni correction; Fig. 1 B and D). No other community member
showed a statistically significant inverse correlation, suggesting
that this bacterium is a host for ϕHSC01. The drop in the relative
abundance of B. caccae was abrupt, occurring over the course of
1 d between days 2 and 3 after VLP gavage. The 74.5 ± 3.7%
decrease relative to pretreatment levels was followed by a re-
covery to 75.8 ± 5.2% of the pre-VLP gavage values within 3–
6 d (Fig. 1). This fourfold decrease was independently validated
using quantitative (q)PCR (from 3.4 × 105 to 7.8 × 104 genome
equivalents/mg of fecal pellet; see SI Methods). The spike in viral
abundance, just like the coincident reduction in B. caccae
abundance, was remarkably consistent in terms of its magnitude
and time course among the individually caged members of this
treatment group.
Evidence That Phage Resistance Occurs Because of Ecological or
Epigenetic Mechanisms. To determine whether B. caccae’s re-
covery after viral attack was based on acquisition of identifiable
fixed changes in its genome, we performed deep shotgun se-
quencing of total fecal community DNA isolated from samples
obtained 9–19 d after bacterial gavage and 9–25 d after gavage of
live and heat-killed p-VLPs. Pooling sequencing reads from
these four groups of samples allowed us to assemble the
B. caccae genome at an average coverage of 30-fold per treat-
ment group, giving us enough resolution to identify mutations
that could be responsible for conferring viral resistance. The
results did not reveal deletions, insertions, or SNPs that were
unique to the live p-VLP treatment group after the viral gavage
and fixed in more than 10% of the B. caccae population (SI
Results). Incorporation of short fragments of viral DNA within
a locus flanked by short repeats [Clustered Regularly Inter-
spaced Short Palindromic Repeats (CRISPR, elements)] leads to
bacterial resistance to viruses whose genomes have sequence
similarity to the incorporated fragments (10). B. caccae does not
contain any discernible CRISPR loci or associated proteins
(Dataset S1). Moreover, no other prominent community mem-
ber accumulated new spacers during the experiment (SI Results).
One interpretation of these findings is that phage “resistance”
occurred because of ecological rather than genetic mechanisms.
In this conceptualization, the gut environment consists of a
number of microhabitats, some of which are occupied by B. caccae
in ways that make it inaccessible to viral attack; the rise of B. caccae
following the staged phage attack is not due to emerging re-
sistance to the virus but rather an expansion of an unexposed
population after the virus is washed out of the ecosystem. An
alternative but not mutually exclusive possibility is that resistance
is acquired due to phase variants or down-regulation of a phage
receptor, making B. caccae resistant to viral attack without any
discernible mutations in its genome (epigenetic mechanism). An-
other explanation is that mutations occur in one or more regions of
the genome that are difficult to sequence and/or assemble.
Nonsimultaneous Detection of Viruses and Community Rearrangements.
The second virus to show an increase in abundance was ϕHSC02.
All four predicted proteins encoded by this phage with a 6.2-kb
genome (Fig. 1E) exhibit significant similarity to the Alpavirinae,
a recently described subfamily identified from Bacteroidetes
prophages, that belongs to the Microviridae (previously consid-
ered to be exclusively lytic) (11, 12). The changes in relative
abundance of ϕHSC02 best correlated with a change (reduction)
in the abundance of Bacteroides ovatus. Expansion of this virus
and the attendant decrease in B. ovatus were first detected 2 d
after the “crash” of B. caccae (i.e., within 5 d of gavage with the
live p-VLP preparation) and coincided with the onset of recovery
of the B. caccae population (Fig. 1 B–E).
The six- to eightfold reductions in relative representations of
these two Bacteroides species took place during the 7-d period
after gavage with live p-VLPs and were followed by a rise in
abundance over a 7- to 8-d interval (Fig. 1 B and D). As these
organisms increased their representation, we documented tran-
sient decreases in Bacteroides cellulosilyticus, as well as the two
Bacteroides thetaiotaomicron strains present in the community.
At the same time, levels of Parabacteroides distasonis, Clostridium
symbiosum, Clostridium scindens, and Ruminococcus obeum rose.
These successional changes in bacterial abundance were limited
to the group of mice that had received the live p-VLPs (Fig. S3).
The rise and fall of these organisms in the live p-VLP group
occurred during a time period when three other previously
undescribed viruses appeared: ϕHSC03 (153.4 kb), ϕHSC04
(104.2 kb), and ϕHSC05 (95.7 kb). These viruses, initially
detected 7 d after gavage of the live p-VLP preparation, sub-
sequently increased in abundance to approximately equivalent
levels and persisted during the remaining 14 d of the experiment
(Fig. S4 C–H). Unlike the distinctive negative correlation be-
tween ϕHSC01 and B. caccae abundance, and subsequently
ϕHSC02 and B. ovatus abundance, the simultaneous appearance
and rise of ϕHSC03, ϕHSC04, and ϕHSC05, their subsequent
persistence, and the coincident complex patterns of change in
the abundances of bacterial community members during this
later period of the experiment made it difficult for us to assign
candidate bacterial hosts to these three previously undescribed
phages. Therefore, the same live p-VLPs used for the in vivo
staged phage attack were also used for in vitro “attacks” of
monocultures of each of the species present in the 15-member
artificial community (SI Methods). There was no enrichment of
any of the five previously undescribed viruses in any of the cul-
tures (n = 2 independent experiments), suggesting that the
bacterial host susceptibilities and requirements for infection with
these phages are not recapitulated under these in vitro con-
ditions (SI Results and Dataset S1). This observation highlights
the value of gnotobiotic animal models for isolation of previously
undescribed gut viruses.
Tracking the Origin of Each of the Five Phages Among the Human
Donors as Well as Their Genome Variation Between and Within
Recipient Mice. To determine whether ϕHSC01–ϕHSC05 were
distributed among all of the human VLP donors or whether they
were unique to particular individuals, we generated a hybrid
assembly using reads from the original VLP-derived viromes
from each of the five donors as well as from the p-VLP prepa-
ration used for gavage (SI Methods). The hybrid assembly yielded
159 contigs greater than 2 kb. Based on read distribution and
percent identity in contigs, we concluded that ϕHSC01 and
ϕHSC04 originated from a twin in family 2 (F2T1.2), whereas
ϕHSC02 and ϕHSC03 originated from the twin in family 4
(F4T1.2) (Fig. S5A). ϕHSC05 was observed in four of the five
individuals used to construct the VLP pool. Mapping reads from
each human donor fecal virome to ϕHSC05 revealed that the
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virus recovered from mice likely came from individual F3T1.2
because the average percent identity of reads from this person’s
virome mapping to the ϕHSC05 genome was equivalent to the
percent identity obtained from VLPs isolated from mouse fecal
samples (Fig. S5B). Nonetheless, analyzing VLP DNA purified
from fecal samples obtained from each recipient mouse 9 d and
17 d after gavage of the live p-VLPs, and from cecal samples
obtained at sacrifice, revealed animal-to-animal variations in
ϕHSC05 genome structure (Fig. S5C). These genomic variations
could have been present in the human donor fecal virome and
distributed to different mouse recipients. However, we also ob-
served variations in ϕHSC05 genome structure within mice over
time (Fig. S5C), raising the possibility of a red queen dynamic
(evolution of the viral genome in response to evolution of the
bacterial host over time). It is important to note that none of the
other four phages (ϕHSC01–4) showed this type of variation
between animals, or within individual animals as a function of
time (Fig. S5 D–G), indicating that ϕHSC05’s genome evolution
is not a general feature in mice harboring this artificial com-
munity. Together, our findings not only illustrate the utility of
gnotobiotic mice for identifying candidate bacterial hosts for
human gut-associated phage, but also for identifying differences
in properties among related virotypes derived from different
human gut viromes.
Distribution and Persistence of Phages Within the Gut. Intestinal
transit time in mice is on the order of several hours (13). We
collected intestinal contents from the proximal and distal small
intestine, cecum, and colon, as well as a fecal sample from each
mouse in the live and heat-killed p-VLP treatment groups at the
time of their sacrifice (25 d after the staged p-VLP attack). All
gut samples were processed for COPRO-Seq analysis, and an
aliquot of cecal contents was used to isolate VLPs for subsequent
shotgun sequencing of viral DNA (Dataset S1). The results
revealed no detectable phages in any of the gut segments from
mice that received the heat-killed p-VLP preparation (Fig. S6A).
In the live p-VLP treatment group, neither ϕHSC03, ϕHSC04,
nor ϕHSC05 exhibited significant differences in their relative
abundances between the distal small intestine and distal colon, and
between luminal contents and feces (Fig. S6A). Moreover, at the
time of sacrifice, there were no significant biogeographical differ-
ences in the relative abundance of bacterial species within or be-
tween members of the two treatment groups (Fig. S6B).
The fact that ϕHSC03, ϕHSC04, and ϕHSC05 first appeared
in members of the live p-VLP treatment group 7 d after the
single gavage of p-VLPs suggests that an intra- and/or extracel-
lular compartment/reservoir exists that harbors components of the
administered human fecal phage population. Pseudolysogeny,
a state where phages exist in a host bacterial cell without multi-
plying or synchronizing their replication with the host (14) could
represent one potential mechanism for persistence. Hypervariable
domains, including C-type lectins, have been identified in gut-as-
sociated phages (15), suggesting that extracellular sequestration
with binding to mucus or epithelial cell surface glycans could rep-
resent another potential mechanism. Barr et al. found that en-
richment of phages in mucus occurs through binding of Ig-like
domains exposed on phage capsids to carbohydrate residues pres-
ent in the mucin glycoprotein component of mucus, thereby cre-
ating a form of antimicrobial defense that could protect mucosal
surfaces (16). COPRO-Seq analysis of cecal samples obtained from
mice in the germ-free treatment group that lacked the 15-member
artificial community and were gavaged with the live p-VLP prep-
aration alone revealed no detectable phages in the cecum at the
time of sacrifice (Dataset S1), supporting the notion that persis-
tence of ϕHSC03–ϕHSC05 may be dependent upon the presence
of bacteria. [Note that members of the gut microbiota, including
Bacteroides spp. represented in the artificial community, are known
to impact the mucus layer and mucosal glycans through a variety of
means (17–19).] Although we cannot completely rule out the pos-
sibility that ϕHSC03 and ϕHSC04 were first detected at later time
points because there had been a selection for mutants that could
replicate better, this seems unlikely; their late appearance was
a common feature in mice receiving the live p-VLP preparation,
and, as noted above, there was no obvious variation in their viral
genomes between animals and within a given mouse over time (Fig.
S5 F and G).
Prophage Activation in the 15-Member Artificial Community. Thir-
teen of the 15 bacterial taxa in the artificial community had
predicted prophages in their genomes (Dataset S1). To verify
these predictions and to assess the capacity of these prophages to
undergo induction, we used reads obtained from shotgun pyro-
sequencing of DNA isolated from two sources: (i) VLPs purified
from fecal samples collected at weekly intervals from animals
gavaged with live p-VLP preparation and (ii) VLPs purified from
cecal samples obtained at sacrifice. Instead of mapping randomly
throughout bacterial genomes (implying a background level of
bacterial DNA contamination in the purified VLPs), VLP reads
mapped to one or more of the predicted prophages. In this way, we
identified 10 prophages derived from seven bacterial genomes that
had the capacity to undergo induction in vivo (Fig. S7).
B. cellulosilyticus WH2 has two prophages, one of which
(prophage 1) exhibited the greatest fold-induction among these
10 prophages. Prophage 1 has a lambdoid genome architecture
(Fig. 2A) with syntenic arrangements identified in other Bacter-
oides genomes (Fig. S8A). Its induction was observed in all mice 5–
9 d after initial gavage of the 15-member artificial community
prior to introduction of either live or heat-killed p-VLPs. In-
duction occurred at the end of the period of initial bacterial
community assembly, right after microbial biomass reached its
peak (Fig. S2A), suggesting a potential role of bacterial density in
the induction process. Induction of prophage 1 correlated with
a decrease in the relative abundance of its bacterial host (Fig. 2 B
and C). The other B. cellulosilyticus prophage (prophage 2) did not
exhibit significant levels of induction at any time point surveyed
during the experiment (Fig. 2D and Fig. S8B; also see SI Results
showing that prophage 2 can be induced in vitro).
B. cellulosilyticus WH2 was represented in the 15-member
artificial community by a library of 93,458 isogenic mutants, with
each mutant strain containing a single randomly inserted modi-
fied mariner transposon (Tn) (91.5% of predicted ORFs had
insertions covering the first 80% of each gene with an average of
13.9 insertions per ORF). Because the modified Tn had engi-
neered recognition sites for the type II restriction endonuclease
MmeI at its ends, 16 bp of flanking chromosomal DNA could be
excised together with the Tn after MmeI digestion of community
DNA and sequenced (20). This makes it possible to use high
throughput sequencing to define the precise location and abun-
dance of each transposon mutant in the library (SI Methods).
Comparing the number of reads for each mutant in an “output”
population after a given selection to the number of reads gen-
erated from an “input” population provides information about
the effect each transposon insertion had on the fitness of the
organism under the selection condition applied (20, 21).
Applying this Tn INsertion Sequencing (INSeq) analysis to
DNA prepared from fecal samples collected before, during, and
after prophage 1 induction showed a dramatic enrichment for
transposons located within a ∼600bp intergenic region posi-
tioned between the ORFs encoding the prophage’s putative Rha
protein (22) and cI repressor at the time of its induction 5–9 d after
introduction of the 15-member artificial community (Fig. S9 A and
B and SI Results). The intergenic region upstream of cI in phage
lambda is an extremely well-studied transcriptional regulatory re-
gion; the right operator (OR) with its three sites that competitively
bind the repressor and Cro proteins, constitutes a carefully regu-
lated switch between lysogenic and lytic cycles (23, 24). Upon
RecA activation, the repressor is cleaved and the prophage is in-
duced (25). Thus, accumulation of mutations in this region could
have important consequences on the regulation and lifecycle of the
lambdoid prophage 1 and its bacterial host.
In some mice, enrichment of strains with Tn inserts in the
cI-rha intergenic region was observed as early as 2 d after gavage
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of the 15-member artificial community (before prophage in-
duction). Enrichment did not reflect clonal expansion of a single
mutant strain within a given animal, but rather expansion of 1 or
more of 10 independent mutants, each harboring a single
transposon insertion within this intergenic region. The number
and sites of these insertion mutants varied between animals (Fig.
S9A). Moreover, no Tn insertions were observed within the ORF
encoding the putative cI repressor or in the region 100 bp im-
mediately upstream of the ORF in the input library, nor in any of
the output fecal samples (Fig. S9A), suggesting an essential role
for the repressor and the upstream OR region in bacterial host
fitness (Fig. S9 C and D).
Control experiments were carried out for 20 d (the time before
p-VLP gavage) using the same 15-member artificial commu-
nity but where B. cellulosilyticus WH2 was represented by the
wild-type strain rather than by a library of Tn mutants. Although
community assembly and structure were highly similar to that
observed when the artificial community contained the Tn mutant
library (compare Fig. S8C with Fig. 1A), neither prophage 1 nor
prophage 2 were induced, and no drop in B. cellulosilyticus WH2
abundance was observed (Fig. S8D). These findings suggest that
Tn mutations in the cI-rha intergenic region facilitate prophage
induction in the mouse model.
We defined the time course of clonal expansion of bacteria
containing Tn inserts in this intergenic region to quantify the
fitness effects of disrupting this part of the prophage genome.
Reads mapping to this locus represented 77.9 ± 4.6% (mean ±
SEM) of all Tn reads in fecal samples collected between 5 d and
9 d after bacterial gavage (range, 61.3–96.9%). A sliding window
analysis was performed to determine if any other 600-bp region
of the B. cellulosilyticus WH2 genome containing a Tn insertion
went through a clonal expansion analogous to that documented
for the cI-rha intergenic region during the first 31 d of the ex-
periment in mice belonging to the live and heat-killed p-VLP
treatment groups. The results revealed that on average any given
600-bp window with a Tn decreased its abundance over time,
usually to less than 0.001% of the B. cellulosilyticus WH2 pop-
ulation. Only 5–10% of the windows other than the cI-rha
intergenic region exhibited any enrichment over time, with less
than 0.1% of the windows reaching levels >1% of the population
(Fig. S9B). However, all of these other enrichments occurred
11 d or more following gavage when the bacterial host pop-
ulation was recovering from prophage induction (Fig. S9B).
Importantly, strains with the Tn-containing cI-rha intergenic
region selected for before and during prophage 1 induction
subsequently maintained high relative abundance (∼4%) in the
B. cellulosilyticus population in both the live and heat-killed
p-VLP treatment groups (Fig. S9B).
These results indicate that prophage 1 induction is restricted
in time (i.e., nonrecurring over the course of the experiment) and
insensitive to the attack of other members of the artificial com-
munity by exogenous human fecal phage. Together, the data
demonstrate how disruption of an intergenic region, located just
upstream of the predicted OR region that functions as a switch
between lysogenic and lytic cycles in other lambda phages, and
between a putative repressor and antiterminator, is capable of
conferring a fitness advantage to its bacterial host strain before
and independently of prophage induction.
Prospectus. Gnotobiotic mice containing defined consortia of
sequenced human gut bacterial symbionts provide a tractable
system that is more realistic than in vitro approaches for char-
acterizing phage–bacterial host dynamics. These mice disclosed
that: (i) a deliberately executed phage attack with a mixture of
diverse human phages did not result in a simultaneous attack of
all susceptible members of the artificial human gut microbiota,
but rather was manifested by a succession of changes in the
abundance of a subset of its bacterial taxa; (ii) phage resistance
can occur through an ecological or epigenetic mechanism (i.e.,
without changes in bacterial CRISPR elements or bacterial
genes encoding cell surface markers); (iii) one phage that was
widely distributed among the five human donors but only
reached low abundance in mice exhibited variations in its ge-
nome sequence in gnotobiotic animals over time, raising the
possibility of red queen dynamics in this case; and (iv) prophages
contain important in vivo fitness determinants for their host strains;
these determinants can reside in regulatory regions responsible for
prophage induction (as illustrated by B. cellulosilyticus WH2).
The model gut microbial community that these animals har-
bored was remarkably resilient with several fold changes in the
relative abundance of different taxa occurring for only brief
periods of time. Nonetheless, the identified targets of phage at-
tack (B. caccae and B. ovatus) did not fully return to preattack
levels in the artificial community or to levels seen in mice re-
ceiving the heat-killed p-VLPs that were sampled at corre-
sponding time points, suggesting modest long-lasting effects. The
transient nature of the changes in community structure observed
after p-VLP attack, and the fact that prophage induction was
modest in most bacterial hosts, support the view that the phage–
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Fig. 2. Prophage induction in B. cellulosilyticus
WH2. (A) VLP-derived sequencing reads from
mouse fecal samples mapped to a 150-kbp fragment
of the B. cellulosilyticus WH2 genome containing
prophage 1. The y axis corresponds to the log (10) of
the read coverage (blue) for a given position in the
prophage genome. Mapping VLP reads to the bac-
terial genome identified the prophage insertion site
at an arg-tRNA gene, with the corresponding du-
plicated region generating the attachment (att)
sites. No reads were obtained from potential cos
sites (red arrow, zoomed-in fragment). (B–D) Rela-
tive abundance (mean ± SEM) of the bacterial host
and its prophage in the fecal microbiota of in-
dividually caged mice. Relative abundance was
measured based on the ratio of COPRO-Seq reads
mapping to each prophage and elsewhere in the
bacterial genome. Bacterial relative abundance was
scaled to its community relative abundance (Fig. S3B);
prophage abundance was also scaled accordingly.
Equivalent abundances correspond to phage in an
uninduced state, whereas relative increases in pro-
phage abundance indicate induction.
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bacterial host dynamic in this simplified defined gut ecosystem is
predominately temperate rather than lytic (4).
Our findings extend previous work analyzing the dynamics of
well-characterized T4 and T7 phages in gnotobiotic mice mon-
ocolonized with Escherichia coli, where their in vitro behavior
was a very limited predictor of their in vivo behavior (26). Using
a more complex defined microbiota, we also observe a diverse
range of viral dynamics: (i) exogenous viruses rising in abundance
soon after their introduction (with a corresponding decrease in
abundance of their putative bacterial hosts) followed by depletion
of these viruses from the community without any obvious trace of
genetic resistance or adaptation; (ii) exogenous viruses that sur-
vive at undetectable levels for almost a week before increasing
their abundances, and in one case, displaying genetic variability
over time; and (iii) basal levels of induction of 10 prophages with
only one prophage achieving a level that produced detectable al-
teration in the abundance of its bacterial host. Duerkop et al. also
showed that prophage induction differed in vitro and in vivo, and
how under the appropriate conditions induction could provide
a fitness benefit to the bacterial host (27), further highlighting the
importance of a temperate lifestyle in the gut, and why prophages
are so widely distributed in gut bacterial genomes without neces-
sarily being induced at significant levels. Our findings are also
consistent with the previous finding that T7 phages are capable of
surviving at undetectable levels for 1 wk in germ-free animals
before they rise in abundance after gavage of a bacterial host (26);
this capacity to maintain infectivity has potential implications for
preventive phage therapy.
We envision a future where gnotobiotic mouse models allow
“personalized” assessment of phage–bacterial interactions. Com-
plex mixtures of VLPs, isolated from previously frozen fecal
samples obtained from human donors representing various ages,
physiological or disease states, or geographical regions/cultural
traditions of interest, can be introduced into recipient mice har-
boring a defined collection of human gut community members.
The community can be used as a “filter” to identify and assemble
the genomes of phages present in the human donor viromes and
link them to bacterial hosts. Miniaturization of methods for pre-
paring VLPs from mouse fecal pellets provides a way for purifying
these phages and at the same time verifying that they have lytic
activity. The system is capable of distinguishing very closely related
virotypes present in multiple human gut microbiota based on their
differential ability to establish themselves in recipient gnotobiotic
mice. These attributes not only provide a discovery pipeline that
complements metagenomic surveys of the human gut virome by
identifying phages “buried” in large gut microbiome datasets, but
facilitate identification of phages that can be used as experimental
tools to deliberately manipulate model microbial communities or
that can be considered as candidate therapeutic agents.
Methods
Protocols for the recruitment of human subjects and sampling of their fecal
microbiota were approved by the Washington University Human Research
Protection Office. All experiments involving mice were performed with pro-
tocols approved by the Washington University Animal Studies Committee.
Procedures for gnotobiotic mouse husbandry, introduction of VLPs purified
from human fecal samples into mice, sampling fecal microbiota from gno-
tobiotic mice, isolation of total DNA from mouse feces and intestinal con-
tents, quantification of microbial cells in fecal samples by flow cytometry,
preparation of DNA libraries for Illumina HiSeq or MiSeq sequencing, prepa-
ration of VLP DNA from mouse fecal samples, 454 pyrosequencing of VLP-
derived DNA, COPRO-Seq analysis, assembly and annotation of viral genomes,
cross-contig comparisons, INSeq analysis of fitness determinants present in the
B. cellulosilyticusWH2 prophage, PCR quantification of B. caccae abundance in
the fecal microbiota of gnotobiotic mice, CRISPR analysis, PCR determination
of Tn insertions in uninduced and induced B. cellulosilyticusWH2 prophage 1,
in vitro induction of B. cellulosilyticus WH2 prophages, and in vitro assays for
bacterial host tropism of phages represented in the pooled human fecal VLP
preparation are described in SI Methods.
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SI Methods
Gnotobiotic Mouse Husbandry. Germ-free mice belonging to the
C57BL/6J inbred strain were maintained in plastic gnotobiotic
isolators under a strict 12-h light/dark cycle and fed a standard,
autoclaved, low-fat, plant polysaccharide-rich chow diet (B&K
Universal) ad libitum. Three groups of age-matched germ-free
animals (n = 5 per group) were individually caged in three sep-
arate isolators. At ∼8 wk of age, mice from two groups were
colonized with a single gavage of 300 μL of supplemented tryp-
tone, yeast extract, glucose (TYG) medium (1) representing 15
sequenced human gut-derived bacterial taxa pooled from mon-
ocultures (∼6 × 108 cfu per strain). One of the 15 strains, Bac-
teroides cellulosilyticus WH2, was represented as a library of
93,550 isogenic transposon mutants (see INSeq analysis below).
Introduction of Virus-Like Particles Purified from Human Fecal Samples
into Gnotobiotic Mice. Five frozen de-identified fecal samples from
healthy adult humans were selected for isolation of virus-like
particles (VLPs). These fecal samples had been collected pre-
viously as part of a study of the viromes of four healthy adult
monozygotic twin pairs and their mothers (2). Recruitment and
sampling of these individuals over the course of 1 y had been
performed using a protocol approved by the Washington Uni-
versity Human Research Protection Office (2).
We chose those fecal samples from individuals in three families
whose viromes together encompassed the broadest range of di-
versity present among the 32 samples in our collection (i.e.,
F3T1.2, F4T1.2, F2T1.2, F2M.2, F4T2.2, where FX = family
number; TX = co-twin identifier; and .X = time point). A 2- to 3-
g aliquot of each frozen sample was resuspended by vortexing in
10 mL of saline magnesium (SM) buffer [100 mM NaCl, 8 mM
MgSO4, 50 mM Tris (pH 7.5), and 0.002% (wt/vol) gelatin;
sterilized by passage through a 0.02-μm pore diameter filter
(Anotop 10; Whatman)]. The suspension was centrifuged at
2,500 × g at 4 °C for 10 min to pellet large particles and bacteria.
The supernatant was then passed twice through a 0.45-μm di-
ameter Sterivix-HV filter (Millipore). A 20-μL aliquot of a 1:10
dilution of the resulting filtrate containing VLPs was used to
confirm the absence of bacterial cells and for viral particle enu-
meration using SYBR Gold and fluorescence microscopy (yield =
3.77 ± 2.79 × 109 VLP/g frozen fecal sample; n = 5 samples).
Aliquots (1.2 mL) from each of the five VLP preparations were
pooled and the remaining sample stored at 4 °C in 0.1 volumes of
chloroform. The p-VLPs were split into three 2-mL aliquots. One
of the aliquots was further subdivided into 100-μL volumes and
heat-killed by incubation at 95 °C for 15 min followed by DNase
treatment for 1 h (10 units of DNase Baseline Zero; Epicentre).
Three weeks after bacterial gavage, mice were gavaged with the
pooled, human-derived VLPs. To ensure that the gastric pH
would not affect the viability of the viral particles, mice were
fasted for 12 h. Each mouse was then gavaged with 100 μL of 1 M
NaHCO3 to keep gastric pH at 7.4 (3) followed 10 min later by
300 μL of the VLP pool (3.28 × 108 p-VLPs, either live or heat-
killed, per animal).
Sampling the Fecal Microbiota of Gnotobiotic Mice. Fecal samples
were collected at the time points shown in Fig. S1. Fecal samples
dedicated to VLP purification were collected at least once per
week. Samples were placed in 1.7-mL screw cap tubes immedi-
ately after they were produced by the animal and stored at −80 °C
until further processing. After mice were killed, the small in-
testine was subdivided into two segments of equal length. Con-
tents from the proximal and distal segments, plus contents
obtained from the cecum and colon, were snap frozen in liquid
nitrogen and stored at −80 °C.
Isolation of Total DNA from Mouse Feces and Intestinal Contents.
Microbial community DNA was extracted in a semiautomated
96-sample format. Starting with a single fecal pellet (30–70 mg) or
70–400 mg of frozen intestinal contents (e.g., from the cecum),
material was transferred to a 1.7-mL screw cap tube containing
250 μL of sterile 0.1 mm zirconia beads (BioSpec Products), and
a steel ball (3.97 mm diameter). Using a Tecan Genesis series
robot (Tecan), 800 μL of a 500:210 mixture of 2× buffer A (200
mM NaCl, 200 mM Tris, 20 mM EDTA) and 20% SDS were
added, followed by 563 μL of phenol:chloroform:isoamyl alcohol
(25:24:1; Ambion). The tubes were capped, mixed using a Bio-
Spec Minibeadbeater-96 (4 min), and then centrifuged at 3,200 × g
for 4 min. A total of 480 μL of the aqueous phase from each
sample was subsequently transferred to an Axygen P-DW-11-C
96-well plate with the Genesis series robot. Using the Biomek FX
laboratory automation workstation (Beckman Coulter), 180 μL of
the stored aqueous phase was transferred along with 720 μL of
a 675:45 mixture of Qiagen buffer PM and 3 M sodium acetate
(pH 5) to a QiaQuick 96 plate stacked on a Nunc 260251 plate.
After mixing 10 times by pipetting, the plate was centrifuged at
3,200 × g for 4 min. The plate was washed twice with Qiagen PE
buffer (900 μL per well) and centrifuged at 3,200 × g for 2 min.
Following another centrifugation step to remove leftover ethanol,
the multiwell plate was placed on a vacuum manifold to remove
residual liquid from the membranes. To elute the DNA, 100 μL of
buffer EB (Qiagen) was added to each well, and the plate was left
standing for 2 min before centrifugation at 3,200 × g for 2 min.
Purified DNA and leftover aqueous phase were stored at −20 °C.
DNA concentration was measured using the Qubit Quant-IT
dsDNA BR protocol as recommended by the manufacturer (Life
Technologies).
Quantifying Microbial Cell Counts in Fecal Samples by Flow Cytometry.
To quantify the number of microbial cells per fecal pellet and to
compare the results with fecal DNA yields, we used the Bacteria
Counting kit (B7277; Life Technologies) and the manufacturer’s
protocol, with some modifications. In brief, each frozen fecal
pellet was weighed and transferred to a sterile 2-mL screw cap
tube; 500 μL of sample buffer [10mM TrisHC1, 1mM, EDTA
(1×TE), 0.9% wt/vol NaCl] was added, and the pellet was re-
suspended by vortexing for 5 min. The slurry was allowed to settle
for 5 min at room temperature and a 10-μL aliquot of the clarified
supernatant was transferred to a new tube. The remaining sus-
pension was stored at −20 °C for extraction of total community
DNA. Serial dilutions of the clarified sample were performed to
a final dilution of 1:10,000 in 200 μL of sample buffer containing
1× SYTO BC dye and the kit’s standard counting control beads at
a concentration of 250 beads/μL. The sample was then passed
through a nylon mesh (60-μm pore diameter) to remove large
particles that could potentially clog the cytometer [note that the
control beads (6-μm diameter) are larger than bacterial cells and
the number of beads present was not affected by passage through
the nylon mesh]. The flow-thru was then split into three equal
parts and each replicate was counted for 1 min in the Cytomics FC
500 MPL low cytometer (Beckman Coulter). Forward and side
scatter data were collected along with fluorescence data in the
525-nm channel. Gates were drawn on the total bacterial cell
population, the SYTO BC positive population, and the control
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beads. Quantifying the control beads allowed us to calculate the
number of bacterial cells (positive fluorescent cells) per milligram
(wet weight) of fecal material.
To extract DNA from these samples, we added zirconia and
steel beads to the resuspended pellet described above, along with
300 μL of extraction buffer (118 mM NaCl, 435 mM Tris, 44 mM
EDTA, 547 mM SDS), so that the final concentration of com-
ponents was equivalent to 2× buffer A (see above) and 20%
SDS. At this point, the protocol for extracting total community
DNA was performed exactly as described above.
Preparation of DNA Libraries for Sequencing on Illumina Instruments
(HiSEq 2000 orMiSeq).One hundred microliters of total community
DNA in TE buffer (pH 7.0; 5 ng/μL), was fragmented by soni-
cation in thin-walled 0.2-mL 8-strip PCR tubes using a Bio-
ruptorXL multisample sonicator (Diagenode) set on “high”;
sonication occurred over the course of 20 min using successive
cycles of 30 s “on” followed by 30 s “off.” Sonicated samples
were subsequently cleaned up using the MinElute 96 UF PCR
Purification kit (Qiagen) per the manufacturer’s instructions.
Each sonicated DNA sample in each well of the 96-well plate
was eluted with 22 μL nuclease-free sterile water. For end repair
and A-tailing, 20 μL of sonicated DNA was mixed with 5 μL of
a mixture containing 2.5 μL of 10× T4 DNA ligase buffer (NEB),
1 μL of 1 mM dNTPs (NEB), and 0.5 μL of each of the following
enzymes: T4 polymerase (3 units/μL; NEB), T4 polynucleotide
kinase (10 units/μL; NEB), and Taq polymerase (5 units/μL; Life
Technologies). The solution was mixed by vortexing and then
incubated for 30 min at 25 °C followed by 20 min at 75 °C.
Customized Illumina adapters containing maximally distant 4- to
6-bp barcodes (Dataset S1) were ligated to the A-tailed DNA in
a 27-μL reaction by adding 1 μL of 25 μM adapter mix plus 1 μL
of T4 DNA ligase (2,000,000 units/mL; NEB). Adapter mix was
prepared by mixing 12.5 μL of a 100-μM stock of each adapter
oligo (constituting the forward and reverse strands) and 25 μL of
oligo buffer (1× TE, 0.1 M NaCl), incubating the mixture at 95 °C
for 1 min, then slowly decreasing the temperature (0.1 °C per
second) until reaching 4 °C. After 30 min incubation at 16 °C, 2.5
μL of 50 mM EDTA was added to stop the ligation reaction. Sets
of 24 samples, all harboring different adapter sequences, were
pooled, and the pool was purified using MinElute PCR purifi-
cation columns according to the manufacturer’s instructions (fi-
nal elution volume, 15 μL). A 10-μL aliquot of the purified pool
was subjected to 2% agarose gel electrophoresis. DNA (∼200
bp) was excised and purified using the QIAquick Gel Extraction
kit and MinElute purification columns (Qiagen; final elution
volume, 12 μL). Finally, 1 μL of the size-selected library was used
as the template in an enrichment PCR [19 cycles of 98 °C for 10 s,
67 °C for 30 s, and 72 °C for 30 s, using Phusion HF Master mix
(NEB) and Illumina’s standard amplification primers (Dataset S1)
in a final volume of 25 μL]. The PCR product was purified using
MinElute PCR purification columns and DNA was quantified
using the Quant-iT dsDNA High-Sensitivity (HS) Assay kit (Life
Technologies). Library concentrations were then normalized, and
an equimolar pool was subjected to multiplex sequencing with
either an Illumina HiSEq 2000 or MiSeq instrument (2.5 pM/lane).
Preparation of VLP DNA fromMouse Fecal Samples.VLP purification
and DNA extraction were performed as described previously (2),
with some modifications. Because a single mouse fecal pellet had
too little viral mass for efficient viral purification, pairs of fecal
pellets obtained from either one or two mice in a given treatment
group at the same time point (30–100 mg) were resuspended in
400 μL of SM buffer (filter-sterilized, 0.02-μm pore diameter;
Whatman). After homogenization by vortexing for 5 min, sam-
ples were centrifuged twice at 2,500 × g for 10 min at 4 °C to
remove large particles and bacterial cells. The resulting super-
natant was filtered once through a 0.45-μm pore diameter Millex
filter (Millipore) and twice through 0.22-μm pore diameter
Millex filters (Millipore). The volume of the filtrate was adjusted
to 200 μL with SM buffer if needed. Each sample was treated
with 20 μL of lysozyme (100 mg/mL) for 30 min at 37 °C, fol-
lowed by incubation for 10 min with 0.2 volumes of chloroform.
The sample was then centrifuged at 2,500 × g for 5 min at room
temperature. The aqueous phase was collected and incubated
with 3 units of DNaseI (Sigma) and 20 μL of 10× DNase buffer
(50 mM MgCl2, 10 mM CaCl2) for 1 h at 37 °C, after which time
enzyme activity was inactivated by incubation at 65 °C for 15 min.
To isolate DNA, VLPs were incubated with 10 μL of 10% SDS
and 1 μL of proteinase K (Sigma, 20 mg/mL) for 20 min at 56 °C,
after which 35 μL of 5 M NaCl and 28 μL of 10% (wt/vol) ce-
tyltrimethylammonium bromide (CTAB)/0.7 M NaCl were added,
followed by incubation at 65 °C for 10 min. The sample was then
mixed with an equal volume of phenol:chloroform:isoamyl alcohol
(25:24:1), vortexed, and centrifuged at 8,000 × g for 5 min at room
temperature. The resulting aqueous phase was mixed with an equal
volume of chloroform and spun at 8,000 × g for 5 min at room
temperature. The resulting aqueous phase was passed through a
Qiagen MinElute purification column (elution volume, 30 μL).
Multiple displacement amplification (MDA) was performed
with Illustra GenomiPhi V2 (GE Healthcare Life Sciences),
according to the manufacturer’s instructions [n = 4 independent
reactions/sample to prevent single amplification bias; reactions
were subsequently pooled and the DNA product was purified
using a Qiagen DNeasy purification kit (elution volume, 75 μL)].
The 454 Shotgun Pyrosequencing of VLP-Derived DNA.Libraries were
generated for 454 shotgun pyrosequencing using a protocol
similar to that used for the Illumina libraries. The protocol dif-
fered slightly in that sonication was performed for 8min instead of
20 min. Each library was purified using Agencourt AMPure XP
beads (Beckman Coulter) and quantified using the recommended
454 rapid library barcoded fluorescent-labeled adapters and
a plate reader (Synergy2; Biotek). A total of 24 independent
adapters were synthesized containing 24 different multiplex
identifier (MID) barcodes. After quantification, normalized pools of
24 samples were sequenced using 454 FLX Titanium chemistry.
Initial quality filtering of the raw data consisted of parsing the se-
quenced reads by their MID followed by removal of short reads
(fewer than 60 nt), reads with three or more ambiguous (“N”) bases
anywhere in the sequence, reads with two continuous N bases, and
replicate reads (reads where the first 20 nt were >97% identical).
Community Profiling by Sequencing Analysis Pipeline.A combination
of preexisting stand-alone software and custom Perl scripts were
used for performing community profiling by sequencing (COPRO-
Seq) analysis in a high-performance computing environment run-
ning Sun Grid Engine. For raw Illumina reads, sequences were
demultiplexed using the 4-bp barcode at the beginning of each read.
The short barcode lacks the complexity required for error correction.
However, with low error rates at the beginning of Illumina reads and
a Hamming distance between any two barcodes of at least 2, re-
quiring a perfect match to a barcode sequence allowed us to
efficiently and accurately assign the reads to specific samples.
After dividing the sequences by sample, we were able to run the
downstream analysis in parallel. This downstream processing
consisted of first screening for adapter sequences that indicated
the presence of either short inserts or adapter dimer [screening
was performed using Cross_match (version 1.090518; www.
phrap.org) with slight modifications to the default parameters
(-gap1_only -minmatch 6 -minscore 10 -gap_init -3 –screen)].
Next, reads were either trimmed back when an adapter sequence
was seen or removed entirely in the event that (i) the sequence
was shorter than 35 nt after removing the adapter sequence, or
(ii) more than three N’s were found anywhere in the read. The
“clean” reads were used to query the 15 sequenced bacterial
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genomes represented in the artificial community, as well as their
predicted prophages, using FR-HIT v.0.7 (4) with default pa-
rameters except that the minimum percent identity was set to
90% (-c 90). The mapping file was parsed as described pre-
viously (5). In particular, reads mapping uniquely to a single
genome were used to determine relative abundances. Sub-
sequently, exact ties or reads mapping equally to more than one
genome were weighted, based on the relative abundance of the
genomes involved. Raw counts were then normalized to reads/
kb/million mapped reads. Reads that did not map to any bac-
terial genome were then mapped against other known plasmids
from these bacterial species, PhiX174 (used as the internal
control on the Illumina sequencer) and to the reference mouse
genome. All remaining reads were used for de novo hybrid as-
sembly to identify exogenous viruses (see below).
Normalized counts for the different bacterial species and
virotypes present in each sample were used to calculate relative
abundances or genome equivalents (GE; the latter by normalizing
the percentage of mapped reads to the length of the genome and
the DNA yield/sample). Matrices of either relative or absolute
abundances were generated for principal coordinates analysis
(PCoA) and generation of 3D plots using scripts in QIIME
(version 1.3.0-dev; ref 6). Statistical analysis and figure genera-
tion were performed in Prism (v6).
Assembly and Annotation of Exogenous Viral Genomes. Reads gen-
erated from either VLP-derived DNA (454 FLX pyrosequencer
using titanium chemistry) or from total community DNA (Illu-
mina HiSEq. 2000 instrument) that did not map to any of the
reference genomes were pooled together and submitted for
a hybrid assembly using MIRA V3.4.0 (7) with minimum overlap
of 70 nt (454) or 20 nt (Illumina) and a minimum relative score
of 90%. Note that raw data from 454 pyrosequencing of VLPs
were parsed with essentially the same pipeline used for Illumina
reads except for the adapter-mapping step that is incorporated
by default in 454 sfftools. Given that 454 FLX reads are longer
than Illumina reads, FR-HIT parameters used were 90 for per-
cent similarity (-c) and 40 for minimal length of the alignment
(-m). A de novo assembly was performed for the first round.
After assembly, contigs were analyzed individually using Tablet
v.1.12.09.03 (8) to identify potential chimeras in the assembly,
and checked using blastn for overlapping ends either within
contigs (indicating a complete, circular phage genome) or be-
tween contigs (indicating a potential link between two contigs).
Raw reads were then mapped to the contigs using mapping-
based assembly in MIRA, which allows extension of previously
assembled contigs via the incorporation of new reads at the
edges of these contigs. The process was repeated five times,
yielding in the final iteration a total of five large circular contigs
covering most of the nonmapped reads from both the 454 and
Illumina datasets. These exogenous viral genomes were used in
conjunction with the reference bacterial genomes as an updated
reference dataset for analysis of the relative abundances of the
viruses and host bacteria (from the VLP and total fecal com-
munity DNA shotgun sequencing datasets).
The five viral genomes were annotated first with Glimmer v3.02
(9) trained on all ORFs predicted from viral ref_seq (National
Center for Biotechnology Information, NCBI). Predicted ORFs
were then blasted (blastp; threshold <10−5, no low redundancy
filter) against COG (STRING v9.0), KEGG (v58), ACLAME
(v0.4), CDD (online Batch CD-search), NCBI nr (retrieved 13/
08/2012), and Phantome (retrieved 01/09/2012).
Cross-Contig Comparison.To determine which human donors were
the source of the viral genomes assembled from the mouse fecal
VLP and COPRO-Seq datasets, we first retrieved FASTA files of
pyrosequencing datasets that we had previously generated from
each of the five purified human donor VLP DNA preparations
used to create the input pool for ourmouse experiments (GenBank
ID SRX028824; ref 2). The sequences were pooled together with
454 FLX titanium sequences obtained from the p-VLP input
(71,546 reads). The assembly pipeline consisted of the following
steps: (i) CD-HIT v4.6 (10) was used to cluster reads at 90%
global identity from each cluster and the top five sequences were
taken as representatives; (ii) these reads were used for de novo
assembly using Newbler v2.6 (454 Life Sciences) with default pa-
rameters; (iii) FR-HIT was used to map all raw reads to the as-
sembled contigs at 90% identity; (iv) reads that did not map were
pooled and reassembled using Newbler; (v) contigs >500 bp after
both rounds of assembly were pooled together along with se-
quences from the five previously undescribed viral genomes and
all raw reads were mapped using MIRA in mapping assembly
mode, which allows for extension at the edges of contigs; (vi) the
extended contigs were assembled using Phrap; (vii) the Phrap
output files “contigs,” “singlets,” and “problems” were concate-
nated, renamed, and used to map the reads using FR-HIT; (viii)
chimeras were identified as sudden drops in coverage given by the
FR-HIT mapping (contigs were split at these chimeric junctions);
(ix) contigs were sorted by size and the program Megablast was
then used to compare “all-against-all” and to identify contigs that
were fully contained within another contig and contigs with over-
lapping ends; and (x) the final set of contigs over 2 kbp was used as
a reference set for mapping (FR-HIT) all raw reads from each of
the fecal VLP-derived viromes from each of the individual human
fecal samples used to generate the input pooled (p)-VLPs for the
staged viral attack, the p-VLPs used to gavage the mice, and mouse
fecal VLP DNA. A matrix of reads per kilo base pair of contig
sequence per million reads of sample was generated. The matrix
was then log transformed, and a heat map was built using R (11).
INSeq Analysis of Fitness Determinants Present in the B. cellulosilyticus
WH2 Prophage. Whole genome transposon mutagenesis of B. cel-
lulosilyticus WH2 was performed using protocols described in
earlier publications (1, 12). Total fecal community DNA was
isolated from fecal pellets obtained from mice belonging to the
live and heat-killed VLP treatment groups at time points between
3 and 13 d after they had received a single gavage of this library of
93,550 transposon mutants together with the other bacterial
members of the defined community. Each DNA sample was ad-
justed to 500 ng in 15 μL of TE buffer and then digested with
MmeI (4 units; NEB) in a 20-μL reaction supplemented with
10 pmol of a 12-bp DNA with an MmeI restriction site (to im-
prove the efficiency of restriction enzyme digestion; ref. 1). The
reaction was incubated for 1 h at 37 °C and then terminated (80 °C
for 20 min). MmeI-digested DNA was subsequently purified using
125 μL of AMPure beads [after washing the beads once with
100 μL of sizing solution (1.2 M NaCl and 8.4% PEG 8000)]. The
digested DNA was added to the beads and the solution incubated
at room temperature for 5 min. Beads were pelleted with a mag-
netic particle collector (MPC), washed twice [each time using
a mixture composed of 20 μL TE (pH 7.0) and 100 μL sizing
solution, with bead recovery via MPC after each wash], followed
by two ethanol washes (180 μL 70% ethanol per wash) and air
drying for 10 min. Samples were resuspended in 18 μL TE (pH
7.0) and the DNA was removed after pelleting beads with the
MPC. Ligation of adapters was performed in a 20-μL reaction that
contained 16 μL of purified DNA, 1 μL of T4 ligase (2,000 units/
μL; NEB), 2 μL 10× ligase buffer, and 10 pmol of barcoded
adapter (incubation for 1 h at 16 °C). Ligations were subsequently
diluted with TE buffer (pH 7.0) to a final volume of 50 μL, mixed
with 60 μL of AMPure beads, and incubated at room temperature
for 5 min. Beads with bound DNA were pelleted using the MPC
and washed twice with 70% ethanol as above. After allowing the
ethanol to evaporate for 10 min, 35 μL of nuclease-free water was
added and the mixture was incubated at room temperature for
2 min before collecting the beads with the MPC. Enrichment PCR
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was performed in a final volume of 50 μL using 32 μL of the
cleaned up sample DNA, 10 μL 10× Pfx polymerase buffer, 2 μL
10 mM dNTPs, 0.5 μL 50 mMMgSO4, 2 μL of 5 μM amplification
primers (forward primer: 5′ CAAGCAGAAGACGGCATACG 3′
and reverse primer: 5′AATGATACGGCGACCACCGAACAC-
TCTTTCCCTACACGA 3′), and 1.5 μL Pfx polymerase (2.5 units/
μL; Life Technologies) and 22 cycles of denaturation at 94 °C for
15 s, annealing at 65 °C for 1 min and extension at 68 °C for 30 s.
The 134-bp PCR product from each reaction was purified [(4% (wt/
vol) metaphore gel; MinElute gel extraction kit; Qiagen)] in a final
volume of 20 μL, and was quantified (Qubit, dsDNA HS assay kit;
Life Technologies). Reaction products were then combined in
equimolar amounts into a pool that was subsequently adjusted to
10 nM and sequenced (Illumina HiSEq 2000 instrument).
Illumina 50-nt short reads were separated by sample using 4- or
7-nt sample-specific barcodes. The remaining read contains either
the 5′ or 3′ end of the transposon (Tn) sequence along with 16–
17 nt of flanking genomic DNA. After trimming the Tn se-
quences, reads were mapped to the B. cellulosilyticus WH2 ge-
nome, allowing up to a 1-nt mismatch. The read counts derived
from mapping the 5′ or 3′ termini of the transposon were sum-
med, and a normalized count of reads per million for each in-
sertion position was generated. For the sliding window analysis,
normalized read counts were added up for every 600-bp window
throughout the reference genome, while sliding the window in
increments of 100 bp. The final distribution of counts per win-
dow for any given sample obtained at any given time point was
analyzed using the quantile function on R (11) to determine the
different abundance levels. Final plots of the quantiles over time
were generated using Prism (v6).
PCR Quantification of Bacteroides caccae Abundance in the Fecal
Microbiota of Gnotobiotic Mice. B. caccae abundance was evalu-
ated using total fecal community DNA isolated from samples
obtained 22 or 23 d after gavage of the 15-member artificial
community (i.e., 2 and 3 d following gavage with p-VLPs). Pu-
rified B. caccae genomic DNA was used to generate a standard
curve. The standard curve and amplification plots for the sam-
ples, generated employing the PCR primer set dpg_11 (Dataset
S1), were used to calculate the number of genome copies per
milligram of fecal pellet obtained at each selected time point from
members of both the live and heat-killed p-VLP treatment groups.
Clustered Regularly Interspaced Short Palindromic Repeats Analysis.
The genome sequences of the bacterial species introduced into
gnotobiotic mice were searched using the program CRISPRFinder
(Clustered Regularly Interspaced Short Palindromic Repeats
Finder) (13). All Illumina HiSeq reads generated for COPRO-
Seq analyses of fecal DNA samples collected throughout the
course of the experiment from all animals that received p-VLPs
were screened for CRISPR repeats using tre-agrep (v0.8) for
fuzzy string matching. Any read covering the repeat with three
or fewer mismatches was retrieved for each CRISPR locus we
had identified (Dataset S1). Cross_match was subsequently
used to screen each locus for all individual spacer sequences.
The number of reads mapping per spacer was then scored.
Accumulation of new spacers should be identifiable as se-
quences without similarity to known spacers but present at
abundances similar to known spacers. Therefore, reads map-
ping to the repeat but not to the spacer were separated and
clustered at 90% identity using CD-Hit-est (after masking for
known repeat and spacers). The size of the cluster should be
indicative of the relative abundance of the novel spacer. In
every case, >85% of the sequences were present as singletons at
an abundance that was below the average for known spacers,
and within what would be expected for sequencing artifacts (SI
Results and Dataset S1).
PCR Determination of the Tn Insertions in Uninduced and Induced
B. cellulosilyticus WH2 Prophage 1. Total DNAs from mouse 1
(M1)–M4 plus M7 (negative control) isolated 2–13 d after ga-
vage of the 15-member bacterial consortium were used to con-
firm the presence and enrichment of Tn insertions at one of the
10-distinct locations identified within the ∼600-bp cI-rha inter-
genic region (Fig. S9A, black arrow). Primers were designed to
anneal to: (i) the prophage sequence at the insertion site (primer
“Intergenic F” in Dataset S1); (ii) the junction between the Tn
and the prophage at the insertion site (primer “Intergenic + Tn F”
in Dataset S1); (iii) the host bacterial genome 165 bp upstream of
the att site, outside of the prophage (primer “Genome R” in
Dataset S1); (iv) putative phage integrase, 117 bp downstream of
the att site, inside the prophage region (primer “Integrase R” in
Dataset S1). PCRs were fashioned so that amplification with any
combination of primers would yield products of approximately the
same size (∼2,300 bp). The combination of primers Intergenic
F and Genome R functioned as a positive control, amplifying
uninduced prophages whether or not they contain a Tn insertion.
Primers Intergenic F and Integrase R should only yield products
when there was recombination at att sites. A product obtained with
primers Intergenic + Tn F and Genomic R would indicate that
a Tn insert was present in the prophage, whereas products ob-
tained with Intergenic + Tn F and Integrase R would indicate that
the Tn was present in induced phages. Amplifications were per-
formed in 25-μL reaction mixtures that contained 1× Platinum Taq
HiFi PCR buffer (Life Technologies), 0.3 μM PCR primers, 2 mM
MgSO4, 0.2 mM dNTPs, 0.1 mg/mL BSA, 0.01% Tween 20, 0.5 M
betaine (Sigma-Aldrich), 0.02 units/μL Platinum Taq (Life Tech-
nologies), and total fecal community DNA (10 ng). Amplification
was performed using 30 cycles of denaturation at 94 °C for 30 s,
annealing at 54 °C for 1 min, and elongation at 68 °C for 2 min.
In Vitro Induction Assay of B. cellulosilyticus WH2 Prophages.
B. cellulosilyticus WH2 was inoculated in 5 mL of TYG me-
dium. The culture was allowed to grow overnight at 37 °C under
anaerobic conditions. Aliquots were taken and diluted 1:100 into
seven tubes containing 5 mL each of TYG medium. These cul-
tures were grown until they reached early log phase (OD600 = 0.1)
before adding a commercial brand of soy sauce [Kikkoman; 1:10
or 1:50 dilution (vol/vol)], or mitomycin C (Sigma; final concen-
tration, 0.2 μg/mL or 1 μg/mL), or hydrogen peroxide (Sigma; final
concentration 0.0025% or 0.005%). Control cultures contained no
additions. All cultures were incubated at 37 °C until the no-
treatment control reached late log phase (OD600 = 1). At this
point, bacterial cells were pelleted by centrifugation (3,000 × g,
10 min at 4 °C), the resulting supernatant was filtered through
a 0.22-μm pore diameter filter and viral particles and nucleic acids
were precipitated by adjusting the filtrate to 0.5 M NaCl, 10%
PEG-8000, and incubating at 4 °C for 16 h. The solution was
centrifuged at 18,000 × g for 30 min at 4 °C, and the resulting
pellet was resuspended in SM buffer (2). DNA was extracted from
viral particles, MDA was performed, and the resulting DNA
subjected to shotgun sequencing as described above (MiSeq, sin-
gle-end 76-nt-long reads).
In Vitro Assays for Bacterial Host Tropism of Phages Represented in
the Pooled Human Fecal VLP Preparation. The following procedure
was performed for each of the 14 members of the artificial
community (of the two Bacteroides thetaiotaomicron strains
present, only VPI-5482 was characterized). Initial cultures were
started from frozen stocks in supplemented TYG medium
(TYGs; ref 1) and incubated overnight at 37 °C in prereduced
Balch tubes under anaerobic conditions (20% CO2, 75% N2, and
5% H2). At midlog phase, each of the 14 monocultures was split;
one-half remained as a noninfected control used to follow the
growth of the other half of the culture, which was inoculated with
50 μL of the same p-VLP preparation that had been introduced
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into gnotobiotic mice. After a 5-h incubation, bacterial cells from
each culture that received the human p-VLP preparation were
pelleted (3,000 × g for 10 min at 4 °C). Fifty microliters of each
supernatant was used to inoculate a fresh midlog phase culture
of the corresponding bacterial species. These second round viral
enrichment cultures were processed following the same protocol
used for the first round. Precipitation of viral particles and iso-
lation of VLP DNA were performed exactly as described above
in Preparation of VLP DNA from Mouse Fecal Samples. Purified
DNA was subject to PCR amplification with five different sets of
primers designed to specifically anneal to each of the five pre-
viously undescribed viral particles identified in gnotobiotic mice
(Dataset S1). Moreover, each primer set was designed to gen-
erate a different length of amplicon. PCR was performed using
ThermoPrime 1.1× ReddyMix (Thermo Scientific; 1× final
concentration) with 10 pmol of primer mix, 2 μL of purified
DNA, and the following cycling conditions: initial denaturation
for 5 min at 95 °C followed by 30 cycles of 95 °C for 30 s, 50 °C
for 30 s, and 72 °C for 1 min. A second independent in vitro
liquid enrichment experiment for viral particles was performed
as described above with the exception that the VLP inoculum
was reduced fivefold and the incubation was extended from 5 h
to 16 h for each round of enrichment. Following MDA ampli-
fication, each of the VLP-derived DNA preparations was se-
quenced (Illumina MiSeq, single end, 78-nt-long reads).
SI Results
A Search for Fixed Mutations in the B. caccae Genome That Could
Potentially Confer Viral Resistance After the Staged Attack with
Pooled Human VLPs. Reads derived from total community shot-
gun sequencing that mapped to the B. caccae genome were se-
lected from fecal samples collected 11–21 d after introduction of
the 15-member artificial human gut bacterial community and 11–
25 d following p-VLP gavage. Reads were initially grouped into
four datasets: (i) live p-VLPs, pre-VLP gavage; (ii) live p-VLPs
post-VLP gavage; (iii) heat-killed p-VLPs; pre-VLP gavage; and
(iv) heat-killed p-VLPs post-VLP gavage. A mutation conferring
resistance should be fixed in the population represented in da-
taset ii. All of the reads from i to iv were pooled and used for
assembly in mapping mode (MIRA), while keeping track of the
dataset from which the reads originated. Thirty-fold coverage of
the genome was obtained on average from each dataset. We
identified no single nucleotide substitution specific to any given
dataset and fixed in over 10% of the B. caccae population (as
defined by the sequence coverage at a given nucleotide position).
A total of nine loci were identified where there was low or no
coverage in one of the four datasets, suggesting possible insertions
or deletions (InDels). These loci were selected after filtering for
repetitive regions that can mask true SNPs due to variation be-
tween the repeats and for regions with an overall coverage
(added for all four datasets) of less than 25-fold. We designed
a pair of PCR primers flanking each of the nine loci to amplify
a product between 270 and 370 bp (Dataset S1). DNA from each
of the five mice in each treatment group were selected as tem-
plates for the PCR: (i) fecal DNAs from all mice in the live p-
VLP treatment group that had been sampled on day 17 following
gavage with the 15-member artificial community (live p-VLP,
pre-VLP gavage group); (ii) fecal DNAs from all mice in this
treatment group prepared from samples obtained 21 d after viral
gavage (live p-VLP, post-VLP gavage group); (iii) fecal DNAs
from all mice from the heat-killed p-VLP treatment group
sampled 17 d postbacterial gavage (heat-killed p-VLP, pre-VLP
gavage group); and (iv) fecal DNAs from all mice in this heat-
killed p-VLP treatment group sampled 21 d after viral gavage
(heat-killed p-VLPs, post-VLP gavage group).
Amplifications were performed using PCR primers described in
Dataset S1. After amplification, a standard dissociation curve
was generated to assess the specificity of the amplification, fol-
lowed by a 10-min incubation at 68 °C to ensure that the amplified
products had an additional adenine at the 3′ terminus (A-over-
hang). PCR products were subsequently purified, quantified, and
pooled by treatment group and primer set (100 ng/sample). A
total of 500 ng of amplified DNA for each treatment group and
primer set was added to a ligation reaction mixture that contained
Illumina adapters (Dataset S1). The resulting adapter-ligated
DNAs were purified using AMPure beads as described in SI
Methods for the INSeq protocol, quantified, and a 4-ng aliquot was
used per treatment per primer set for enrichment PCR, as de-
scribed above for preparation of Illumina libraries. Barcoded
amplicons were subjected to 2% (wt/vol) agarose gel electropho-
resis to confirm their molecular weight and purified. After quan-
tification, the different products were pooled in equimolar
amounts and sequenced using an Illumina MiSeq instrument
(paired end, 250-nt reads). Sequencing reads were split by bar-
code; for each sample, reads were trimmed by quality and the
paired-end products were assembled using FLASH (14) (note that
assembly of the paired-end reads is expected under these con-
ditions because the largest PCR product is 370 bp and reads are
242 bp after removing the 8-bp barcode at each end of the am-
plicon). Even after quality trimming of the reads, overlaps >30 bp
were observed, allowing assembly of >80% of the data. Once the
amplicons were assembled, they were pooled with the reference
sequence and CD-Hit-est (10) was used to generate 100% iden-
tical clusters of sequences. A table of read counts per treatment
per cluster was generated; the percentages of reads in any cluster
that were different from the reference cluster never exceeded 5%
of the total reads, indicating that no single mutation was fixed in B.
caccae at the time points and conditions surveyed.
CRISPR Analysis. CRISPRs play a role in conveying resistance to
foreign DNA through a mechanism that involves accumulation of
spacers in the bacterial genome that map to short segments in the
invading DNA (15). Only six of the 15 bacterial species com-
prising our artificial community contained CRISPR regions;
five were members of the Firmicutes; the other, Parabacteroides
distasonis, is a member of the Bacteroidetes (Dataset S1). Our
analysis of the sequencing datasets indicated that none of the
CRISPR loci appeared to accumulate new spacer sequences
(Dataset S1). It is important to note that the number of reads that
contain a given CRISPR repeat will be proportional to the length
of the locus (number of spacers) and to the relative abundance of
the bacterial species in the artificial community. We could not
make any conclusions about CRISPR loci in Dorea longicatena
due to its low abundance throughout the experiment. For all other
species, except Clostridium spiroforme, the average number of
reads mapping to each individual CRISPR spacer was greater than
100 (Dataset S1). A newly incorporated spacer should be covered
with a similar or significant fraction of the read coverage of other
spacers. However, for all of the bacterial species analyzed, reads
with similarity to a CRISPR repeat but not to any given spacer,
cluster as singletons (i.e., >85% reads are singletons), suggesting
that they correspond to sequencing artifacts and not to accumula-
tion of novel spacers. Nonetheless, this finding has to be interpreted
cautiously because none of these bacterial species reached a rela-
tive abundance greater than 10% at any time point after p-VLP
gavage, thereby limiting our coverage at particular time points.
PCR Determination of the Tn Insertions in Uninduced and Induced
B. cellulosilyticus WH2 Prophage 1. A PCR assay was designed to
discriminate an intergenic Tn insertion within the uninduced
prophage from one within the genome of an induced lytic phage
(for details of the assay see Fig. S9A and SI Methods). Results
from the assay indicated that whereas the lytic phage contained
the Tn insertion, it was also present in the uninduced prophage,
indicating that Tn insertions do not prevent prophage induction.
The PCR assay did not allow us to precisely quantify the proportion
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of Tn inserts in lytic viruses versus the prophage. Therefore, we
cannot formally rule out the possibility that persistence of mutants
with Tn insertions in this region was due to reduced spontaneous
induction and reduced host bacterial cell lysis.
In Vitro Induction of B. cellulosilyticus WH2 Prophages. To further
characterize the biology of the lambdoid prophage and un-
derstand its genetic regulation, we attempted to identify con-
ditions for its induction in vitro. Three different treatments were
evaluated, each at two different concentrations: mitomycin C,
hydrogen peroxide (to generate an oxidative stress; ref 16), and
soy sauce (has been reported to induce prophage in bacterial
hosts present in the mouth; ref. 17). When VLP DNA was pu-
rified from the culture supernatants and sequenced, we found
that 99.48 ± 0.28% (mean ± SD) of the reads from each sample
mapped to the B. cellulosilyticus WH2 chromosome (includes
prophage 1 and prophage 2) and its two plasmids. The ratio of
the abundance of the two B. cellulosilyticus WH2 plasmids was
comparable for all conditions tested. The fold-induction of
B. cellulosilyticus WH2 prophage 2 (the ratio of relative abun-
dance of the phage genome to bacterial chromosome) after
treatment with 0.0025% hydrogen peroxide was 17-fold higher
than observed in the no-treatment control. This was the only
condition that produced a higher level of prophage induction
than the control (Fig. S8B). However, prophage 2 is not induced
in vivo. Prophage 1, which is induced in mice, was never present
at a higher relative abundance than the corresponding bacterial
chromosome. We concluded that conditions that promote in-
duction in vivo differ significantly from the ones we tested in
vitro. Previous work with other gut bacterial species has shown
that in vitro and in vivo conditions for induction of their pro-
phage can be quite distinct (2, 18).
In Vitro Enrichment for Viral Particles. To further establish the
bacterial hosts of the phage identified during the staged in vivo
attack of the 15-member artificial community, we turned to an in
vitro liquid culture system. Performing a large screen based on
plaque assays of multiple potential host bacterial strains in an-
aerobic chambers can be problematic due to space constraints and
other technical challenges. Therefore, we turned to liquid
monocultures. Our protocol involved exposure of midlog phase
cultures to the same p-VLP preparation that we used for the
staged phage attack inmice. After the first round of incubation, an
aliquot of the supernatant was taken and used to infect a fresh
monoculture. At the end of this second round, bacterial cells were
pelleted, the supernatant was passed through 0.22-μm diameter
filters, and viral particles together with DNA were precipitated
from the filtrate. DNA was further purified and assayed by PCR
using primers specific for each of the five previously undescribed
phage genomes, and by shotgun sequencing (n = 14 monoculture
experiments, five virus-specific PCR assays/culture, and two in-
dependent experiments). Enrichment was defined as an increase
in the relative abundance of a virus in a given culture compared
with any other culture. The results revealed no enrichment for
any of the phages in any of the monocultures. In the case of B.
caccae, Parabacteroides distasonis, B. thetaiotaomicron, and C.
spiroforme, the yield of DNA from the monocultures was too low
for sequencing (even after MDA). Therefore, we assumed that
none of these organisms served as hosts for the previously un-
described phage. Sequencing the remaining samples [212,408 ±
135,200 (mean ± SD) 78-nt-long reads per sample; MiSeq] re-
vealed that the majority of reads generated from each culture
mapped to bacterial genomic DNA isolated from the cellular
debris that passed through the 0.22-μm filter (Dataset S1). Im-
portantly, in cases where the cultured bacterial species harbored
an inducible prophage identified in the mouse experiments,
93.11% ± 6.8% (mean ± SD) of the reads mapped to that
prophage sequence, indicating some, albeit very low, levels of
basal induction occurred in vitro. We concluded that the sus-
ceptibilities and/or requirements for infection of these bacterial
species with any of the five phages differ substantially within the
intestine compared with our in vitro culture conditions.
Identification of a Putative B. cellulosilyticus WH2 Prophage 1 Right
Operator Region and Its Relationship to Enriched Tn Insertions. As
noted in the main text, the genomic features of B. cellulosilyticus
WH2 prophage 1 and the identification of cos sites used for
linearization of its genome upon induction led us to classify it as
lambdoid type. Lambdoid replication machinery generates con-
catemers of the genome that are linearized at cos sites before
being packed inside the viral capsid. The absence of reads
spanning the potential cos sites (Fig. 2A) emphasizes the quality
of the VLP purification. Principal control of the switch between
lysogenic and lytic cycles in phage lambda is provided by the
repressor, cI, which binds to the right operator region (OR) lo-
cated immediately upstream of the cI gene. The repressor binds
with different affinities to three different binding sites (OR1–
OR3) within the OR; these sites finely regulate expression of
early lytic genes and cI itself. In silico comparison of the pre-
dicted ORFs of prophage 1 and other lambdoid phages yielded
a candidate repressor (BACWH2_5232) with 54% amino acid
similarity to lambda cI. BACWH2_5232 contains a helix-turn-
helix DNA binding domain, a peptidase S24 LexA-like protein
domain, and significant similarity to a pfam01381 domain that
is conserved in cI and cro. The gene immediately upstream of
BACWH2_5232 (BACWH2_5233) is present in the opposite ori-
entation: its predicted protein product has no significant similarity
to cro, but rather to rha (43% identity over 50% of the protein),
pfam09669 (phage regulatory protein rha) and pfam03374 (phage
antirepressor protein KilAC domain).
The intergenic region between these two genes would be
expected to contain the OR sequence. Given that there is es-
sentially no nucleotide sequence similarity between this region
and the lambda genome, we performed a secondary structure
prediction of the regions comprising the intergenic region and
two flanking genes (Fig. S9 C and D). The analysis showed that
lambda OR has a 63-nt almost perfect stem loop located just 11
nt upstream from the cI start codon. We also identified a 66-nt
stem loop starting 20 nt upstream from the putative start site of
the BACWH2_5232 repressor homolog. All of the Tn insertions
that were enriched were positioned upstream of the predicted
OR; no Tn inserts were observed in BACWH2_5232 or the pre-
dicted OR in the intergenic region, even in the input
B. cellulosilyticus WH2 mutant library, suggesting that disruption
of either the repressor or the OR is detrimental to the fitness of
the bacterial host.
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Fig. S1. Experimental design. Three groups of 8-wk-old C57BL/6J germ-free mice (n = 5 per treatment group) were gavaged with a 15-member artificial
community of sequenced human gut bacterial symbionts and/or a pool of VLPs that had been isolated from frozen fecal samples obtained from five healthy
human adults. Each group of mice was kept in a separate gnotobiotic isolator where each mouse was individually caged. Each vertical line represents a day.
Arrows denote the time of gavage with the 15-member bacterial community and with live or heat-killed VLPs. Time points selected for sampling the fecal
microbiota of each mouse in each treatment group are represented as circles. Samples were subjected to shotgun sequencing of total community DNA (COPRO-
Seq) and/or shotgun sequencing of purified VLP DNA.
Fig. S1
Fig. S2. Measurements of fecal microbial biomass in mice gavaged with live or heat-killed human VLPs. (A) Plot of fecal DNA yields (mean ± SEM) over time.
Microbial biomass increases linearly during the 4 d after introduction of the 15-member artificial community of human gut bacterial symbionts. Note that
during the 25-d period after inoculation of the human fecal p-VLP preparation (20 d postgavage of the artificial community), fecal microbial biomass changed
no more than twofold and was not significantly different between recipients of live versus heat-killed p-VLP preparations at comparable time points in the
experiment (P = 0.459; Wilcoxon matched-pairs signed rank test). (B) Correlation per fecal pellet between microbial DNA concentration and microbial cell
concentration, as measured by flow cytometry, (n = 94 fecal samples). A Spearman correlation of 0.8429 and an associated P value of <0.0001 indicated
a significant association.
Fig. S2
Fig. S3. Changes in the configuration of the 15-member artificial bacterial community as a function of time after colonization with the species consortium
and type of VLP treatment. (A) PCoA of a matrix of Hellinger distances measured using shotgun COPRO-Seq data. Samples are plotted in a 2D representation of
the first vector (49%) of variance against time. Most of the variation occurs while the community assembles during the first week of the experiment. The arrow
notes the time of the p-VLP gavage. Red and blue dots represent individual samples from the two different treatment groups. (B–N) Relative abundance (mean ±
SEM) is plotted as a function of time for the bacterial species not shown in Fig. 1. Data are based on COPRO-Seq analysis of fecal samples collected after the 15-
member artificial community had established itself in the intestines of gnotobiotic mice (A). The upward pointing arrow at day 20 indicates the time when the
live or heat-killed human p-VLP preparation was administered to animals with a single gavage. Some but not all community members change their represen-
tation (either increase or decrease) after introduction of live as opposed to heat-killed p-VLP preparations.
Fig. S3
Fig. S4. Abundance and genome annotation of human phages identified in the fecal microbial communities of gnotobiotic mice. (A–H) The assembled
annotated phage genomes and their changes in abundance in the fecal microbiota of mice belonging to the live and heat-killed VLP treatment groups are
shown (mean values ± SEM; n = 5 animals per group). The upward pointing arrow at day 20 of the experiment indicates the time when the live or heat-killed p-
VLP preparation was administered. The circular representation of each phage genome illustrates the location of genes on the positive (green) and negative
(red) strands. Genes significantly similar to known viral genes are noted (blue; blastp E value <10−5; Dataset S1). The inner plot represents GC skew based on
200-bp windows (yellow, G/C ratio is greater than the average for the viral genome; purple, ratio is lower than the average). Note that A and B correspond to
Insets in Fig. 1 D and E but here they have been enlarged to facilitate visualization of genome features.
Fig. S4
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Fig. S5. Human donor assignment and viral genome variation in phages ϕHSC01, ϕHSC02 ϕHSC03, ϕHSC04, and ϕHSC05. (A) Heat map of the cross-assembly
between different input human p-VLP samples. To determine whether the viruses identified in gnotobiotic mice were distributed among all of five human VLP
donors or whether they were unique to particular individuals or subset of individuals, a cross-assembly was generated that included reads from each fecal VLP-
derived virome from each individual human fecal sample used to generate the input p-VLP preparation for the staged viral attack, reads from the p-VLPs
introduced into mice by gavage, and reads generated from VLPs purified from mouse fecal samples. Shown are the normalized abundances of the different
contigs greater than 2 kbp (n = 159), including those assembled from the human phages identified in gnotobiotic mice. Each column presents data for the five
individual human donor fecal VLP-derived viromes plus the p-VLP sample introduced into gnotobiotic mice. (FX, family number; M, mother of twin pair; TX,
cotwin 1 or 2 in a given monozygotic twin pair; .X, one of 3 time points where feces were collected from the human donor over the course of a year).
Abundance is shown as the log (10) transformation of RPKM (reads per kb of contig per million pyrosequencer reads; see SI Methods and main text for further
details). Rows representing the five previously undescribed viruses isolated and their corresponding human donor are enlarged for visualization purposes. The
name of each phage is positioned to indicate the human donor where its abundance and nucleotide sequence conservation is greatest. (B) Individual py-
rosequencing reads obtained from each of the five human donor VLP-derived viromes used for the pooled “input” VLP preparation were mapped to the
assembled viral genome for ϕHSC05. In the case of human VLP donor F3T1.2, 87.5% of her virome had 98.45 ± 0.02% identity (mean ± SEM) to the assembled
ϕHSC05 genome. In the case of the other individuals, ϕHSC05 detected in mice was present at significantly lower abundance (e.g., for F4T1.2, 0.01% of VLP-
derived reads) and/or had lower percent sequence identity. The panel labeled “mice” shows the results of mapping reads from all mouse fecal samples de-
scribed in C. (C) Percent identity of pyrosequencer reads, generated from VLP DNA purified from individual mouse fecal or cecal samples, to the assembled
ϕHSC05 genome. Fecal samples were obtained on days 29 and 37 from mice in the live p-VLP treatment group [mouse (M)1–M4]. Cecal samples were collected
at the time of sacrifice on day 45 of the experiment. The dashed boxes highlight loci in the ϕHSC05 genome that show sequence variation between different
mice and/or over time within animals. For animal-to-animal variation, compare locus 1, which is 100% conserved in M1 and M4 but only 90–95% conserved in
M2 and M3 (red arrows). Variation within mice over time can be observed in locus 8, which is 100% conserved in the viromes of animals M3 and M4, 9 d after
viral gavage but subsequently undergoes sequence changes over the remaining 16 d of the experiment (red arrows). Each locus is numbered as follows: locus 1
encompasses genes ϕHSC05_01 to ϕHSC05_05 (includes a predicted phage secretion activator protein); locus 2, ϕHSC05_09 to ϕHSC05_11 (all hypothetical
proteins); locus 3, ϕHSC05_24 and ϕHSC05_25 (best blast hits to a DNA helicase and a DNA polymerase-associated protein, respectively); locus 4, ϕHSC05_26
(putative DNA polymerase); locus 5, ϕHSC05_56 (hypothetical protein); locus 6, ϕHSC05_67 (hypothetical protein); locus 7, ϕHSC05_68 to ϕHSC05_70, (includes
a putative tail tape measure protein); and locus 8, ϕHSC05_73 to ϕHSC05_75 (all hypothetical proteins). (D–G). Mapping data comparable to that shown in C for
the other four phage genomes. The human donor harboring a given phage was identified based on the analysis shown in A. Note that ϕHSC02 is a single-
stranded phage that is overamplified with MDA. The red arrow points to a locus that appears to show sequence variation. However, this variation occurs in
a homopolymeric region and may be a pyrosequencing artifact.
Fig. S5
Fig. S6. Relationship between the abundance of bacterial species and ϕHSC03, ϕHSC04, and ϕHSC05 along the length of the gut of gnotobiotic recipients of
the live p-VLP preparation, at the time of sacrifice. (A) Viral abundance for each mouse in the indicated treatment group as defined by shotgun sequencing of
DNA isolated from different gut locations. The five columns for each mouse (M1–M10) are organized from left to right as follows: proximal small intestine (PSI),
distal small intestine (DSI), cecum (Ce), colon (Co), and fecal sample (Fe). Note that no virus was detected in mice that had received the heat-killed human fecal
p-VLP preparation. ND, not detected. Due to the lower density of bacteria in the proximal gut, samples from the proximal half of the small intestine may
harbor phages at levels below what could be detected by COPRO-Seq at the depth of sequencing used. (B) Relative abundance of each of the 15 bacterial
members along the length of the gut of mice belonging to the two p-VLP treatment groups. The order of the columns for each mouse is the same as in A.
Fig. S6
Fig. S7. Shotgun 454 pyrosequencing data generated from VLPs isolated frommouse fecal samples validate predicted prophage regions in bacterial genomes.
Mapping of VLP-derived shotgun sequencing reads to the genomes of the 15-member artificial community assembled in gnotobiotic mice allows identification
of prophages that are induced. The number of reads mapping to bacterial genomes outside the prophage region was low in all mice. Therefore, all hits to any
bacterial genome (outside of a prophage region) are depicted in black. Each bar represents data generated from VLPs prepared from two fecal pellets ob-
tained from one or two mice within a given treatment group at a given time point (Dataset S1). Cecal samples were collected at the time of sacrifice and are
numbered according to the mouse ID in each treatment group. Relative abundance is defined as the number of VLP reads mapping to any of the specific
prophage genomes (or elsewhere on the bacterial genome) divided by the total number of VLP reads that did not map to any of the 5 exogenous phages.
Fig. S7
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Fig. S8. Genomic characteristics, conservation, and results of in vivo and in vitro induction assays for B. cellulosilyticusWH2 prophages. (A) Subset of genes in
B. cellulosilyticus WH2 prophage 1 that are conserved in the genomes of four other human gut Bacteroides. Only genes conserved in synteny with B. cellu-
losilyticus WH2 prophage 1 are shown, along with the average similarity for their protein products. Each box represents a predicted ORF. Colored boxes
represent the products of ORFs that are characteristic of this and other lambdoid phages. Starting from the cos sites, the prophage 1 genome contains a group
of genes that are conserved and organized in a way common to lambdoid viruses of the Siphoviridae family (1); the cos site is followed by ORFs encoding small
and large terminases, portal protein, protease, the major head protein, several small capsid structural proteins, the major tail protein, and tape measure
protein, ending with an integrase next to the att site. The intergenic region positioned between the putative rha homolog and cI (lambda repressor) is
highlighted. Arrows drawn on top of genes indicate the relative positions and directionality of PCR primers designed to identify the presence of Tn inserts in
the prophage and/or the induced lytic virus. The red arrow indicates a primer designed to anneal at the junction between the Tn and the intergenic region
between cI-rha (see SI Methods for details). Searching the genomes of 38 human gut Bacteroides (Dataset S1.) revealed four other bacterial species, including
another strain of B. cellulosilyticus (DSM 14838), that contained homologs of all or most of the viral structural proteins in a syntenic arrangement. Moreover,
homologs of six genes in B. cellulosilyticus prophage 1 are present in 35–37 of the 38 Bacteroides genomes. Thus, our identification of prophage 1 in B.
cellulosilyticus revealed lambdoid viruses that had not been associated previously with Bacteroides spp. (B) In vitro assays for B. cellulosilyticus WH2 prophage
induction. Three different treatments at two different concentrations of various known prophage-inducing agents were evaluated in monocultures of B.
cellulosilyticus WH2 grown anaerobically. DNA extracted from the culture supernatants was sequenced. Mapping reads to either of the two prophages or the
rest of the bacterial chromosome showed no detectable or very low levels of spontaneous induction of prophage 1 under any of the in vitro conditions tested
(prophage 1 is induced in vivo). Hydrogen peroxide at a concentration of 0.0025% produces a 48-fold induction of prophage 2 (17-fold greater than the no-
treatment control). (C and D) Prophage induction is not observed in wild-type B. cellulosilyticus WH2 in the context of the 15-member artificial community. (C)
Relative abundance (mean ± SEM, n = 6 mice) of each bacterial species as a function of time. Mice were sampled daily for 20 d after gavage with the 15-
member artificial community. The color key next to the plot indicates the identity of each community member. (D) COPRO-Seq analysis of the relative
abundance (mean ± SEM) of B. cellulosilyticus WH2 and its two associated prophages in the fecal microbiota of mice colonized with a 15-member community
that contains wild-type B. cellulosilyticus WH2 rather than a library of Tn mutants. Prophage induction was not observed at any time during the 20-d ex-
periment. See Fig. 2 for comparison with the community containing transposon-mutagenized B. cellulosilyticus WH2.
Fig. S8
1. Brüssow H, Desiere F (2001) Comparative phage genomics and the evolution of Siphoviridae: Insights from dairy phages. Mol Microbiol 39(2):213–222.
Fig. S9. INSeq reveals clonal selection for Tn mutants with insertions in the region between genes encoding the Rha protein and cI homolog in B. cellulo-
silyticus WH2 prophage 1. (A) Heat map of log-transformed, normalized abundance of reads (reads per million, RPM) that mapped to a site of transposon
insertion in the BACWH2_5233 gene (rha homolog) or the intergenic region between the rha homolog and BACWH2_5232 (cI homolog). Each row represents
a time point 3–9 d after gavage with the 15-member bacterial community (before subsequent gavage with either live or heat-killed p-VLPs). All mice were
individually caged. Fecal samples collected from five mice in each treatment group were characterized (M1–M5 in the live p-VLP group and M6–M10 in the
heat-killed p-VLP control group). Each column represents the total number of normalized reads, in a window of 20 bp, obtained with a given fecal DNA sample.
Tick marks between nucleotides 7,078,320 and 7,080,520 of the B. cellulosilyticus WH2 genome represent 100-bp increments. The bottom four rows labeled
“input” represent the read distribution for four technical replicates of the INSeq analysis for the input B. cellulosilyticus WH2 mutant library. Note that no Tn
mutants were identified in BACWH2_5232 (cI homolog). There is no change in the representation of Tn insertion mutations in BACWH2_5233 (rha homolog) in
the output library. In contrast, a marked increase in the representation of Tn inserts at 10 sites in the intergenic region is seen over the time period sampled.
The number and abundance of Tn mutants represented in each mouse differ. The increase in representation of Tn mutants correlates with the time before and
during induction of prophage 1. The 600-bp cI-rha intergenic region is shown as a thin green line. The black arrow indicates the Tn insertion site used for PCR
assay of whether the mutation was present in the prophage and/or induced virus (SI Methods and SI Results). (B) Insertions in a 600-bp intergenic region
provide a fitness advantage to the bacterial host that is maintained over time. The number of Tn reads per million obtained by INSeq analysis of fecal DNA was
calculated for a 600-bp intergenic region between the ORFs encoding the cI regulator and putative Rha protein. The relative abundance of bacterial cells
harboring this Tn insertion as a fraction of the total B. cellulosilyticus WH2 population is represented by the RPM value at any given time point. Mean values ±
SEM for the mice in each treatment group are plotted for 13 different time points sampled during the first 31 d of the experiment. Live p-VLPs or heat-killed
p-VLPs were introduced at day 20 (downward arrow). A sliding window of 600 bp was used, at intervals of 100 bp, to scan the whole B. cellulosilyticus WH2
genome (except the 600-bp cI-rha intergenic region) to quantify the abundance of mutants containing Tn insertions. The resulting distribution of reads is
plotted for any given time point with lines at the 25th, 50th, 75th, 99th, and 100th quantiles (100th = maximum value of Tn reads observed within a 600-bp
window). Shaded areas represent the area where 25–75% of the data (RPM/600-bp window) falls (i.e., the second and third quartiles). In general, the
abundance of Tn mutations falls over time with less than 10% of the Tn-containing windows increasing their abundance. The relative abundance of bacterial
strains harboring Tn-containing cI-rha intergenic mutants was maintained at significantly higher levels than all other mutants. (C and D) Computational
analysis of the intergenic region affected by Tn insertions in B. cellulosilyticus WH2 prophage 1. (C) Secondary structure prediction using Mfold (1) for the
region containing cI (green line with arrow) and cro (red line with arrow) plus the corresponding intergenic region in phage lambda (GenBank accession:
NC_001416). Zoomed in at Right is the intergenic region containing the right operator (OR) with its three binding sites (OR1–OR3). (D) The same secondary
structure analysis was performed to identify the corresponding regulatory region upstream of the cI homolog (green line with arrow) in B. cellulosilyticusWH2
prophage 1. The 600-bp intergenic region significantly enriched for Tn insertions is highlighted with a thick green line (see corresponding region in A). Each Tn
insertion site is shown with a red arrow. Note that only one stem loop is positioned outside of the Tn-enriched intergenic region. This stem loop (labeled
predicted operator region) has a similar length and location as the known operator region in phage lambda (zoomed in at Right).
Fig. S9
1. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31(13):3406–3415.
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